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ABSTRACT 
 
GENOME-WIDE SYSTEMS GENETICS OF ALCOHOL CONSUMPTION 
AND DEPENDENCE 
 
A Dissertation submitted in partial fulfillment of the requirements for the degree of 
Doctorate of Philosophy from Virginia Commonwealth University 
 
 
By 
 
KRISTIN M. MIGNOGNA 
 
Directed by: MICHAEL F. MILES, MD, PhD 
Professor, Departments of Pharmacology & Toxicology, Neurology, and Human & 
Molecular Genetics 
 
 
Alcohol use disorder is a debilitating disease for which widely effective treatment is not 
yet available, because the exact biological mechanisms that underlie this disorder are not 
completely understood. One way to gain a better understanding of these mechanisms is to 
examine the genetic frameworks that contribute to the risk for developing this disorder. 
However, because of its genetic complexity, genetic association studies have traditionally 
struggled to identify replicable affective loci. Even more recent, better-powered studies have yet 
	xvii	
to account for the 50% heritability estimated by twin studies. Furthermore, these studies do not 
provide information regarding the mechanistic frameworks through which the identified loci 
affect the trait. Gene expression studies can both provide insight into these frameworks, but also 
identify groups of co-regulated and co-functioning genes that may be individually identified by 
different association studies. Gene expression in the brain is difficult to study in humans, due to 
lack of experimental control. Mouse models can be used to examine gene expression patterns in 
the brain, in the context of ethanol treatment and consumption, in an experimentally controlled 
environment. However, human behavior is more complex than mouse behavior, and the genetic 
drivers of behavior interact with the environment.  
The study presented in Chapter 1 capitalizes on the benefits of the behavioral complexity 
of human samples and the experimental capabilities provided by mouse models by co-analyzing 
gene expression networks in the mesolimbocortical system of acute ethanol-treated recombinant 
inbred mice and human genetic alcohol dependence association data. This study successfully 
identified ethanol-responsive gene expression networks unique to the Ventral Tegmental Area, 
Nucleus Accumbens, and Prefrontal Cortex. Modules from each brain region were significantly 
overrepresented with genes suggestively associated with alcohol dependence in an independent 
human sample. These networks were functionally overrepresented with pathways related to 
actin-related activity, transcript regulation, ubiquitination, and Syndecan and Wnt signaling, 
implicating the involvement of these pathways in the association between initial alcohol 
sensitivity and dependence. These results indicated that gene expression networks in mouse 
models are informative for identifying mechanistic networks relevant to the risk for developing 
dependence, and for bridging the gap between human association studies.  
	xviii	
The idea study population would allow for fine genetic mapping and gene expression 
network identification in the same organism. Outbred mice, such as the Diversity Outbred (DO) 
sock, are more genetically, and therefore behaviorally diverse than traditional inbred mouse 
strains. The genomes of these mice contain variants not present in other mouse strains, but also 
provide for mapping precision similar to that in humans, due to relatively small linkage 
disequilibrium blocks resulting from several generations of outbreeding. However, to our 
knowledge, ethanol drinking behaviors have not yet been genetically studied in DO mice, or the 
eight progenitor strains used to create this outbred stock. Our study in Chapter 3 characterizes 
voluntary ethanol consumption and preference under intermittent (shown to model the relapse-
like progressive increase in drinking seen in the beginning stages of dependence development) 
and chronic ethanol access paradigms in each of the progenitor strains. This study determined 
that these phenotypes are highly heritable amongst these strains, and therefore likely genetically 
mappable in the DO mice. In Chapter 4, we identify several previously identified, and one novel, 
genetic loci associated with these traits under an intermittent access model, with unprecedented 
precision. One of these loci replicated results seen in a human association study of alcohol 
consumption, and provided insight to the potentially contributing genes. Finally, in Chapter 5, 
we identified gene expression networks in these mice whose expression levels were associated 
with ethanol exposure and consumption, and were overrepresented with genes associated with 
consumption in human association studies. We also mapped genetic loci that contributed to the 
gene expression levels of these networks, some of which overlapped with the behavioral loci, 
indicating that the functions represented by these modules mediate the relationship between the 
genotypes in that region and drinking behaviors. The functions related to these modules largely 
involved actin-mediated synaptic remodeling, neurite outgrowth, and ubiquitination. Overall, our 
	xix	
studies revealed neuroplastic and ubiquitin-related genes pathways involved in alcohol 
consumption in mice and humans, and that likely contribute to the risk for developing 
dependence. 
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Introduction 
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  Not only can alcohol misuse cause liver disease, pancreatic disease, chronic 
neurological problems, and even death (3), but it can also affect the population at large, via 
belligerent behaviors and drunk driving. In fact, alcohol misuse is the third leading 
preventable cause of death in the United States (4), and the fifth leading risk factor for 
premature death and disability, globally (5). Alcoholism can be defined in many different 
ways, but the gold standard for Alcohol Use Disorder (AUD) diagnosis is the Diagnostic 
Statistical Manual (DSM) (6). As annotated in the DSM-V, AUD spans the spectrum of 
problematic alcohol use, from abuse (sometimes called misuse) to dependence, with varying 
levels of severity: mild, moderate, and severe, marked by exhibiting 2, 3-5, and at least 6 of 
the 11 possible symptoms, respectively (7). The lifetime prevalence of AUD has been 
estimated to be as high as 29.1% in the United States, and 13.9% for specifically severe AUD 
(5). The 11 possible symptoms are as follows:  
 
1) drinking more or for longer stretches of time than intended 
2) failing to reduce or prevent oneself from drinking, despite desire to do so 
3) spending a substantial amount of time drinking and/or recovering from drinking 
4) preoccupation with desire to drink 
5) failing to perform duties associated with life roles, due to drinking 
6) drinking despite knowledge that it is harming one’s personal relationships 
7) reducing participation in normally desirable leisure activities in order to drink 
8) experiencing potentially harmful situations due to drinking, more than once 
9) continuing to drink despite known psychological, neurological, and/or systemic harm 
10) exhibiting tolerance (needing to drink more to feel the same positive effects) 
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11) exhibiting withdrawal symptoms (insomnia, nausea, tremors or seizures, restlessness, 
sweating, heart-racing, or hallucination) (7). 
 
 Older versions of the DSM considered abuse and dependence to be distinct disorders, 
with abuse reflecting more of what could be considered to be excessive use, and dependence 
reflecting more of what could be considered addictive use. In the DSM-IV, Alcohol Abuse 
was defined as the presence of at least one of AUD symptoms 5, 6, and 8, or multiple 
instances of arrest or legal issues related to alcohol use. DSM-IV Alcohol Dependence (AD) 
was defined as the presence of 3 or more of AUD symptoms 1-3 and 7-1 (7). However, the 
DSM-V recognizes that abusive use often gives rise to dependence by merging the diagnoses 
under a single umbrella that better reflects the developmental process of dependence.  
Although the initial motivation behind drinking and the developmental timescale 
varies between individuals, the developmental pathway of dependence generally follows 3 
stages: acute use, chronic use, and compulsive use (8). At first, one drinks for the positive 
reinforcing effects of alcohol largely mediated by the dopaminergic reward pathway, such as 
social inhibition, feelings of relaxation, or anxiolysis. After continuous use, the brain’s 
neurochemistry begins to change, causing tolerance, leading the frequency and amount of 
alcohol drinking to increase (i.e. chronic use or abuse) (9). This consistent elevated level of 
drinking leads to not only increased changes in neurochemistry, but also eventually reroutes 
neuronal circuits, via synaptic plasticity (10). It is at this point at which people begin to feel 
withdrawal and craving symptoms during periods of abstinence from alcohol (10)These 
symptoms are the hallmarks of what is colloquially known as “alcoholism”, “addiction”, or 
“dependence” (6).  
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Despite the clear widespread personal and interpersonal disruption this disorder 
causes, a truly effective method of reducing its impact, particularly after onset, has yet to be 
discovered. Although psychological and pharmacological therapies are available for AUD, 
the short-term remission rate is only 43% after treatment, with the long-term relapse rate as 
high as 80% (11). Additionally, there are only 3 pharmacological treatments officially 
labeled for AUD treatment (Naltrexone, Disulfiram, and Acamprosate). Naltrexone and 
Disulfiram both work by disrupting the association between alcohol and positive 
reinforcement, by acting on two very distinct pathways. Naltrexone (a selective mu-kappa-
opioid antagonist) decreases the acute dopaminergic reward response to alcohol (12). 
Disulfiram (an acetaldehyde dehydrogenase inhibitor) increases the systemic negative 
physiological response to alcohol by preventing the metabolism of acetaldehyde into acetic 
acid (12). The resulting accumulation of acetaldehyde in the blood results in several 
unpleasant symptoms such as facial flushing, nausea, dizziness, and headache (13). Despite 
the disruption of association between alcohol and acute positive reinforcement, the symptoms 
of craving and withdrawal still remain (Fig. 1). Acamprosate (an NMDA inhibitor and 
GABAA agonist), on the other hand, acts by decreasing the symptoms of withdrawal (12). 
These symptoms include, but are not limited to: irritability, anxiousness, vomiting, headache, 
excessive sweating, tremors, seizures, delirium tremens, and sometimes hallucination. These 
symptoms can begin after only hours of abstinence, and can continue for up to a week (14). 
However, Acamprosate is a relatively non-specific drug that can actually increase psychiatric 
symptoms that often drive people to drink, such as depression and anxiety. Furthermore, it 
has no direct effects on craving, which can occur throughout the rest of the person’s life, 
even after withdrawal symptoms are no longer present (14). It would therefore be beneficial 
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to create a therapeutic drug that specifically targets biological pathways involved in alcohol 
craving. Unfortunately, these specific signaling cascades and neurological pathways have yet 
to be identified. However, we do know of several neurotransmitters and brain regions that are 
likely involved, particularly those that compose the “reward system”. 
6	
 
 
 
Figure	1:	The	three	stages	of	alcohol	dependence	development	(left)	and	the	mechanisms	by	which	they	confer	neurological	changes	and	therefore	risk	for	progressing	to	a	later	stage	of	development.	Blue	text	and	arrows	represent	approved	pharmacotherapies	for	dependence,	and	in	stages	in	which	they	interfere.	Red	and	green	arrows	indicate	the	actions	of	the	medications	with	respect	to	the	alcohol-related	traits	and	symptoms	on	the	right.		
Disulfiram 
Acamprosate 
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One general neurological pathway that is known to be involved in reward and craving 
are the mesolimbocortical reward pathway, a dopaminergic pathway originating in the 
Ventral Tegmental Area (VTA), and projecting to the Nucleus Accumbens (NAc), and 
Prefrontal Cortex (PFC) (14). This pathway is acutely activated by alcohol, with a resulting 
release of dopamine in the NAc and PFC. This is thought to cause or mediate the rewarding 
properties of alcohol (14). However, after long-term use, these reward pathways are blunted, 
basally. This is due to over-stimulation of neurons, triggering negative feedback that results 
in the reduction of post-synaptic dopaminergic receptors (14). This means that an alcohol 
dependent individual’s neurons responds less to dopamine than that of a non-dependent 
individual, which is thought to contribute to cravings, particularly in the PFC (14). The 
Prefrontal Cortex’s relationship with craving corresponds with increased levels of dopamine, 
with respect to baseline, indicating that the involved pathways are similar to (or the same as) 
those related to reward (15). The same type of feedback response occurs in many other 
pathways, resulting from long-term alcohol use. These pathways involve neurotransmitters 
such as GABA (gamma-aminobutyric acid) and serotonin (14). The effects of other 
neurotransmitters, such as glutamate, are acutely inhibited by alcohol have the opposite 
response: the brain’s response to those neurotransmitters increases after long-term use (14).  
 The role of the Prefrontal Cortex in drinking behaviors extends beyond initial reward. 
It is associated with the behavioral disinhibition and impulsivity, both of which contribute to 
alcohol dependent individuals’ inability to control their drinking behaviors (16). It has been 
shown that people with greater average drinking levels and behavioral disinhibition correlate 
had decreased medial PFC activity while performing reward-seeking behaviors, indicating 
involvement of the medial PFC in controlling reward-seeking behaviors, including alcohol 
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consumption (17). The effects of alcohol on disinhibition and impulsivity span from the acute 
effects of intoxication to long-lasting effects caused by chronic drinking (14). The long-term 
effects play a role in the inability of individuals to control their drinking behaviors when they 
experience craving. It has been proposed that the long-term effects of alcohol on prefrontal 
cortical mediated decision-making and loss of regulation of limbic anxiety are mediated by 
neuroplasticity, demyelination, and neurodegeneration (14) (9) (15). In fact, alcoholic 
individuals with greater amounts of cortical white matter have shown the ability to maintain 
sobriety for longer periods of time than those with less (18). Finally, this damage to the PFC 
leads to disregulation of the limbic system and increased levels of glucocorticoids in the 
PFC, which leads to an increase in anxiety in the absence of alcohol, contributing to the 
pathological desire to consume alcohol for its anxiolytic effects (19). Overall, the PFC plays 
an important role in linking alcohol-induced dopaminergic reward with longer-term 
symptoms of alcoholism, including abstinence-induced anxiety, craving, behavioral 
disinhibition, and impulsivity.  
 Although a lot is known about the neurotransmitters and brain regions that are 
involved in alcoholism, many of the exact mechanistic pathways involved in the alcohol-
induced changes that occur in neurons have yet to be discovered. Importantly, little is known 
about the susceptibility and sensitivity of each individual’s neural circuits and cognitive, 
psychiatric, and behavioral responses to those changes. It is well known that this 
susceptibility runs in families, which could be driven by environment or genetics (20). Twin 
studies have explored the source of this familial clustering, and have estimated a heritability 
of roughly 50%, meaning half of the variance in alcohol use disorders in the population can 
be attributed to genetic differences and the other half to the environment (21) (22).  
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Genome-Wide Association Studies (GWAS), which query alleles at loci across the 
entire genome for association with a phenotype, have identified several genes that are 
significantly associated with alcohol consumption and dependence (Table 1). However, aside 
from a small handful of genes, few results have been significant after correction for multiple 
testing or replicate significance across samples (23). (Replicated genes include: ALDH2 for 
dependence; and AUTS2, KLB, for alcohol consumption; and ADH1C and ADH1B for both 
phenotypes.) One of the leading theories for this “missing heritability” is that hundreds, or 
even thousands, of genes with individually small effect sizes are acting together to contribute 
to overall risk, and most studies to date have lacked the necessary power to detect these loci 
(24). As sample sizes in such studies become larger, some novel loci (such as COL6A3, 
CADM2, DNAJB14, FAM69C, GCKR, JCAD, SLC39A13, and STPG2) are being detected 
and others are being replicated (such as ADH1B, ADH1C, AUTS2, and KLB) for alcohol 
consumption and AUDIT (Alcohol Use Disorders Identification Test) non-problematic 
(AUDIT-C) and problematic (AUDIT-P) consumption scores (25) (26). However, even these 
studies have yet to reach the expected large numbers of significant loci. Furthermore, these 
studies do not implicitly provide mechanistic information regarding the relationship between 
the alleles and the trait. 
 One alternative method of exploring genetic pathways that underlie alcohol-related 
traits is to study gene expression patterns in relevant tissues, such as brain regions that are 
known to be involved in addiction, like the Nucleus Accumbens, Amygdala, Prefrontal 
Cortex, and Ventral Tegmental Area. One other potential reason for the general lack of 
success in GWAS is phenotypic admixture. AUD is a complex behavioral disorder that may 
be driven by several different etiologies. Individuals have many different reasons for 
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drinking, such as social anxiety, social conformation, self-medication for depression or 
anxiety, mental escape from traumatic memories or environment, or one of many other 
potential motivations. Additionally, different biological pathways, and therefore different 
genes, may be responsible for the progression from chronic consumption to dependence 
between people. Including all of these individuals in the same sample can mask the effects of 
genes relevant to dependence only in subgroups of the studied population. An additional 
benefit of gene network analysis is that it can reveal groups of genes that function together in 
some of these distinct pathways, whose constituent genes display sub-significant GWAS 
signals due to this phenotypic admixture.
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Table 1: GWAS Summary Table 
Study Phenotype Sample	Ancestry Discovery	Sample	
Name
Discovery	Sample	
Size
Genes	Containing	SNPs	with	
p<5e-8
Within-Study	
Replication
Treutlein	et	al.,	2009 AD	case/control German German	GWAS 1,024	cases;	996	
controls
PECR NA
Bierut	et	al.,	2010 AD	case/control
European	
American		and	
African	American
SAGE
1,235	EA	and	662	
AA	cases;	1,433	EA	
and	449	AA	controls
No	Significant	SNPs No	significant	
replication
Edenberg	et	al.,	2010 AD	case/control European	
American
COGA 847	cases;	552	
controls
No	Significant	SNPs No	significant	
replication
Kendler	et	al.,	2011 AD	factor	score
European	
American		and	
African	American
MGS2
2,375	cases;	3,393	
controls No	Significant	SNPs
No	significant	
replication
Heath	et	al.,	2011 AD	symptom	factor	
score
Australian OZALC 1,333	cases;	1,268	
controls
No	Significant	SNPs No	significant	
replication
Schumann	et	al.,	
2011
Average	g(ethanol)	
per	day
European
Combined	
samples	from	12	
studies
26,316 AUTS2
Replication	in	dataset	
from	independent	
European	samples	from	
7	studies	
Frank	et	al.,	2012 AD	case/control German German	GWAS 1,333	cases;	2,168	
controls	
ADH1C Replication	in	COGA
Zuo	et	al.,	2012 AD	case/control European	
American
SAGE	and	COGA 1,409	cases;	1,518	
controls
No	Significant	SNPs No	significant	
replication
Wang	et	al.,	2013 DSM-IV	AD	symptom	
count
European	
American
COGA 2,322 No	Significant	SNPs No	significant	
replication
McGue	et	al.,	2013 AD	factor	score European	
American
MCTFR 7,188 No	Significant	SNPs No	significant	
replication
Park	et	al.,	2013 AD	case/control Korean Korean	GWAS
117	cases;		279	
controls ADH7	and	ALDH2
Replication	in	
independent	Kroean	
sample
Quillen	et	al.,	2014 AD	case/control Chinese Chinese	GWAS 102	cases;	212	
controls
ALDH2 NA
Gelernter	et	al.,	2014
DSM-IV	AD	symptom	
count;	AD	
case/control
European	and	
African	American
Yale-Penn	and	
SAGE
Yale-Penn:	2,379	EA	
and	3,318	AA								
SAGE:	2,752	EA	and	
1,311	AA
LOC100507053,	ADH1B,	and	
one	intergenic	SNP
Replication	in	
independent	Yale-
Penn/SAGE	sample	and	
German	GWAS	case-
control	sample
Edwards	et	al.,	2015
AUDIT	+	DSM-IV	AD	
symptom	factor	score British ALSPAC 4,304 One	intergenic	SNP
No	significant	
replication
Schumann	et	al.,	
2016
Average	g(ethanol)	
per	day
European
Combined	
samples	from	20	
studies
70,460 KLB
Replication	in	dataset	
from	independent	
European	samples	from	
15	studies	
Adkins	et	al.,	2017 AD	case/control Irish IASPSAD 706	cases;	1748	
controls
COL6A3 No	significant	
replication
Clarke	et	al.,	2017 Average	drinks	per	
week
British UK	Biobank 112,171
ADH1B,	ADH1C,	ADH5,	
ARID4A	(excluding	never-
drinkers),	CADM2,	CTNNA2	
(males	only)	DNAJB14,	
FAM69C,	GCKR,	KLB,	STPG2,	
and	two	intergenic	SNPs
NA
Walters	et	al.,	2018	
(BioRXiv)
AD	case/control European	and	
African	American
PGC										
(Combined	
samples	from	14	
case/control	
studies	and	9	
family	studies)
	11,569	EU	cases	
and	3,335		AA	
cases;	34,999	EU	
controls	and	2,945	
AA	controls
ADH1B	and	one	intergeneic	
SNP
Replication	of	ADH1B	
across	EU-only	and	AA-
only	PGC	samples
Sanchez-Roige	et	al.,	
2019
AUDIT-P	and	AUDIT-C	
scores European
UK	Biobank	and		
23andMe
UK	Biobank:	
121,604;	23andMe:	
20,328
ADH1B,	ADH1C,	GCKR,	JCAD,	
KLB,	SLC39A13 NA
Kranzler	et	al.,	2019
AUDIT-C	scores	and	
AUD	(ICD	abuse	+	
dependence)
European	
American,	African	
American,	Latino	
American,	East	
Asian	American,	
South	Asian	
American
Million	Veteran	
Program
242,317	EA;	61,762	
AA;	15,864	LA;	
1,565	EAA;	and	228	
SAA	
AUD	only:	ADH4,	SIX3,	
chr10q25.1,	and	DRD2;																																			
AUD	and	AUDIT-C:	ADH1B,	
ADH1C,	FTO,	GCKR,	and	
SLC39A8;																											
AUDIT-C	only: 	KLB,	VRK2,	
DCLK2,	ISL2,	IGF2BP1,	BRAP,	
PPR1R3B,	BAHCC1,	and	
RBX1	
Replication	of	ADH1B	
across	EA-only	and	LA-
only	ancestry	groups
Liu	et	al.,	2019 Average	drinks	per	
week
Wide	varietied	
meta-sample
GSCAN 941,280 99		significant	SNPs NA
 
  
A summary of prominent Genome-Wide Association Studies conducted between 2009 and 2019, adapted 
from Hart et al., 2015.   
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Gene expression changes are thought to play a major role in the brain’s response to 
short- and long-term exposure to alcohol, ultimately mediating neuroplastic changes that can 
be permanent even after drinking cessation in long-time alcoholics (9). In fact, several 
studies have identified alcohol-responsive genes and gene expression networks, meaning the 
genes’ expression levels change in response to alcohol (27) (28) (29) (30) (31) (15). Many of 
these networks showed overrepresentation of genes having similar functionality, indicating 
that those functional pathways may be associated with the brain’s response to alcohol. Such 
results include a wide array of functions largely involving regulatory, immune, and 
neurological pathways, with some examples being: ribosomal function, oxidative 
phosphorylation, RNA processing, GTPase activity, actin cytoskeleton regulation, immune 
response, calcium signaling, opioid signaling, neuroplasticity, neuroinflammatory response, 
and regulation of neurotransmission (28) (27) (31) (29). Findings like these display the utility 
of genomics in gaining a better understanding of the neurological mechanisms involved in 
AUD.  
Using this information in combination with expression data can paint a more 
complete picture of congenital differences associated with a higher risk for developing AUD. 
Information from such studies will eventually lead to a deeper understanding of the disease 
process, both in a generalizable way and in a patient-specific way, lending itself to the 
development of more effective, precise, and personalized pharmacotherapies. However, 
conducting gene expression analysis on human brain tissue can be difficult to conduct and 
interpret, due to: inability to collect brain tissue from living participants; unmeasured and 
uncontrollable environmental variables; differing causes of death; inability to control alcohol 
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access in frequency, amount, or timing with respect to death; variability in post-mortem time 
interval prior to tissue collection; and the small sample sizes.  
Mouse models provide control over these variables and availability of larger sample 
sizes, while allowing for the examination of mammalian tissue collected under experimental 
conditions. In fact, many of the previously conducted alcohol-related brain-region-specific 
studies mentioned above have identified the aforementioned alcohol-responsive genes in 
mouse brains (27) (28) (31). However, many mouse strains and stocks are genetically limited 
in mapping (i.e. localization of a phenotype-contributing allele on a chromosome) resolution, 
due to large LD blocks across the genome caused by lack of chromosomal recombination (as 
a result of few cross-breeding generations) (32). They are also limited in genetic and 
behavioral variability, meaning their genomes do not consist of as large of an array of alleles 
as the human genome, due to the limited number of inbred strains initially bred (i.e. founder 
or progenitor strains) to form the crossed strains (32). This means that these strains are not 
typically ideal for precise mapping of genetic loci that contribute not only to the behavior in 
question, but also to variability in gene expression.  
The Diversity Outbred stock breeding scheme mitigates these issues by incorporating 
8 unique progenitor strains, including 3 wild-derived strains (which provide additional alleles 
not seen in most laboratory strains), into different breeding patterns followed by several 
generations of outbreeding. The genomes of the resulting mice is more similar to the human 
genome than that of other strains, in that it contains roughly 45 million SNPs (compared to 
the 10 million in the human genome) (33) and smaller LD blocks, resulting in higher 
behavioral variability, more potentially contributing loci to be examined, and more precise 
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mapping resolution (34) (35). However, to our knowledge, alcohol-related behaviors have yet 
to be studied in these mice.  
This study aims to identify behavioral Quantitative Trait Loci voluntary ethanol 
consumption in the DO mice, and to examine related gene expression networks in the 
Prefrontal Cortex. Before this could be done, however, the phenotype needed to be 
characterized in each of the 8 progenitor strains, to confirm heritability and therefore genetic 
mappability. Specifically, we characterized voluntary ethanol consumption in these strains 
under Chronic and Intermittent Ethanol Access models, and determined high heritability for 
ethanol consumption and preference for ethanol over water. This experiment is described in 
Chapter 3. To our knowledge, this was the first study to characterize voluntary alcohol 
consumption in several of the 8 progenitor strains, and to estimate the heritability of an 
alcohol-related trait amongst them.  
Results from the DO progenitor strain study indicated that ethanol consumption and 
preference were not significantly higher under the intermittent than chronic ethanol access 
paradigm for these particular strains. However, this could be due to small sample sizes, 
particularly for the C57BL/6J mice, in which intermittent access has previously shown to 
increase ethanol consumption over chronic access (36) (37). Additionally, the heritability for 
these traits was higher under intermittent access, indicating that it may be more genetically 
driven. Therefore, for the experiment described in Chapter 4, we exposed DO mice to an 
intermittent ethanol access paradigm in order to map genetic loci that contain alleles that 
contribute to the variation in this behavior. Because of the genetic and behavioral diversity in 
the DO genome, we were able to map several unprecedentedly low, replicated and novel, 
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genetic loci associated with ethanol consumption, preference for ethanol over water, and 
preference for a higher concentration of ethanol over lower concentration.  
One of the benefits of using model organisms, as opposed to humans, for genetic 
mapping of behavioral phenotypes is that gene expression in the brain can be examined in the 
same samples in which the genetic associations were identified. This allows for the 
investigation of potential neurological pathways through which the associated loci affect the 
phenotype. In order to gain insight into pathways that may potentially mediate the association 
between alleles and their associations with voluntary drinking behaviors, we analyzed gene 
expression levels in the PFC of the DO mice (using RNAseq), as detailed in Chapter 5. 
Specifically, we 1) mapped gene networks in the PFC and determined which ones correlated 
with ethanol consumption or preference, 2) compared expression levels between the 100 
highest and 100 lowest drinkers to identify alcohol-regulated or alcohol-regulating genes, and 
3) tested for QTL for expression values of each gene across the genome, and identified those 
that regulated genes without the PFC networks. We then identified QTL for each network’s 
first principal component (also known as the “Eigen gene”, or theoretical gene whose 
expression levels account for the maximum possible variance in the expression levels of all 
other genes in that network) (38). Finally, we tested for physical overlap between the 
expression QTL (both network-wide and for individual genes within the network) and 
behavioral QTL, and tested for overrepresentation of genes contained in behavioral QTL 
intervals in networks. To our knowledge, this was the first to examine alcohol-associated 
gene expression patterns in the DO mouse brain.  These results identified candidate PFC-
related mechanisms related to ubiquitination and neuroplasticity through which the 
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significantly overrepresented or overlapping behavioral QTL may take effect on drinking 
behaviors.  
For our final study, as opposed to utilizing a complex mouse model, we took the 
approach of capitalizing on the benefits of each model organism gene expression data and 
human genetic association data. As described in Chapter 2, we did so by co-analyzing human 
AD GWAS summary statistics with gene expression data from the Ventral Tegmental Area, 
Nucleus Accumbens, and Prefrontal Cortex of acute-ethanol-treated BXD mice. For this 
particular experiment, because allelic association statistics were gleaned from human data 
and no behaviors were measured in the mice, there was less of a need for the QTL mapping 
and behavioral benefits provided by outbred strains. We therefore took advantage of the 
reliability provided by technical replicates by utilizing BXD recombinant inbred mice, as 
opposed to DO mice. This is thought to be the first study to directly simultaneously co-
analyze human GWAS, protein interaction, and mouse gene expression data to identify gene 
networks associated with the brains initial response to alcohol and the development of 
dependence. By identifying networks that were overrepresented with nominally (or 
suggestively) AD-associated genes from an independent yet similar GWAS dataset, this 
study also provided evidence that, although different genes may be identified between 
GWAS samples, these genes may take part in the same gene-region-specific biological 
pathways.   
 
17	
 
 
 
 
 
Chapter 1 
Background 
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Human Genetic Studies of Alcohol Consumption and Dependence 
 
The heritability of Alcohol Use Disorder has been estimated to be roughly 50%, by 
twin studies (22) (21), meaning that half of the variability of this disorder in the population 
can be attributed to genetic differences. However, it has been argued that twin studies likely 
overestimate heritability, due to violated assumptions, such as the “equal environment 
assumption” and the assumption of no genetic dominance, epistasis (gene-gene interactions), 
or gene-environment correlations or interactions (39) (24). The “equal environment 
assumption” states that monozygotic twins and dizygotic twins have an equal amount of 
shared environment between twins, allowing for all increased similarities between 
monozygotic twins (compared to dizygotic twins) to be attributed to increased genetic 
similarity (39). This could possibly lead to overestimation of heritability, if monozygotic 
twins have more similar environments between them than dizygotic twins (39). However, 
this has been shown to only have a mild effect on heritability estimates (39), and a relatively 
recent meta-analysis of several twin and adoption studies estimated 49% heritability for 
alcohol use disorders (21). Furthermore, SNP-heritability, which is estimated based on 
measured relatedness according to SNP similarity, of AD has been reported to be as high as 
33% (40). Given that SNP-heritability does not account for complex epistasis (interactions 
between genes) beyond additive SNP effects, or other types of genetic similarities such as 
epigenetic (regulatory chemical groups bound to DNA) and gene expression similarities, 
SNP-heritability may be an underestimation. However, it likely estimates the majority of the 
variance that can be captured by GWAS. 
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Many of the first attempts to identify specific genes associated with the disorder are 
known as linkage studies (41) (42) (43) (44). The linkage approach examines the co-
inheritance of a phenotype with chromosomal segments within families (45). If a specific 
segment is consistently inherited with the phenotypes of interest, then the effective locus is 
thought to be in linkage disequilibrium (LD) (or co-inherited more often than chance, due to 
physical proximity preventing frequent genetic recombination) with the target locus that is 
used to identify that chromosomal region (45). Some of these studies tested loci across the 
genome, and others tested a specific gene of interest (41) (42) (43) (44). While informative, 
these studies had very limited genomic resolution, and results often did not replicate across 
studies or did not explain a significant portion of the population variance (46).  
Another common method, known as the “candidate gene study”, was to test alleles 
within a single candidate gene for association with a phenotype (i.e. alcoholism) in a 
population of unrelated individuals. These genes were chosen in a hypothesis-driven manner, 
based on previously established associations or alcohol-related metabolic or neurological 
pathways (ex. dopamine-, GABA-, or serotonin-related) (47). Results often did not replicated 
across candidate gene studies and linkage studies, or even across multiple candidate gene 
studies (47) (41). Consistent results were found for alcohol and aldehyde dehydrogenase 
genes, which code for proteins that are directly involved in the metabolism of alcohol into 
acetaldehyde, and acetaldehyde into acetic acid, respectively (42) (48) (49). Any mutations 
that cause ADH to work more effectively, or ALDH to work less effectively, cause a buildup 
of acetaldehyde in the body. Just as with ALDH-inhibiting AUD medication Disulfiram, 
these types of genetic variation result in a plethora of negatively reinforcing side effects due 
to the increase in aldehyde dehydrogenase. Therefore, such alleles are actually protective 
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against the development of AUD, meaning individuals who carry these mutations are less 
likely to develop AUD because they are less likely to drink as much as someone who does 
not experience those negative side effects at such an extreme level (13). ALDH2, in 
particular, has been identified primarily in samples of Asian ancestry, because the loss-of-
function mutation is the major allele in Asian populations, and it is protective against the 
development of AD. This gene is a good example of how behavioral phenotypes, such as 
AD, challenge the conventional ideology of loss-of-function mutations being phenotypically 
deleterious. This scenario also suggests that AD may be the body’s “wild type” response to 
chronic alcohol consumption, and molecularly deleterious alleles (such as loss-of-function 
mutations) prevent this “normal” progression from chronic consumption to dependence.  
Findings regarding association between GABA receptor genes GABRA2 and 
alcoholism were also replicated in linkage studies (50) (42) (51). However, variation in these 
alleles does not account for a large proportion of the overall heritability (24) (52). 
Furthermore, very few genes displayed this level of consistency across studies. Over time, 
the failure of replication between studies, the inability to account for the heritability 
estimated by twin and adoption studies, and the rising theory that many genes with small 
effects were collectively contributing to these traits, all indicated that many of the significant 
findings in candidate gene studies (which assume large effect sizes for each association) were 
likely false positives (53) (54) (55). With this revelation came the realization that the genes 
we think might be responsible for these traits may not be the only ones contributing 
significantly to the heritability of these disorders. It was clear that a hypothesis-generating 
approach would behoove genetic association studies.  
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The theory-unbiased, hypothesis-generating genome-wide association study (GWAS), 
which tests for association between alleles across the whole genome and the trait of interest, 
is now a common method currently used to identify SNPs (single nucleotide polymorphisms) 
associated with psychiatric (and other complex) traits. Because these studies involve a large 
number of association tests, a multiple-testing-corrected p-value of <5*10-8 is the generally 
accepted significance threshold (56). This represents a Bonferroni threshold (α/N) divided by 
the number of independent tests, which has been estimated to be 1.2 million, based on 
linkage disequilibrium between common polymorphisms (57) (58) (56). When GWASs on 
AD and alcohol consumption first began, and no loci were significant under this stringent 
threshold, it became evident that the usual sample sizes did not provide enough power (59). 
This supported the theory that each individual locus likely has an extremely small effect size, 
and only in combination with hundreds (or even thousands) of other loci do these effects 
amount to a significant portion of the overall heritability. Other explanations could account 
for the lack of findings, including the possible overestimation of heritability by twin studies. 
However, even granting a heritability estimate as low as 33% (as estimated by SNP-
heritability) (40), as opposed to 50% (as estimated by twin studies) (22) (21), GWAS 
findings have yet to account for this amount of population variance. This failure to account 
for the expected heritability with the combined effects of individual genetic variants is 
known as the “missing heritability” problem (24). It is believed that missing heritability is 
largely due to lack of power of GWAS (also partly to epistatic (or gene-gene) interactions 
and the exclusion of rare variants in GWAS (because of the technical uncertainty associated 
with microarray genotyping methods)), as opposed to over-estimation of heritability by other 
methods (24) (52).  
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Once sample sizes reached >1,000 participants, some GWAS were able to identify 
SNPs significantly associated with AD (23). However, most of the associations with 
dependence in work prior to 2016 failed to replicate across studies, even when considering 
alternate SNPs that affect the same genes. The exceptions to this were the ADH (alcohol 
dehydrogenase) and ALDH (aldehyde dehydrogenase) genes, as seen in the early linkage and 
candidate gene studies mentioned above (Table 1). While ADH and ALDH associations with 
alcohol dependence are well-accepted and have a straightforward biological explanation, as 
mentioned above, they do not account for a large proportion of the population variance (24) 
(52).  
This lack of power in GWAS of psychiatric disorders is thought to stem from the 
individually small effects each of the anticipated hundreds, or even thousands, of associated 
genes have on the trait, which collectively contribute to the overall heritability, as mentioned 
above (55). However, newer investigations have tackled this problem by increasing sample 
sizes (in order to increase power) to hundreds of thousands of individuals. The first of such 
studies to be published was performed by Schumann et al. (60) on a sample of ~105k 
participants of European ancestry. They first identified novel nominally significant (p<1*10-
6) associations with weekly alcohol consumption in 5 different genes (AUTS2, TRAF, KLB, 
GCKR, ASB3) in ~70k samples, 1 of which replicated in the remaining ~35k samples: KLB 
(β-klotho).  
Another example of GWASs with large samples sizes is Clarke et al. (26), on a 
sample of ~112k individuals from a ~500k-person population sample of adults from the 
United Kingdom, called the UK Biobank. This study not only replicated previous GWAS 
findings for weekly alcohol consumption, including ADH genes, KLB, and GCKR (which 
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was of nominal significance in Schumann et al.’s study) (60), it also identified novel 
associations in two genes: CADM2, and FAM69C. Most recently, the GWAS & Sequencing 
Consortium of Alcohol and Nicotine use (GSCAN) work group combined data from multiple 
datasets in order to obtain a sample size of ~940k. This study identified 111 loci associated 
with weekly alcohol consumption, 11 of which fell within an ADH gene (ADH1B), as well as 
loci that fell within genes associated with dopaminergic and glutamatergic pathways (61).  
Most of these larger studies have focused on alcohol consumption, as opposed to AD 
or AUD, because it is difficult to obtain deep phenotypic data from such a large number of 
participants, largely due to required participant time commitment and limited monetary 
resources (Table 1). Somewhat surprisingly, these studies may not be capturing the same 
biological processes as those that are involved in alcohol use disorders. A recent 
investigation of AUDIT (Alcohol Use Disorders Identification Test) provided evidence that 
alcohol consumption in the general population is not driven by the same genetic factors as 
problematic alcohol use (25). Rather, the genetic correlation (the similarity in contributing 
loci) between problem use and other psychiatric disorders, such as Schizophrenia, was higher 
that that between AD and alcohol consumption. This genetic correlation could be due to a 
causal phenotypic relationship, such as drinking to self-medicate psychiatric symptoms or 
drinking triggering psychiatric symptoms in those who are genetically predisposed to 
developing them. This relationship could also be due to shared etiology between AUD and 
other psychiatric disorders. Shared etiology could indicate that symptoms across diagnostic 
categories could be different presentations of the same disorder, or that the same biological 
mechanisms contribute to the susceptibility for developing AUD and other psychiatric 
disorders.  However, this is not to say that alcohol consumption is totally genetically 
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unrelated to AD. The genes identified for non-problematic drinking in this study may have 
been tapping into loci specifically associated with social drinking, and therefore may have 
been reflecting traits such as social group association, social class, extroversion, and 
gregariousness. Therefore, we believe it is still beneficial to our knowledge of AUD to study 
drinking behaviors, but with refined methodology that helps preclude social drinking 
situations that may be less closely related to dependence.  
Despite the recent progress in GWAS, it is believed that there are still many more 
unidentified contributing genetic variants (59) (52). Additionally, with genotypic data alone, 
it can be difficult to identify the biological pathways through which these variants take effect 
on the trait. Functional information could reveal whether or not many different variants are 
being identified from the same mechanistic pathways within studies, or even across samples. 
General functional overrepresentation of identified SNPs may not tell the whole story, as 
there may be groups of genes that work together in an alcohol-specific manner. Furthermore, 
proteins or RNA molecules that participate in these frameworks may be coded by genes that 
do not necessarily contain associated alleles, but could be more suitable targets for 
pharmacotherapy than those that have been identified by GWAS. While association studies 
are necessary for gaining understanding of genetic contributions to AUD, they are not 
sufficient. Model organisms provide a platform for studying mechanistic frameworks at a 
more holistic level, with all of the benefits of experimental control. 
 
Mouse Genetics of Voluntary Alcohol Consumption 
Mouse Genetic Models 
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 Classic inbred mouse strains are all genetically identical within each strain, which is 
beneficial for non-genetic studies, as it provides behavioral and biological consistency. They 
are also useful for studies aimed at studying single genes, using an inbred genome as a 
backdrop to a mutation or genetic abnormality, producing what are called congenic mice (62) 
(63). However, these mice are not suitable for the genome-wide mapping approaches 
necessary for studying complex traits (such as alcohol-related behaviors), because behavioral 
differences between strains could be cause by any one of the millions of variants that exist 
between the two inbred genomes. Conversely, mice that stem from crossbreeding between 
these strains possess a combination of variants from the progenitor (or founder) strains, and 
mice bred in different lines possess different combinations. Therefore, researchers can obtain 
populations of genetically distinct mice, allowing for the detection of the contribution of 
genetic differences to a measured phenotype. If the measured phenotype is consistently 
similar between mice that share an allele at a specific (i.e. if mice with allele 1 have a 
different phenotype than mice with allele 2), despite being genetically different at many other 
loci across the genome, this locus likely contains one of the genes contributing to the 
phenotypic differences.  
Another approach that researchers take to genetically manipulate mouse lines is to 
“outcross” two genetically distinct inbred progenitor strains, in order to obtain offspring that 
carry alleles from each of the two strains (F1) (64). Breeding F1 mice to each other results in 
F2 progeny, whose genomes contain an admixture of alleles from each of the progenitor 
strains, some of which they carry homozygously and others heterozygously (64). F1 mice can 
also be “backcrossed” to one of the progenitor to produce offspring. Offspring from such 
lines can be iteratively backcrossed over several generations in order to obtain mice that have 
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a genetic background primarily similar to the progenitor strain of choice, but possess a 
desired (natural or genetically engineered) allele from the other F0 (original generation) 
progenitor strain (64). This method requires genetic testing in each generation, so that 
heterozygosity of the target allele can be preserved (64). Alternatively, because of their 
genetic variability, F2 and backcrossed mice can be used to map quantitative trait loci (QTL), 
or regions in the genome that contain polymorphisms that are associated with a measured 
phenotype (64, 65). However, the precision with which the contributing locus can be 
identified is determined by the number of detectable chromosomal recombinations that have 
occurred in that region (66). By comparing several crossed lines, given that recombination 
event locations are not the same across all mice, the LD block size that can be analyzed is 
effectively smaller, even if the number of recombination events in each line of mice, is 
roughly the same.   
One method of obtaining populations of mice on which this type of mapping can be 
performed is to inbreed intercrossed mice, via brother-sister mating, to form homozygous 
“recombinant inbred” (RI) lines (62, 64). For these strains of mice, two or more inbred 
progenitor strains are crossed to at least eh F2 generation, and then undergo a minimum of 20 
generations of inbreeding, until all mice within that breeding line are genetically identical 
(62, 64). Different lines are created in separate breeding panels, in order to create strains of 
mice that are genetically identical within lines, but different between lines. These mice 
present an admixture of genetically moderated behaviors that can be attributed to specific 
loci across the genome, and are therefore useful for QTL mapping, with the added benefit of 
the availability of technical replicates within each line (62, 67-71). However, the limited 
number of crossbreeding generations prior to inbreeding still limits the mapping resolution of 
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many RI strains (66). Another way to increase the resolution is to examine a strain whose 
genome contains several recombination events compared to F1 mice, rendering the LD 
blocks much smaller. One example of such mice is the BXD RI strain. This strain involves 
the crossing of the inbred lines C57BL/6J and DBA/2J, between which there are 
approximately 4.8 million SNPs (72). Not only are these two strains genetically different, but 
C57BL/6J mice prefer alcohol at a much higher level than DBA/2J mice (62). Therefore, 
these lines have been used for genetically mapping alcohol-related behaviors and 
physiological responses (62, 69-71).  
A more complex recombinant inbred strain used for behavioral genetic studies is the 
Collaborative Cross (CC) strain, which was created from 8 progenitor strains: C57BL/6J, 
A/J, 129S1/SvImJ, NOD, NZO, WSB/EiJ, CAST, and PWK (35, 73). The latter three strains 
are wild-derived, meaning the initial mice used to create these strains were found in the wild 
and never domesticated, whereas lab-derived strains were bred for behaviors that were 
amicable for handling. This means that wild-derived strains contain alleles that are not seen 
in lab-derived strains, which contribute to behaviors not exhibited by lab-derived strains (35). 
Because of the large number of progenitor strains and the wild-contributed alleles, mice 
derived from these progenitors exhibit a wide array of genetically-derived behaviors and pose 
the potential for the identification of behavior-associated loci that cannot be identified in 
most other crosses or RI strains (35). The CC mice allow for mapping of behavioral QTLs 
with support intervals ranging from 0.5Mbp to 15.5Mbp in length (74).  
Unlike RI strains, outbred mice are each genetically distinct from the rest of the stock, 
much like a human population. Each mouse possesses a unique combination of haplotypes 
from each of the originating progenitor strains, across each chromosome. Exact experimental 
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replication cannot be performed in this type of mouse, because, unlike RI strains, there are no 
genetically identical replicates. The lack of technical replicates also decreases power, so that 
very large (in the hundreds) sample sizes are needed to genetically map behavioral traits. 
However, the unique behavioral and genetic diversity of these mice allow for mapping novel 
behavioral QTL with greater precision than most other strains, which continues to increase 
with each generation of outbreeding (35, 75). One example of this type of mouse is the 
Diversity Outbred (DO) stock, which originated from interbreeding 144 different CC lines 
(76). Several additional generations of random outbreeding (i.e. breeding of mice in pairs that 
are less related to each other than first cousins) led to the richly phenotypically and 
genetically diverse DO stock, which has already afforded the identification of behavioral 
trait-related loci with incredible precision (regions < 1Mbp at only the 4th and 5th generation 
of outbreeding) (35). However, to our knowledge, research on alcohol-related traits in these 
mice has not yet been published. Before this can be done, it is important to determine 
heritability and feasibility by studying the progenitor strains. However, voluntary alcohol 
consumption behaviors have not yet been characterized in all of the progenitor strains. 
Voluntary Ethanol Consumption in Mice 
As seen in the previous section, some tissue-specific gene expression studies have 
been conducted on human alcoholic postmortem brain tissue. However, studies such as these 
are difficult to conduct and interpret, due to the large amounts of environmental variation 
between human subjects. Such environmental variables include, but are not limited to: 
environmental drivers of alcohol consumption, access to alcohol, bias in self-reporting of 
alcohol consumption and other behaviors, timing of last drink with respect to death, and time 
between death and tissue harvest. Furthermore, it is difficult and time consuming to obtain 
29	
large sample sizes, due to the need for consent to use postmortem tissue for scientific 
research, and the inability to collect brain tissue from living participants. Unlike human 
studies on alcohol consumption or dependence, these environmental factors that may obscure 
genetic signals can be controlled in animal model genetic experiments. Although such 
models do not account for all of the nuances of human behavior, they are useful for 
identifying broadly applicable biological mechanisms underlying specific behaviors 
associated with a disorder.  
The most widely utilized animal model for genetic studies on alcohol behaviors 
including consumption, is the mouse. The mouse genome was sequenced earlier than that of 
the rat and genetic strains and techniques for manipulating the genome are better 
characterized in mice. Many paradigms exist for studying alcohol-related behaviors in mice, 
modeling different addiction-related endophenotypes, such as acute functional tolerance, 
withdrawal symptoms, alcohol sensitivity of locomotor activity and coordination, alcohol-
induced anxiolysis, and behavioral disinhibition (via operant conditioning) (77). However, 
voluntary ethanol consumption paradigms capture a more complex behavior which models 
alcohol consumption in humans. In such paradigms, mice have access to both water and 
alcohol, giving them the choice to drink either. The underlying premise is that mice learn, by 
associating smell and taste (or bottle placement) with physiological response, that alcohol 
provides feelings of reward (provided by the subsequent increase in dopamine) and 
anxiolysis, whereas water does not. Some mouse strains will voluntarily drink higher 
quantities of alcohol, and even prefer it over water, such as C57BL/6J, whereas other strains 
rarely choose to consume ethanol, such as DBA/2J (62, 78, 79). This indicates that the choice 
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to consume alcohol in high quantities, or to prefer it over water, is genetically driven in mice, 
just as it is in humans.  
There are many variations of paradigms that produced increased voluntary ethanol 
consumption in mouse or rat models. Some of these include addition of taste additives, such 
as sucrose, while others involve prior forced exposure to ethanol, which tends to lead to 
higher levels of voluntary consumption. A popular version of this type of protocol is the 
Chronic Intermittent Ethanol Paradigm, which exposes mice to intermittent periods of 
ethanol vapor before voluntary access to ethanol begins (80). The downfall of such studies is 
that the forced exposure does not model the situations that occur in humans’ lives. Some 
researchers have chosen to omit forced exposure, and have shown that certain strains of 
alcohol-naïve mice will still voluntarily consumed ethanol, after long-term access (36, 37, 
79). This benefit of this type of protocol is that it models a situation more similar to the 
human experience with alcohol, which is most often voluntarily consumed. One downfall of 
this type of model is that alcohol-naïve mice often typically do not voluntarily consume as 
much alcohol as alcohol-pretreated mice (80).  
Intermittent Ethanol Access Paradigm 
Some studies have been able to achieve high levels of voluntary consumption without 
prior ethanol treatment, however, by imposing periods of forced abstinence (i.e. access to 
water only). These abstinence periods cause increases in drinking upon reintroduction, which 
is thought to be due to craving (81). This effect is thought to be driven by craving or 
withdrawal, neither of which have the chance to occur when alcohol is continuously 
available. In particular, intermittent ethanol access paradigms, comprised of regularly 
alternating periods of free-choice ethanol access and forced abstinence, have produced higher 
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levels of ethanol consumption than chronic (or continuous) ethanol access, despite varying 
durations of access and forced abstinence between studies (36, 37, 77, 79). Some strains 
increase their consumption over time under this type of paradigm more so than they do when 
provided with continuous alcohol access. However, studies have also shown that this 
response to IEA varies by strain, suggesting genetic involvement in consumption behaviors 
under intermittent access, just as it is in studies with continuous access or prior ethanol 
exposure (77-79).  
 Results from one recent study have indicated that problematic alcohol use is not as 
highly genetically correlated with alcohol consumption, as it is with other psychiatric 
disorders in human GWAS samples (25). This study used the polygenic risk score method of 
calculating genetic overlap, in which the top-scoring SNPs from the GWAS of one 
phenotype are weighted by their effect sizes and are then used to determine how well they 
predict the values of the other phenotype (20). However, twin studies have shown that 
drinking levels do genetically correlate with AD (82). It is possible that the causative SNPs 
that are common between consumption and dependence are not those that explain the 
maximum amount of variance for either of the phenotypes alone, causing twin studies and 
polygenic analyses to have contrasting results. Additionally, IEA paradigms are frequently 
used to model the progressive increase in drinking levels seen in humans during AUD 
development, as people are gradually exposed to drinking during intermittent periods of 
access, such as social gatherings (77). Mice that exhibit an ethanol deprivation-like effect are 
therefore seen as mice that model genetic predisposition for developing dependence. 
Furthermore, social drinking is not a factor in these experiments, as mice are often 
individually housed to prevent social interactions, and mice (quite obviously) do not exhibit 
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the same types of social norms as humans, in the context of drinking. We therefore believe 
that ethanol consumption in the early stages of this paradigm models non-problematic 
drinking, whereas post-long-term-exposure consumption models problematic drinking that 
leads to dependence. Based on this assumption, we predict that initial consumption will be 
driven by different genetic loci than post-exposure consumption, and we therefore test the 
two time periods separately, reflecting these two distinct behaviors.  
Behavioral Quantitative Trait Loci for Voluntary Ethanol Consumption  
In order to test exactly which genes are associated with voluntary ethanol 
consumption in mice, multiple studies have aimed to map behavioral quantitative trait loci 
(bQTLs) for ethanol consumption and preference for alcohol over water. bQTLs are regions 
of the genome that contain SNPs, or other types of polymorphisms, associated with the 
phenotype of interest. QTL analysis is similar to GWAS in theory, but is mathematically 
different. For GWAS, p-values are used to determine the significance of an association of an 
individual SNP with a trait. In QTL analysis, or linkage analysis, LOD (logarithm of the 
odds) scores are used to indicate the likelihood that a given region of DNA is associated with 
the phenotype. Technically speaking, it represents the log10 of the probability ratio that the 
tested DNA locus is in LD with a locus that affects the phenotype (83).  
The size of a bQTL is determined by a support interval, which is akin to a physical 
confidence interval on a chromosome. Specifically, a 95% Bayesian support interval 
indicates the region of DNA in which there is 95% confidence that the effective 
polymorphism is present (84). Other methods, such as 1.5 LOD-drop in either direction 
(proximal and distal) from the top-scoring location in that region, do not specify an exact 
level of confidence, but rely on the shape of the LOD score peak across the chromosome. 
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Regardless of support interval calculation methodology, the precision of this interval is 
affected by LD block length and genetic diversity (i.e. the number of testable alleles across 
that region of DNA), such that smaller LD blocks and a larger number of alleles result in 
more precise (i.e. smaller) intervals. The goal is to winnow this interval down until the 
effective polymorphism(s) has (4) been identified.  
Many studies have identified bQTL for voluntary ethanol consumption and 
preference in various strain crosses (85) (86) (87) (88) (89). These researchers have crossed 
at least one strain that voluntarily drinks alcohol at high levels (ex. C57BL6/J) with at least 
one other strain that does not (ex. DBA/2J), with the goal of identifying the specific regions 
of DNA that likely contribute to this behavioral difference. One such study, on ethanol 
consumption under a Drinking in the Dark paradigm, a binge-like model, in the BXD 
recombinant inbred strain (originating from C57BL6/J and DBA/2J) was able to achieve 
support intervals as small as 6Mbp (89).  However, many of the support intervals remained 
≥9Mbp, due to the small number of progenitor strains (and limited variation between those 
two strains, roughly 4.8 million), and the limited number of cross-breeding generations prior 
to inbreeding for the creation of inbred lines. Furthermore, to our knowledge no published 
studies on daily ethanol consumption or preference have achieved such precise mapping.  
Some studies have narrowed down support intervals to a small list of candidate genes, 
for other alcohol-related behaviors, following genetic mapping in recombinant inbred lines 
by selectively breeding these lines for subsequent generations of “Advanced Recombinant 
Inbred” mice. However, these experiments require several generations of breeding in order to 
achieve enough recombination within that support interval to winnow the region down to an 
interpretable number of candidate genes. One example of this is a study performed by 
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Putman et al. (69), who fine-mapped a QTL for alcohol-induced anxiolysis (or reduction in 
anxiety-like behaviors) down to 3.5Mbp by first mapping the region in earlier BXD 
generations, then later taking advantage of later generations of the intercrossed strain, 
specifically those in which the target region had undergone recombination. However, to our 
knowledge, this has yet to be done for loci identified for alcohol consumption or preference. 
One way to avoid having to go through the multi-generational process of traditional fine-
mapping in order to achieve reasonably small support intervals is to use outbred mice for 
QTL analysis.  
Therefore, the project described in the Chapter 3 aims to assess voluntary ethanol 
consumption and preference in the DO progenitor strains, prior to genetically mapping this 
trait in a DO population. This study had the additional advantage determining feasibility of 
using each of the eight progenitor strains in future voluntary ethanol consumption studies. 
This is particularly important for the wild-derived strains, which are being used more 
frequently to study complex behaviors not seen in lab-derived strains, due to their phenotypic 
and genetic uniqueness (32, 35, 90). To our knowledge, this study was the first to 
characterize voluntary ethanol intake and preference in several of these strains (specifically 
NZO/HiLtJ, CAST/EiJ, WSB/EiJ, and PWK/PhJ). 
 
Genome-Wide Systems Genetics of Alcohol Use Disorder 
Genome-Wide Gene Expression Analysis for Studies on Alcohol Behaviors  
Systems genetics, or the study of various levels of genetics from DNA to proteins, 
specifically related to alcohol consumption and dependence can provide a more complete 
explanation of potentially pharmacologically targetable biological mechanisms that 
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contribute to the development or persistence of AUD. Some systems genetics studies focus 
on a single gene or group of genes, which is helpful for identifying specific mechanisms 
through which those genes affect the trait. However, for complex traits such as AUD and 
alcohol consumption, not all of the contributing genes are know. There is therefore the need 
for a genome-wide, hypothesis-generating approach to identify novel groups of genes that 
function together in a tissue-specific manner to affect the risk for high alcohol consumption 
or dependence. In fact, hundreds of genes have been identified as being differentially 
expressed between the postmortem brains of alcohol dependent individuals and non-
dependent controls, or between brains of alcohol-exposed mice and alcohol-naïve controls 
(29). Whether ethanol-regulating (meaning that differences in expression cause differences in 
ethanol consumption or other ethanol-evoked behaviors) or ethanol-regulated (meaning that 
differences in ethanol exposure cause differences in gene expression), these genes likely 
affect the way the brain responds to alcohol, and thus the risk for becoming or remaining 
dependent.  
Because the brain is regionally organized with respect to function and neuron 
composition, and therefore gene expression patterns, it is important for studies to focus on 
distinct brain regions to identify region-specific networks (91). The NAc, VTA, and PFC are 
often the focus of addiction-related genetic studies, due to their known role in the reward 
system (mesolimbocortical pathway) and behavioral control (specifically the PFC) (27-29, 
31, 92-95). Such studies have identified regionally specific expression patterns associated 
with alcohol exposure or consumption, although some were common across these three brain 
regions (9, 27-29, 31, 93-96). Both common and the region-specific expression patterns 
provide information about the systematic functioning of the brain and how it interacts with 
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alcohol, and can help pinpoint candidate systems to target with pharmacotherapies for AUD 
(97). 
Gene Expression Network Analysis 
One method of utilizing genome-wide data for studying systems genetics, in a more 
comprehensive and mechanistic way, is to map gene expression networks. The underlying 
premise is that genes with correlated expression levels code for RNA or protein products that 
are likely interacting in some mechanistic way, or participating in the same biological 
function (98, 99). These networks are portrayed as graphical schematics, where each “node” 
(or circle) represents a single gene, and each “edge” (or line) represents a relationship 
between those two genes (Fig. 2). In this case, this relationship reflects a measurement 
related to expression values, such as expression correlation. These nodes and edges can be 
“weighted” by various gene-specific and relationship-specific parameters, respectively, or 
they can be binary (present or not present) with no weighting. Many different types of 
network algorithms exist, some of which map networks using machine learning algorithms, 
and others that mine existing background networks for nested sub-networks.  There are also 
several different heuristics on which clustering of genes can rely, but here we focus on 
methods that cluster genes by covariance-based metrics without imposing an arbitrary 
association coefficient threshold.  
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Figure 2: Nodes, or graph vertices, represent individual genes. Node-weights (often reflected by color or size) 
represent the effect size of the gene’s allelic association with a phenotype or that node’s connectivity. 
Connectivity metrics rely largely on the number of edges attached to a node, and sometimes incorporates the 
weights of those connections (or edges) into the calculation. Edges, represent biological interactions or 
relationships (ex. expression correlation) between genes. Edge-weights (often reflected by the thickness of the 
lines) represent the magnitude or effect size of that relationship. Hub genes (in blue) are nodes characterized by 
high connectivity.  
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One common method of network mapping is to use hierarchical clustering. In its most 
basic form, this method “clusters” genes by expression level correlation values, starting with 
the most highly correlated pair of genes and eventually working its way down to the smallest 
values in a correlation matrix of all gene pairs. Weighted Gene Co-Expression Network 
Association (WGCNA) is a program that hierarchically clusters genes based on Topological 
Overlap. For each pair of genes, the Topological Overlap value incorporates information 
from adjacency (i.e. transformed correlation values, or the theoretical inverse of graphical 
distance) between the two genes, but also their adjacency with all other genes that could 
potentially indirectly connect them in a network (38). The adjacency is raised to a user-
defined power to create a “scale-free” network, which is a network for which the probability 
of a gene having k connections depends on a power distribution of k (100). Such networks 
are characterized by the presence of hub genes (or genes that are very highly connected to 
other genes, compared to the mean number of connections), making the network relatively 
robust in its structure, with respect to the removal of single connections (101, 102). This 
structure is thought to mimic naturally-occurring networks, such as biological interactions, 
hence the frequent use of WGCNA to map gene expression networks (28, 29, 100). In fact, 
this method had been used to map gene networks in brain tissue in both humans and mice, 
and has identified functionally enriched networks that are significantly overrepresented with 
alcohol-regulated genes (29, 30). Such studies provide important information with respect to 
candidate genes and functional pathways to be tested further for association with 
dependence, and to potentially eventually be targeted with therapeutic drugs to treat 
addiction.   
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An example of a network-mining algorithm used in gene expression studies is the 
Edge-Weighted dense module-searching algorithm for Genome-Wide Association Studies 
(EW-dmGWAS). This program queries a background network of binary connections 
(meaning two genes are either connected, or they are not, with no quantitative weighting) 
using independently derived gene expression-related values as weights to determine sub-
network membership. This method is unique in that it is also capable of incorporating 
weights unique to each gene, typically a value that represents that gene’s association with a 
phenotype, which will be discussed in more detail below.  For each pair of genes that is 
connected in the initial network, the algorithm calculates the difference in their correlation 
between experimental groups. The more the experimental treatment perturbs the interaction 
(i.e. the larger the difference in correlation values between groups), the larger the assigned 
weight. Genes are iteratively added to a sub-network, following the connections of the initial 
network outward, based on a combined metric that incorporates its weight with each of the 
genes already placed in the sub-newtork (and its gene-specific phenotype-related weight, if 
that value is being incorporated).  This algorithm is beneficial for combining data from 
multiple sources, as opposed to relying solely on gene expression to map networks. Its 
intended use is for the integration of the following three types of data, into one streamlined 
analysis: protein interaction data, as the initial background network; gene expression data, for 
the connected weights and determination of sub-network belongingness; and GWAS data, for 
the phenotype association-related gene-specific weights, which can also be incorporated into 
sub-network belongingness determination. More details on this exact implementation are 
described below. To our knowledge, this method has been used to map networks of genes of 
protein-protein interaction background network that have Alcohol Dependence GWAS p-
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values (used as the gene-specific weights), but alcohol treatment-related expression values 
have never been incorporated into this type of analysis (103). However, previous studies 
have integrated alcohol-regulated gene expression and genetic association data using 
different method, in order to identify gene expression networks whose constituent genes 
contained SNPs associated with Alcohol Dependence in GWAS. 
Regardless of the network-building tools used, gene expression networks identified in 
human studies are informative, but the contributions to differences between alcoholics and 
controls, and therefore their potential roles in dependence development, are ambiguous. 
Because of the environmental control in mouse models, and the experimental control over 
alcohol-related behaviors, it is possible to identify networks specifically related to 
endophenotype-like traits at pre-specified stages of life and dependence development. There 
are over 17,000 orthologs (104) between the human and mouse genome, and evidence shows 
that network structure is highly conserved between mice and humans (105). Several studies 
have identified mouse brain gene networks that respond to different levels of ethanol 
exposure. For example, in addition to identifying ethanol-regulated genes, Wolen et al. (27) 
and Smith et al. (28) identified gene networks in the PFC, NAc, and VTA of recombinant 
inbred mice that were responsive to acute ethanol administration (via intraperitoneal 
injection) and chronic involuntary ethanol vapor exposure, respectively. Two additional 
studies have measured gene expression differences related to ethanol consumption 
specifically under an IEA paradigm (the paradigm used in the studies discussed in Chapters 
3-5 of this manuscript) in C57BL/6 mice: Wolstenholme et al. (31) identified several genes 
with brain region-specific ethanol consumption-correlated expression levels in PFC, NAc 
and VTA; and Ostendorff-Kahanek et al. (95) identified 702 significantly differentially 
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expressed genes between IEA-exposed and control PFC. However, to our knowledge, no 
studies have directly integrated mouse gene expression data with human GWAS, in order to 
capitalize on the advantages of each.  
Integration of Gene Expression Networks with Genotypic Data  
A common integration method for gene expression and GWAS data is known as 
enrichment or overrepresentation analysis. These studies identify groups of co-expressed 
genes, based on gene expression data, and determine how well each network represents genes 
with lower (i.e. more significant) GWAS p-values for AD or alcohol-related behavior. For 
overrepresentation, a threshold GWAS p-value is chosen, the number of genes whose p-
values fall below that threshold are counted, and the probability that a group of that size 
would contain that number or more of GWAS-suggestive or –significant genes by chance 
(typically via permutation), which becomes the empirical overrepresentation p-value. 
Enrichment is similarly calculated, but instead of counting the number of genes that pass 
some threshold, a metric (such as the mean or Fisher’s combined statistic) is calculated for 
each group of genes, and that value is compared to values that would occur by chance. One 
example of a study that utilized this type of method was conducted by Farris et al., (92) gene 
region-specific gene co-expression networks in human postmortem PFC tissue, which 
contained significantly different network structures between alcohol-dependent individuals 
and controls. Many of these networks were also correlated with lifetime alcohol consumption 
in dependent participants. The most highly alcohol consumption-correlated networks were 
overrepresented with genes containing SNPs associated with AD in each of two GWAS 
datasets, meaning they contained more genes with associated SNPs than expected for a 
random group of the same number of genes. Similarly, Mamdani et al. (106) found that 
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expression quantitative trait loci (eQTL, or QTL associated with expression levels) for AD-
associated gene expression networks in human NAc tissue had significant enrichment with 
AD diagnosis and symptom count GWAS signals. This finding is especially informative, 
because it indicates that some genes identified in GWAS are likely affecting AD risk via 
these multi-gene mechanistic networks in the brain. Additionally, many of the gene networks 
they identified were enriched for neuronal systems in a functional overrepresentation 
analysis. These results indicate that gene co-expression networks associated with alcohol 
consumption are informative for identifying groups of genes that collectively contribute to 
dependence via neurological pathways. 
Other studies have integrated GWAS and human gene expression or gene network 
data to cross-validate behavioral genetic findings (107). For example, the Psychiatric 
Genomics Consortium (108) has tested for enrichment of nominally GWAS significant genes 
previously identified functional pathways. Their results showed shared enrichment of signals 
for schizophrenia, major depression disorder, and bipolar disorder in several functional 
categories, including histone methylation, neural signaling, and the immune system (108). 
Yet another approach to cross-species validation is to provide additional confirmation for 
GWAS significant or suggestive results for AD by showing that expression levels for such 
genes showed correlations with ethanol behaviors in rodent models, providing evidence of 
consilience of gene-trait relationships for alcohol-related behaviors across mice and humans 
(109).  These types methods provide information regarding the function of genes that have 
already reached significance. However, they do not provide information about sub-threshold 
signals that possibly still contribute to the genetic risk and mechanisms of AUD. 
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Furthermore, as mentioned in Section 1.2, gene expression studies can be difficult to interpret 
when using human tissue. 
Direct integrative algorithms allow for identification of gene networks coordinately 
weighted for GWAS significance for AD in humans and ethanol-responsiveness in model 
organism brain gene expression data. The EW-dmGWAS algorithm, mentioned above, can 
be used to directly integrate GWAS data and other biological network information in order to 
identify gene networks contributing to a genetic disorder, even for truly affective genes with 
sub-threshold significance values due to lack of power (110). One of the first studies to take 
this approach utilized Protein-Protein Interaction (PPI) network data to identify networks 
associated with AD GWAS signals. Modules mined from protein-protein interactions were 
scored based on node-weights based on gene-level GWAS p-values. This approach 
successfully identified AD-associated PPI networks that replicated across ethnicities. 
Furthermore, the resulting modules showed significant aggregate AD-association in 
independent GWAS datasets (103), thus demonstrating the potential utility of the method. An 
updated iteration of the dmGWAS algorithm, termed Edge-Weighted dense module 
searching for GWAS (EW-dmGWAS), allows integration of gene expression data to provide 
a direct co-analysis of gene expression, PPI, and GWAS data (111).  
This type of approach utilizes the best of both worlds, regarding the integration of 
data from humans and mice. It takes advantage of the behavioral complexity in humans, 
while minimizing the effect of cofounding environmental factors on the biological variable, 
by focusing on data that explains the relationship between a trait and genotype (GWAS data), 
which is largely unchanging across time and environment. It also capitalizes on the ability to 
minimize noisy variation in time- and environment-sensitive parameters, such as gene 
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expression, in model organisms. For these reasons, this algorithm was used for our network 
studies in Chapter 5, for identifying alcohol-responsive, AD-associated gene networks. In 
order to fully capitalize on the benefits of experimental control, this analysis uses data from 
the ethanol-naïve recombinant inbred mice that were involuntarily exposed to ethanol via 
intraperitoneal injection seen in Wolen et al., (27). Although this type of experiment does not 
involve the measurement of an ethanol-related behavior, it minimizes error variance within 
groups caused by differing levels of ethanol exposure or of stress in response to behavioral 
testing. In contrast, the human data used for the incorporated GWASs was collected via 
survey, in the absence of experimental control, which creates unrealistic behavioral and 
environmental constraints. Finally, it has been shown that risk for developing alcohol 
dependence can be partially predicted by initial response to alcohol (112, 113). Whereas the 
IEA study reported in Chapters 3-5 identifies genetic loci associated uniquely with naïve 
versus post-long-term-exposure consumption, this study allowed us to examine mechanistic 
pathways involved in the relationship between initial response to ethanol and its effects on 
long-term use.    
 
Summary 
 In this Introduction, we have reviewed evidence that the mesolimbocortical pathway 
(including the Prefrontal Cortex, Ventral Tegmental Area, and Nucleus Accumbens) plays a 
role in the development of alcohol use disorder. However, many of the exact mechanisms 
and neural pathways involved have yet to be identified, and the current medications labeled 
for AUD treatment are neither precise, nor incredibly effective. Because roughly 50% of 
AUD’s population variance can be accounted for by genetic differences, it is believed that 
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discovery of specific genetic associations with this disorder, or related phenotypes, can direct 
us towards specific biological pathways that can be targeted by pharmacotherapies. However, 
genome-wide association studies in humans have yet to account for as much of the trait 
variance as expected.  
The contributing biological pathways can be examined via systems genetics 
approaches, which assess genetic systems from DNA to proteins. Genome-wide systems 
genetics approaches are particularly useful for complex traits, such as alcohol-related 
phenotypes, because they provide a broader, more comprehensive picture of the complex 
web of systems involved than single-gene or single-pathway studies. However, gene 
expression is tissue-specific, and it is difficult to collect gene expression data from post-
mortem human brain tissue with proper environmental control or in large samples sizes. 
Model organisms, such as mice, provide researchers with the capability to practice 
experimental control and obtain large samples. In particular, the Intermittent Ethanol Access 
voluntary ethanol consumption mouse paradigm allows researchers to model the abstinence-
driven increase in drinking seen at the beginning stages of AUD development, under an 
environment- and alcohol-access-controlled experimental setting. Previous genetic 
association studies on voluntarily alcohol-consuming mice have been limited, in both 
precision and number of testable loci, by the genetic simplicity of laboratory strains. These 
limitations likely extend to gene expression analysis, because of the effects of local and distal 
loci on gene expression. The Diversity Outbred stock of mice was created specifically to 
mitigate this issue, stemming from a complex breeding scheme involving 8 genetically 
distinct progenitor strains. To our knowledge, no behavioral QTL or brain region-specific 
gene expression studies on alcohol-related behaviors in DO mice have been published. 
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Therefore, this project aims to characterize voluntary ethanol consumption and dependence, 
and their heritability, in the 8 progenitor strains of the DO mice (Chapter 3). Given a high 
heritability (as was anticipated), indicating genetic mappability, we then sought to identify 
novel and unprecedentedly precise QTL for these behaviors in a sample of 600 DO mice 
(Chapter 4). We expected to see loci both unique to and common between drinking 
behaviors during the first and last weeks of ethanol exposure, reflecting initial and 
dependence-like consumption, respectively. Finally, we aimed to identify gene expression 
networks in the prefrontal cortex that potentially mediate the effects of these loci on drinking 
behaviors.  
 One might assume that, given the independence of the genetic influences between 
initial and long-term ethanol consumption in mice, that initial subjective response to ethanol 
would not be related to the risk for dependence. However, it has been shown that initial 
response to alcohol predicts risk for developing dependent use, although the exact 
neurological mechanisms that lead to this correlation are largely unknown (112, 113). The 
link between initial response to ethanol and long-term risk for dependence may be less 
dependent on initial drinking levels, and more dependent on the rate of acceleration of 
drinking levels over time, leading to differences in the likelihood of developing tolerance and 
the rate at which this development occurs. To gain a better understanding of this relationship, 
and to capitalize on the advantages of using mouse data and those of using human data, in 
Chapter 2 we describe co-analysis of human Alcohol Dependence GWAS summary statistics 
with gene expression data from reward center-related brain regions (PFC, VTA, and NAc) 
acute-ethanol-treated, in the context of protein interactions. Gene expression changes in these 
brain regions, in response to a single dose of ethanol in ethanol-naïve mice, represents the 
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brain’s acute response to initial alcohol exposure; whereas the human data examines the 
relationship between genetic loci and risk for developing dependence. The main goal was to 
identify gene networks associated with both initial ethanol-responsiveness and dependence.  
Overall, this manuscript examines systems genetic mechanisms that underlie alcohol 
consumption and dependence, and the relationship between these two phenotypes. 
Specifically it examines networks common between ethanol responsiveness in the brain’s 
reward pathways and alcohol dependence. It also explores the biological pathways unique to 
and shared between initial drinking and long-term early-dependence-like drinking . 
Specifically, the aims of this dissertation were to: 1) examine the relationship between initial 
ethanol responsiveness of gene expression to alcohol exposure and the risk for developing 
dependence, by capitalizing on the benefits of both model organisms and human samples (as 
seen in Chapter 2); 2) determine the genetic mappability of ethanol consumption and 
preference over water, by analyzing the variance in these traits between the 8 progenitor 
strains (as seen in Chapter 3); 3) to then identify novel and unprecedentedly precise bQTL 
that contribute to these behaviors, during naïve and post-exposure time periods, in a large 
sample (N≈600) of DO mice (as seen in Chapter 4); and 4) identify ethanol-responsive gene 
networks in the Prefrontal Cortex, and their respective eQTL, to gain insight to the 
mechanistic frameworks through which the bQTL affect drinking in DO mice (as seen in 
Chapter 5). Corresponding to these aims, we expected to find: 1) identification of novel 
candidate genes and gene networks involved in the relationship between initial response to 
alcohol and long-term risk for dependence, including genes that did not reach significance in 
human GWAS; 2) high heritability of ethanol consumption and preference across the 8 
genetically distinct DO progenitor strains, indicating that these phenotypes are genetically 
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mappable in the DO mice; 3) novel and refined quantitative trait loci for ethanol consumption 
and preference in the DO mice; 4) gene networks in the Prefrontal Cortex that are associated 
with ethanol consumption levels and provide candidate biological mechanisms through 
which genetic variants might affect drinking behaviors. 
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Chapter 2 
 
Cross-species alcohol dependence-associated gene networks: Co-analysis of 
mouse brain gene expression and human genome-wide association data 
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Introduction 
Twin studies estimate that AUD is roughly 50% heritable (21, 22). Multiple rodent 
model studies have used selective breeding to enrich for ethanol behavioral phenotypes or 
have identified ethanol-related behavioral quantitative trait loci (87, 114, 115), further 
confirming the large genetic contribution to alcohol behaviors. Recent studies have also 
documented genetic factors influencing the effectiveness of existing pharmacological 
treatments for AD, further substantiating genetic contributions to the mechanisms and 
treatment of AUD (116). Genome-wide association studies (GWAS) in humans have 
identified several genetic variants associated with alcohol use and dependence (23, 26, 60, 
117). However, they have yet to account for a large portion of the heritability estimated by 
twin studies. Lack of power, due to a large number of variants with small effects, is believed 
to the source of this “missing heritability”” (24). Although recent large-scale studies have 
shown promise in identifying novel genetic contributions to alcohol consumption, these 
studies do not contain the deep phenotypic information necessary for identifying variants 
associated with dependence (26, 60). Further, such GWAS results still generally lack 
information about how detected single gene variants are mechanistically related to the 
disease phenotype.  
Genome-wide gene expression studies are capable of improving the power of GWAS 
by providing information about the gene networks and biological mechanisms in which 
GWAS variants function (92, 107, 118, 119). Although gene expression in brain tissue has 
been studied in AD humans (92, 107), these studies are often difficult to conduct and 
interpret, due to lack of control over experimental variables and small sample sizes. 
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However, studies have found high conservation in gene expression correlation patterns 
between mice and humans, particularly in brain tissue (105). Furthermore, extensive studies 
in rodent models have successfully identified ethanol-associated gene expression differences 
and gene networks in brain tissue (28, 30, 96, 120, 121). Multiple ethanol-behavioral rodent 
models exist to measure different aspects of the developmental trajectory from initial 
exposure to compulsive consumption (77). Acute administration to naïve mice models the 
response of initial alcohol exposure in humans, which is an important predictor of risk for 
AD (112, 113). Wolen et al. used microarray analysis across a mouse genetic panel to  
identify expression correlation-based networks of acute ethanol-responsive genes (genes 
whose expression levels change after ethanol consumption or treatment), along with 
significantly associated expression quantitative trait loci in brain regions involved in the 
mesolimbocortical dopamine reward pathway -- the prefrontal cortex (PFC), nucleus 
accumbens (NAc), and ventral tegmental area (VTA) (120). Furthermore, specific networks 
also correlated with ethanol behavioral data derived from the same mouse genetic panel 
(BXD recombinant inbred lines) (115). Importantly, these gene expression responses to acute 
ethanol in BXD mice were later shown by our laboratory to have highly significant overlap 
with expression responses in a chronic ethanol exposure model known to mimic aspects of 
alcohol dependence in humans (97), and also contained a gene expression network associated 
with alcohol dependence that we recently identified Gsk3b as a potential candidate gene for 
treatment of alcoholism (122). Together, these results support our premise that acute ethanol-
exposed rodent brain gene expression could provide insight into relevant mechanistic 
frameworks and pathways underlying ethanol behaviors and risk for dependence in humans.  
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Several studies have integrated GWAS and gene expression or gene network data to 
cross-validate behavioral genetic findings (107). For instance, the Psychiatric Genomics 
Consortium (108) tested for enrichment of nominally significant genes from human GWAS 
in previously identified functional pathways, and found shared functional enrichment of 
signals for schizophrenia, major depression disorder, and bipolar disorder in several 
categories. These pathways included histone methylation, neural signaling, and immune 
pathways (108). Mamdani et al. reversed this type of analysis by testing for significant 
enrichment of previously identified GWAS signals in gene networks from their study. They 
found that expression quantitative trait loci for AD-associated gene expression networks in 
human nucleus accumbens tissue had significant enrichment with AD diagnosis and 
symptom count GWAS signals from the Collaborative Study on the Genetics of Alcoholism 
dataset (107). Additional approaches have taken human GWAS significant (or suggestive) 
results for AD and provided additional confirmation by showing that expression levels for 
such genes showed correlations with ethanol behaviors in rodent models (109).  Such 
methods are informative with respect to analyzing the function of genes that have already 
reached some association significance threshold. However, they do not provide information 
about genes not reaching such statistical thresholds, but possibly still having important 
contributions to the genetic risk and mechanisms of AUD 
As discussed in the Background section, dense module searching for GWAS 
(dmGWAS) is an algorithm for directly integrating GWAS data and other biological network 
information so as to identify gene networks contributing to a genetic disorder, even if few of 
the individual network genes exceed genome-wide statistical association thresholds (110). 
The initial description of this approach utilized Protein-Protein Interaction (PPI) network 
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data to identify networks associated with a GWAS phenotype. Modules derived from 
protein-protein interactions were scored from node-weights based on gene-level GWAS p-
values. This approach was used to identify AD-associated PPI networks that replicated across 
ethnicities and showed significant aggregate AD-association in independent GWAS datasets 
(103), thus demonstrating the potential utility of the method. A more recent iteration of the 
dmGWAS algorithm, termed Edge-Weighted dense module searching for GWAS (EW-
dmGWAS), allows integration of gene expression data to provide a direct co-analysis of gene 
expression, PPI, and GWAS data (111).  
Utilization of the EW-dmGWAS algorithm would allow for identification of gene 
networks coordinately weighted for GWAS significance for AD in humans and ethanol-
responsiveness in model organism brain gene expression data. We hypothesized that such an 
approach could provide novel information about candidate gene networks likely contributing 
to the genetic risk for AUD, while also adding mechanistic information about the role of such 
networks in ethanol behaviors. We show here the first use of such an approach for the 
integration of human PPI connectivity with mouse brain expression responses to acute 
ethanol and human GWAS results on AD. Our design incorporated the genome-wide 
microarray expression dataset derived from the acute ethanol-exposed mouse brain tissue 
used in Wolen et al. (115, 120), human protein-protein interaction data from the Protein 
Interaction Network database, and AD GWAS summary statistics from the Irish Affected 
Sib-Pair Study of Alcohol Dependence (109). Importantly, we validated the identified 
ethanol-responsive and AD-associated networks by co-analysis with an additional, 
independent AD GWAS study on the Avon Longitudinal Study of Parents and Children 
dataset. Our results, although requiring further detailed investigation, could provide 
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important methodological and biological function insight for future studies on the 
mechanisms and treatment of AUD.  
 
Materials and methods 
Samples 
Mouse gene expression data 
In order to maximize the utility of the mouse model by minimizing effects of 
behavioral and environmental variation, and to afford the identification of dependence-
contributing genes involved in initial ethanol response, this study utilized gene expression 
data from ethanol-naïve mice treated with a single dose of acute ethanol. All mouse brain 
microarray data (Affymetrix GeneChip Mouse Genome 430 2.0) are from Wolen et al., 2012 
(120) and can be downloaded from the GeneNetwork resource (www.genenetwork.org), via 
accession numbers GN135-137, GN154-156 and GN228-230, respectively for PFC, NAc and 
VTA data. Treatment and control groups each contained one sample (pooled RNA from 3 
mice) from each strain and were given IP injections of saline or 1.8 g/kg of ethanol, 
respectively. Euthanasia and brain tissue collection took place 4 hours later. Data used for 
edge weighting in EW-dmGWAS analysis included Robust Multi-array Average (RMA) 
values, background-corrected and normalized measures of probe-wise expression, from the 
PFC, VTA, and NAc of male mice in 27-35 BXD recombinant inbred strains and two 
progenitor strains (DBA/2J and C57BL/6J).  
Ethanol-responsive genes are predicted to be involved in pathways of neural 
adaptations that lead to dependence (120). We predicted they would also be involved in 
mechanistic pathways from which GWAS signals are being detected. We therefore filtered 
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for ethanol-responsive gene expression as done in Wolen et al.(120) prior to EW-dmGWAS 
so as to ensure edge weighting focused on ethanol responsiveness. Probe-level expression 
differences between control and ethanol-treated groups using the S-score algorithm which 
performs a probe-level analysis of expression between two groups (96, 123, 124) were 
obtained from the Wolen study (120) (S1 Table). Fisher’s Combined Test determined S-score 
significance values for ethanol responsiveness of each probeset across the entire BXD panel, 
and empirical p-values were calculated by 1,000 random permutations. Finally, q-values 
were calculated from empirical p-values to determine the false discovery rates due to 
multiple testing (120). We defined an ethanol responsive gene set using a S-score probeset-
level threshold of qFDR<0.1 for differential expression, in any one of the three brain regions. 
Genes associated with these probesets were carried forward in our analysis (Fig 1a). Multiple 
probesets from single genes were reduced to single gene-wise expression levels within a 
particular brain region by selecting the maximum brain region-specific RMA value for each 
gene. After removing genes that were absent from the human datasets, 6,050 genes remained 
with expression values across all three brain regions (Fig 1a).  
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Figure 1: (a) Pipeline used to prepare the data for the present analysis. The first cell contains the starting number 
of genes in the BXD mouse PFC, NAc, and VTA gene expression dataset.  (b) Implementations made to the 
standard EW- dmGWAS pipeline. Empirical p-values were calculated from standardized module scores based 
on a Z-distribution. Original EW-dmGWAS module score, permutation, and score standardization algorithms 
were used to calculate the respective Mega Modules parameters. Modules were considered to have >80% 
overlap if >80% of the genes in the smaller module were contained in the larger module. False Discovery Rates 
were calculated based on the Benjamini-Hochberg algorithm, using the “stats” package in R. Intramodular 
connectivity was defined as the number of edges (i.e. connections) attached to that node (i.e. gene). Eigen-
Centrality was calculated using the “igraph” package in R. 
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Human GWAS data 
 
  Although many GWAS datasets now exist for AD, alcohol consumption and other 
ethanol responses, we chose two AD-related datasets for our analysis because of the 
phenotypic and methodological similarity between the studies and their availability at the 
time this work was initiated. The Irish Affected Sib-Pair Study of Alcohol Dependence 
(IASPSAD) AD GWAS dataset was used for the EW-dmGWAS analysis. It contains 
information from 1,748 unscreened controls (43.2% male) and 706 probands and affected 
siblings (65.7% male) from a native Irish population, after quality control (109). Samples 
were genotyped on Affymetrix v6.0 SNP arrays. Diagnostic criteria for AD were based on 
the DSM-IV, and probands were ascertained from in- and out-patient alcoholism treatment 
facilities. Association of each Single Nucleotide Polymorphisms (SNP) with AD diagnosis 
status was tested by the Modified Quasi-Likelihood Score method (125), which accounts for 
participant relatedness. SNPs were imputed using IMPUTE2 (126) to hg19/1000 Genomes, 
and gene-wise p-values were calculated using Knowledge-Based mining system for Genome-
wide Genetic studies (KGG2.5) (127). This dataset was chosen because of its deep 
phenotyping and its theoretical consistency with findings from mouse experiments. The 
expression of the top-scoring genes in IASPSAD (COL6A3, RYR3, and KLF12) in mouse 
brain correlates with handling-induced convulsions, anxiety-like behavior, and acute 
functional tolerance to ethanol, respectively(109).  
 The Avon Longitudinal Study of Parents and Children (ALSPAC) GWAS gene-wise 
p-values were used to examine the ability of EW-dmGWAS to validate the EW-dmGWAS 
networks. This GWAS tested SNP association with a factor score calculated from 10 Alcohol 
Use Disorder Identification Test items for 4,304 (42.9% male) participants from Avon, UK. 
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Samples were genotyped by the Illumina HumanHap550 quad genome-wide SNP platform 
(128). This dataset was chosen because of its overall similarity to IASPSAD. Although the 
analyzed phenotypes were not identical between these two datasets, they were similar in that 
they both studied dependence symptoms, as opposed to non-diagnostic drinking measures. 
Additionally like IASPSAD, ALSPAC possessed the following important qualities: 100% of 
the sample was from the United Kingdom; the male to female ratio was roughly 1:1; SNPs 
were imputed to hg19/1000 Genomes; and gene-wise p-values were calculated by KGG2.5. 
No other GWAS dataset is as similar to IASPSAD to our knowledge, with respect to 
ancestral origin, genotyping, and phenotyping.  
Protein network data 
The Protein-Protein Interaction (PPI) network was obtained from the Protein 
Interaction Network Analysis (PINA 2.0) Platform 
(http://omics.bjcancer.org/pina/interactome.pina4ms.do). This platform was chosen because 
it includes PPI data from a wide array of databases, including: Intact, MINT, BioGRID, DIP, 
HPRD, and MIPS/Mpact. The Homo sapiens dataset was used for this analysis, due to it 
having much more content (166,776 binary interactions) than the mouse repository (only 
13,865 binary interactions) (129, 130). Uniprot IDs were used to match protein symbols to 
their corresponding gene symbols (131).  
 
Statistical methods 
EW-dmGWAS 
The edge-weighted dense module searching for GWAS (dmGWAS_3.0) R package 
was used to identify treatment-dependent edge-weighted modules (small, constituent 
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networks) nested within the background network(s) of non-weighted, binary interactions 
(https://bioinfo.uth.edu/dmGWAS/). We used the PPI framework for the background 
network, IASPSAD GWAS gene-wise p-values (109) for the node-weights, and RMA values 
from acute ethanol- and saline-exposed mouse PFC, VTA, and NAc genomic data for edge-
weights (120). For the remainder of this manuscript, we will use the term “network” to refer 
to the background PPI framework, and “module” to refer to the resulting groups of 
interrelated genes nested within this larger network. By the EW-dmGWAS algorithm, higher 
node-weights represent lower (i.e. more significant) GWAS p-values, whereas higher edge-
weights represent a greater difference in the correlation of two genes between ethanol and 
control groups. This is calculated by taking the difference of correlations in RMA expression 
values of the two genes in control vs. ethanol treated BXD lines. The module score algorithm 
incorporated edge- and node-weights, which were each weighted to prevent bias towards 
representation of nodes or edges in module score calculations. Such bias could cause some 
modules to be identified based almost solely on edge-weights or node-weights, as opposed to 
the two combined, which would defeat the purpose of integration. The respective weighting 
depends upon a parameter (λ) which is calculated prior to module searching, based on the 
entire set of node- and edge-weights and used across all module score calculations, as part of 
the EW-dmGWAS algorithm. Higher module scores thus represent higher edge- and node-
weights. Genes were kept in a module if they increased the standardized module score (Sn) 
by 0.5%. Sn corresponding to a permutation-based, empirical qFDR<0.05 were considered 
significant. A significant Sn (i.e. more significant qFDR values) indicates that a module’s 
constituent genes are more highly associated with AD in humans, and their interactions with 
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each other are more strongly perturbed by acute ethanol exposure in mice than randomly 
constructed modules of the same size.  
Due to the redundancy of genes between modules, we modified the EW-dmGWAS 
output by iteratively merging significant modules that overlapped >80% until no modules 
had >80% overlap, for each brain region. Percent overlap represented the number of genes 
contained in both modules (for every possible pair) divided by the number of genes in the 
smaller module. We call the final resulting modules “mega-modules”. Standardized mega-
module scores (MM-Sn) were calculated using the algorithms employed by EW-dmGWAS. 
MM-Sn corresponding to qFDR<0.05 were considered significant (Fig 1b). Finally, 
connectivity (k) and Eigen-centrality (EC) were calculated using the igraph R package for 
each gene in each module to identify hub genes. Nodes with EC>0.2 and in the top quartile 
for connectivity for a module were considered to be hub genes. 
Overlap with ALSPAC 
 Genes with an ALSPAC GWAS gene-wise p<0.001 were considered nominally 
significant, and will be referred to as “ALSPAC-nominal genes”. We used linear regression 
to test MM-Sn’s prediction of mean ALSPAC GWAS gene-wise p-value of each mega-
module. Given our hypothesis that EW-dmGWAS would identify alcohol-associated gene 
networks and prioritize them by association, we predicted that higher MM-Sn’s would predict 
lower (i.e. more significant) mean GWAS p-values. Empirical p-values<0.017, reflecting 
Bonferroni correction for 3 independent tests (one per brain region): α=0.05/3, were 
considered to represent significant association.  
Overrepresentation of ALSPAC-nominal genes within each mega-module was analyzed 
for those modules containing  >1 such gene.  For each of these mega-modules, 10,000 
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modules containing the same number of genes were permuted to determine significance. 
Empirical p-values < 0.05/n (where n = total number of mega-modules tested) were 
considered significant. 
Functional enrichment analysis 
 To determine if mega-modules with significant overrepresentation of ALSPAC-
nominal genes represented an aggregation of functionally related genes, ToppGene 
(https://toppgene.cchmc.org/) was used to analyze functional enrichment. Categories of 
biological function, molecular function, cellular component, mouse phenotype, human 
phenotype, pathways, and drug interaction were tested for over-representation. All genes in 
the human genome were included in the reference gene set. This set was not limited to the 
ethanol-responsive genes included in this analysis, in order to preclude functional bias. 
Significant over-representation results were defined as p<0.01 (uncorrected), n≥3 genes 
overlap and n≤1000 genes per functional group. Given the number of categories and gene 
sets tested, our discussion below was narrowed to the most relevant categories, defined as 
Bonferroni-corrected p<0.1. 
 
Results 
 Of the initial 45,037 probesets for the mouse gene expression arrays, 16,131 were 
associated with human-mouse homologues and had qFDR<0.1 for ethanol responsiveness (S-
score) in at least one of the three brain regions (Fig 1a). These probesets corresponded to a 
total of 7,730 genes and were trimmed to a single probeset per gene by filtering for the most 
abundant probeset as described in Methods. After removing genes that were absent from 
either the PPI network or the IASPSAD dataset, the final background PPI network for EW-
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dmGWAS analysis contained 6,050 genes (nodes) and 30,497 interactions (edges). The 
nodes contained 25 of the 78 IASPSAD-nominal genes and 24 of the 100 ALSPAC-nominal 
genes. There was no overlap between the IASPSAD and ALSPAC nominal gene sets. 
 
Prefrontal Cortex 
 For analysis using PFC expression data for edge-weights, results revealed 3,545 
significant modules (qFDR<0.05) containing a total of 4,300 genes, with 14 ALSPAC-nominal 
genes and 18 IASPSAD-nominal genes. These modules were merged to form 314 mega-
modules, all with significant MM-Sn. Twelve mega-modules contained at least one 
ALSPAC-nominal gene, and 160 contained at least one IASPSAD-nominal gene. However, 
MM-Sn did not significantly predict mean ALSPAC GWAS gene-wise p-value (β=-0.003, 
p=0.327, Fig 2). 
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Figure 2: Correlation between each Mega Module’s score and average ALSPAC gene-wise GWAS p-value, for 
the Prefrontal Cortex (PFC) (β=-0.003, p=0.327), Nucleus Accumbens (NAc) (β=0.003, p=0.390), and Ventral 
Tegmental Area (VTA) (β=-0.02, p=0.003). Blue lines represent the line of best fit, estimated by linear 
regression, surrounded by their 95% confidence intervals (shaded gray). 
 
Two mega-modules, Aliceblue and Cadetblue, contained multiple ALSPAC-nominal 
genes (Table 1). Because overrepresentation was tested for 2 mega-modules, p<0.025 
(α=0.05/2) was considered significant. Cadetblue, was significantly overrepresented with 
ALSPAC-nominal genes (Table 1). Each of Cadetblue’s ALSPAC- and IASPSAD-nominal 
genes was connected to one of its most highly connected hub genes, ESR1 (estrogen receptor 
1; connectivity (k)=31, Eigen-centrality (EC)=1) and ARRB2 (beta-arrestin-2; k=13, 
EC=0.25) (Fig 3). Although the ALSPAC-nominal gene overrepresentation was not 
64	
significant for Aliceblue, it approached significance (Table 1). Further, Aliceblue had the 
second-highest MM-Sn in the PFC and contained 3 ALSPAC-nominal genes and 3 
IASPSAD-nominal genes (Table 1).  For these reasons, Aliceblue was carried through to 
functional enrichment analysis. Aliceblue’s two hub genes were ELAVL1 ((embryonic lethal, 
abnormal vision)-like 1; k=165, EC=1) and CUL3 (cullin 3; k=75, EC=0.21), which were 
connected to two of the three ALSPAC-nominal genes. Of these, CPM’s (carboxypeptidase 
M’s) only edge was with ELAVL1, and EIF5A2’s (eukaryotic translation initiation factor 
5A2’s) only edge was with CUL3 (Fig 3). 
Both Cadetblue and Aliceblue showed significant enrichment in several functional 
categories (S3 Table). In sum, top functional enrichment categories for Aliceblue were 
related to actin-based movement, cardiac muscle signaling and action, increased triglyceride 
levels in mice, cell-cell and cell-extracellular matrix adhesion, and syndecan-2-mediated 
signaling. In contrast, Cadetblue’s top enrichment categories involved transcription-
regulatory processes, specifically: RNA splicing, chromatin remodeling, protein alkylation 
and methylation, DNA replication regulation, several immune-related pathways, NF-κβ and 
Wnt signaling pathways, and reductase activity (Tables 2 and 3; S3 Table). 
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Table 1. ALSPAC Nominal Gene Overrepresentation. 
Brain&Region Mega,modules kg MM,Sn& MM,Sn&qFDR Overrep.&p Gene IASPSAD&GWAS&p ALSPAC&GWAS&p
PFC aliceblue 392 11.19 <1E,16* 0.063 CPM 0.493 6.48E,05*
CACNB2 0.978 4.97E,04*
EIF5A2 0.163 8.06E,04*
RSL1D1 3.48E,04* 0.217
SMARCA2 4.91E,04* 0.877
KIAA1217 8.84E,04* 0.904
cadetblue 125 6.30 1.08E,06* 0.013* BCAS2 0.029 4.65E,04*
PIK3C2A 0.432 9.52E,04*
RSL1D1 3.48E,04* 0.217
AKT2 3.90E,05* 0.980
NAc cadetblue2 195 8.04 8.06E,16* 0.042 CPM 0.493 6.48E,05*
MGST3 0.358 4.62E,04*
gray26 12 6.39 9.95E,11* <0.001* PCDH7 0.007 2.10E,04*
BCAS2 0.029 4.65E,04*
VTA coral 399 4.78 1.00E,06* 0.068 CPM 0.493 6.48E,05*
DENND2C 0.018 4.33E,04*
BIRC7 0.930 4.37E,04*
MGST3 0.358 4.62E,04*
PIK3CA 7.06E,05* 0.007
TNN 3.00E,04* 0.018
ANO6 6.32E,04* 0.780
SMARCA2 4.91E,04* 0.877
SIMC1 2.04E,04* 0.977
limegreen 220 5.22 1.19E,07* 0.054 DENND2C 0.018 4.33E,04*
EIF5A2 0.163 8.06E,04*
RSL1D1 3.48E,04* 0.217
CCND2 1.94E,04* 0.603
AKT2 3.90E,05* 0.980
bisque 89 6.22 7.57E,10* 0.006* ACLY 0.701 2.21E,04*
PRKG1 0.647 8.26E,04*
AKT2 3.90E,05* 0.980
 
The following characteristics are displayed for each mega-module that contained >1 
ALSPAC-nominal gene: affiliated brain region; total number of constituent genes (kg); 
constituent ALSPAC- and IASPSAD-nominal genes; empirical p-values for ALSPAC-
nominal overrepresentation (Overrep. p); MM-Sn, and the associated False Discovery Rate 
(MM-Sn qFDR).  * Significant p-values: p<0.05 for MM Sn;  p<0.05/n for ALSPAC 
overrepresentation, where n=number of tests per brain region; p<0.001 for IASPSAD and 
ALPSAC GWAS.  
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Figure 3: Prefrontal Cortex Mega Modules Cadetblue (a) and Aliceblue (b).  Solid black arrows point to 
ALSPAC GWAS nominal genes, and dotted black arrows represent IASPSAD nominal genes. Edge-width is 
proportional to the difference in correlation strength between treatment and control mice, and node color 
represents IASPSAD GWAS p-values. 
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Table 2. Top Gene Ontology Enrichment Results for PFC Mega Module Cadetblue. 
Category Name p,value
q,value1
Bonferroni
Hit1Count1in1
Query1List
Hit1Count1
in1Genome Hit1in1Query1List
GO:1Biological1Process chromatin1organization 1.50E,09 4.12E,06 23 776
SMYD1,1ESR1,1KAT6A,1ASH1L,1PAGR1,1CBX4,11KDM6B,1ASH2L,1
MYSM1,1PHF21A,1BPTF,1UBN1,11CBX6,1SUPT16H,1SMARCD3,1
H3F3B,1PAX5,1PAX7,11BRD1,1CABIN1,1MGEA5,1NR1H4,1CBX8
histone1modification 1.97E,06 5.40E,03 14 453 SMYD1,1KAT6A,1ASH1L,1PAGR1,1KDM6B,1ASH2L,1MYSM1,1
PHF21A,1PAX5,1PAX7,1BRD1,1MGEA5,11NR1H4,1CBX8
covalent1chromatin1modification 2.87E,06 7.89E,03 14 468 SMYD1,1KAT6A,1ASH1L,1PAGR1,1KDM6B,1ASH2L,1MYSM1,1
PHF21A,1PAX5,1PAX7,1BRD1,1MGEA5,11NR1H4,1CBX8
chromatin1remodeling 1.47E,05 4.04E,02 8 165 SMYD1,1ESR1,1ASH2L,1MYSM1,1BPTF,1SMARCD3,1H3F3B,1
PAX7
RNA1splicing 1.60E,05 4.40E,02 12 403 SRSF6,1NUDT21,1BCAS2,1RBM39,1RALY,1RBM5,11PRPF19,1
AKT2,11CPSF2,1SNRPD3,1WDR77,1AQR
protein1alkylation 2.44E,05 6.71E,02 8 177 SMYD1,1ASH1L,1ASH2L,1PAX5,1PAX7,1SNRPD3,11WDR77,1
NR1H4
protein1methylation 2.44E,05 6.71E,02 8 177 SMYD1,1ASH1L,1ASH2L,1PAX5,1PAX7,1SNRPD3,11WDR77,1
NR1H4
GO:1Cellular1Component nucleoplasm1part 2.23E,05 7.49E,03 16 738
MMS22L,1SRSF6,1NUDT21,1KAT6A,1PAGR1,1CBX4,1ELMSAN1,1
ASH2L,1RBM39,1PHF21A,1UBN1,11TONSL,1PRPF19,1SPOP,1
CPSF2,11BRD1
chromosome 1.21E,04 4.07E,02 17 943
MMS22L,1PSEN2,1BCAS2,1ESR1,1KAT6A,1ASH1L,11ZNF207,1
ASH2L,1ESCO2,1CBX6,1TONSL,1SUPT16H,1PRPF19,1SMARCD3,1
H3F3B,11NR1H4,1CBX8
ribonucleoside,diphosphate1
reductase1complex
1.24E,04 4.17E,02 2 3 RRM2B,1RRM2
DNA1replication1factor1A1
complex
1.39E,04 4.67E,02 3 16 BCAS2,1TONSL,1PRPF19
nuclear1replication1fork 1.40E,04 4.71E,02 4 41 MMS22L,1BCAS2,1TONSL,1PRPF19
catalytic1step121spliceosome 2.96E,04 9.94E,02 5 90 BCAS2,1RALY,1PRPF19,1SNRPD3,1AQR
GO:1Molecular1Function oxidoreductase1activity,1acting1
on1CH1or1CH21groups
3.32E,05 1.62E,02 3 10 CYP2C8,1RRM2B,1RRM2
oxidoreductase1activity,1acting1
on1CH1or1CH21groups,1disulfide1
as1acceptor
1.31E,04 6.38E,02 2 3 RRM2B,1RRM2
ribonucleoside,diphosphate1
reductase1activity,1thioredoxin1
disulfide1as1acceptor
1.31E,04 6.38E,02 2 3 RRM2B,1RRM2
ribonucleoside,diphosphate1
reductase1activity
1.31E,04 6.38E,02 2 3 RRM2B,1RRM2
chromatin1binding 1.69E,04 8.24E,02 12 516 ESR1,1KAT6A,1ASH1L,1RELB,1CBX4,1KDM6B,1ASH2L,1PHF21A,1
TLE4,1SMARCD3,1H3F3B,1CABIN1
Mouse1Phenotype increased1immunoglobulin1level 1.16E,06 2.92E,03 14 307 TRAF3IP2,1GADD45B,1SEMA4B,1PSEN2,1ESR1,11SPTA1,1ASH1L,1
BIRC3,1RELB,1MYSM1,1CD4,11PIK3C2A,1RABGEF1,1CABIN1
abnormal1humoral1immune1
response 5.52E,06 1.39E,02 18 566
TRAF3IP2,1GADD45B,1SEMA4B,1PSEN2,1ESR1,11SPTA1,1
MAP3K14,1ASH1L,1BIRC3,1RELB,11TNFRSF11A,1MYSM1,1CD4,1
PIK3C2A,1CD38,11RABGEF1,1PAX5,1CABIN1
abnormal1immunoglobulin1level 7.68E,06 1.93E,02 17 522
TRAF3IP2,1GADD45B,1SEMA4B,1PSEN2,1ESR1,11SPTA1,1
MAP3K14,1ASH1L,1BIRC3,1RELB,11TNFRSF11A,1MYSM1,1CD4,1
PIK3C2A,1RABGEF1,11PAX5,1CABIN1
increased1IgG1level 9.35E,06 2.35E,02 11 225 TRAF3IP2,1GADD45B,1SEMA4B,1ESR1,1SPTA1,11ASH1L,1BIRC3,11
MYSM1,1CD4,1PIK3C2A,1CABIN1
cortical1renal1glomerulopathies 1.18E,05 2.96E,02 10 188 TRAF3IP2,1GADD45B,1PSEN2,1MYO1E,1ESR11,1SPTA1,1RRM2B,11
ASH1L,1RELB,1PIK3C2A
abnormal1lymph1node1
morphology
1.85E,05 4.66E,02 14 390 SELL,1TRAF3IP2,1TRAF1,1PSEN2,1ESR1,1SPTA1,11RRM2B,1
MAP3K14,1BIRC3,1RELB,1TNFRSF11A,11CD4,1PIK3C2A,1PIP
glomerulonephritis 1.95E,05 4.91E,02 8 121 TRAF3IP2,1GADD45B,1PSEN2,1ESR1,1SPTA1,1ASH1L,1RELB,1
PIK3C2A
abnormal1B1cell1physiology 3.21E,05 8.07E,02 18 644
MYO1G,1TRAF3IP2,1GADD45B,1SEMA4B,1PSEN2,1ESR1,1
SPTA1,1MAP3K14,1ASH1L,1BIRC3,1RELB,1TNFRSF11A,1MYSM1,1
CD4,1PIK3C2A,1RABGEF1,1PAX5,1CABIN1
Pathway Signaling1by1Wnt 2.78E,06 2.47E,03 13 340 LGR4,1ASH2L,1FZD4,1ARRB2,1ZNRF3,1TLE4,1VPS35,1H3F3B,1
AKT2,11GNAO1,1FZD2,1MOV10,1RAC3
NF,kappa1B1signaling1pathway 1.07E,04 9.44E,02 6 95 GADD45B,1TRAF1,1MAP3K14,1BIRC3,1RELB,1TNFRSF11A
Apoptosis 1.13E,04 9.97E,02 7 138 GADD45B,1TRAF1,1SEPT4,1SPTA1,1MAP3K14,1BIRC3,1AKT2
 
Functional enrichment results from ToppFun for Prefrontal Cortex Mega Module Cadetblue, 
where Bonferroni-corrected p<0.1. 
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Table 3. Top Gene Ontology Enrichment Results for PFC Mega Module Aliceblue. 
Category Name p,value
q,value1
Bonferroni
Hit1Count1in1
Query1List
Hit1Count1in1
Genome Hit1in1Query1List
GO:1Biological1Process regulation1of1actin1filament,based1
movement
4.76E,08 2.07E,04 9 37 FXYD1,1ATP1A2,1DBN1,1GJA5,1JUP,1KCNJ2,1DSC2,1DSG2,1DSP
cardiac1muscle1cell,cardiac1muscle1
cell1adhesion
7.53E,08 3.27E,04 5 7 CXADR,1JUP,1DSC2,1DSG2,1DSP
regulation1of1cardiac1muscle1cell1
contraction
1.64E,07 7.11E,04 8 31 FXYD1,1ATP1A2,1GJA5,1JUP,1KCNJ2,1DSC2,1DSG2,1DSP
actin1filament,based1process 3.57E,07 1.55E,03 36 688
CDC42EP4,1ACTN1,1MYOZ1,1MKLN1,1FXYD1,1RHOF,1SDC4,1
CUL3,1PRR5,1CRYAA,1ARHGDIA,1ATP2C1,1CCDC88A,1STAU2,1
DYNLL1,1DIXDC1,1ATP1A2,1CXADR,1DBN1,1PTGER4,1GJA5,1
JUP,1CDK5R1,1NF1,1KCNJ2,1CACNB2,11DSC2,1DSG2,1DSP,1
ARHGEF5,1CASP4,1LCP1,1CSRP3,1LIMK1,1LDB3,1LRP1
cell1communication1involved1in1
cardiac1conduction
4.34E,07 1.89E,03 9 47 PRKACA,1ATP1A2,1CXADR,1GJA5,1JUP,1CACNB2,1DSC2,1DSG2,1
DSP
desmosome1organization 8.59E,07 3.73E,03 5 10 SNAI2,1JUP,1DSG2,1DSP,1PKP3
cardiac1muscle1cell1action1potential 1.07E,06 4.65E,03 9 52 ATP1A2,1CXADR,1GJA5,1JUP,1KCNJ2,1CACNB2,1DSC2,1DSG2,1
DSP
cardiac1muscle1cell1contraction 1.07E,06 4.65E,03 9 52 FXYD1,1ATP1A2,1GJA5,1JUP,1KCNJ2,1CACNB2,1DSC2,1DSG2,1
DSP
bundle1of1His1cell1to1Purkinje1
myocyte1communication
1.55E,06 6.72E,03 5 11 GJA5,1JUP,1DSC2,1DSG2,1DSP
regulation1of1cardiac1muscle1cell1
action1potential
2.30E,06 9.99E,03 6 20 CXADR,1GJA5,1JUP,1DSC2,1DSG2,1DSP
bundle1of1His1cell,Purkinje1
myocyte1adhesion1involved1in1cell1
communication
2.63E,06 1.14E,02 4 6 JUP,1DSC2,1DSG2,1DSP
regulation1of1heart1rate1by1cardiac1
conduction
2.65E,06 1.15E,02 7 31 GJA5,1JUP,1KCNJ2,1CACNB2,1DSC2,1DSG2,1DSP
cardiac1conduction 3.37E,06 1.46E,02 13 131 FXYD1,1PRKACA,1ATP1A2,1ATP1A4,1CXADR,1GJA5,1JUP,1KCNJ2,1
CACNB2,1CACNB4,1DSC2,1DSG2,1DSP
cardiac1muscle1cell1action1
potential1involved1in1contraction
7.69E,06 3.34E,02 7 36 GJA5,1JUP,1KCNJ2,1CACNB2,1DSC2,1DSG2,1DSP
regulation1of1actin1filament,based1
process 1.05E,05 4.58E,02 21 343
CDC42EP4,1FXYD1,1SDC4,1ARHGDIA,1CCDC88A,1STAU2,1
DIXDC1,1ATP1A2,1DBN1,1PTGER4,1GJA5,1JUP,1CDK5R1,1KCNJ2,1
DSC2,1DSG2,1DSP,1ARHGEF5,1CSRP3,1LIMK1,1LRP1
lipoprotein1localization 1.34E,05 5.83E,02 5 16 APOB,1APOC2,1MSR1,1CUBN,1LRP1
lipoprotein1transport 1.34E,05 5.83E,02 5 16 APOB,1APOC2,1MSR1,1CUBN,1LRP1
regulation1of1cardiac1muscle1
contraction
1.36E,05 5.91E,02 9 70 FXYD1,1PRKACA,1ATP1A2,1GJA5,1JUP,1KCNJ2,1DSC2,1DSG2,1
DSP
GO:1Cellular1Component intercalated1disc 2.90E,06 1.53E,03 9 59 ACTN1,1ATP1A2,1CXADR,1GJA5,1JUP,1KCNJ2,1DSC2,1DSG2,1DSP
cell,cell1contact1zone 1.56E,05 8.21E,03 9 72 ACTN1,1ATP1A2,1CXADR,1GJA5,1JUP,1KCNJ2,1DSC2,1DSG2,1DSP
desmosome 1.61E,04 8.49E,02 5 26 JUP,1DSC2,1DSG2,1DSP,1PKP3
GO:1Molecular1Function protein1binding1involved1in1
heterotypic1cell,cell1adhesion
8.62E,07 7.88E,04 5 10 CXADR,1JUP,1DSC2,1DSG2,1DSP
protein1binding1involved1in1cell1
adhesion
1.15E,06 1.05E,03 6 18 CXADR,1ITGA2,1JUP,1DSC2,1DSG2,1DSP
protein1binding1involved1in1cell,cell1
adhesion
2.62E,06 2.39E,03 5 12 CXADR,1JUP,1DSC2,1DSG2,1DSP
cell1adhesive1protein1binding1
involved1in1bundle1of1His1cell,
Purkinje1myocyte1communication
2.64E,06 2.41E,03 4 6 JUP,1DSC2,1DSG2,1DSP
Human1Phenotype Dilated1cardiomyopathy 4.35E,05 3.89E,02 9 87 ACAD9,1CRYAB,1UBR1,1JUP,1DSG2,1DSP,1LAMA4,1CSRP3,1LDB3
Right1ventricular1cardiomyopathy 8.82E,05 7.90E,02 4 13 JUP,1DSC2,1DSG2,1DSP
Mouse1Phenotype increased1circulating1triglyceride1
level
1.27E,05 4.77E,02 16 179 ALPI,1COL1A1,1VLDLR,1AGPAT2,1WRN,1APOB,1APOC2,1TXNIP,1
RSBN1,1CSF2,1PRKACA,1BGLAP,1MED13,1LEPR,1LIPC,1LRP1
Pathway Non,integrin1membrane,ECM1
interactions
3.41E,05 4.72E,02 7 46 ACTN1,1SDC2,1SDC4,1ITGA2,1LAMA3,1LAMA4,1LAMB3
Syndecan,2,mediated1signaling1
events
4.44E,05 6.14E,02 6 33 SDC2,1CSF2,1PRKACA,1ITGA2,1NF1,1LAMA3
 
Functional enrichment results from ToppFun for Prefrontal Cortex Mega Module Aliceblue, 
where Bonferroni-corrected p<0.1. 
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Nucleus Accumbens 
 Using NAc acute ethanol expression data for edge-weights yielded 3,460 significant 
modules containing a total of 4,213 genes, 15 of which were ALSPAC-nominal and 16 of 
which were IASPSAD-nominal.  After merging by content similarity, there were 171 
significant mega-modules. Nineteen MM contained at least one ALSPAC-nominal gene, and 
73 MM contained at least one IASPSAD-nominal gene. However, MM Sn did not 
significantly predict MM mean ALSPAC GWAS gene-wise p-value (β=0.003, p=0.390). 
Two MMs, Cadetblue2 and Gray26, each contained two ALSPAC-nominal genes (Table 1). 
Because there were 2 tests for overrepresentation, p<0.025 (α=0.05/2) was considered 
significant. Gray26, was significantly overrepresented with ALSPAC-nominal genes, and 
Cadetblue2 showed a trend towards overrepresentation with significance before correcting 
for multiple testing (Table 1).  
Gray26’s most central hub gene was HNRNPU (heterogeneous nuclear 
ribonucleoprotein U; connectivity=6, Eigen-centrality=1), followed by RBM39 (RNA 
binding motif protein 39; k=3, EC=0.46) and CSNK1A1 (k=3, EC=0.37). The two ALSPAC-
nominal genes BCAS2 (breast carcinoma amplified sequence 2) and PCDH7 (protocadherin 
7), shared their only edges with RBM39 and HNRPNPU, respectively (Fig 4a). As seen in the 
PFC’s Aliceblue, ELAVL1 was a hub gene of Cadetblue2. ELAVL1 (k=136, EC=1) was 
connected to both of the ALSPAC-nominal genes, and served as the only connection for 
CPM and one of two connections for MGST3 (microsomal glutathione S-transferase 3) (Fig 
4b). Strikingly, PFC Aliceblue and NAc Cadetblue 2 showed a highly significant overlap in 
their gene content, with 72 overlapping genes (S2 Table; p=2.2 x 10-16). 
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Nucleus Accumbens Mega Module Cadet Blue 2
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Figure 4: Nucleus Accumbens Mega Modules Gray26 (a) and Cadetblue2 (b).  Solid black arrows point to 
ALSPAC GWAS nominal genes. These modules did not contain IASPSAD nominal genes. Edge-width is 
proportional to the difference in correlation strength treatment and control mice, and node color represents 
IASPSAD GWAS p-values.  
 
 
 Both Cadetblue2 and Gray26 were significantly enriched with several functional 
categories (S3 Table). Like PFC Cadetblue, NAc Cadetblue2 was functionally enriched for 
gene groups related to nuclear function with transcription regulation pathways, particularly 
those involving RNA polymerase activity. Gray26 was most significantly enriched with 
genes related to functions involving: telomere maintenance, organelle organization, 
ribonucleoprotein complexes, and syndecan-mediated signaling (Tables 4 and 5; S3 Table).
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Table 4. Top Gene Ontology Enrichment Results for Nucleus Accumbens Mega Module 
Cadetblue2. 
Category Name p,value
q,value1
Bonferroni
Hit1Count1in1
Query1List
Hit1Count1in1
Genome Hit1in1Query1List
GO:1Biological1Process
negative1regulation1of1transcription1
from1RNA1polymerase1II1promoter 9.38E,06 2.93E,02 23 810
TGIF2,1ZBTB20,1SREBF2,1E2F7,1FOXL2,1NFIB,1NFIC,1NFIX,1
MITF,1MNT,1TBX2,1MLX,1YBX3,1TFAP2C,1MXD4,1E2F8,1
ZBTB14,1MLXIPL,1UHRF1,1TNF,1ELK4,11PAX3,1LEF1
GO:1Molecular1Function
RNA1polymerase1II1transcription1
factor1activity,1sequence,specific1
DNA1binding
1.80E,09 1.20E,06 27 678
ZBTB20,1SREBF2,1GATA4,1E2F7,1CSRNP1,1FOXL2,1NFIB,1
NFIC,1NFIX,1MITF,11NFYA,1MNT,1HAND2,1TBX2,1TFEB,1
TEAD2,1MLX,1YBX3,1FOXJ3,1TFAP2C,11E2F8,1MLXIPL,1
KLF13,1ELF2,1ELK4,1PAX3,1LEF1
transcriptional1repressor1activity,1
RNA1polymerase1II1transcription1
regulatory1region1sequence,specific1
binding
3.04E,06 2.03E,03 11 182 ZBTB20,1SREBF2,1E2F7,1MITF,1MNT,1TBX2,1MLX,1YBX3,1
TFAP2C,1E2F8,11MLXIPL
transcription1factor1activity,1RNA1
polymerase1II1core1promoter1
proximal1region1sequence,specific1
binding
6.11E,06 4.08E,03 15 365
ZBTB20,1SREBF2,1FOXL2,1NFIB,1NFIC,1MITF,1NFYA,1
HAND2,1TBX2,1TFEB,11TFAP2C,1E2F8,1MLXIPL,1KLF13,1
LEF1
RNA1polymerase1II1regulatory1
region1sequence,specific1DNA1
binding
8.95E,06 5.98E,03 20 632
SREBF2,1GATA4,1E2F7,1FOXL2,1NFIB,1NFIC,1NFIX,1MITF,1
NFYA,1MNT,11HAND2,1TBX2,1TFEB,1MLX,1YBX3,1TFAP2C,1
E2F8,1MLXIPL,1KLF13,1LEF1
transcription1regulatory1region1DNA1
binding 9.52E,06 6.36E,03 24 862
SREBF2,1GATA4,1E2F7,1FOXL2,1NFIB,1NFIC,1NFIX,1MITF,1
NFYA,1MNT,11HAND2,1TBX2,1TFEB,1MLX,1YBX3,1TFAP2C,1
E2F8,1ZBTB14,1MLXIPL,1KLF13,1UHRF1,1TNF,1ELK4,1LEF1
regulatory1region1DNA1binding 1.01E,05 6.74E,03 24 865
SREBF2,1GATA4,1E2F7,1FOXL2,1NFIB,1NFIC,1NFIX,1MITF,1
NFYA,1MNT,11HAND2,1TBX2,1TFEB,1MLX,1YBX3,1TFAP2C,1
E2F8,1ZBTB14,1MLXIPL,1KLF13,1UHRF1,1TNF,1ELK4,1LEF1
RNA1polymerase1II1regulatory1
region1DNA1binding 1.03E,05 6.87E,03 20 638
SREBF2,1GATA4,1E2F7,1FOXL2,1NFIB,1NFIC,1NFIX,1MITF,1
NFYA,1MNT,11HAND2,1TBX2,1TFEB,1MLX,1YBX3,1TFAP2C,1
E2F8,1MLXIPL,1KLF13,1LEF1
regulatory1region1nucleic1acid1
binding 1.07E,05 7.14E,03 24 868
SREBF2,1GATA4,1E2F7,1FOXL2,1NFIB,1NFIC,1NFIX,1MITF,1
NFYA,1MNT,11HAND2,1TBX2,1TFEB,1MLX,1YBX3,1TFAP2C,1
E2F8,1ZBTB14,1MLXIPL,1KLF13,1UHRF1,1TNF,1ELK4,1LEF1
transcription1regulatory1region1
sequence,specific1DNA1binding 1.32E,05 8.82E,03 21 705
SREBF2,1GATA4,1E2F7,1FOXL2,1NFIB,1NFIC,1NFIX,1MITF,1
NFYA,1MNT,11HAND2,1TBX2,1TFEB,1MLX,1YBX3,1TFAP2C,1
E2F8,1MLXIPL,1KLF13,1UHRF1,1LEF1
sequence,specific1double,stranded1
DNA1binding 2.50E,05 1.67E,02 21 736
SREBF2,1GATA4,1E2F7,1FOXL2,1NFIB,1NFIC,1NFIX,1MITF,1
NFYA,1MNT,11HAND2,1TBX2,1TFEB,1MLX,1YBX3,1TFAP2C,1
E2F8,1MLXIPL,1KLF13,1UHRF1,1LEF1
core1promoter1proximal1region1
sequence,specific1DNA1binding
7.08E,05 4.73E,02 14 399 SREBF2,1GATA4,1FOXL2,1NFIB,1NFIC,1MITF,1NFYA,1TBX2,1
TFEB,1E2F8,11MLXIPL,1KLF13,1UHRF1,1LEF1
core1promoter1proximal1region1DNA1
binding
7.47E,05 4.99E,02 14 401 SREBF2,1GATA4,1FOXL2,1NFIB,1NFIC,1MITF,1NFYA,1TBX2,1
TFEB,1E2F8,11MLXIPL,1KLF13,1UHRF1,1LEF1
transcriptional1activator1activity,1
RNA1polymerase1II1transcription1
regulatory1region1sequence,specific1
binding
9.15E,05 6.11E,02 13 358 GATA4,1CSRNP1,1FOXL2,1NFIB,1NFIC,1NFIX,1MITF,1NFYA,1
HAND2,1TFEB,11TFAP2C,1KLF13,1LEF1
double,stranded1DNA1binding 1.25E,04 8.37E,02 21 824
SREBF2,1GATA4,1E2F7,1FOXL2,1NFIB,1NFIC,1NFIX,1MITF,1
NFYA,1MNT,11HAND2,1TBX2,1TFEB,1MLX,1YBX3,1TFAP2C,1
E2F8,1MLXIPL,1KLF13,1UHRF1,1LEF1
Human1Phenotype Synophrys 3.61E,05 2.06E,02 5 48 ZBTB20,1NFIX,1MITF,1KLF13,1PAX3
Mouse1Phenotype absent1coat1pigmentation 2.38E,05 6.28E,02 4 15 MITF,1TFEB,1TFEC,1PAX3
 
Functional enrichment results from ToppFun for Nucleus Accumbens Mega Module 
Cadetblue2, where Bonferroni-corrected p<0.1.  
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Table 5. Top Gene Ontology Enrichment Results for Nucleus Accumbens Mega Module 
Gray26. 
Category Name p,value
q,value1
Bonferroni
Hit1Count1in1
Query1List
Hit1Count1in1
Genome Hit1in1Query1List
GO:1Biological1Process negative1regulation1of1telomere1maintenance1via1
telomerase
2.46E,05 2.92E,02 2 12 HNRNPU,1PML
negative1regulation1of1organelle1organization 4.65E,05 5.52E,02 4 340 PRKCD,1FGFR2,1HNRNPU,1PML
negative1regulation1of1telomere1maintenance1via1
telomere1lengthening
5.06E,05 6.00E,02 2 17 HNRNPU,1PML
GO:1Cellular1Component ribonucleoprotein1complex 8.99E,04 8.99E,02 4 751 CSNK1A1,1RPS18,1BCAS2,1HNRNPU
intracellular1ribonucleoprotein1complex 8.99E,04 8.99E,02 4 751 CSNK1A1,1RPS18,1BCAS2,1HNRNPU
Pathway Syndecan,4,mediated1signaling1events 2.67E,04 7.44E,02 2 31 PRKCD,1ITGA5
Syndecan,2,mediated1signaling1events 3.03E,04 8.44E,02 2 33 PRKCD,1ITGA5
 
Functional enrichment results from ToppFun for Nucleus Accumbens Mega Module Gray26, 
where Bonferroni-corrected p<0.1.  
  
Ventral Tegmental Area 
 Use of VTA control/ethanol gene expression responses for edge weighting initially 
resulted in 3,519 significant modules containing a total of 4,188 genes in EW-dmGWAS 
analysis. Merging by content similarity, resulted in 276 MMs, each with a significant MM Sn. 
Seventeen ALSPAC-nominal genes and 19 IASPSAD-nominal genes were spread across 25 
and 156 mega-modules, respectively. Furthermore, MM-Sn significantly predicted mean 
ALSPAC GWAS gene-wise p-value (β=-0.02, p=0.003).  
Mega-modules with the highest representation of ALSPAC-nominal genes included 
Coral, Limegreen, and Bisque (Table 1). Because there were 3 tests for overrepresentation, 
p<0.017 (α=0.05/3) was considered significant. Although overrepresentation of ALSPAC-
nominal genes was not significant in Coral and Limegreen, it was significant in Bisque, 
which has the highest MM-Sn of the three (Table 1; Fig 5). Bisque contained four highly 
interconnected genes: USP21 (ubiquitin specific peptidase 21; k=10, EC=1), USP15 
(ubiquitin specific peptidase 15; k=10, EC=0.65), TRIM25 (tripartite motif-containing 25; 
73	
k=10, EC=0.49), and HECW2 (HECT, C2 and WW domain containing E3 ubiquitin protein 
ligase 2; k=12, EC=0.48). HECW2 and TRIM25 shared edges with this MM’s IASPSAD-
nominal genes PRKG1 (protein kinase, cGMP-dependent, type I) and ACLY (ATP citrate 
lyase), respectively. However, none of the hub genes shared an edge with Bisque’s ALSPAC 
nominal gene, AKT2 (AKT serine/threonine kinase 2). Finally, Bisque had significant 
enrichment in several functional categories (S3 Table). It was most significantly enriched 
with genes associated with ubiquitination, ligase and helicase activity, and eukaryotic 
translation elongation (Table 6; S3 Table). 
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Table 6. Top Gene Ontology Enrichment Results for Ventral Tegmental Area Mega 
Module Bisque. 
Category Name p,value
q,value1
Bonferroni
Hit1Count1in1
Query1List
Hit1Count1in1
Genome Hit1in1Query1List
GO:1Cellular1Component nucleolus 6.41E,07 1.24E,04 17 894
ZNF106,1NEK2,1EEF1D,1RPL36,1PNKP,1SELENBP1,1
ZNF655,1RPS9,1WRN,1GATA3,1ZFHX3,1RORC,1DGCR8,11
TTC3,1ARNTL2,1NEK11,1RPL18
eukaryotic1translation1elongation1
factor111complex
1.27E,04 2.47E,02 2 4 EEF1D,1EEF1A2
GO:1Molecular1Function ubiquitin,protein1transferase1
activity
4.98E,07 1.33E,04 12 414 RC3H2,1TRAF4,1UBE2K,1TRIM2,1TRIM25,1TRIM9,1
HECW2,1TRIM8,1UBE2S,1RNF114,1TTC3,1TRIM37
ubiquitin,like1protein1transferase1
activity
9.70E,07 2.59E,04 12 441 RC3H2,1TRAF4,1UBE2K,1TRIM2,1TRIM25,1TRIM9,1
HECW2,1TRIM8,1UBE2S,1RNF114,1TTC3,1TRIM37
acid,amino1acid1ligase1activity 3.42E,06 9.12E,04 9 259 RC3H2,1TRIM2,1TRIM25,1TRIM9,1HECW2,1TRIM8,11
RNF114,1TTC3,1TRIM37
ligase1activity,1forming1carbon,
nitrogen1bonds
9.78E,06 2.61E,03 9 295 RC3H2,1TRIM2,1TRIM25,1TRIM9,1HECW2,1TRIM8,11
RNF114,1TTC3,1TRIM37
tubulin,glycine1ligase1activity 1.87E,05 5.00E,03 8 244 RC3H2,1TRIM2,1TRIM9,1HECW2,1TRIM8,1RNF114,1
TTC3,11TRIM37
protein,glycine1ligase1activity 1.87E,05 5.00E,03 8 244 RC3H2,1TRIM2,1TRIM9,1HECW2,1TRIM8,1RNF114,1
TTC3,11TRIM37
protein,glycine1ligase1activity,1
initiating
1.87E,05 5.00E,03 8 244 RC3H2,1TRIM2,1TRIM9,1HECW2,1TRIM8,1RNF114,1
TTC3,11TRIM37
coenzyme1F420,01gamma,glutamyl1
ligase1activity
1.87E,05 5.00E,03 8 244 RC3H2,1TRIM2,1TRIM9,1HECW2,1TRIM8,1RNF114,1
TTC3,11TRIM37
ribosomal1S6,glutamic1acid1ligase1
activity
1.87E,05 5.00E,03 8 244 RC3H2,1TRIM2,1TRIM9,1HECW2,1TRIM8,1RNF114,1
TTC3,11TRIM37
coenzyme1F420,21alpha,glutamyl1
ligase1activity
1.87E,05 5.00E,03 8 244 RC3H2,1TRIM2,1TRIM9,1HECW2,1TRIM8,1RNF114,1
TTC3,11TRIM37
UDP,N,acetylmuramoylalanyl,D,
glutamyl,2,6,diaminopimelate,D,
alanyl,D,alanine1ligase1activity
1.87E,05 5.00E,03 8 244
RC3H2,1TRIM2,1TRIM9,1HECW2,1TRIM8,1RNF114,1
TTC3,11TRIM37
protein,glycine1ligase1activity,1
elongating
1.87E,05 5.00E,03 8 244 RC3H2,1TRIM2,1TRIM9,1HECW2,1TRIM8,1RNF114,1
TTC3,11TRIM37
tubulin,glutamic1acid1ligase1
activity
2.05E,05 5.46E,03 8 247 RC3H2,1TRIM2,1TRIM9,1HECW2,1TRIM8,1RNF114,1
TTC3,11TRIM37
protein,glutamic1acid1ligase1
activity
2.17E,05 5.79E,03 8 249 RC3H2,1TRIM2,1TRIM9,1HECW2,1TRIM8,1RNF114,1
TTC3,11TRIM37
ligase1activity 2.38E,05 6.35E,03 10 415 LIG3,1RC3H2,1TRIM2,1TRIM25,1TRIM9,1HECW2,1TRIM8,11
RNF114,1TTC3,1TRIM37
DNA1helicase1activity 2.43E,04 6.49E,02 4 65 ERCC2,1GTF2H4,1RAD54B,1WRN
Pathway Eukaryotic1Translation1Elongation 1.67E,04 8.37E,02 5 98 EEF1D,1RPL36,1RPS9,1EEF1A2,1RPL18
 
Functional enrichment results from ToppFun for Ventral Tegmental Area Mega Module 
Bisque, where Bonferroni-corrected p<0.1.  
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Ventral Tegmental Area Mega Module Bisque
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Figure 5: Ventral Tegmental Area Mega Modules Bisque.  Solid black arrows point to ALSPAC GWAS 
nominal genes, and dotted black arrows represent IASPSAD nominal genes. Edge-width is proportional to the 
difference in correlation strength between treatment and control mice, and node color represents IASPSAD 
GWAS p-values. 
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Discussion 
To our knowledge, this is the first study to directly co-analyze human GWAS with 
mouse brain ethanol-responsive gene expression data to identify ethanol-related gene 
networks relevant to AD. Unlike previous studies that have employed cross-species 
validation methods for specific genes or gene sets, this study analyzed human and mouse 
data in tandem to identify gene networks across the entire genome, using the EW-dmGWAS 
algorithm. This approach successfully identified significantly ethanol-responsive and AD-
associated gene networks, or modules. We further improved the existing EW-dmGWAS 
algorithm by merging highly redundant modules to create more parsimonious mega-modules, 
thus decreasing complexity without sacrificing significance. Additionally, we validated these 
results by testing for overrepresentation with, and mega-module score prediction by, signals 
from an independent GWAS dataset. Overall, our findings suggest that such direct 
integration of model organism expression data with human protein interaction and GWAS 
data can productively leverage these data sources. Furthermore, we present initial evidence 
for novel, cross-validated gene networks warranting further study for mechanisms underlying 
AUD. 
 
Identification of Network-Level Associations Across GWAS Datasets 
One major concern with existing GWASs on AD had been the relative lack of 
replication across studies. Although some very large GWASs on alcohol consumption have 
shown replicable results (23, 26, 60), those do not account for all previously identified 
associations. We reasoned that our integrative gene network-querying approach might 
identify networks that shared signals from different GWASs on AD, even if the signals were 
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not from the same genes across GWASs. Concordant with this hypothesis, VTA mega-
module scores significantly predicted average gene-wise p-values from an independent 
GWAS dataset, ALSPAC (Fig 2). This suggests that ethanol-responsive gene expression 
networks in this brain region may be particularly sensitive to genetic variance and thus are 
highly relevant to mechanisms contributing to genetic risk for AD. This is possibly 
attributable to the involvement of VTA dopaminergic reward pathways in the development of 
AD (15). Further investigation of dopaminergic neuronal response to acute ethanol 
administration, and the association between this response and proclivity for developing 
dependence is needed. 
Although scores did not prioritize mega-modules with respect to ALSPAC results in 
PFC and NAc, individual mega-modules were overrepresented with ALSPAC signals (Table 
1). The ALSPAC-overrepresented VTA and PFC mega-modules also contained nominally 
significant genes from the GWAS dataset used for the network analysis, IASPSAD. These 
results suggest that the integration of acute ethanol-related expression data from mice and 
human PPI can identify functional networks that associate signals from different GWAS 
datasets. 
 
Composition and Structure of Mega-Modules  
Functional composition of mega-modules varied between brain regions for the most 
part. For example, although Aliceblue (PFC) and Cadetblue2 (NAc) shared the hub gene 
ELAVL1, ALSPAC-nominal gene CPM, and had a significant overlap in their gene content, 
their functional enrichment results were very different (Tables 3 and 4). These results suggest 
that brain regional ethanol-responsive gene expression results likely had an important impact 
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on composition of networks, thus leveraging protein-protein interaction network information 
and GWAS results.   
Despite such differences, the mega-modules presented in Table 1 shared certain 
structural similarities. Most of the IAPSAD- and ALSPAC-nominal genes in these modules 
shared edges with hub genes (Fig 3-5). These hub genes included: CUL3 and ELAVL1 from 
PFC Aliceblue; ESR1 from PFC Cadetblue; ELAVL1rom NAc Cadetblue2; TRIM25 and 
HECW2 from VTA Bisque. Further, GWAS nominally significant genes (IASPAD or 
ALSPAC) generally were not hub genes in the derived networks (see Fig 3-5; S2 Table). 
This may be consistent with the general tenet that genetic variation in complex traits does not 
produce major alterations in cellular function, but rather modulation of cellular mechanisms 
for maintaining homeostasis. Hub genes may be more closely functionally related to a given 
trait, but likely have such widespread influence so as to be evolutionarily resistant to genetic 
variation in complex traits. This is also consistent with the hypothesis that omnigenic 
influences are an important feature of complex traits such as AUD (132). 
One hub gene was found to influence network structure in both PFC and NAc. ELAVL1 
is a broadly expressed gene that acts as a RNA-binding protein in AU-rich domains, 
generally localized within 3’-UTRs of mRNA. As such, ELAVL1 has been shown to alter 
mRNA stability by altering binding of miRNA or other factors influencing mRNA 
degradation (133) and has been implicated in activity-dependent regulation of gene 
expression in the brain with drug abuse (134). The large interaction space for ELAVL1 in 
PFC Alice Blue and NAc Cadetblue 2 and the multiple nominal GWAS hits within these 
genes suggest that ELAVL1 could have an important modulatory function on the network of 
genes susceptible to genetic variation in AUD. 
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Functional Aspects of Mega-Modules 
This theory regarding network structure is further supported by our functional 
enrichment analysis, which revealed several small groups of functionally related genes within 
each mega-module. All of the mega-modules discussed above (Table 1) contained at least 
one GWAS-nominal gene in the top enrichment groups, except Cadetblue2, which still had 
GWAS-nominal genes in its significant enrichment groups (S3 Table). 
Another unifying feature across these mega-modules, except Aliceblue, was 
significant functional enrichment for pathways that regulate gene expression. Specifically, 
these pathways were related to chromatin organization, RNA splicing, and translation- and 
transcription-related processes (S3 Table). This is not surprising, as alterations in gene 
expression have long been proposed as a mechanism underlying long-term neuroplasticity 
resulting in ethanol-dependent behavioral changes, and eventually dependence (135). 
In contrast, the largest functional enrichment groups unique to Aliceblue were related to 
actin-based filaments and cardiac function (Tables 2 and 3). Actin not only provides 
cytoskeletal structure to neurons, but also functions in dendritic remodeling in neuronal 
plasticity, which likely contributes to AD development (136, 137). Aliceblue was also 
significantly enriched for the syndecan-2 signaling pathway, and contained the SDC2 gene 
itself, which functions in dendritic structural changes together with F-actin (138). 
Additionally, the most significant enrichment group unique to Cadetblue was the Wnt 
signaling pathway, which also regulates actin function (139, 140). Of note, a prior study has 
shown that ARRB2 (a Cadetblue hub gene and member of Wnt signaling pathway) knockout 
rats display significantly decreased levels of voluntary ethanol consumption and 
psychomotor stimulation in response to ethanol (141). These findings highlight the potential 
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importance of postsynaptic actin-related signaling and dendritic plasticity in PFC gene 
networks responding to acute ethanol and contributing to genetic risk for AD. Future studies 
may aim to confirm this association by investigating changes in actin and dendritic processes 
in response to acute ethanol exposure, and whether or not the degree of these changes is 
associated with development of dependence. 
Finally, although the NAc Cadetblue2 mega-module was highly enriched for functions 
related to transcriptional regulation, it also contained the gene FGF21 within its interaction 
space (S2 Table and Fig 4b). FGF21 is a member of the fibroblast growth factor gene family 
and is a macronutrient responsive gene largely expressed in liver. Importantly FGF21 has 
been shown to be released from the liver by ethanol consumption and negatively regulates 
ethanol consumption by interaction with brain FGF-receptor/beta-Klotho complexes. Beta-
Klotho, a product of the KLB gene, is an obligate partner of the FGF receptor and has 
recently been shown to have a highly significant association with alcohol consumption in 
recent very large GWAS studies (26, 60). Although the role of FGF21 and KLB in AD are 
not currently known, the association of FGF21 with the Cadetblue2 mega-module, 
containing nominally associated genes from AD GWAS studies, is a possible additional 
validation of the utility of our studies integrating protein-protein interaction information 
(tissue non-specific), AD GWAS (tissue non-specific) and brain ethanol-responsive gene 
expression. 
 
Potential Weaknesses and Future Studies  
The studies presented here provide evidence for the utility of integrating genomic 
expression data with protein-protein interaction networks and GWAS data in order to gain a 
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better understanding of the genetic architecture of complex traits, such as AD. Our analysis 
also generated several testable hypotheses regarding gene networks and signaling 
mechanisms related to ethanol action and genetic burden for AD. However, these studies 
utilized acute ethanol-related expression data in attempting to identify mechanisms of AD, a 
chronic ethanol exposure disease. Use of a chronic exposure model could provide for a more 
robust integration of the expression data and GWAS signals. However, we feel the current 
study is valid, since acute responses to ethanol have been repeatedly shown to be a heritable 
risk factor for AD (142-144). Further, large GWAS studies have recently shown significant 
genetic correlation and overlapping significant genes between alcohol consumption and 
alcohol dependence phenotypes (145, 146). We have also recently demonstrated a very high 
degree of overlap in mouse brain expression changes between acute ethanol exposure and a 
chronic ethanol vapor exposure model thought to mimic aspects of alcohol dependence (97). 
Our laboratory has also recently reported that an acute ethanol-responsive gene network from 
the same microarray data used for studies in this manuscript showed significant association, 
at a network level, with AD in data from the COGA GWAS analysis of AD (122). Finally, 
the cross-species analysis of acute ethanol responses and AD allowed us to explore networks 
involved in specific brain regional initial response to ethanol that are also related to 
dependence. Therefore, our findings may have implications for mechanistic activations or 
changes occurring upon initial ethanol exposure, and ultimately contributing to the 
development of dependence. 
A potential shortcoming for this work regards the limited size of the GWAS studies 
utilized and differences in phenotypic assessment. The IASPSAD study was based on AD 
diagnosis, whereas ALSPAC was based on a symptom factor score. Had we used larger 
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GWAS studies based on the same assessment criteria, it is possible that greater overlap of 
GWAS signals within mega-modules would have been observed.  Recent large GWAS 
studies on ethanol have, to date, generally concerned measures of ethanol consumption, 
rather than a diagnosis of alcohol dependence per se (26, 60). For this reason, we focused this 
initial effort on GWAS studies concerned with alcohol dependence. However, using the 
IASPAD and ALSPAC studies allowed us to identify gene networks that are robust across 
both the severe end of the phenotypic spectrum (i.e. diagnosable AD), and for symptoms at 
the sub-diagnostic level.  
Finally, although gene expression correlations are relatively largely conserved across 
mice and humans (105), network structure can vary across time and ethanol exposure (147) 
(28), as can the associations between genetic variants and gene expression (i.e. eQTL). This 
study examines networks and eQTL across low and high drinkers at one specific time point 
(24hrs after last ethanol access period), which could fail to represent networks and 
contributing loci unique to each drinking group or to other post-exposure time points. 
Networks and their respective eQTL are being examined within each of these drinking 
groups, in ongoing analyses in our laboratory. However, power to detect network eQTL will 
be decreased for eQTL that are common between low and high drinkers, due to the decreased 
sample size (N=100 per group, as opposed to N=200 total), hence the benefits of performing 
these analyses on all 200 ethanol-exposed mice. Future studies should examine gene 
expression networks in the PFC and their eQTL in larger samples of high and low voluntarily 
drinking mice, and collect brain tissue at various time points after (and possibly during) the 
last period of ethanol exposure. 
83	
Overall, this analysis successfully identified novel ethanol-responsive, AD-associated, 
functionally enriched gene expression networks in the brain that may play a causal role in the 
developmental pathway from first ethanol exposure to AD. This is the first analysis to 
identify such networks by directly co-analyzing brain regional gene expression data, protein-
protein interaction data, and GWAS summary statistics. The identified modules provided 
insight into common pathways between differing signals from independent, largely 
underpowered, yet deeply phenotyped GWAS datasets. This supports the conjecture that the 
integration of different GWAS results at a gene network level, rather than simply looking for 
replication of individual gene signals, could make use of previously underpowered datasets 
and identify common genetic mechanisms relevant to AD. Future expansion of such 
approaches to integrate additional model organism chronic ethanol-responsive gene sets with 
the rapidly evolving GWAS literature on alcohol consumption and dependence, together with 
validation of key targets by gene targeting in animals models, may provide both novel insight 
for the neurobiology of AD and the development of improved therapeutic approaches. 
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Chapter 3 
 
 
Characterization of Voluntary Ethanol Consumption in 8 Inbred Mouse 
Strains with Chronic versus Intermittent Ethanol Access 
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Introduction 
 
Model organism genetic studies, particularly in mice, have thus been used extensively 
to identify loci/genes associated with behavioral responses to ethanol. Furthermore, as human 
genome-wide association studies on AUD become larger and produce more significant 
findings, there will be a need to compare these to model organism findings to validate 
candidate genes and decipher biological mechanisms. However, mouse forward genetic 
studies on ethanol behaviors to date have produced few candidate genes validated in humans. 
This has largely been due to several factors, including: possible inaccurate modeling of 
human abusive alcohol consumption, limited genetic diversity and limited mapping 
resolution. 
Commonly used inbred mouse lines lack allelic diversity compared to humans. 
Furthermore, common laboratory mouse strains possess many large DNA blocks of linkage 
disequilibrium (LD), often showing extensive cross-strain homology, due to common 
ancestries and lack of sufficient meiotic events to produce recombination. Large LD blocks 
and allelic homogeneity preclude the identification of novel alcohol behavior-associated 
variants, and the narrowing of trait-associated regions to identify candidate genes. Recent 
efforts at increasing allelic diversity and mapping precision in mouse models, however, have 
used complex breeding schemes of multiple traditional inbred lines and incorporation of 
wild-derived strains, which harbor considerable genetic diversity (35). 
The Diversity Outbred (DO) panel, in particular, was created specifically for genetic 
analysis of complex behavioral traits. DO mice originated from interbreeding mice from the 
earlier generations of inbreeding in the creation of the Collaborative Cross lines. These 
mouse lines have great allelic heterogeneity resulting from 144 different breeding patterns 
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involving 8 progenitor strains: C57BL/6J, A/J, 129S1/SvlmJ, NOD/ShiLtJ, NZO/HiLtJ, 
CAST/EiJ, WSB/EiJ, and PWK/PhJ (35). The latter 3 strains are wild-derived lab strains, 
whose “wild” alleles contribute greatly and uniquely to both genetic and behavioral variation 
in the DO mice (32, 90). DO mice have already afforded identification of behavioral trait-
related loci (35). However, to our knowledge, research on alcohol-related traits in DO mice 
has not yet been published.  
Recent progress has also been made in the development of experimental designs 
providing possible increased consilience for studying AUD. Intermittent ethanol access 
(IEA) paradigms, comprised of alternating periods of free-choice ethanol access and forced 
abstinence, produce higher levels of ethanol consumption than continuous access models and 
have been shown to mimic aspects of compulsive ethanol consumption seen in humans (36, 
37, 77, 79, 148). IEA paradigms model the progressive increase in ethanol drinking seen in 
humans during the early stages of development of Alcohol Use Disorder (AUD) (77). Prior 
studies have identified strain-dependent variance in IEA, as seen with ethanol consumption 
and preference under chronic access paradigms, suggesting genetic contributions to variance 
in IEA (77-79).  
However, to our knowledge, use of DO mice for studies on ethanol-related traits such 
as IEA consumption has not been reported. Prior to pursuit of such complex analyses in DO 
mice, we hypothesized that studies on the heritability and diversity of constant vs. IEA 
consumption in the DO progenitor lines would determine the feasibility and aid design of an 
extensive genetic study in DO mice. Therefore, here we assess voluntary ethanol 
consumption and preference in the DO progenitor strains, to contrast both constant access 
and IEA consumption variation across these strains. To our knowledge, this study is the first 
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to characterize voluntary ethanol intake and preference in several of these strains 
(specifically NZO/HiLtJ, CAST/EiJ, WSB/EiJ, and PWK/PhJ). Our results show remarkable 
diversity in ethanol consumption patterns across the progenitor strains with IEA having 
strong strain-dependent contrasts with the constant ethanol access paradigm. The large 
heritability for these traits across the progenitor strains suggests that future large scale 
genetic screens for ethanol consumption in the DO mice are both feasible and likely to 
provide novel understanding of molecular factors influencing progression of ethanol 
consumption as seen in AUD. 
 
Materials and Methods 
Ethics Statement 
All animal care and euthanasia procedures were performed in accordance with the 
requirements and recommendations presented by the United States Department of 
Agriculture Animal Welfare Act and Regulations, Public Health Services Policy on Humane 
Care and Use of Laboratory Animals, and American Association for Accreditation of 
Laboratory Animal Care**. Humane endpoints were established by the same standards.  
Animals 
All mice were obtained from Jackson Laboratories at 8 weeks of age and were 
initially habituated to the animal vivarium for 1-2 weeks in group housing (n=4) before then 
being habituated to single housing for 1 week prior to experimentation. Mice were housed 
with 12-hour light-dark cycles and ad libitum access to water and standard chow (#7912, 
Harlan Teklad, Madison, WI, United States), in humidity-and temperature-controlled rooms 
with shaved cedar bedding. Cages were changed and body weights were recorded weekly.  
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Due to availability of strains from the supplier, two separate experiments were run for 
complete analysis of all progenitor strains. Experiment 1 contained 10 mice from each of the 
following strains: 1) C57BL/6J, A/J, 129S1/SvlmJ, NOD/ShiLtJ, NZO/HiLtJ, and CAST/EiJ. 
For Experiment 2 mice from the two remaining progenitor strains (WSB/EiJ and PWK/PhJ) 
were obtained from Jackson Laboratories on a later date. C57BL/6J mice were also included 
in this group, as a standard comparison.  
 
Experimental Design 
Experiment 1  
Five mice from each strain were exposed to a Chronic Ethanol Access (2) paradigm, 
and five were exposed to an Intermittent Ethanol Access (IEA) paradigm, each with three-
bottle choice (15% and 30% ethanol v/v, and water), for 8 weeks. Ethanol mixtures were 
composed of anhydrous ethanol and tap water. Mice undergoing CEA had constant access to 
the three bottles, whereas mice undergoing IEA had 3 periods of 24-hour access (12 hours in 
the dark, then 12 hours in the light) each week (Monday, Wednesday and Friday), alternating 
with periods of access to three bottles of water only, as seen in Hwa et al. (36) (Fig. 1). 
Ethanol and water consumption were measured for each 24-hour period of access under IEA, 
for both paradigms, resulting in 3 recordings per week and 23 recordings total for each 
paradigm. On IEA ethanol access days, placement order of bottles was randomized for both 
paradigms to avoid place preference confounds. Bottles of each fluid were placed in 
uninhabited cages to measure evaporation and spillage. Measurements from these bottles 
were taken concurrently with consumption measurements, and were subtracted from that 
day’s consumption values.  
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Figure 1: Experimental paradigms for Chronic Ethanol Access (2) and Intermittent Ethanol Access 
(IEA). Each block represents a day of the week, for which horizontal stripes represent the dark phases 
of the light-dark cycle, and solid areas represent light phases. White space represents periods during 
which mice had access to water only, and blue space represents period of ethanol access (1 bottle 15% 
EtOH, 1 bottle 30% EtOH, and 1 bottle water). These paradigms were repeated 8 times, resulting in 8 
weeks of IEA or CEA.  	
 
 
 
 
 
 
 
 
 
 
 
 
 
 
On the 24th ethanol access day of IEA, ethanol bottles were removed for all mice to 
begin a 7-10 day period of forced abstinence. At the end of this period, mice received 
intraperitoneal injections of 4 g/kg of 20% v/v ethanol, for pharmacokinetic analysis. Trunk 
blood was collected during euthanasia via cervical dislocation and decapitation, which was 
staggered across the following time points: 30 mins, 60 mins, and 240 minutes. One to two 
mice per strain from each treatment group were euthanized at each time point. Blood Ethanol 
Concentration (BEC) was quantified via Analox AM1 Analyzer (Analox Instruments, North 
Yorkshire, UK), and recorded in mgEtOH/dLblood (or %BEC). 
Experiment 2  
Because there were no significant differences between paradigms in Exp. 1, all mice 
in Exp. 2 were exposed to CEA, to increase power. Mice were exposed to 5 weeks of the 
same CEA paradigm described in Exp. 1. Additionally, to gather information about possible 
binge-like ethanol consumption in the PWK and WSB wild-derived strains, we measured 
ethanol and water consumption at 3 hrs after bottle placement, in addition to 24 hrs (as in 
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Exp. 1), and the additional time point of 3 hrs, after bottle order was changed for 5 
consecutive days per week, to characterize the pace at which they consumed ethanol on the 
final day of CEA. After 3 weeks of CEA access, bottles were removed to begin a one-week 
period of forced abstinence.  
As done in Exp. 1, following the week of forced abstinence, mice received 
intraperitoneal injections of 4 g/kg of 20% v/v ethanol. Trunk blood was collected during 
euthanasia via cervical dislocation and decapitation, which was staggered across the 
following time points, with 2 mice per time point: 15 mins, 30 mins, 60 mins, 120 mins, and 
180 mins. These time points, which differ from those used in Exp. 1, were chosen to achieve 
a better estimation of the shape of the metabolism curve. Due to deaths by unknown causes 
during the abstinence period, data was collected from only one mouse for C57/BL6J at 
15mins and PWK at 30mins. BEC was quantified using the same methods as Exp. 1. 
 
Statistical Analysis 
Experiment 1 
Ethanol consumption was measured as gEtOH/kgmouse, to account for weight 
differences. Total ethanol consumption was calculated by summing the 15% and 30% 
ethanol consumption values. Total ethanol preference was calculated as 
mLTotalEtOH/mLTotalFluid consumed. For heritability analysis and paradigm effect testing, each 
mouse’s total ethanol consumption and preference were averaged across the entire study. 
Because these mice were ethanol-naïve on the first day of ethanol access, this day was 
excluded from these calculations. All statistical analyses were run using the “stats” and 
“DescTools” R packages (http://www.R-project.org/). 
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Heritability was calculated using one-way ANOVA, such that broad-sense heritability 
(h2) = SSB/(SSB+SSW), where SSB and SSW represent the sum of squared error between and 
within strains, respectively ((149, 150)). Heritability was calculated for consumption and 
preference for each paradigm separately, and significance was determined by the p-value for 
mouse strain effect on the trait. Tukey Post-Hoc Test was performed to determine which 
strain differences contributed to significant heritability estimates.  
Because we were interested in the distinct effect of paradigm on consumption and 
preference within each strain, we tested this effect via two-tailed Welch’s t-test for each 
individual strain. We calculated False Discovery Rates to account for multiple testing within 
each trait.  
To test for an increase in ethanol consumption or preference over time for each strain, 
every mouse’s daily values were averaged over each the first and last week of ethanol access. 
We ran repeated-measures two-tailed Welch’s T-tests for consumption and preference within 
each strain, under CEA and IEA separately. False Discovery Rates were calculated to 
account for multiple-testing within each paradigm for each trait. We were further interested 
in the difference in this effect across strains, also known as a gene x environment interaction 
(151). Where at least one strain showed significant or suggestive time (i.e. ethanol exposure 
duration) effects, we tested for gene x environment interaction (i.e. time x strain interaction) 
via two-way ANOVA.  Although the main effects of strain and time period were not of 
interest here, they were included in each model to preclude false inflation of the interaction 
effect. 
Pearson correlations were used to assess the relationship between mean total ethanol 
consumption and BEC, at each post-injection time point. Because there were < 3 mice per 
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strain at some time points, the contribution of metabolic variation to strain differences was 
assessed qualitatively. This was done by calculating the cumulative BEC across all post-
injection time points and the ethanol elimination rate for each strain. Cumulative BEC was 
estimated by the area under the curve, based on strain mean BEC at each time point. 
Elimination rate was estimated by the slope of the same curve from point of highest 
measured BEC for that strain, to the final time point, calculated by linear regression. Because 
paradigm did not significantly effect ethanol consumption or preference (see Results), and all 
mice had been abstinent for ≥1 week, data were collapsed across treatment group for this 
analysis.  
Experiment 2  
Whole-study mean total ethanol consumption was calculated as seen in Exp. 1, for the 
3hr and 24hr time points. The proportion of daily ethanol consumed during the first 3hrs of 
access was calculated for each day. These values were averaged across the entire study, again 
excluding the first day of ethanol access.   
The same algorithms presented in Exp. 1 were used for the following analyses: 
heritability of mean total ethanol consumption and preference, and the associated post-hoc 
comparisons; change in consumption over time (first v. last week of ethanol access); and 
strain-specific ethanol kinetics and the relationship between BEC and total ethanol 
consumption. One-Way ANOVA was used to test for between-strain differences in 
proportion of daily ethanol consumed in the first 3hrs of access.  
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Results 
Experiment 1 
Paradigm did not have significant main effects on ethanol consumption or preference 
for any strain (Fig. 2; Table S2). There was also no significant increase in ethanol 
consumption or preference, for any strains after correction for multiple testing (Table S4a, 
Fig. 3a-b). However, increase in ethanol preference for NOD/ShiLtJ mice (t=2.41, p=0.022, 
qFDR =0.199) was significant (p<0.05) before adjustment for multiple testing, under CEA. 
The same was true for total ethanol consumption under IEA in A/J mice, but the direction of 
change was negative (t=-2.84, p=0.042, qFDR =0.190). Strain x time interactive effects on 
total ethanol consumption and preference, tested via two-way ANOVA, were not significant 
for either preference or consumption under CEA or IEA (Table S4b). 
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Figure 2: Average total ethanol consumption (a) and preference over water (b), across the entire experiment 
(except for access day1) for each strain in the first experimental group. Red and blue bars represent values 
under the Intermittent Ethanol Access (IEA) and Chronic Ethanol Access (2) paradigms, respectively. Black 
lines depict standard error around each mean, and letters represent significant differences between the strain 
depicted on x-axis and the corresponding strain listed in the legend.  
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Paradigm Trait Experiment Strains h2 p    
CEA Consumption 1 C57BL/6J, 129S1, CAST, NOD, NZO, A/J 0.71 6.659E-06 ***
2 C57BL/6J, WSB, PWK 0.78 1.695E-09 ***
Preference 1 C57BL/6J, 129S1, CAST, NOD, NZO, A/J 0.69 1.606E-05 ***
2 C57BL/6J, WSB, PWK 0.74 1.010E-08 ***
IEA Consumption 1 C57BL/6J, 129S1, CAST, NOD, NZO, A/J 0.88 3.199E-10 ***
Preference 1 C57BL/6J, 129S1, CAST, NOD, NZO, A/J 0.70 1.162E-05 ***
Table 1: Heritability of Total Ethanol Consumption and Preference 
Heritability coefficients for total ethanol consumption and preference under chronic 
ethanol access (2) and intermittent ethanol access (IEA).  
*** p < 0.0001 
 There were large differences in ethanol consumption and preference across strains 
with highly significant heritability estimates under both CEA and IEA (Table 1). Post-hoc 
analysis revealed several significant pairwise comparisons across strains (Fig. 2, Table S1). 
For both phenotypes, the significant genetic effect stems from relatively low values for A/J, 
129S1/SvlmJ, and NZO/HiLtJ compared to other strains, under each paradigm. 
To assess whether consumption values might be modulated by differences in ethanol 
metabolism, we performed a pharmacokinetic analysis. Because there was no significant 
effect of paradigm on ethanol consumption or preference, and all mice had been abstinent for 
at least 1 week, mice were not separated by treatment group for this analysis.  This analysis 
revealed a significant negative correlation between BEC and whole-study mean total ethanol 
consumption, 240mins after intraperitoneal ethanol injection (Fig. 4a). Although this 
correlation was not significant for other time points, there is a similar association pattern for 
initial BEC (30 mins) (Fig. 4a). Mice appear to cluster by strain, in accordance with this 
relationship. The cumulative BEC and ethanol elimination rate for each strain are represented 
in Table 2, and Fig. 4b. 
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Figure 3 (a and b, see next slide for b plot) represents average total ethanol consumption (a) and preference 
for ethanol over water (b) for each strain, during the first and last weeks of ethanol access, with black lines 
representing standard errors. Dark blue and light blue bars represent values for the first and last week under 
Chronic Ethanol Access (2), respectively; and salmon and peach bars represent values for the first and last 
week under Intermittent Ethanol Access (IEA), respectively. There were no significant differences between 
time points for any strain.  
 
97	
●
●
●●
●
●
●●
●
●
●
●
●
●
●
●
●
r = −0.26
q = 0.473
● ●●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
● ●
●
r = −0.02
q = 0.925
●
● ●●
●
● ●
●
● ●●
●
● ● ●
r = −0.77
q = 0.002 *
240mins
60mins
30mins
0 10 20 30
200
400
600
200
400
600
200
400
600
Mean Total Ethanol Consumption (g/kg)
Bl
oo
d 
Et
ha
no
l C
on
ce
nt
ra
tio
n 
(m
g/
dL
)
Strain
●
●
●
●
●
●
129S1
AJ
C57
CAST
NOD
NZO
●
●
●
●
●
r = −0.54
q = 0.437
●
●
●
●
●
●
r = −0.51
q = 0.437
●
●
●
●
● ●
r = −0.33
q = 0.526
●
●
●
●
●
r = 0.86
q = 0.296
●
●
● ●
●
●
r = −0.61
q = 0.437
180mins
60mins 120mins
15mins 30mins
10 20 30 40
10 20 30 40
100
200
300
400
500
100
200
300
400
500
100
200
300
400
500
Mean Total Ethanol Consumption (g/kg)
Bl
oo
d 
Et
ha
no
l C
on
ce
nt
ra
tio
n 
(m
g/
dL
)
Strain
●
●
●
WSB
PWK
C57
a 
b 
 
98	
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
Experiment 1 Experiment 2
50 100 150 200 250 50 100 150
0
200
400
600
Time After Injection (mins)
BE
C 
(m
g/
dL
)
Strain
●
●
●
●
●
●
●
●
129S1
AJ
C57
CAST
NOD
NZO
PWK
WSB
c 
Figure 4: (a) blood ethanol concentrations (BEC) taken after intraperitoneal injections of 0.8g/kg(EtOH) at 
each of several time points following injection, depicted at the top of each plot, for Experiments 1 (left) and 2 
(right). Each point represents one mouse, with color representing strain. These values are plotted over total 
ethanol consumption, averaged over the entire study, for each mouse. Black lines represent the line of best fit, 
and the surrounding gray-shaded area represents standard error. The corresponding correlation coefficient (r) 
and False Discovery Rate (q) are listed in the lower right corner of each plot, with * representing significance.  
(b) Blood ethanol concentration (BEC) values for each strain, for Experiments 1 (left) and 2 (right), across 
post-intraperitoneal-ethanol-injection time points. Each point represents one mouse, with colors representing 
strain. Lines run through the strain means at each time point, demonstrating the rate of change in BEC over 
time. Notches on x-axis represent time points at which BEC was measured. 
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Experiment 2 
Just as in Exp. 1, there was no significant increase in ethanol consumption or 
preference over the course of the experiment, for any strains after correction for multiple 
testing (Table S4; Fig. 5a-b). However, there was a significant decrease in ethanol preference 
for WSB mice (t=-4.02, p=0.003, qFDR=0.009) (Fig. 5b). Further, ANOVA results revealed a 
significant interaction between strain and time on ethanol preference only, meaning change 
in preference over time varies significantly between strains (Table 3; Fig. 5b). Notice that, in 
comparison with CEA consumption and preference values in Exp. 1 (Fig. 3), C57 mice 
consumed ethanol at similar levels between experiments (although preference levels were 
slightly different), indicating reliability between experimental groups. However, PWK and 
WSB mice consumed and preferred ethanol at much higher levels than the other strains, 
meaning that they would have contributed to an even higher estimate of heritability, had the 
two experimental groups been combined.  
Also similar to Exp. 1, both total ethanol consumption and preference were highly 
and significantly heritable (Table 1). Post-hoc analysis revealed significant differences 
between all three strains for total ethanol consumption, and between PWK and the other two 
strains for preference (Fig. 6a-b). However, the proportion of daily ethanol consumed in the 
first 3hrs of the dark phase did not differ significantly between strains (Fig. 6c). All three 
strains consumed roughly 14-15% of their daily ethanol during the first 3 hrs of access. 
Although the correlation between BEC and whole-study mean total ethanol 
consumption was not significant, the relationship appears negative for all time points except 
30 mins (Fig. 4a). As in Exp. 1, mice appear to cluster by strain, along the lines of best fit 
(Fig. 4b). The cumulative BEC and ethanol elimination rate for each strain are represented in 
Table 2. 
100	
Experiment Strain Slope.From.Peak AUC Time.Point.(mins) N Mean.BEC.mg/dL .BEC.mg/dL.SE Max.BEC
1 129S1 C0.81 101950.0 30 3 526.67 88.38 No
60 4 550.00 17.32 Yes
240 3 403.33 21.86 No
AJ C0.65 58675.0 30 3 416.67 26.03 Yes
60 4 285.00 53.15 No
240 1 250.00 NA No
C57 C0.93 69050.0 30 3 423.33 20.28 Yes
60 3 400.00 5.77 No
240 3 230.00 10.00 No
CAST C1.57 77075.0 30 2 535.00 5.00 Yes
60 3 483.33 48.07 No
240 3 203.33 8.82 No
NOD C1.43 93750.0 30 3 510.00 55.08 No
60 3 560.00 10.00 Yes
240 3 303.33 3.33 No
NZO C1.08 114787.5 30 3 700.00 30.55 Yes
60 4 607.50 11.09 No
240 2 450.00 30.00 No
2 WSB C1.52 59610.0 15 2 485.50 25.50 Yes
30 2 388.50 18.50 No
60 2 479.50 75.50 No
120 2 321.50 36.50 No
180 2 212.00 9.00 No
PWK C1.65 55053.0 15 2 417.40 10.60 No
30 1 477.00 NA Yes
60 2 393.00 20.00 No
120 2 284.50 0.50 No
180 2 214.50 7.50 No
C57 C1.03 60997.5 15 1 395.00 NA No
30 2 444.00 14.00 Yes
60 2 417.00 26.00 No
120 2 340.50 21.50 No
180 2 295.00 1.00 No
Trait I.V. df F,value ,,,,,,,,,,,p ,,,,,,,,,,qFDR
Consumption Strain,,,,,,,,,,, 2 61.09 1.740EC14 *** 5.221EC14 ***
TimePeriod,,,,,,, 1 0.07 7.966EC01 7.966EC01
Strain:TimePeriod 2 2.77 7.162EC02 1.074EC01
Preference Strain,,,,,,,,,,, 2 47.96 1.289EC12 *** 3.868EC12 ***
TimePeriod,,,,,,, 1 9.75 2.904EC03 ** 4.355EC03 **
Strain:TimePeriod 2 4.75 1.271EC02 * 1.271EC02 *
Table	2:	Blood	Ethanol	Concentration	Statistics	by	Strain	
Slope, area under the curve (AUC), timespan between ethanol treatment and blood collection, number of 
mice in each group (N), mean and standard deviation (SD) blood ethanol concentration (BEC), and whether 
or not the maximum BEC for the respective strain occurred the respective time point.  
Table	3:	ANOVA	Results	for	Effect	of	Time	and	Strain	on	Drinking	Behaviors	
The F-statistic, degrees of freedom (1), p-value, and FDR-adjusted q-value for ANOVAs testing for the 
effects of each independent variable (IV) on total ethanol consumption and preference. 
* p<0.05; ** p<0.01; *** p<0.001 
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Figure 5: Mean total ethanol consumption (a) and preference over water (b) for the first (dark blue) and last 
(light blue) weeks of Chronic Ethanol Access, for each strain in Experiment 2. Bars with asterisks represent 
significant differences between time points for that strain.  
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Figure 6: Average total ethanol consumption (a) and preference (b) under Chronic Ethanol Access for each 
strain in Experiment 2, across the entire study. Black lines depict standard error around each mean, and 
letters represent significant differences between the strain depicted on x-axis and the corresponding strain 
listed in the legend. (c) Average proportion of daily total ethanol consumed in the first 3hrs of ethanol 
access (light blue) compared to the remaining 21hrs of access (dark blue), for each strain. There were no 
significant differences in proportions seen between strains.  
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Discussion 
 The goal of this study was to characterize voluntary ethanol consumption levels and 
ethanol preference in each of the Diversity Outbred stock progenitor strains, and to determine 
the feasibility of genetically mapping these traits in a DO sample. We accomplished this by 
longitudinally measuring voluntary ethanol and water consumption in mice from each of the 
progenitor strains during exposure to several weeks of Intermittent or Chronic Ethanol 
Access paradigms, in the absence of prior ethanol treatment or exposure. Specifically, we 
determined the heritability of total ethanol consumption and preference over water, and 
characterized within-strain consistency of these characteristics across paradigms and 
experimental time points. We also measured BEC in these mice at various time points 
following intraperitoneal ethanol injection to examine the potential contribution of metabolic 
variation to strain differences in ethanol consumption and preference. Overall, our studies 
show highly significant and heritable cross-strain variation in ethanol consumption and 
preference and suggestive strain differences in the temporal pattern of ethanol consumption, 
supporting use of the DO mice for genetic mapping of ethanol drinking behaviors. 
IEA v. CEA 
 Within-strain analysis suggested that total ethanol consumption and preference 
behaviors were consistent across paradigms in Exp. 1 (examining C57, AJ, NOD, NZO, 
129S1, and CAST), resulting in the use of CEA only in Exp. 2 (examining C57, PWK, and 
WSB). These phenotypes were also consistent across time for most strains, under both the 
intermittent and chronic paradigms. However, there was a significant decrease in ethanol 
preference for WSB mice in Exp. 2 (which only examined CEA), and a trending decrease in 
ethanol consumption for A/J mice, under IEA only. There was also a trending (significant 
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before multiple testing adjustment) increase in ethanol preference for NOD/ShiLtJ mice, 
under CEA only. Despite these differences, there was no significant time x strain interaction 
in either experiment for ethanol consumption, or for ethanol preference in Exp 1. This 
interaction was significant for ethanol preference in Exp 2. However, instead of having 
positive slopes of different grades, C57 and WSB mice actually decreased their preference 
over time, while PWK increased. These findings are inconsistent with findings from previous 
studies on C57BL/6J mice  , which suggest that intermittent access leads to greater overall 
ethanol consumption, and a greater increase in ethanol consumption and preference 
compared to chronic access in C57BL/6J mice.  
One possible explanation for the similarities in phenotypes between IEA and CEA in 
this study is that we employed an IEA paradigm with 24hr abstinence periods, which likely 
did not allow for a true alcohol deprivation effect (148) to occur. Another possible 
contributor is the use of a 3-bottle choice model, as opposed to 2-bottle choice, which likely 
increased within-group variation. Finally, although we used the IEA paradigm reported in 
Hwa et al., we did not implement an initial period of habituation to progressively increasing 
concentrations of ethanol, due to the use of a 3-bottle choice paradigm. The absence of this 
habituation period may have created a ceiling effect (with ceiling levels varying between 
strains), meaning the mice were not driven to drink over a certain amount, regardless of 
access frequency. Also counter to what we hypothesized, the effect of intermittent v. chronic 
access on ethanol consumption (gene x environment interaction) did not differ between 
strains. Although Rosenwasser et al. (79) saw higher ethanol consumption under IEA versus 
chronic access in only 4 (C57BL/6J, C3H/HeJ, HDID-1, and HS/Npt) of the 6 (WSP-1 and 
WSR-2) strains they studied, they studied different strains from the present study (aside from 
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C57BL/6J), and employed an IEA paradigm with longer periods of abstinence. Additionally, 
they did not test for a paradigm x strain interaction directly. To our knowledge, this study is 
the first to directly test the effect of this interaction and the paradigm x strain interaction on 
ethanol consumption and preference.  
Heritability 
Our between-strain analysis showed moderate to high heritability of voluntary ethanol 
consumption and preference, under intermittent and chronic access paradigms among the DO 
progenitor strains. Post-hoc analysis indicated that 129S1, NZO, and A/J mice will not 
voluntarily consume ethanol at high levels, and do not prefer it over water, unlike the 
remaining DO progenitor strains, particularly the PWK and CAST wild-derived strains. 
These findings are consistent with those of previous studies, which have shown much lower 
consumption and preference values for A/J and 129S1 mice, and slightly lower values for 
NOD mice, than C57BL/6J mice (78, 152, 153). These results suggest that this trait possesses 
the variance between strains necessary for detecting quantitative trait loci in an outbred 
mouse panel derived from these strains. Although results from such studies would likely be 
highly complex and polygenic in nature, they would likely identify some loci within 
haplotypes inherited from 129S1, NZO, or AJ progenitors, with protective effects (i.e. confer 
lower consumption levels or preference), and some loci within haplotypes inherited from 
PWK or CAST, conferring risk for higher consumption levels or preference. Moreover, these 
results demonstrate the uniqueness of wild-derived strains, supporting the theory (32, 90) that 
they possess behavioral traits and contributing loci that could not be detected in studies of 
only lab-derived strains.  
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Although PWK mice had higher ethanol consumption than C57 and WSB, in Exp. 2, 
the amount of ethanol they consumed in the first 3 hrs of ethanol access did not represent a 
higher proportion of their daily consumption than the other two strains. This indicates that 
they all steadily consumed ethanol over a 24 hr period (3hrs/24hrs=12%), as opposed to 
binging. In other words, the PWK mice consistently drank more ethanol over the course of 
the 24 hrs of access than the other two strains, as opposed to acutely consuming large 
amounts of ethanol at the onset of ethanol access, then “sobering up” for the duration of that 
access period. These results suggest that PWK mice may metabolize ethanol differently than 
the other two strains, as they are able to sustain high levels of consumption over a 24-hr 
period. 
Ethanol pharmacokinetics 
Overall relative relationship of ethanol elimination rates between strains (Table 2) 
were consistent with findings from Crabbe et al. (154), which examined ethanol elimination 
rate following IP injections of 2g/kg EtOH in C57, 129S1, A/J, NOD, and CAST, among 
other strains. In both studies, CAST had the fastest elimination rate, and A/J and 129S1 had 
the slowest rates, with C57 falling in between. However, in Crabbe et al., NOD had the same 
rate as AJ, whereas NOD’s rate was faster than C57 in the present study. This could be due to 
the use of different BEC measurement time points between studies. The final time point in 
Crabbe et al. was 150mins, whereas our final time point in Exp. 1 was 240mins to our 
knowledge no prior studies have characterized ethanol kinetics in PWK, WSB, or NZO.  
Our preliminary BEC analyses suggest that the heritability of ethanol consumption 
and preference between the DO progenitor strains is likely partly attributable to differences 
in ethanol pharmacokinetics. There was a significant correlation between BEC and mean 
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total ethanol consumption at the 240min time point after intraperitoneal ethanol injections in 
Exp. 1. As would be expected, the lower the BEC, the more ethanol the mice drank, 
suggesting that mice that consume higher amounts of ethanol have a faster ethanol 
metabolism. Unexpectedly, this relationship was not significant for earlier time points in 
Exps. 1 or 2. Moreover, mean total ethanol consumption within strains appears to be 
independent of strain-wise cumulative BEC (area under the curve) and ethanol elimination 
rate (slope).  
Together, these findings indicate that overall ethanol kinetics plays a role in the 
heritability of voluntary ethanol consumption. However, this relationship seems to be driven 
by BEC levels after several hours of metabolism, as opposed to the initial ethanol 
concentrations that might reflect differences in volume of distribution. These results are also 
consistent with findings from Crabbe et al. (154), which found that BEC 35mins after IP 
injection of 2g/kg EtOH did not correlate with ethanol sensitivity.  
Shortcomings and Future Directions 
As mentioned above, the use of 3-bottle choice and the absence of an ethanol 
habituation period may have precluded the detection of differences between intermittent and 
chronic paradigms, due to increased within-strain variance. Moreover, the size of this pilot 
study may have limited our power to detect differences across paradigms or time points. 
Overall, this study exhibits that these progenitor strains offer a large degree of inter-
strain variability in ethanol consumption, preference, and pharmacokinetics. Future 
Quantitative Trait Locus studies on Diversity Outbred mice will likely be able to map genetic 
loci contributing to voluntary ethanol consumption and preference. Markers within ethanol 
metabolism genes are likely to be amongst the significantly associated loci. These studies 
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also characterized longitudinal voluntary ethanol consumption and preference under chronic 
and intermittent paradigms, within each of the DO progenitor strains, and suggested possible 
strain-dependent temporal patterns that might also be amenable to genetic dissection in DO 
mice. Such studies could have high relevance to identifying genetic mechanisms contributing 
to the progression from social to abusive ethanol consumption.  
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Chapter 4 
Mapping Precise Quantitative Trait Loci for Voluntary Ethanol 
Consumption in Diversity Outbred Mice  
110	
 
Introduction 
Alcohol Use Disorder (AUD) is a debilitating illness that has many negative health 
and behavioral outcomes, with even short-term abstinence being as low as 43% for those 
who seek pharmacological or cognitive-behavioral treatment (11). One way to gain a better 
understanding of the biological processes, and therefore improve treatment, is to explore 
genetic contributions to the disorder. However, despite the 50% heritability estimated by twin 
studies (21), Genome-Wide Association Studies have had limited success in identifying 
significant and replicable loci. Unlike human studies, environmental factors that may muddle 
genetic signals can be controlled in mouse experiments. Although mouse models do not 
account for all of the nuances of human behavior, they are useful for identifying broadly 
applicable biological mechanisms underlying specific behaviors associated with a disorder, 
such as alcohol consumption and preference. In fact, mouse models have successfully 
identified several genetic loci associated with these two traits (65).  However, these studies 
are often plagued by limited genetic heterogeneity (due to a limited number of progenitor 
strains) and low precision due to large linkage disequilibrium blocks, or regions of co-
inherited DNA with limited amounts of detectable genetic cross-over (due to a small number 
of cross-breeding generations) (57).  
To address these issues, this study aims to identify genetic loci associated with 
alcohol consumption and preference in a genetically heterogeneous mouse population from 
the Diversity Outbred (DO) stock. This stock was especially created for the precise mapping 
of genetic loci associated with complex behavioral traits, by interbreeding across 
Collaborative Cross recombinant lines, followed by several generations of random 
outbreeding (155). The Collaborative Cross mice were created from 144 different breeding 
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patterns, each incorporating 8 progenitor strains, 3 of which are wild-derived (155). These 8 
strains afford the DO mice with roughly 4.5 times as many variants as there are in the human 
genome, and 36 possible diplotypes, which can be inferred from these SNPs, at each locus 
across the genome (156). This genetic diversity and complex breeding scheme make for a 
mouse stock with wide behavioral variability (similar to that seen within a human 
population), a vast array of detectable polymorphisms (including those present in the genome 
of wild mice), and smaller discernable haplotypic blocks than most other laboratory mouse 
strains. Despite their utility, to our knowledge, alcohol drinking phenotypes have not yet 
been genetically mapped using the DO mice.  
In particular, this study aims to map behavioral Quantitative Trait Loci (bQTL), or 
regions of DNA within which genetic variants are associated with a behavioral trait, for 
consumption and preference under an Intermittent Ethanol Access (IEA) paradigm. This 
paradigm models relapse-like drinking seen in the early stages of dependence development 
with alternating periods of ethanol access and forced abstinence, which leads to increased 
ethanol consumption over time in some mouse strains (36). Ethanol consumption and 
preference have been determined to be highly heritable under this paradigm across the 8 DO 
progenitor strains, indicating that they can be genetically mapped in DO mice, as seen in 
Chapter 3. This experiment is anticipated to identify previously published as well as novel 
loci associated with ethanol consumption and preference, with greater precision than any 
previous study. Specific to this paradigm, loci associated with naïve ethanol consumption and 
preference at the beginning of the study are expected to differ from those associated with 
consumption after repeated exposure to abstinence.  These findings would provide insight to 
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biological mechanisms involved in the development of progressive ethanol consumption that 
could potentially be targeted for treatment of AUD.  
 
Materials and Methods 
Ethics Statement 
All animal care and euthanasia procedures were performed in accordance with the 
rules and regulations established by the United States Department of Agriculture Animal 
Welfare Act and Regulations, Public Health Services Policy on Humane Care and Use of 
Laboratory Animals, and American Association for Accreditation of Laboratory Animal 
Care**. Humane endpoints were established by the same standards.  
 
Behavioral Experimentation 
Male DO mice (N=636) were acquired from Jackson Laboratories at 4 weeks of age, 
in cohorts of 106 mice on average, spanning across DO generations 21-24.  Mice were singly 
housed on cedar shaving bedding, with ad libitum access to water and standard chow (#7912, 
Harlan Teklad, Madison, WI, United States), and alternating 12hr light and dark phases, upon 
arrival and remained housed under these conditions for the remainder of the study. All mice 
were weighed weekly. Given their likely genetically driven ethanol-related behavioral 
differences, females were excluded from this study, so as to avoid losing power due to sex 
effects (157-159).  
At between 8 and 12 weeks of age, adult mice underwent a 10min paradigm of 
anxiety-like behavioral testing in light-dark boxes. Mice were placed in Med Associates Inc. 
Mouse Locomotor Boxes with light-dark inserts to create a “dark” side and a “light” side. 
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Laser beams were used to track mouse movement between sides of the box, with longer time 
spent in the light considered to implicated lower levels of anxiety-like behavior. Mice were 
habituated in the experimental room that houses these boxes for 1hr prior to testing. Lateral 
and vertical movements were recorded across 5min time intervals, during the 10min 
exposure. Measurements calculated included, but were not limited to: time spent in the light, 
percent time spent in the light, total distance traveled, distance traveled in the light, percent 
distance traveled in the light, and stereotypy. This data was collected for future analyses on 
the relationship between drinking levels and anxiety-like behavior before and after (see 
marble burying test described below) ethanol exposure, and will not be discussed further in 
this manuscript. The following day, the Intermittent Ethanol Access (IEA) paradigm was 
initiated. This paradigm was consistent with that described in Chapter 3 with alternating 24hr 
periods of water and ethanol (Mon. Wed., Fri.), and water only (Sat., Sun., Tues., Thurs.) 
(Fig. 1). For ethanol exposure periods, three bottles (15% and 30% ethanol, and water) were 
placed in cages at the beginning of the dark phase, and consumption was measured in mL of 
fluid at the end of the following light phase, at which point ethanol bottles were replaced 
with water bottles. Controls (N=49) were exposed to water only, with water consumption 
measured on the treatment group’s ethanol access days, throughout the course of the 
experiment.  
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Figure 1: Intermittent Ethanol Access (IEA)  paradigm employed in this study. Each block represents a day of 
the week, with dashed area indicating the 12hr dark phase of each 24hr light-dark cycle. Blue coloration 
represents 24hr periods of access to ethanol, with 3-bottle choice (15% EtOH, 30% EtOH, and water), and 
uncolored areas represent periods of forced abstinence, with access to 3 bottles of water only. This was repeated 
for 4 weeks prior to anxiety-like behavioral testing, and 1 additional week to reestablish unperturbed drinking 
behaviors and gene expression levels.  	
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After 4 weeks of IEA, another anxiety-like behavioral test, marble burying, was 
performed. For this test, mice were placed in 13” x 15” rat cages filled 3/4 full with cedar 
chip bedding, and 16 marbles placed on top of the bedding. Mice were left in these boxes for 
a total of 20mins, and the number of marbles at least 2/3 buried was counted. These results 
can be interpreted as a larger number of marbles being buried indicating anxiety-like 
behavior. Like the light-dark box data, this data was collected for ancillary analysis, and will 
not be discussed further. Mice were then exposed to an additional week of IEA to re-establish 
gene expression patterns that may have been disrupted by other behavioral tests, for future 
gene expression-related experiments. Only the first 4, uninterrupted weeks of drinking 
behaviors were used for the purposes of this study. Mice were sacrificed via cervical 
dislocation and decapitation, 24hrs after the end of their last ethanol exposure period, and 
tissue samples were immediately collected and dissected for genotyping and gene expression 
assays. Tail snips, specifically, were collected for genotyping. Liver, spleen, and brain tissue 
were also collected for gene expression analyses performed in Chapter 5, and for future 
studies. Brains were microdissected into 9 regions, including the Prefrontal Cortex. Tissue 
was collected from 630 mice, as 6 mice reached human endpoints due to likely congenital 
health problems, before the end of experimentation. All tissue was immediately flash frozen 
after dissection, to preserve RNA integrity. 
Ethanol consumption was measured as g(EtOH)/kg(mouse), to control for effects of 
mouse size on fluid consumption. Daily consumption values were marked as missing when: 
any one bottle had been emptied past the sipper opening; the bedding under the bottles was 
wet, indicating spillage or leakage; the sippers had been tampered with (ex. woodchip 
bedding packed into the opening) in a way that would prevent drinking or cause leaking; or 
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the consumption value were large negatives, indicating irreconcilable recording error. Values 
were marked as 0mL if the readings yielded a slight negative value (down to roughly -
0.3mL), indicating inter-rater variation on a true 0 read. Because of the expectation of wide 
variation in such a genetically diverse sample, only extreme outlying values were removed, 
leading to one sample’s consumption values being removed for one access day. If more than 
half of the values needed for weekly or whole-study mean calculations were missing for any 
given mouse (due to bottle leakage or complete emptying of any one of the 3 bottles), that 
sample’s mean was marked as missing. Total ethanol consumption was calculated by 
summing the g/kg values for 15% and 30% ethanol. Total ethanol preference was represented 
by the fraction of mL total ethanol (mL(15%EtOH) + mL(30%EtOH)) over mL total fluid 
(mL(water  + mL(15%EtOH) + mL(30%EtOH)) intake. Finally, 30% ethanol preference over 
15% ethanol, hereafter referred to as “30% choice”, was represented by the fraction of g/kg 
30% ethanol over g/kg total ethanol consumed. For QTL mapping, all values were averaged 
over the first week (the 3 days following the first day), the last week (the final 3 days of 
ethanol access), and the whole study course (all 10 ethanol access days, excluding the first 
day) of IEA. First and last week values are meant to map genetic loci associated with naïve 
and post-exposure drinking, respectively; whereas whole study values are meant to capture 
loci associated with overall drinking behaviors, irrespective of exposure time.    
 
Genotyping 
Tail tissue from each mouse was sent to NeoGen Inc. (Lincoln, NE) for DNA 
isolation and microarray genotyping.  The GigaMUGA microarray, created specifically for 
identifying single nucleotide polymorphisms (SNPs; NSNP=141,090) and copy number 
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variants (CNVs and indels; NCNV=2,169) that are informative between the DO mouse stock’s 
8 progenitor strains (160). Mice were genotyped in two batches (NBatch1=210, NBatch2=420). 
Four samples from the first batch were run again on the sample batch, due to low quality. 
Three high-quality samples from the first batch were run with the second batch, so that the 
results between the two arrays could be compared, in order to detect batch effects. Quality 
and genotype calls were consistent between arrays, indicating little technical variation (Fig. 
2-5). (Genotyping batch correlates perfectly with Cohort, so the inclusion of Cohort as a 
covariate in our analyses corrected for any undetected differences between genotyping 
batches.)  
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Figure 2: Histograms of 50% (left) and 10% (right) Marker GenCall scores for genotyping batches 1 (top) 
and 2 (bottom). Dotted red lines represent the threshold scores. Markers with 10% scores that fell below this 
line in both batches, or with 50% scores that fell below this line in either batch, were removed during quality 
control. Scores were similarly distributed between batches.  
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Figure 3: Minor allele frequencies (MAFs) for each genotyping batch. On the top are histograms of MAFs in 
each batch, with red dotted lines representing cutoff thresholds for quality control. Markers between these 
lines were kept, and markers that fell outside of these lines were removed. On the bottom is the relationship 
of MAFs between batches, with quality thresholds marked by dotted red lines. MAF was highly similar 
between batches. 
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Figure 4: Marker call rate histograms (left) across all samples (top), then broken down by batch (middle and 
bottom). The right-hand plots are Y-axis-truncated versions of the left-hand plots, so that the shape of the 
distributions can be more easily seen.  Red dotted lines indicate quality thresholds, below which markers 
were removed.  
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Figure 5: Histograms of heterozygous calls for the Y (left) and X (right) chromosomes (top), with red dotted 
lines indicating quality thresholds above which samples were removed. Bottom plots depict overall sample-
wise call rates by the number of heterozygous calls for the Y (left) and X (right) chromosomes, with red 
dotted lines indicating the same thresholds depicted in the upper plots. In general, markers with higher 
numbers of heterozygous calls also appear to have larger call rates; so using only a call rate threshold would 
not have been sufficient quality control for X and Y chromosome markers.  
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Marker-Level Quality Control 
All quality control steps were performed using the base and Argyle R-packages, and 
PLINK in a Unix environment (160, 161). We began with marker-level quality controls, 
because this was the order that was anticipated to conserve the most samples, while 
maintaining quality. The GigaMUGA array is thought to be slightly noisier than previous 
versions of this array, due to the high concentration of markers on the array, sometimes 
leading to signal saturation or bleeding of signal between samples. This leads to failing call 
quality or low call rates in a large number of the markers. It is important to remove these 
markers before assessing the quality of samples, so that samples are not penalized for 
containing large numbers missing calls for low-quality, unusable markers. 
Individual genotype calls with Gen Call scores < 0.05 were marked as missing in 
Genome Studio by Neogen, before data was received 
(https://support.illumina.com/array/array_software/genomestudio/downloads.html). Gen Call 
scores are calculated by a Genome Studio proprietary algorithm, which incorporates distance 
of points on intensity value plot (X intensity by Y intensity) from the reference call cluster to 
determine the quality of each call. The 10% and 50% marker-level Gen Call scores are 
represent the Gen Call score value at the 10th and 50th percentiles of the score distribution of 
all calls (NCalls=NSamples) for each marker. Essentially, these scores represent the lower tail 
and median of the quality distribution for each marker, respectively. Our first step of quality 
control (QC) was to remove markers with: 10% Gen Call scores < 0.55 in both genotyping 
batches; or 50% Gen Call scores < 0.55 in either batch (Fig. 2). There were 27,391 markers 
that failed to meet the 10% Gen Call score threshold, 25,065 of which failed to meet the 50% 
Gen Call score threshold. An additional 25 markers failed to meet the 50% Gen Call score 
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threshold, leading to a total of 27,416 (27,391+25) markers being removed, with 115,843 
markers remaining.  
The second step of our QC pipeline was to remove markers with a low minor allele 
frequency (MAF), meaning the frequency of the less common allele in your sample. Rare 
alleles are hard to differentiate from technical error, and there is typically not enough power 
to detect their effects on the phenotype (162). Markers were removed if they had: a MAF of 0 
in either genotyping batch; or MAF<0.02 when batches were combined. Because some of the 
“minor alleles” designated by Genome Studio were not necessarily the minor alleles (or 
alleles of lesser frequency for that locus) in our dataset, we also used an MAF=1 and 
MAF>0.98 (so that the frequency of the actual minor allele was 0 or 0.02, respectively) for 
these respective thresholds (Fig. 3). There were 7,745 markers with MAF = 0 or 1 in the first 
genotyping batch, 7,074 of which also had MAF = 0 or 1 in the second batch, and an 
additional 30 markers with MAF = 0 or 1 in the second batch. There were 295 markers with 
MAF < 0.2 and 3 markers with MAF > 0.98 when batches were combined, once MAF = 0 or 
1 had been removed. This led to removal of a total of 8,142 ((7,745+30)+(295+3)) markers, 
leaving 107,701 markers remaining.  
Finally, markers with a < 94% call rate in either genotyping batch were removed, 
based on spline of the left-hand tail of call rate histograms (Fig. 4). Low call rate indicates 
poor marker quality, possibly due to ineffective of oligonucleotide binding to DNA 
fragments. There were 1,661 markers in the first batch and 1,378 markers in the second batch 
with < 94% call rates, 765 of which overlapped between batches. This led to the removal of a 
total of 2,274 (1,661+1,378-765) markers, with 105,427 markers remaining (Fig. 4). Only 6 
of these markers were on chrY, and 3,631 were on chrX. Because all of our samples are 
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males, heterozygosity in these markers, in non-pseudoautosomal regions, indicates calling 
error. Therefore, we removed sex chromosome markers for which > 10% (i.e. in > 63 
samples) of the samples had heterozygous calls. This threshold was chosen based on the 
distribution of heterozygous call numbers (Fig. 5). 
The remaining marker-level quality control step is to remove markers for which the 
allele distribution has an extreme deviation from Hardy-Weinberg equilibrium. However, the 
deviation statistic can be affected by relatedness between samples. Explained in more detail 
below, the process of determining relatedness required good quality samples. Therefore, this 
step was not performed until after sample quality control was performed.  
Sample-Level Quality Control 
 The first step in sample quality control was to remove samples with low call rates, 
indicating overall low call quality. Samples with call rates < 98% were removed. A total of 
21 mice were removed, 1 from the first microarray batch and 20 from the second, with 604 
samples remaining. This threshold was chosen by visually determining the location of 
outliers in the overall distribution of call rates across samples (Fig. 6). Although this may 
seem like a large number of samples to remove, the inclusion of poor-quality samples 
actually decreases power due to noise. We therefore aimed for a stringent threshold that 
demarcated outlying nature from clusters of high-quality samples (Fig. 6). Mice that fell 
below this threshold likely possessed other confounds of technical variation from other mice, 
due to their outlying nature. 
 We next tested for sample cross-contamination by examining the heterozygosity rates 
within samples. Samples with abnormally high numbers of heterozygous calls across the 
genome have likely been contaminated by DNA from other samples, creating heterozygous 
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calls where the original sample is actually homozygous. Because the genotypic distributions 
at each locus likely vary across DO populations coming from varying combinations of 
breeders and generations, it is important to determine a unique threshold for each study. For 
our population, a heterozygosity frequency > 0.41 was > 3 standard deviations above the 
mean, and was considered to be contaminated (Fig. 7). Only one mouse was removed at this 
step, leaving 603 samples. 
Figure 6: Histogram of sample call rates across all samples (top), and the relationship between call rate and 
the order in which samples were genotyped (bottom). Samples marked in green were genotyped in the first 
batch, and those in blue were genotyped in the second batch. The red dotted line depicts the same quality 
threshold seen in the left plot. Overall, the two batches had similar call rates, with minor deviations, 
although a slightly higher proportion of samples were removed from Batch 2 due to outlying low call rates.  
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Figure 7: Histograms of heterozygosity frequency (or the proportion of each sample’s total calls that were 
heterozygous) (top) and Z-normalized heterozygosity frequency (middle), and a scatter plot representing the 
relationship between heterozygosity frequency and call rate (bottom). Dotted lines in Plot B represent 
thresholds of  + or – 3 standard deviations from the mean frequency. Samples falling outside of these quality 
threshold lines were removed. Dotted line in Plots A & C represents the raw heterozygosity frequency value 
that corresponds with the upper quality threshold in Plot B. No samples fell below the lower threshold. One 
sample fell above the upper threshold, indicating cross-sample contamination, and was removed. Call Rate 
did not seem to decrease as heterozygosity values became more extreme. Therefore, call rate would not have 
been a sufficient quality metric for sample-level quality control.  
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The final step of sample QC was to assure that all mice were genetically male, to assure there 
are no sex effects within our sample. Because of the relatively poor quality of the sex 
chromosomes, compared to the autosomes, we confirmed genetic sex using several different 
methods provided by the Argyle R-package (160). The first method was to identify true 
females based on the presence of high chrX marker heterozygosity paired with fewer than 
average high-quality chrY marker calls, or high chrX marker signal intensity and outlying 
low chrY marker intensity. No samples matched this description, and therefore all mice were 
considered to be genetically male. The second, more precise method was based on an 
algorithm in Argyle that calculates the probability of being male based on X and Y 
chromosome marker intensity. No mice appeared to have a much lower probability of being 
male than the other samples, and therefore all samples were still considered to be genetically 
male. For the final method, chrY calls were used to calculate the probability that these mice 
actually do not have a Y chromosome, but instead have two X chromosomes. Because of the 
lack of markers on the Y-chromosome after QC, all mice were called as “unknown”, and this 
method was considered to be uninformative. All mice appeared to have been correctly sexed 
as male, so no samples were removed at this step.   
As seen in Figure 8, overall sample quality was greatly improved by marker-level and 
sample-level QC. Overall missingness was lower, genotype distributions were more stable 
across samples, and intensity varied less across samples. (Notice the difference in the Y-axis 
scale between before and after plots). The genotype distributions were originally skewed, 
particularly in the samples with lower median signal intensity. However, after QC, the 
distributions appear as would be expected, with consistently low minor allele homozygous 
rates and proportionately higher heterozygous and major allele homozygous rates.  
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Figure 8: Stacked genotype call numbers (Nmarkers/sample) and linearly plotted raw intensity value quantiles 
for samples before (top) and after (bottom) marker- and sample-level quality control. Red shading and lines 
represent missing calls, orange represents heterozygous calls, and blue and green represents major and 
minor allele homozygous calls, respectively. Overall, missingness was reduced, and extreme intensity values 
were removed (notice the change in Y-axis range). 
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Sibling Identification and Hardy-Weinberg Equilibrium Test 
 Severe deviation from Hardy-Weinberg Equilibrium, or the expected distribution of 
genotypes in a randomly mating population at loci unaffected by natural selection or genetic 
drift, indicates genotyping error. In order to follow the expectations of Hardy-Weinberg 
Equilibrium, genotypes must have a distribution close to p2+q2+2pq=1, where p = minor 
allele frequency, and q = major allele frequency. However, as referenced above, high 
relatedness between samples can lead false positive deviations. Therefore, it was important to 
remove siblings from our population before identifying markers that do not satisfy this 
distribution. Although pedigrees for these mice were not available, it was possible to identify 
sibships via a relatedness metric, such as pi-hat estimated by PLINK (163). The pi-hat 
parameter indicates the estimated proportion of loci shared across the genome, with identity 
by descent, meaning they share the same alleles inherited from the same ancestor.  
 Based on distribution of pi-hat values across pairs of mice within each breeding 
generation of our sample, and with Identity By State (IBS; or sharing of the same alleles 
inherited from different ancestors) information, we were able to distinguish what range of pi-
hat values likely indicated sibship (Fig. 9). Pi-hat values were calculated in PLINK1.7, using 
hard genotype calls from array markers (164). The small peak to the far right of the 
distribution of pi-hat values for each generation is likely composed of sibling pairs. This 
mode of the distribution appears to start around a pi-hat value of 0.3 - 0.4. We tested pi-hat 
sibship thresholds between 0.3 and 0.38, by intervals of 0.01 by examining the structure of 
sibship structure. Where a cluster of siblings in the family network plot were completely 
interconnected (i.e. every node shares an edge with every other node in that network), it was 
assumed that estimated sibships were true positives (i.e. the sibships identified were likely 
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true sibships). Where sibling clusters were mostly interconnected but were missing some 
links, it was assumed that the missing links were likely false negative sibships (i.e. sibships 
that truly exist were not identified). These assumptions followed the logic that if mouse A is 
a sibling of mouse B, and mouse B is a sibling of mouse C, then mouse A should also be a 
sibling of mouse C. Where single links of sibship existed between clusters of siblings, or 
links of sibships existed between mice from different generations, it was assumed that those 
were false positives (i.e. sibships were identified where one did not exist). Where a mouse 
displayed sibships with most of the mice in a cluster, but not with all of the mice (ex. if a 
mouse displayed sibships with 4 of 5 mice in a cluster that all shared sibships with each 
another), those missing links were assumed to be false negative sibships (Fig. 10). The ideal 
pi-hat threshold for determining sibship would balance the number of false negatives and 
false positives, indicating that most identified sibships were true positives, where lower 
thresholds would lead to a larger number of false positives and a higher threshold would lead 
to a larger number of false negatives.  
A pi-hat value of 0.34 seemed to best meet these ideal conditions, and also did well at 
identifying the clusters of likely-siblings when comparing IBS values (Fig. 10 & 11).  
Therefore, pairs of mice with a pi-hat > 0.34 were considered to be siblings. Because 518 
mice were identified as having siblings, it was necessary to keep one sample per sibling 
cluster, in order to remove highly related pairs while maintaining a large enough sample size 
to analyze Hardy-Weinberg equilibrium adherence. The mouse with the highest average 
within-cluster pi-hat estimate for each sibling cluster was kept, as they were thought to be the 
best genetic representation of the whole cluster. There were 32 sibship clusters and 8 
unclustered mice in generation 22, 39 clusters and 23 unclustered mice in generation 23, 34 
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clusters and 18 unclustered mice in generation 24, and 53 clusters and 33 unclustered 
individuals in generation 25. This led to a total of 240 mice for estimation of Hardy-
Weinberg equilibrium deviation. Because the remaining mice were still more interrelated 
than a population of unrelated humans, a very lenient threshold of p < 5x10-10 was used to 
specify markers with extreme deviation from Hardy-Weinberg equilibrium. This led to the 
removal of 3,679 markers, leaving us with 101,717 markers.   
   
Figure 9: Pi-hat histograms for each possible pair of  mice within each generation of mice, with our chosen 
threshold (blue) and the threshold published in Morgan et al., 2017, above which pairs are defined as 
siblings. The large disparity between our thresholds shows the importance of redefining such parameters 
according to each study’s sample.  
 
132	
 
Figure 10: Probability of sharing 0 (Z0), 1(Z1), or 2 (Z2) alleles Identity by Decent (IBD) for any locus in 
the genome, for each possibly mouse pair. Color represents pi-hat values (top), by which sibships were 
defined, or by sibship status (bottom), defined as pairs with pi-hat > 0.34. As should be seen, siblings cluster 
closer to the upper right quadrant of the left-most plots and towards the upper left quadrant in the right-most 
plots, indicating accurate identification of sibship with pi-hat threshold 0.34.  
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Figure 11: Sibling clusters, for which sibships are defined as mouse pairs with pi-hat > 0.34, for each 
generation of mice (a) and across all generations (b). Each circle or node represents a single mouse, colored 
by experimental cohort (a) or generation (b), and each connection or edge represents a sibship. Incomplete 
interconnectedness within clusters (ex. Cohort 3 triad on far right of Generation 23’s plot) indicates false 
negatives in sibship identification, and sparse connections between clusters (ex. connections between one 
cluster from each cohort seen on far left of Generation 23’s plot) or between generations (ex. bottom right 
blue and green cluster of Plot B) indicate false positives.   
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Final Numbers and Generation Effects 
Before analyses began, seven additional mice were removed due to potential sample 
mix-up during data collection documented in laboratory notes. This left a final number of 
101,717 markers and a total of 603 mice, 554 from the treatment group and 49 controls. 
Because markers on the Y chromosome were few and likely unreliable, it was not assessed in 
the analysis. The X chromosome was included in the analysis but was separated from the 
autosomes for permutations, and results were interpreted with caution, as fewer than 20 
markers remained after QC to be used for imputation. Both sex chromosomes were excluded 
from kinship calculations. This treatment of sex chromosomes is provided as an option in the 
R/qtl2 package’s permutation function (165).   
 
Choosing Covariates 
 Several potential covariates with genotype existed in this dataset, including: breeding 
generation, litter order, experimental cohort, experimental room (2 rooms per cohort), age (8 
weeks vs. 12 weeks), and genotyping batch. We first wanted to ensure that there were no 
major effects of generation on genotypic similarity, aside from what might otherwise be 
accounted for by a kinship coefficient. Although the inclusion of a kinship coefficient 
corrects for familial relatedness between mice within generations, there may still be genetic 
differences between generations that are shared between unrelated individuals within 
generations. These differences could be due to differing levels of LD (decreasing with each 
generation of breeding), genetic drift, or even fertility-based natural selection (73).  
To visualize the effects that generation might be having on genotype, we performed 
principal component analysis for genotype calls across the entire genome, using PLINK, 
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using the maximum number of principal components (PCs) (NPCmax=NMouse=603). We 
performed the same analysis with siblings removed, in order to remove effects of true 
relatedness on generational clustering (NPCmax=NMouse=243). (The number of sibships was 
slightly lower after removing Hardy-Weinberg-failing markers, leading to 3 additional 
samples after removing sibships.) Scree plots indicated that the first 3 PCs explained slightly 
more than 1% of the overall variance, each (Fig. 12). The projection of values onto each of 
the first 3 PCs was plotted against each other, and points were colored by generation, to 
visualize generational clustering (Fig. 12). Before removing sibships, it appears that there are 
3 clusters (2 along both the 1st and 2nd PCs, and one along the 3rd PC) of mice from 
generation 23 (and some from generation 24) that are genetic outliers. These groups seem to 
dissolve into a single point for each cluster, once sibships were removed. This indicates that 
there were actually 3 outlying families in generation 23 (and 3 cryptic relatives from 
generation 24), as opposed to generation 23 being genetically distinct from the other 
generations, overall. In fact, each of these groups represented clusters of closely related 
sibling groups, with a likely cryptically related sibling cluster from generation 24, that are 
less closely related to the overall sample than most other groups of siblings (Fig. 13).  
Therefore, we concluded that the outlying nature of these mice is likely due to family 
structure, as opposed to generational differences, and inclusion of a kinship covariate in 
analyses would correct for these differences, with no further correction needed for 
generational differences.  
All of the covariates mentioned at the beginning of this section are highly correlated 
with experimental cohort, and could therefore not all be included in the analysis together. For 
this reason, we aimed to identify the covariate(s) that accounted for the largest amount of 
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variation in ethanol consumption. To do this, we performed linear regression and/or ANOVA 
(depending on the nature of the covariate) to test for linear and nominal (or group-wise) 
effects of each covariate, and their interactions, on first-week, last-week, and whole-study 
mean total ethanol consumption. Ordinal covariates, such as cohort and generation, were 
tested as both continuous and categorical variables, to examine linear and group-wise effects. 
When tested by themselves, the following covariates had significant (p<0.05) effects on 
ethanol consumption for at least one time range: generation, weight, genotyping batch, and 
cohort.  Generation, genotyping batch, and cohort were collinear with each other, and 
therefore could not be included as independent variables in the same analysis.  Because 
cohort has 7 levels (compared to the 2 levels for genotyping batch and 4 for generation) over 
which consumption significantly varied for all time intervals tested, it is the most nuanced of 
the three covariates, while encompassing the effects of the other two, as well. Cohort needs 
to remain in the model, because it captures experimental, microarray batch, and generational 
variance. Therefore, we chose cohort as the covariate to carry forward for QTL analysis. 
Although there was an overall significant negative linear relationship between cohort and 
ethanol consumption, it is not a directly linear relationship (meaning not all cohorts drank 
more than the cohort that directly followed them). In fact, cohorts 6 and 7 drank more than 
cohorts 4 and 5 at all time intervals. Therefore, cohort was operationalized as a categorical 
variable in QTL analysis by creating 6 contrasting binary variables (representing membership 
(1) or non-membership (0) for each of cohorts 2-7), using the first cohort as the reference (all 
0s), meaning each cohort’s effects were measured in reference to its difference from the first 
cohort.  
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b  
Figure 12: Scree (a) and principal component (b) plots from principal components on all samples (top) vs. 
after siblings were removed (bottom).  Colors in (b) represent breeding generation, and axes represent 
projections of genome-wide genotypes for each mouse on each of the first 3 principal components (PC1, 
PC2, and PC3).  
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Figure 13: Histograms of pi-hat values for each possible pair of mice within each outlier cluster from principal 
component analysis on genome-wide genotypes (top). Bimodal distributions, as seen in Groups 1 and 3, indicate the 
presence of multiple levels of relatedness within a group. Unimodal distributions, seen in Group 2, with a lower pi-
hat limit greater than the sibship threshold (0.34), indicate the presence of sibships only. Network plots of clusters (b) 
show clusters of siblings and cryptic relatives or first cousins (multiple clusters, either sparsely connected or 
unconnected with each other, within each group) for each group of outliers. Node colors represent experimental 
cohort, whereas background color represents outlier group membership.  
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Behavioral QTL Mapping 
Genotype calls were converted to progenitor haplotype probabilities (one probability 
per progenitor strain at each locus) for QTL mapping. SNP probabilities, used for SNP 
mapping within QTL support intervals, were then imputed at intervals of 0.01Mb, based on 
these haplotype probabilities.  
For each bQTL analysis, we applied linear mixed modeling via the R/qtl2 package 
(165), which contains functions catered specifically to QTL mapping in DO populations. The 
kinship matrix, representing the pairwise relatedness between all mice, was calculated using 
the calc.kinship() function in R/qtl2, using the Leave One Chromosome Out, haplotype-based 
method. Kinship was included as a random predictive variable in all of our analyses, to 
preclude false positives attributable to increased behavioral similarities between more highly 
related mice. Because generation covaried linearly with cohort, but cohort captured more 
variance, cohort was included as the only covariate (aside from kinship) in our analyses. 
Phenotypes were either log- or square-root-transformed to obtain normality, before running 
analyses. The QTL analysis for each trait was run on haplotype probabilities, resulting in 7 
degrees of freedom. Because of the computational intensity of SNP analysis using R/qtl2 
given the large number of SNPs within the DO genome, SNP associations (with 1 degree of 
freedom) were only calculated for all imputed SNPs within the 95% Bayesian support 
interval of each significant or suggested locus.  
Selecting Kinship Estimation Method 
Before selecting a method of estimating kinship, we compared bQTL results between 
analyses that incorporated relatedness matrices of the following types: haplotype probability-
based kinship; haplotype probability-based kinship, leave one chromosome out (LOCO); 
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diplotype probability-based kinship; diplotype probability-based kinship, LOCO; Genomic 
Relatedness Matrix (GRM). The former 4 types of kinship were estimated using the qtl2 
package, based on progenitor haplotype and diplotype probabilities at each locus, 
respectively. This was done using the first genotyping batch of mice (Experimental Cohorts 1 
& 2, N=210) for Coat Color, expecting to see a peak at the known contributing locus on 
Chr7. The GRM was estimated using standard methods in PLINK1.7 (161). In order to 
determine the relative quality of each method, with respect for correcting for relatedness 
between samples to reduce the false positive rate, we compared the size of the LOD peaks at 
the known Coat Color loci and the noise for each set of results. The signals within the 
expected regions (Chr7: 87.43-87.49Mbp for albinism, and Chr2:154.79-155.05Mbp for 
black coat color) were considered to be true positives, whereas all other signals were 
considered to be noise. For these two separate analyses, albinism was considered to be a 
binary trait (due to it’s recessive nature); and black coat was considered to be a categorical 
variable with 1 indicating albinism, 2 indicating an agouti coat, and 3 indicating a black coat 
(due to this locus’s co-dominant nature). The number of noise-attributable loci was 
determined by the number of LOD peaks with a top score of at least LOD=4 and a LOD-drop 
of 1.5 on either side of the peak. The level of real signal was determined by the top LOD 
score of the peak that fell within the expected interval. The goal was to achieve the highest 
signal with respect to noise (i.e. the largest difference between mean true signal LOD scores 
and mean background LOD scores).  
The inclusion of diplotype-based kinship estimates in the model led to the highest 
peak LOD scores, but also the highest noise, indicating underestimation of relatedness, which 
imparts the potential for a higher rate of false positives in behavioral analysis. Similar results 
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were seen when using GRM in place of kinship. Haplotype-based method of kinship 
estimation seemed to lead to the highest LOD peaks while maintaining relatively little noise, 
indicating that it balanced the false and true positive rates better than the other methods. To 
compare relatedness coefficients directly, we plotted out the histograms of values for each 
method and determined sibship thresholds based on the location of the beginning of the 
second curve of the bimodal distributions (as described for the first step of sibship 
determination for quality control purposes) (Fig. 14). We then plotted the values estimated by 
each method against each other, to identify relative over- or under-relatedness (Fig. 14). 
Keeping in mind that the X -and Y-axes are of different ranges, it appears that the diplotype-
based kinship estimates are lower than the haplotype-based estimates for non-siblings, but 
higher for siblings. The same is true for the GRM values. However, the GRM values were 
lower than the diplotype-based estimates, particularly for non-siblings. Although the GRM 
values may not be directly comparable to the other two estimates (because the GRM was 
estimated using original genotype hard-calls, and the other two were based on estimated 
progenitor haplotype or diplotype probabilities), the overall distribution of comparisons is 
informative.  
Based on the QTL results and the kinship estimate value comparisons, it appears that 
GRM values underestimate relatedness between “unrelated” (as unrelated as possible in this 
type of population) mice and overestimate relatedness between siblings (Fig. 14-15 & S1). 
This means that it is overcorrecting for the differences in similarity between related and 
unrelated mice, masking both false-positive and real signals. The same is true for the 
diplotype-based estimates, but to a lesser extent. These results indicate that the haplotype-
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based estimation method is best suited for this type of analysis, balancing specificity and 
sensitivity better than the other two types of estimates. 
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Figure 14: Scatter plots comparing relatedness metrics for each possible pair of mice, from each estimation 
method: pi-hat, Genomic Relatedness Matrix (GRM), haplotype-based kinship, and diplotype-based kinship. 
Self relatedness values are missing from plots containing pi-hat and GRM estimates, as those estimates are 
not calculated for these metrics in PLINK. Where self relatedness was calculated (can be < 1 due to 
weighting by probability of allele sharing estimates), these values are colored in blue. Dotted red lines 
indicate what would be used as sibship thresholds for each metric, above which pairs are likely siblings.  
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Figure 15: (a) LOD plots for the albino locus on Chr7 (left) and the black coat color locus on Chr2 (right), for separate 
analyses using each type of relatedness estimation (Diplotype Probability-Based Kinship, Haplotype Probability-Based 
Kinship, Genomic Relatedness Matrix (GRM), Diplotype Probability-Based Leave One Chromosome Out (LOCO) Kinship, 
and Haplotype Probability-Based LOCO Kinship) as a random variable covariate, across all chromosomes. Peaks on all other 
chromosomes are likely detecting noise. (b) Founder effect plots for these respective analyses. Each line represents the average 
phenotypic value (although traits were binary, only linear regression methods were available in the R/qtl2 package) for mice in 
which the haplotype in that region most likely came from the same founder, with contributing founder strain denoted by color.  
Vertical purple shading on Chr2 represent areas in which the frequency of the WSB haplotype has been fixed to 0, due to 
breeding complications, leading to zero genotypic variance in that region. R/qtl2-calculated kinship metrics incorporate this 
information into the model, whereas GRM does not.   
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Phenotype LOD,Threshold,
(p<0.05)
Whole,Study,Tot.,EtOH,Cons. 7.470
First,Week,Tot.,EtOH,Cons. 7.546
Lasat,Week,Tot.,EtOH,Cons. 7.691
Whole,Study,Tot.,EtOH,Pref. 7.535
First,Week,Tot.,EtOH,Pref. 7.517
Lasat,Week,Tot.,EtOH,Pref. 7.573
Whole,Study,30%,EtOH,Choice 7.700
First,Week,30%,EtOH,Choice 7.470
Last,Week,30%,EtOH,Choice 7.488
Table 1: Permutation-Derived LOD Thresholds for QTL Significance 
LOD scores corresponding to the 5th percentile of the permuted LOD score distributions, for each tested 
phenotype. Values greater than these thresholds were considered to be significant. 
As explained in Cheng et al. (166), the LOCO methods for estimating haplotype- and 
diplotype-based kinships increase signal. This method leaves the chromosome that is 
currently being analyzed out of the kinship estimation, so that it does not account for 
differences attributable to loci on that chromosome, which would lead to false negative 
results. In order to ensure that the LOCO method maintained a good signal-to-noise ratio, we 
compared the haplotype- and diplotype-based estimated with and without LOCO. The LOCO 
estimates led to much higher signals with only slightly higher levels of noise, compared to 
the whole-genome kinship estimates. We therefore chose to use the haplotype probability-
based LOCO kinship estimates as the relatedness covariate in our bQTL analyses. The 
location of peaks relative to the know location of the effective loci are depicted in Figure 16. 
These results show that our data correctly estimated the locations of these QTL, with very 
few peaks more than 8Mbp away from the true signal. Furthermore, the founder effects were 
correctly estimated (A/J and NOD haplotypes conferring albinism and C57/BL6J and A/J 
haplotypes conferring black coat color) by our data (Figure 16). (A/J mice are homozygous at 
both loci, but the homozygous recessive albino phenotype is dominant over the black coat 
gene.) These results indicated accurate, clean genotypic data, and that there have been no 
large sample mix-ups. 
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Figure 16: Slide 35: Histogram of signal peak locations with LOD > 5 for each QTL peak identified for 
albino (top) and black (bottom) coat color, on chromosomes 7 and 6 in units of megabases, respectively. 
Red lines indication the location of the actual SNPs known to affect these phenotypes. Overall, most peaks 
were within 7Mb of the real affective loci for albinism, and within 5Mb of that for black coat color. All 
peaks with LOD > 5 identified for either phenotype are shown here. These results indicate that genotypic 
data is accurate and of good quality, following quality control.  
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Significance-Level Calculations 
Empirical p-values were calculated from LOD score distributions created from one 
thousand permutations on randomized samples to determine, for each phenotype, using the 
scan1perm() function from the qtl2 package. Phenotypes were randomized across samples, as 
opposed to genotypes, to maintain linkage and kinship structure. For each permutation, the 
highest LOD (logarithm of the odds) score across the genome is stored, creating a final 
distribution of 1,000 highest LOD scores from random samples. An empirical p-value < 0.05 
was considered to be significant (Table 1). Because this method of permutation is highly 
conservative, a threshold of LOD=6 was chosen to identify suggestive peaks, roughly 
corresponding to the conventionally used suggestive threshold of p < 0.63 on our permuted 
distributions and representing peaks that could clearly be visually distinguished from noise in 
LOD plots (35, 167). 
Founder Effect Calculation and Application 
Within each suggestive or significant QTL region, founder effects, or the general 
contribution of each founder strain at loci across a chromosome to the QTL signal, were 
calculated using scan1coef() function in the qtl2 package. This function calculates the mean 
and standard error of a given phenotype for all mice that share the maximally probable 
contributing founder strain at each locus. Plots of these means, by contributing founder 
strain, allows the user to visualize which founder haplotypes confer higher or lower 
phenotypic values. This knowledge can contribute to the narrowing down of SNPs within 
each QTL region, by comparing the distribution of alleles at that SNP to the expected 
grouping for the effective SNP, based on founder effects. For example, if PWK and WSB 
haplotypes at a given locus confer higher ethanol consumption values than the other strains, 
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matching SNPs would be identified as those that possess alleles shared between, and unique 
to, PWK and WSB amongst all of the founder strains. No significance values are produced 
for the effect of each founder haplotype in a given region. Therefore, the expected founder 
allele grouping was determined by viewing the phenotype grouping in the founder effect 
plots (as described in the previous hypothetical). For ambiguous groupings, all possible 
groupings were considered. Consider another example in which PWK and WSB haplotypes 
conferred high ethanol consumption values, CAST haplotypes conferred moderate values, 
and the remaining strains conferred low values. In this situation, SNPs that satisfy the 
observed grouping patterns could have: a) an allele shared between PWK and WSB, and the 
other shared between CAST and all other strains; b) an allele shared between, and unique to, 
PWK, WSB, and CAST; or c) an allele shared between PWK and WSB, an allele unique to 
CAST, and a third allele (rare, but possible, especially when considering copy number 
variants) shared between the remaining strains. A function was written to check all SNPs for 
allelic distributions across the founder strains for matches to any one possible expected 
pattern, within each QTL support interval. Accepted patterns for each QTL can be seen in 
Table S1. Top-scoring SNPs were defined as those with a LOD score within 1.5 of the top 
LOD score, or those that were not analyzed (i.e. did not have enough information or were not 
imputed) but fell within the interval between the SNPs that flanked those that fell within a 
1.5 LOD-drop of the top LOD score. We refer to these specific SNPs within these regions as 
those within the “1.5 LOD-drop interval”. Top candidate SNPs were those that yielded the 
highest LOD scores in the SNP analysis and followed an expected founder haplotype pattern 
based on founder effects.  
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Candidate Gene Identification 
Although all genes within the 95% Bayesian support interval of each bQTL were 
considered to be candidate genes, those that possess the most supporting evidence from other 
studies are considered to be those that are most likely the effective contributors to the QTL 
signal (i.e. “top candidate genes”). The list of candidates was further narrowed down to 
genes: 1) that contained significant cis-acting expression quantitative trait loci (cis-eQTL) in 
mouse liver tissue; 2) whose expression levels were significantly ethanol-responsive (or 
different between acute ethanol-treated and control mice) BXD mouse reward system-related 
brain regions; 3) correlated with ethanol-drinking-related phenotypes in chronically 
voluntarily drinking (under an IEA paradigm, with 22hsr of access to 4% EtOH and 2hrs of 
abstinence per day) male Rhesus Macaque anterior cingulate cortex and subgenual cortex 
(168, 169). Genes with the most supporting evidence from these studies were considered to 
be the top candidates; or 4) significantly associated with alcohol-related traits in any study 
reported in GWAS Catalog (170); or 5) harboring a significant weekly alcohol consumption-
associated SNP the GWAS & Sequencing Consortium of Alcohol and Nicotine (GSCAN) 
(61). However, genes were not excluded as candidates for not having supporting evidence 
from any one of these studies.   
Expression QTL data from liver tissue (the site of ethanol metabolism) was obtained 
from Munger et al. (171), which examined basal expression levels in the liver of DO mice 
(assessed via RNAseq), and assayed genotypes via the MUGA (the original version of the 
DO-catered arrays) for genotyping. Expression QTL with a qBootstrap < 0.05 were considered 
to be significant. Ethanol-responsiveness was defined as significant (qFisherFDR < 0.05) 
different expression levels, for at least one probeset representing that gene, in the Nucleus 
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Accumbens, Prefrontal Cortex, or Ventral Tegmental Area between ethanol-treated (via 
intraperitoneal injection) mice and acute saline-treated mice, in a sample of mice from 27 
BXD strains described in Wolen et al. (27). These three brain regions were chosen due to 
their role in the mesolimbocortical pathway known to be involved in alcohol craving 
(modeled by the post-abstinence increase in ethanol consumption in IEA mouse paradigms).  
Genes were considered to be supported by evidence from Bogenpohl et al. (in 
preparation) if their expression values were suggestively (unadjusted p<0.05) correlated with 
any one of the following phenotypes: treatment group (alcohol-exposed vs. water-only); 
drinking category (scale of 0-4, from no alcohol consumption to high, binge-like levels of 
consumption); average blood ethanol content (BEC) (measured roughly every 5 days) across 
the whole study, the first six months of drinking, or the last six months of drinking; change in 
BEC between first and last six months; average daily ethanol intake across the entire study, 
first six months, and last six months; change in ethanol intake between first and last six 
months; or average daily ethanol preference (g/kg(EtOH)/mL(172)); or if they were 
significantly differentially expressed between ethanol-exposed monkeys and controls. 
 
Results 
 
Behavioral Measures 
 Daily total ethanol consumption values can be seen in Figure 17. As expected, each 
behavior varied quite widely across samples, with last week mean total ethanol consumption 
ranging from 0g/kg to 40g/kg (Fig. 17-18). A Log-transformation (log10(1+value)) for 
ethanol consumption and 30% ethanol choice, and a square-root transformation for ethanol 
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Phenotype First-Week-v.-
Last-Week
First-Week-v.-
Whole-Study
Last-Week-v.-
Whole-Study
Total-EtoH-
Cons.
r=0.51,-------------
p<-2.2eC16-
r=0.80,-------------
p<-2.2eC16-
r=0.89,-------------
p<-2.2eC16-
Total-EtoH-
Pref.-
r=0.47,-------------
p<-2.2eC16-
r=0.47,-------------
p<-2.2eC16-
r=0.51,-------------
p<-2.2eC16-
30%-EtOH-
Choice
r=0.43,-------------
p<-2.2eC16-
r=0.74,-------------
p<-2.2eC16-
r=0.80,-------------
p<-2.2eC16-
Table 2: Correlations Within Phenotypes Across Time Intervals 
Pearson correlation coefficients and p-values for each drinking behavior 
between time frames over which values were averaged for quantitative trait 
preference, worked best for normalizing the respective phenotypic distributions before QTL 
analysis (Fig. 18). There was an overall significant increase in alcohol consumption between 
the first week and last week of IEA (Fig. 19). Although the whole sample’s trend was to 
increase drinking over time, this was not the case for every individual mouse, as we predicted 
based on similar variation between the progenitor strains in our previous study Chapter 3. 
Phenotypes were moderately correlated across time points, with enough variation between 
them to justify analyzing them separately for QTL mapping (Fig. 20; Table 2).  
 
Quantitative Trait Loci 
 Several significant and suggestive QTL were identified for each of the phenotypes 
measured (total ethanol consumption, total ethanol preference, and 30% ethanol choice), all 
of which differed between the first and last week experimental time ranges (Table 3, Fig. 21).  
Support intervals for these loci ranged from an unprecedented 1.05Mbp to 25.38Mbp. One of 
the two significant loci (Chr4:3.37-11.04). was identified for last week mean total ethanol 
consumption, and was suggestive for last week mean total ethanol preference, and whole 
study mean consumption and preference. One other locus was identified for both ethanol 
consumption and preference, but for the first week time interval, on Chr12. Founder effects 
were somewhat ambiguous, even after plotting standard errors, so several different patterns 
were considered for each locus (Fig. 22).  
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Figure 17: Slide 2: Daily total ethanol consumption (g(EtOH)/kg(mouse)) across the first 4 weeks of ethanol 
exposure, excluding the first day of exposure (ethanol access days 2-11), for all ethanol-exposed mice. 
Horizontal black lines represent the median, with grey blocks encapsulating the interquartile range, and 
vertical black lines extend across values calculated by subtracting (truncated on y-axis) or adding 1.5 
multiplied by the interquartile range to the minimum or maximum values, respectively. Each black dot 
represents an individual mouse that fell outside of this range, which could be considered as potential 
outliers. The blue line is the line of best fit for the effect of drinking day on ethanol consumption, with the 
beta statistic and p-value for this regression depicted in the upper right-hand corner.  
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a 
160	
 
b 
161	
 
Figure 18: Histograms of total ethanol consumption (a), preference (b), and 30% ethanol choice (c) for the 
first week, last week, and entire duration of ethanol access, with number of mice exhibiting that level of 
consumption at each time point represented by the Y-axis. On the left are the raw values, and on the right 
are the log- or square-root-transformed values (log10(1+xg/kg) or √ x), which were used for QTL analysis due 
to the normal distribution assumption in the regression calculations.   
 
c 
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SNP effects were analyzed by testing for a relationship between the phenotypes and imputed 
allelic probabilities at each individual locus (2 degrees of freedom, as opposed to 7), 
calculated from the haplotype probabilities (Fig. 23). Top-scoring SNPs are discussed in the 
context of their reported affiliated gene (one gene per SNP) by Sanger Mouse Genome 
(information that is imbedded in the R/qtl2 package), due to their close proximity. We chose 
to identify top candidate SNPs separately from top candidate genes, because it is unlikely 
that every SNP would only affect the gene to which it is most proximal. Candidate SNPs 
represent polymorphisms that are contributing to the signal, and candidate genes refer to the 
functional entities that may be affected by these SNPs. SNP analysis revealed LOD peaks in 
which many of the highest-scoring SNPs (within a 1.5 LOD-drop from the top-scoring SNP) 
matched the expected founder haplotype distribution. We will hence forth refer to SNPs with 
the 5 highest LOD scores, of those that match the expected founder haplotype patterns, as 
“candidate SNPs”. For all but three loci (Chr3 Locus 3, the Chr11 locus for Whole Study 
Total Ethanol Consumption, and the Chr6 Locus), all of the highest scoring SNPs followed 
the expected founder haplotype patterns (Table S1). The SNPs with the top 5 LOD scores for 
each locus are listed in Table 4. However, the top SNPs for the Chr6 locus were shared 
between NOD, NZO, and CAST, and a nearby SNP contained a C57-unique allele. These 
alleles are likely both contributing to the founder effects, together. This could explain the 
higher mean drinking values in mice possessing haplotypes inherited from any one of these 5 
founder strains. Candidate genes were identified as those in which the SNPs were contained.  
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Figure 19: Grand mean and standard errors (vertical black lines) of total ethanol consumption 
(g(EtOH)/kg(mouse)) across all mice, for the first week, last week, and entire duration of ethanol exposure. 
The bar and asterisk indicate a significant difference (p<0.05) between total ethanol consumption between 
those time intervals.  
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Top Candidate Genes 
 All bQTL with significant or suggestive loci were examined for top candidate genes. 
As described above, these genes were assessed for: significant eQTL in DO liver tissue; 
suggestive (unadjusted p<0.05) anterior cingulate cortex and subgenual cortex gene 
expression correlation with ethanol-consumption-related trait in Rhesus Macaques; 
significant expression differences between acute ethanol treatment and control BXD mouse 
reward pathway-related brain regions; and significant GWAS signals for alcohol-related-
traits. A summary of supporting evidence for each of the top candidate genes can be seen in 
Table 5. All supporting evidence for all genes within each bQTL’s support intervals can be 
seen in Table S2-3.  
 Although the support intervals differed slightly between phenotypes, the 
Chromosome 4 QTL was identified for Whole Study Mean Total Ethanol Preference and 
Consumption, as well as Last Week Mean Total Ethanol Preference and Consumption. The 
top candidate genes for this region are: Car8 (Carbonic anhydrase 8), Fam110b (Family with 
sequence similarity 110, member B), Impad1 (Inositol monophosphatase domain-containing 
1), and Tox (Thymocyte selection associated high mobility group box).  Because of its 
narrow support interval, the Last Week Mean Total Ethanol Consumption QTL only 
contained one of the top candidate genes (Car8), whereas all other regions shared all 
candidate genes for this region. The top candidate SNPs for this QTL were determined by 
pooling results from each of these analyses. These SNPs are: rs32098535, rs48821381, 
rs227159729, rs27657700, and rs51487109 (Table 4). Two of these SNPs are not known to 
be associated with any genes, and three others are non-coding transcript variants in Tox. 
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Figure 20: Relationship of average phenotypes (a. total ethanol consumption, b. total ethanol preference, c. 30% ethanol 
choice) between time points (First Week, Last Week, and Whole Study). Each point represents a single mouse, and its 
color reflects the Whole Study mean phenotype.  The black line represents the line of best fit between the First and Last 
Week mean phenotypes, with the shaded grey area representing the standard error.   
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Table 3: bQTL Regions for Ethanol Drinking Phenotypes 
Behavioral quantitative trait loci positions for Last Week, First Week, and Whole Study Mean Total Ethanol 
Consumption and Preference, and 30% Ethanol Choice. Peak LOD scores are annotates with their respective 
genotyping array markers, and their target position in Mega base pairs (Mbp) on the indicated chromosome, 
for each QTL region. 95% Bayesian confidence intervals (CI) were used to determine QTL length. 
Phenotype marker LOD0Score Chr pos_Mbp Downstream0
95%0Bayesian0CI0
Upstream095%0
Bayesian0CI0
CI0Length
Last0Week0Mean030%0EtOH0Choice JAX00221237 8.63 3 108.2251 105.9240 109.6894 3.7654
Last0Week0Mean0Total0EtOH0Cons. UNC6694526 8.23 4 8.4134 8.2352 9.2852 1.0500
First0Week0Mean0Total0EtOH0Pref. UNC21463670 7.52 12 79.3497 78.0891 79.9077 1.8185
Last0Week0Mean030%0EtOH0Choice UNCHS009636 6.93 3 103.5692 101.8533 104.4704 2.6171
Last0Week0Mean0Total0EtOH0Pref. UNC28339832 6.88 17 74.3198 72.9064 75.2112 2.3048
Whole0Study0Mean0Total0EtOH0Cons. UNCHS010637 6.67 4 8.3241 3.7755 9.6532 5.8776
Whole0Study0Mean0Total0EtOH0Pref. UNC1732354 6.65 1 135.3548 134.6418 136.5865 1.9448
Last0Week0Mean030%0EtOH0Choice UNC6068240 6.48 3 118.9298 118.3936 119.8124 1.4189
Last0Week0Mean0Total0EtOH0Cons. c11.loc26.06 6.46 11 50.5751 49.9637 51.5240 1.5603
Last0Week0Mean0Total0EtOH0Pref. UNCHS042680 6.36 16 44.6870 39.4349 45.6827 6.2479
Last0Week0Mean0Total0EtOH0Pref. UNCHS010637 6.32 4 8.3241 3.3708 11.0462 7.6754
Whole0Study0Mean0Total0EtOH0Pref. UNCHS010623 6.30 4 6.9963 3.3708 8.3241 4.9533
Whole0Study0Mean0Total0EtOH0Cons. UNCHS031224 6.29 11 70.6117 69.8561 71.3399 1.4838
First0Week0Mean0Total0EtOH0Cons. c6.loc49.42 6.27 6 113.9204 112.7439 115.3086 2.5647
Last0Week0Mean0Total0EtOH0Pref. UNCHS002448 6.06 1 134.7291 119.5259 144.9080 25.3821
 
 
 
 
 
 
 
 
 
 
 
As for the Chr4 QTL, a bQTL associated with a phenotype for more than one time 
interval (Whole Study and Last Week Mean Total Ethanol Preference) appeared on Chr1, 
with slightly different yet highly overlapping support intervals. The top candidate genes for 
both the Whole Study and Last Week loci are: Csrp1 (Cysteine and glycine-rich protein 1), 
Ipo9 (Importin 9), Lad1 (Ladinin 1), Lmod1 (Leiomodin 1), Nav1 (Neuron navigator 1), 
Rnpep (Arginyl aminopeptidase), Tnni1 (Troponin I, skeletal slow 1), Tnnt2 (Troponin T2, 
cardiac). The top candidate genes unique to the larger Last Week locus are: Cd55 (CD55 
molecule, decay accelerating factor for complement), Cd55b (CD55 molecule, decay 
accelerating factor for complement B), Nucks1 (nuclear casein kinase and cyclin-dependent 
kinase substrate 1), Pm20d1 (peptidase M20 domain containing 1), Slc41a1 (solute carrier 
family 41, member 1), and Timm17a (translocase of inner mitochondrial membrane 17a). 
The top five candidate SNPs in the variant-based analysis were rs32438212, rs51581531, 
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rs48738822, rs108288159, and rs46404195, all of which followed the expected founder 
haplotype patterns and had LOD scores that rounded to 7.36 (Table 4). 
Three QTL were identified on Chr3 for Last Week Mean 30% Ethanol Choice. 
However, the support intervals of the two most proximal loci were only 1.5Mbp apart, and 
only one distinct LOD peak is seen in this region (Fig. 22), indicating that these two peaks 
are actually identifying one locus that spans over 7.84Mbp. The top candidate genes for these 
two loci are: Ahcyl1 (S-adenosylhomocysteine hydrolase-like 1), Ampd2 (adenosine 
monophosphate deaminase 2), Cd53 (Cd53 antigen), Clcc1 (chloride channel clic-like 1), 
Gnai3 (guanine nucleotide binding protein, alpha inhibiting 3), Sort1 (Sortilin 1), Ubl4b 
(ubiquitin-like 4b), Wdr77 (WD repeat domain 77), Hipk1 (homeodomain interacting protein 
kinase 1), Rsbn1 (rosbin, round spermatid baseic protein 1), Syt6 (synaptotagmin 6), and 
Tspan2 (tetraspanin 2). Genes that fell between these two support intervals were also 
considered, but none displayed substantial evidence for being a top candidate gene. The third 
locus, which appears to be a distinct peak distal to the other two (Fig. 22), was a narrower 
region containing only two top candidate genes: Dpyd (dihydropyrimidine dehydrogenase) 
and Ptbp2 (polypyrimidine tract binding protein 2). The top candidate SNPs for the most 
proximal locus are rs49087152, rs217960262, rs244300971, rs246339091, and rs213764891 
(Table 4), which all have LOD scores between 6.06 and 6.07. 
 Two loci were identified for Last Week Mean Total Ethanol Preference, on 
Chromosomes 16 and Chr17. The top candidate genes for the Chr16 locus are: Lsamp (limbic 
system-associated membrane protein), Slc35a5 (solute carrier family 35, member A5), and 
Zbtb20 (zinc finger and BTB domain containing 20). The top five candidate SNPs for the 
Chr16 locus are rs243048813, rs32655787, rs257335011, and rs47507732, all of which are 
168	
intron variants for genes Sidt1 (SID1 transmembrane family, member 1) (for rs243048813) 
and Lsamp (for the remaining four SNPs) with LOD scores between 3.87 and 4.46 (Table 4). 
For Chr17, the top candidate genes are: Capn13 (calpain13), Dpy30 (dpy-30, histone 
methyltransferase complex regulatory subunit), Galnt14 (polypeptide N-
acetylgalactosaminyltransferase 14), Lbh (limb-bud and heart), Lclat1 (lysocardiolipin 
acyltransferase), Memo1 (mediator of cell motility 1), Spast (spastin), and Yipf4 (yip 1 
domain family, member 4). The top five candidate SNPs for the Chr17 locus are rs51050012, 
rs251169915, rs51169739, rs222840432, and rs235513168, which have LOD scores between 
3.99 and 4.01. Two of these SNPs (rs51169739 and rs222840432) are intron variants for the 
gene Lclat1 (lysocardiolipin acyltransferase 1), one is an downstream variant of predicted 
gene Gm25406, and the remaining two are classified as intergenic SNPs. 
  There were two loci that were unique to ethanol-naïve (i.e. First Week) drinking 
behaviors: one on Chr6 for Total Ethanol Consumption, and the other on Chr12 for Total 
Ethanol Preference. The top candidate genes for the Chr6 locus are: Atp2b2 (ATPase, Ca2+ 
transporting, plasma membrane 2), Slc6a1 (solute carrier family 6, member 1), and Slc6a11 
(solute carrier family 6, member 11). The top five candidate SNPs for this region are 
rs30214990, rs46370242, rs252343765, rs36751483, rs48409474, which have LOD scores 
between 3.19 and 3.36. All of these SNPs are all located within the Atp2b2 gene. The Chr12 
top candidate genes are: Arg2 (arginase type II), Gphn (gephyrin), Mpp5 (membrane protein, 
palmitoylate 5), Plekhh1 (pleckstrin homology domain containing, family H (with MyTH4 
domain), member 1), and Zfyve26 (zinc finger, FYVE domain containing 26). The top five 
candidate SNPs for this locus were rs226566367, rs46944281, rs48897594, rs48645692, and 
rs233426717, which fell within the introns or just up-or down-stream of genes Zfyve26, 
169	
Rdh12 (retinol dehydrogenase 12), Rdh11 (retinol dehydrogenase 11), Arg2, and Plekhh1, 
respectively.  There was also one locus unique to a Whole Study ethanol behavior, on Chr11, 
for Total Ethanol Consumption, and an adjacent but distinct locus unique to Last Week Mean 
Total Ethanol Consumption. The former contained several top candidate genes: 
0610010K14Rik (Riken cDNA  0610010K14), Alox12 (arachidonate 12-lipoxygenase), Arrb2 
(arrestin, beta 2), Camta2 (calmodulin binding transcription activator2), Med11 (mediator 
complex subunit 11), Mink1 (misshapen-like kinas 1), Pelp1 (proline, glutamic acid and 
leucine rich protein1), Phf23 (PHD finger protein 23), Psmb6 (proteasome), Rabep1 
(rabaptin, RAB GTPase binding effector protein 1), RNAsek (ribonuclease RNase K), and 
Tm4sf5 (transmembrane superfamily 5). The top five candidate SNPs are 11:70781749_C/T, 
11:70779940_A/T, 11:70618113_C/A, 11:70782944_T/G, and 11:70611698_A/G, each with 
a LOD score of 1.30. Unexpectedly, the top-scoring SNPs, with LODs of 2.74, did not match 
the expected founder haplotype patterns. Therefore, we have chosen not to rely on SNP 
information to identify potential affective genes for this locus. Finally, the Last Week Mean 
Total Ethanol Consumption QTL on Chr11 contained three top candidate genes: Canx 
(calnexin), Clk4 (CDC like kinase 4), and Zfp2 (zinc finger protein 2). The top candidate 
SNPs for this locus are rs258127079, rs243374395, rs26965630, rs261774330, and 
rs26979779. Two of these (rs26965630 and rs26979779) SNPs are not contained in any 
genes. However, the other 3 are classified as intron (rs258127079 and rs261774330) or 
upstream (rs243374395) variants for the gene Adamts2. 
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Phenotype Which,Locus LOD,Score Pos,(Mbp) SNPid Gene Consequence,of,Minor,Allele Variant,Type
Whole,Study,Total,EtOH,Cons Chr4,Locus 3.05 8.3842 4:8384190_G/A NA intergenic_variant snp
3.02 8.4380 rs249655952 Gm37386 downstream_gene_variant snp
2.89 8.3023 4:8302313_A/C NA intergenic_variant snp
2.75 7.9466 rs27708815 NA intergenic_variant snp
2.38 7.8969 rs27655790 NA intergenic_variant snp
Last,Week,Total,EtOH,Cons Chr4,Locus 4.01 8.4380 rs249655952 Gm37386 downstream_gene_variant snp
3.89 8.3842 4:8384190_G/A NA intergenic_variant snp
3.43 8.3023 4:8302313_A/C NA intergenic_variant snp
3.15 9.1646 rs32455519 NA intergenic_variant snp
3.10 9.2412 rs262840752 NA intergenic_variant snp
,Whole,Study,Total,Ethanol,Preference, Chr4,Locus 3.70 7.2540 rs32098535 NA intergenic_variant snp
3.62 7.5980 rs48821381 NA intergenic_variant snp
3.62 7.5982 rs27687625 NA intergenic_variant snp
3.13 6.7412 rs227159729 Tox
non_coding_transcript_exon_vari
ant,non_coding_transcript_variant snp
3.12 6.7416 rs27657700 Tox
non_coding_transcript_exon_vari
ant,non_coding_transcript_variant snp
Last,Week,Total,Ethanol,Preference, Chr4,Locus 3.74 5.2230 SV_4_5223003_5223005 NA NA SV
3.74 5.2577 SV_4_5257666_5257668 NA NA SV
3.74 6.6281 SV_4_6628120_6628122 NA NA SV
,Whole,Study,Total,Ethanol,Preference, Chr1,Locus 3.74 135.7212 rs32438212 Csrp1 intron_variant snp
3.74 135.7238 rs51581531 Csrp1 intron_variant snp
3.74 135.7263 rs45936880 Csrp1 intron_variant snp
3.74 135.7277 rs45881802 Csrp1 intron_variant snp
3.74 135.7311 rs46994917 Csrp1 intron_variant snp
Last,Week,Total,Ethanol,Preference, Chr1,Locus 3.85 135.3568 rs581908485 Lmod1 intron_variant snp
3.80 130.4435 1:130443512_G/C Cd55 intron_variant snp
3.80 130.4436 1:130443642_A/G Cd55 intron_variant snp
3.80 130.4437 1:130443663_A/C Cd55 intron_variant snp
3.80 130.4438 1:130443779_G/T Cd55 intron_variant snp
Whole,Study,Total,EtOH,Cons Chr11,Locus 2.72 70.1879 11:70187893_G/A NA intergenic_variant snp
2.72 70.1879 11:70187943_G/A NA intergenic_variant snp
2.72 70.1879 11:70187945_A/G NA intergenic_variant snp
2.72 70.1879 11:70187948_C/T NA intergenic_variant snp
2.72 70.1880 11:70187951_C/T NA intergenic_variant snp
Last,Week,Total,EtOH,Cons Chr11,Locus 4.02 50.6592 rs258127079 Adamts2 intron_variant snp
4.01 50.5990 rs243374395 Adamts2 upstream_gene_variant snp
4.00 50.5895 rs26965630 NA intergenic_variant snp
4.00 50.5903 rs248344810 NA intergenic_variant snp
4.00 50.5907 rs222454793 NA intergenic_variant snp
First,Week,Total,EtOH,Cons Chr6,Locus 3.36 113.8618 rs30214990 Atp2b2 intron_variant,non_coding_transc
ript_variant
snp
3.25 113.8328 rs46370242 Atp2b2 intron_variant snp
3.25 113.8250 rs252343765 Atp2b2 intron_variant snp
3.25 113.5486 rs36751483 Fancd2 upstream_gene_variant snp
3.20 113.9833 rs48409474 Atp2b2 intron_variant,non_coding_transc
ript_variant
snp
First,Week,Total,Ethanol,Preference, Chr12,Locus 6.14 79.2442 rs226566367 Zfyve26 intron_variant snp
6.14 79.2442 rs46652565 Zfyve26 intron_variant snp
6.14 79.2462 rs220212213 Zfyve26 splice_region_variant,intron_varia
nt
snp
6.14 79.2610 rs258744940 Zfyve26 intron_variant snp
6.14 79.2610 rs221141341 Zfyve26 intron_variant snp
Last,Week,Total,Ethanol,Preference, Chr16,Locus 4.46 44.2681 rs243048813 Sidt1 intron_variant snp
4.46 44.2781 rs219475321 Sidt1 downstream_gene_variant snp
4.46 44.2781 rs257457254 Sidt1 downstream_gene_variant snp
4.46 44.2808 rs226215307 Sidt1 downstream_gene_variant snp
3.98 40.7403 rs32655787 Lsamp intron_variant snp
Chr17,Locus 4.01 73.0464 rs51050012 NA intergenic_variant snp
4.01 73.0467 rs33454915 NA intergenic_variant snp
4.01 73.0474 rs29521103 NA intergenic_variant snp
4.01 73.0486 rs33687405 NA intergenic_variant snp
4.01 73.0522 rs33457925 NA intergenic_variant snp
Last,Week,Mean,30%,EtOH,Choice Chr3,Locus1]2 6.07 108.7610 rs49087152 Aknad1 intron_variant,NMD_transcript_va
riant
snp
6.07 108.7611 rs257383845 Aknad1 intron_variant,NMD_transcript_va
riant
snp
6.07 108.7615 rs238046046 Aknad1 intron_variant,NMD_transcript_va
riant
snp
6.07 108.7618 rs226352210 Aknad1 intron_variant,NMD_transcript_va
riant
snp
6.07 108.7619 rs255653661 Aknad1 intron_variant,NMD_transcript_va
riant
snp
Table 4: Top-Scoring Variants within QTL Support Intervals 
LOD scores, chromosomal position (in Mega base pairs (Mbp)), variant classification, SNP ID, and 
minor allele consequence for each of the top 5 variants within each QTL interval. Top variants were 
selected based on their LOD score and their adherence to the expected genotypic comparisons in the DO 
founder strains. If 5 SNPs did not meet the latter criterion, only those that did were selected.  
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Table 5: Supporting Data for Top Candidate Variants 
Gene chr start stop HumanGene
At0Least010Sig.0
Value0in0Rhesus0
Data
Sig.0cis;eQTL0
in0DO0Liver0
Data
N0Sig.0Alc.0
GWAS0
Sig.0S;score0
Nac
Sig.0S;score0
PFC
Sig.0S;Score0
VTA
Sig.0in0
GSCAN
0610010K14Rik 11 70.2352 70.2379 NA N Y 0 N Y N N
Ahcyl1 3 107.6631 107.6966 AHCYL1 Y Y 0 Y Y Y N
Alox12 11 70.2415 70.2554 ALOX12 Y Y 0 N N N N
Ampd2 3 108.0741 108.0867 AMPD2 N NA 0 Y Y N N
Arg2 12 79.1308 79.1563 ARG2 Y Y 0 Y N N N
Arrb2 11 70.4326 70.4408 ARRB2 N Y 0 Y Y Y N
Atp2b4 1 133.6995 133.8010 ATP2B4 Y Y 0 N N N N
Camta2 11 70.6695 70.6882 CAMTA2 Y Y 0 N Y Y N
Capn13 17 73.3065 73.3993 CAPN13 Y NA 0 N N N N
Car8 4 8.1415 8.2390 CA8 Y Y 0 N Y Y N
Cd53 3 106.7589 106.7901 CD53 Y Y 0 N Y N N
Cd55 1 130.4298 130.4630 CD55 Y Y 0 N N N N
Cd55b 1 130.3885 130.4230 NA Y NA 0 N N N N
Chd7 4 8.6904 8.8684 CHD7 Y NA 0 Y N Y N
Clcc1 3 108.6539 108.6788 CLCC1 Y Y 0 Y Y N N
Csrp1 1 135.7201 135.7522 CSRP1 Y Y 0 Y Y Y N
Dpy30 17 74.2995 74.3239 DPY30 Y Y 0 N N N N
Dpyd 3 118.5621 119.4329 DPYD Y Y 0 N N N N
Fam110b 4 5.6441 6.1082 FAM110B Y Y 0 N N N N
Galnt14 17 73.4932 73.7108 GALNT14 N Y 0 N N N N
Gphn 12 78.2261 78.6848 GPHN Y Y 0 Y Y Y N
Hipk1 3 103.7398 103.7919 HIPK1 Y Y 0 Y Y Y N
Impad1 4 4.7625 4.7934 IMPAD1 Y Y 1 Y Y Y N
Ipo9 1 135.3823 135.4305 IPO9 Y Y 0 N N N N
Lad1 1 135.8186 135.8333 LAD1 Y Y 0 N N N N
Lbh 17 72.9183 72.9419 LBH Y NA 0 Y Y Y N
Lclat1 17 73.1080 73.2434 LCLAT1 Y Y 0 N N N N
Lmod1 1 135.3248 135.3681 LMOD1 Y NA 0 N N N N
Lsamp 16 39.9844 42.1817 LSAMP N Y 2 Y Y Y N
Med11 11 70.4519 70.4537 MED11 Y Y 0 N N N N
Memo1 17 74.1990 74.2955 MEMO1 N Y 0 Y N N N
Mink1 11 70.5627 70.6145 MINK1 Y Y 0 Y N Y N
Mpp5 12 78.7489 78.8407 MPP5 N Y 0 Y Y Y N
Nav1 1 135.4346 135.6881 NAV1 N N 0 Y Y Y N
Nucks1 1 131.9105 131.9363 NUCKS1 Y Y 0 Y Y Y Y
Pelp1 11 70.3929 70.4100 PELP1 N Y 0 Y N Y N
Phf23 11 69.9958 70.0000 PHF23 Y NA 0 N N N N
Plekhh1 12 79.0292 79.0817 PLEKHH1 Y Y 0 Y N Y N
Pm20d1 1 131.7974 131.8215 PM20D1 N Y 0 N N N Y
Psmb6 11 70.5254 70.5279 PSMB6 Y Y 0 N N N N
Ptbp2 3 119.7187 119.7845 PTBP2 Y NA 0 Y Y Y N
Rab2a 4 8.5356 8.6078 RAB2A Y Y 0 N N N N
Rabep1 11 70.8447 70.9431 RABEP1 Y Y 0 N N Y N
Rnasek 11 70.2381 70.2399 RNASEK N Y 0 N N Y N
Rnpep 1 135.2627 135.2844 RNPEP N Y 0 Y N Y N
Rsbn1 3 103.9141 103.9666 RSBN1 Y NA 0 N Y Y N
Slc16a1 3 104.6387 104.6585 SLC16A1 Y NA 0 N N N N
Slc16a11 11 70.2128 70.2164 SLC16A11 N Y 0 N N N N
Slc35a5 16 45.1396 45.1587 SLC35A5 Y Y 0 N N Y N
Slc41a1 1 131.8275 131.8489 SLC41A1 Y Y 0 N N Y Y
Sort1 3 108.2841 108.3615 SORT1 Y Y 0 Y Y Y N
Spast 17 74.3375 74.3911 SPAST Y Y 0 N N N N
Syt6 3 103.5752 103.6456 SYT6 N Y 0 Y N Y N
Timm17a 1 135.2952 135.3138 TIMM17A Y Y 0 N N N N
Tm4sf5 11 70.5052 70.5112 TM4SF5 N NA 1 N N N N
Tnni1 1 135.7794 135.8110 TNNI1 Y NA 0 N N Y N
Tnnt2 1 135.8363 135.8523 TNNT2 Y NA 0 N N N N
Tox 4 6.6864 6.9916 TOX Y Y 0 Y Y N N
Tspan2 3 102.7345 102.8015 TSPAN2 Y N 0 Y Y Y N
Ubl4b 3 107.5537 107.5551 UBL4B Y NA 1 N N N N
Wdr77 3 105.9594 105.9700 WDR77 Y Y 0 N N Y N
Yipf4 17 74.4895 74.5003 YIPF4 Y Y 0 Y N Y N
Zbtb20 16 42.8758 43.6426 ZBTB20 Y Y 0 Y Y Y N
Zfyve26 12 79.2323 79.2963 ZFYVE26 Y Y 0 Y N N N
Top candidate genes, and their chromosomal locations in Mega base pairs, and a summary of supporting data for 
association with alcohol-related phenotypes, gleaned from other studies.  
N=No, Y=Yes 
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Figure 21: LOD plots for all ethanol drinking phenotypes (denoted in top right corner of each plot), across 
all chromosomes. Red and blue dotted lines denote empirical significance (corresponding to p<0.05) and 
suggestive thresholds (corresponding to p<0.63), respectively.  
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Chr 4 position (Mbp)
4 5 6 7 8 9
Lyn→
Gm22781←
9430025C20Rik←
Rps20←
Gm24016←
Gm32823→
Gm24125←
Mos←
Plag1←
Chchd7→
Gm19037→
Gm11808←
Rps10−ps3←
Sdr16c5←
Sdr16c6←
Penk←
A830012C17Rik→
Gm33007→
Gm33057→
Gm11780←
Gm33182→
Gm33259→
Gm26436→
Impad1←
Gm18933←
Gm11779← Gm11782←
Gm11781←
4930423M02Rik→
Fam110b→
Gm24337←
Gm11796←
Gm18158←
Gm11797→
Ubxn2b→
Gm11798←
Cyp7a1←
4930430E12Rik←
Sdcbp→
Gm37689→
Nsmaf←
Gm11803←
Gm11801→
Gm22473←
Tox←
Gm11802→
2610024J18Rik
Gm11804←
Gm33462→
Gm33539→
Gm33646→
8430436N08Rik→
Gm33752←
Gm11795→
Gm11794←
Gm23860→
Gm11800→
Car8←
Gm11799←
Gm25355→
Gm42252←
Gm37386←
Gm11810←
Gm18098→
Rab2a→
D130047N11Rik
C530036F05Rik
Gm42253←
Gm8273←
Gm11809←
Chd7→
Gm46841→
Gm46842←
Rps18−ps2→
Gm34428←
Gm34288←
Clvs1→
Gm23423→
Gm26548←
Gm11816←
D130060J02Rik
Gm11817←
Asph←
Gm19130←
Whole Study Mean Total EtOH Consumption SNP Effects
Chr4 LOD Peak Support Interval
0
1
2
3
4
LO
D 
sc
or
e
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●●
●
●
●
●
●
●●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●●●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●●
●●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●●●
●
●
●
●
●●●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●●
●
●
●
●
●●
●
●●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●●●
●
●
●●
●
●
●
●●
●
●
●
●●
●
●
●
●
●
●●
●
●
●
●
●●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
Chr 4 position (Mbp)
7.5 8.0 8.5 9.0 9.5 10.0
8430436N08Rik→
Gm33752←
Gm11795→
Gm11794←
Gm23860→
Gm11800→
Car8←
Gm11799←
Gm25355→
Gm42252←
Gm37386←
Gm11810←
Gm18098→
Rab2a→
D130047N11Rik
C530036F05Rik
Gm42253←
Gm8273←
Gm11809←
Chd7→
Gm46841→
Gm46842←
Rps18−ps2→
Gm34428←
Gm34288←
Clvs1→
Gm23423→
Gm26548←
Gm11816←
D130060J02Rik
Gm11817←
Asph←
Gm19130←
Gm25677→
Gm24152←
Gm34947→
4930412C18Rik→
Gm42254←
Gdf6→
4930448K20Rik←
Gm11834→
Gm11835→
Gm35008→
Last Week Mean Total EtOH Consumption SNP Effects
Chr4 LOD Peak Support Interval +/− 1Mb
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Chr 4 position (Mbp)
4 5 6 7 8
Gm11784→
Gm11785→
Gm11787←
Mir3471−2→
Tmem68←
B230117O15Rik
Tgs1→
Gm22541→
2210414B05Rik→
Gm42250←
Lyn→
Gm26857←
6330407A03Rik→
Gm11805←
Gm22781←
9430025C20Rik←
Rps20←
Gm24016←
Gm32823→
Gm24125←
Mos←
Plag1←
Chchd7→
Gm19037→
Gm11808←
Rps10−ps3←
Sdr16c5←
Sdr16c6←
Penk←
A830012C17Rik→
Gm33007→
Gm33057→
Gm11780←
Gm33182→
Gm33259→
Gm26436→
Impad1←
Gm18933←
Gm11779← Gm11782←
Gm11781←
4930423M02Rik→
Fam110b→
Gm24337←
Gm11796←
Gm18158←
Gm11797→
Ubxn2b→
Gm11798←
Cyp7a1←
4930430E12Rik←
Sdcbp→
Gm37689→
Nsmaf←
Gm11803←
Gm11801→
Gm22473←
Tox←
Gm11802→
2610024J18Rik
Gm11804←
Gm33462→
Gm33539→
Gm33646→
8430436N08Rik→
Gm33752←
Gm11795→
Gm11794←
Gm23860→
Gm11800→
Car8←
Gm11799←
Gm25355→
Whole Study Mean Total EtOH Preference SNP Effects
Chr4 LOD Peak Support Interval
0
1
2
3
LO
D 
sc
or
e
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Chr 4 position (Mbp)
4 6 8 10
Gm11784→
Gm11785→
Gm11787←
Mir3471−2→
Tmem68←
B230117O15Rik
Tgs1→
Gm22541→
2210414B05Rik→
Gm42250←
Lyn→
Gm26857←
6330407A03Rik→
Gm11805←
Gm22781←
9430025C20Rik←
Rps20←
Gm24016←
Gm32823→
Gm24125←
Mos←
Plag1←
Chchd7→
Gm19037→
Gm11808←
Rps10−ps3←
Sdr16c5←
Sdr16c6←
Penk←
A830012C17Rik→
Gm33007→
Gm33057→
Gm11780←
Gm33182→
Gm33259→
Gm26436→
Impad1←
Gm18933←
Gm11779←
Gm11782←
Gm11781←
4930423M02Rik→
Fam110b→
Gm24337←
Gm11796←
Gm18158←
Gm11797→
Ubxn2b→
Gm11798←
Cyp7a1←
4930430E12Rik←
Sdcbp→
Gm37689→
Nsmaf←
Gm11803←
Gm11801→
Gm22473←
Tox←
Gm11802→
2610024J18Rik
Gm11804←
Gm33462→
Gm33539→
Gm33646→ 8430436N08Rik→
Gm33752←
Gm11795→
Gm11794←
Gm23860→
Gm11800→
Car8←
Gm11799←
Gm25355→
Gm42252←
Gm37386←
Gm11810←
Gm18098→
Rab2a→
D130047N11Rik
C530036F05Rik
Gm42253←
Gm8273←
Gm11809←
Chd7→
Gm46841→
Gm46842←
Rps18−ps2→
Gm34428←
Gm34288←
Clvs1→
Gm23423→
Gm26548←
Gm11816←
D130060J02Rik
Gm11817←
Asph←
Gm19130←
Gm25677→
Gm24152←
Gm34947→
4930412C18Rik→
Gm42254←
Gdf6→
4930448K20Rik←
Gm11834→
Gm11835→
Gm35008→
Gm46879←
Gm11814←
1700123O12Rik←
Gm11815←
Gm11813→
Gm12920→
Mir3471−1←
Gm12918→
Gm12919→
n−TSaga9→
2610301B20Rik→
Rps11−ps3→
Gm2401→
Plekhf2←
Gm46843←
Gm35429←
Last Week Mean Total EtOH Preference SNP Effects
Chr4 LOD Peak Support Interval
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Chr 1 position (Mbp)
135.0 135.5 136.0 136.5
Gm26783←
Syt2→
Ppp1r12b←
Gm32670→
Gm37949←
Gm22232→
Gm37677←
Gm28892→
Ube2t→
Lgr6←
Ptprv←
Gm10535→
Ptpn7→
Arl8a→
Gm26280←
Gm15445→
Gpr37l1←
Gm41955←
Gm4204→
Gm26642→
Elf3←
Rnpep←
Gm19642→
Timm17a←
Gm41956←
Lmod1→
Gm22796←
Shisa4←
Ipo9←
Gm28277←
Nav1←
Mir1231←
2610012C04Rik←
Gm32940→
Gm37333←
Gm4793→
Gm38399←
Gm32835→
Csrp1→
Phlda3→
Tnni1→
AW049021
Lad1→
Tnnt2→
Gm28883→
Pkp1←
Gm36938←
Igfn1←
Tmem9→
Ascl5→
Cacna1s→
Gm37014→
Gm37759←
Gm15850←
Kif21b→
Mroh3←
5730559C18Rik←
Gm26568→
Gm3878→
A430034D21Rik→
Gm37552←
Gpr25←
Gm26781→
Camsap2←
9230116N13Rik←
Ddx59→
Kif14→
Gm29486→
Gm29485→
Gm37799→
Gm33994←
Whole Study Mean Total EtOH Preference SNP Effects
Chr1 LOD Peak Support Interval
120 125 130 135 140
0
1
2
3
Chr 1 position
LO
D 
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Chr 11 position (Mbp)
70.0 70.5 71.0
Tnk1←
Gm32708→
Tmem95←
Kctd11←
Acap1←
Mir6924←
2810408A11Rik←
Neurl4→
Gps2→
Eif5a←
Ybx2→
Slc2a4←
Gm12310→
Cldn7→
Elp5←
Gm44349→
Ctdnep1→
Gabarap→
Phf23→
Dvl2→
Acadvl←
Mir324→
Dlg4→
Asgr1→
Gm32946→
Asgr2→
Gm12311←
Mgl2→
Clec10a→
Slc16a11→
Slc16a13←
Bcl6b←
Mir497b←
Mir497→
Mir195a→
0610010K14Rik←
Gm21988←
Rnasek←
Gm40191→
Alox12←
Gm32992→
Gm33048→
Gm40192→
Alox12e←
Alox15←
Gm12312→
Pelp1←
Gm12313→
Gm12314←
Arrb2→
Mir7115→
Med11→
Cxcl16←
Zmynd15→
Tm4sf5→
Vmo1←
Gm12317←
Gltpd2→
Psmb6→
Gm40193←
Gm10418←
Pld2→
Mink1→
2700008L21Rik
Gm12316←
Chrne←
4930544D05Rik→
Gm12315←
Gp1ba→
Slc25a11←
Rnf167→
Pfn1←
Gm12319←
1700029K24Rik
Eno3→
Spag7←
Camta2←
Inca1←
Kif1c→
Mir6925→
Gm12320←
Gm12318←
Gm22760←
Zfp3→
Scimp←
Rabep1→
Gm19967→
Rpl23a−ps2→
Gm12322←
Nup88←
Rpain→
C1qbp←
Dhx33←
Gm22297←
Derl2←
Mis12→
6330403K07Rik←
Gm12321←
Gm15377→
Nlrp1a←
Nlrp1b←
Gm23266←
Nlrp1c−ps←
Gm23311←
Gm17874←
Whole Study Mean Total EtOH Consumption SNP Effects
Chr11 LOD Peak Support Interval
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●
●
●
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●
●
●
●
●
●
●
●
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●
●
●
●●
●
●
●
●
●
●
●
●
●
Chr 11 position (Mbp)
50.0 50.5 51.0 51.5
Rasgef1c→
Rnf130→
B130040O20Rik
Mir340→
Gm12194←
Tbc1d9b→
Gm12195←
Mrnip→
Sqstm1←
Mgat4b→
Gm36556←
Mir6919→
Ltc4s←
Gm26542→
Maml1←
Canx←
Gm46280→
Gm31865→
Gm12196→
Cby3→
Mir804←
Hnrnph1→
Rufy1←
Gm23824←
Gm36763→
Gm46259→
Gm12198←
Adamts2→
Gm39819→
Gm12199←
Gm12200←
Gm23392→
Zfp354c←
Zfp879←
Grm6→
Gm12660←
Zfp454←
Zfp2←
Zfp354b←
4933414I15Rik←
4930428B07Rik
Prop1←
Olfr1379−ps1→
Olfr1378→
Gm12661→
Olfr1377→
Olfr1376−ps1→
Olfr51→
Olfr54→
Olfr1375→
Zfp354a→
9230009I02Rik→
Gm12202←
Gm12201→
Olfr1374−ps1→
Gm12203←
Platr20←
Gm12569→
BC049762←
Clk4→
Gm25082→
Col23a1
Last Week Mean Total EtOH Consumption SNP Effects
Chr11 LOD Peak Support Interval
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Chr 6 position (Mbp)
113.0 113.5 114.0 114.5 115.0
Srgap3←
2310039F13Rik
Gm19021→
Gm44081→
Gm6134→
Gm43865←
Gm8083→
Gm23244←
Gm43868←
Thumpd3→
Gm22591→
Gt(ROSA)26Sor←
Gm46982→
Setd5→
Lhfpl4←
Mtmr14→
Gm16161←
Cpne9→
Gm43935←
Brpf1→
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Ogg1→
Camk1←
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Tada3←
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Rpusd3←
Gm44280→
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Jagn1→
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Vgll4←
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Gm44010→
Gm17733←
Syn2→
Gm18325←
Gm17482→
Timp4←
Gm38877←
First Week Mean Total EtOH Consumption SNP Effects
Chr6 LOD Peak Support Interval
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Chr 12 position (Mbp)
78.5 79.0 79.5
Gm24994→
Gm6657→
Gphn→
D130095D21Rik
Gm18899←
4633402D09Rik
A230092J17Rik
Fam71d→
Mpp5→
Gm25225←
Atp6v1d←
Eif2s1→
Plek2←
Gm46359→
Gm46360→
E130002L11Rik
Tmem229b←
Plekhh1→
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Pigh←
9230116L04Rik←
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Arg2→
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Rdh11←
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Zfyve26←
Rad51b→
2310061D13Rik Gm36048←
Gm3596←
Gm36132←
Gm46361→
Gm46362→
First Week Mean Total EtOH Preference SNP Effects
Chr12 LOD Peak Support Interval
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Chr 16 position (Mbp)
40 42 44 46
Gm36333→
Adprh←
D930030I03Rik→
Cd80→
Gm8590→
Gm41453←
Ck−ps3→
Timmdc1←
Gm15953→
Poglut1←
9430076D03Rik
C030024C20Rik
Tmem39a→
Gm17103←
Arhgap31←
Gm36482→
Gm15530←
B4galt4→
Gm15575←
Upk1b←
4930435E12Rik←
Gm15803→
Gm15802→
Igsf11→
Gm22500→
Gm34258→
Gm36585→
Gm36742←
Gm36852←
Gm41454→
Gm29855←
Gm36903→
Gm24795→
Gm8609→
Lsamp→
Gm29907→
Gm16498
B230114A03Rik
Gm37508→
Gm22543→
Gm36939→
Gm27887←
Gm18235←
Gm27717←
A330053N03Rik
Gm26381→
2900006G07Rik
Gm27587←
Gm28750← Gm46551← Gap43←
Mir6540←
4930429N05Rik
5430434N17Rik
Gm29960←
4932412D23Rik←
Zbtb20→
Gm19522←
BC002163→
Gm25873→
Gm15712→
Gm37946←
Gm15711→
Gm9968←
Gm15713←
D230002P11Rik
9630033C03Rik
Mir568→
Tigit←
Drd3→
Gm25996→
Gm26074←
Qtrt2←
Gm25989←
Ccdc191→
Zdhhc23←
4930552F14Rik
Gm46552→
Gramd1c←
Mir3470b→
Atp6v1a←
Naa50→
Usf3→
Sidt1←
Gm26732→
Spice1→
Cfap44→
Gm41455←
Boc←
Gm30064→
Mir3081←
Rpl27a−ps3→
Gm30252→
Gm46571→
Gm30311→
Gm30445←
Nepro→
Gtpbp8←
Cd200r1→
Gm5063←
Cd200r4→
Gm19142←
Gm5964←
Cd200r2→
Gm17928→
Cd200r3→
Ccdc80→
D530031A16Rik
Gm10808
Slc35a5←
Atg3→
Gm6030→
Btla→
Gm30636←
9530002O20Rik
Gm30760←
Cd200←
2300009N04Rik
Gm5406→
Gm609←
Gm16011←
Gm17783←
Gm6903←
Slc9c1→
Gcsam→
BC016579←
Tmprss7←
Tagln3←
Abhd10←
Gm15591→
Phldb2←
5430404G13Rik
D130060J10Rik
Gm15640→
Gm15638→
Plcxd2←
Gm41457→
A130072N09Rik
Gm24754←
4930546O09Rik
Gm31198→
Cd96←
Gm4737←
1700020B03Rik
Gm26297→
Nectin3←
Gm17900→
Last Week Mean Total EtOH Preference SNP Effects
Chr16 LOD Peak Support Interval +/− 1Mb
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Chr 17 position (Mbp)
72 73 74 75 76
Alk←
Gm41613→
Gm19183→
Gm24736←
Gm26963←
Ypel5→
Gm30256→
Gm30375←
Lbh→
Gm23649→
Gm30420←
Gm41615←
Gm30476→
Gm41616←
Lclat1→
Gm9311←
Gm25406→
E330032C10Rik→
Capn13←
Galnt14←
D630014O11Rik←
Gm46602→
Ehd3→
Gm4948←
Xdh←
Gm18068←
Gm30983←
Gm24475→
Srd5a2←
Gm31084←
Gm31235←
Memo1←
Gm9316→
Dpy30←
A330106M24Rik
Gm31328←
Gm9349←
Gm9351←
Spast→
Slc30a6→
Nlrc4←
Gm4708←
Gm6476→
Yipf4→
Gm31645←
Birc6→
Gm26749←
Ttc27→
Gm31759←
Gm31818→
Ltbp1→
Gm6276→
Rasgrp3→
Fam98a←
Gm9360→
Gm46584→
Gm4710→
Gm24126→
Gm26124←
Last Week Mean Total EtOH Preference SNP Effects
Chr17 LOD Peak Support Interval +/− 1Mb
 
195	
105 110 115
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5
6
Chr 3 position
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Last Week Mean 30% EtOH Choice SNP Effects
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●
●
●
●
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●
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●
●
●
●
●
Chr 3 position (Mbp)
102.0 102.5 103.0 103.5 104.0
Slc22a15←
Nhlh2→
Gm43243→
Gm18894→
Casq2→
Gm43244→
4632404M16Rik→
Vangl1←
Gm16160→
Gm43241→
A230001M10Rik→
Gm43242→
Gm40110←
Gm33679←
Gm43245←
Ngf→
Gm42679→
Gm46818←
Gm42678→
Gm19202←
Gm42677←
Gm40112→
Gm42682→
Tspan2os←
Tspan2→
Tshb←
Gm42681←
Sycp1←
Gm42816→
Gm33952→
Gm33866→
Nr1h5←
Gm22826←
Sike1→
Csde1→
Nras→
Gm43062→
Ampd1→
Gm23820→
Gm43063→
Dennd2c→
Bcas2→
Gm27024←
Gm40113←
2410024N13Rik←
Gm43060←
Trim33→
Gm43061→
Gm25009→
Gm25869→
Gm25199←
Gm34049→
Syt6→
Gm43066→
Atg4a−ps←
Gm25325←
Gm15986→
Olfml3←
BC027582
Gm10964→
Hipk1←
Gm43149←
Gm15886→
Gm43387←
Dclre1b←
Gm15471→
Ap4b1→
Gm43064→
Bcl2l15→
Ptpn22→
Gm15472→
Gm43065→
Gm15602←
Rsbn1→
Phtf1os←
Phtf1→
Magi3←
Gm42696←
9530097N15Rik←
Gm23830→
Gm42700←
Gm42699←
Gm17956→
Gm42702←
Gm42701←
Gm43258←
C030032O16Rik←
Gm43259←
Gm43260←
Gm43256←
Gm23077→
2010002M09Rik
Gm5546←
Lrig2←
Gm38412→
Gm9273←
Last Week Mean 30% EtOH Choice SNP Effects
Chr3 LOD Peak Support Interval 2
0
1
2
3
4
5
6
LO
D 
sc
or
e
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
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Chr 3 position (Mbp)
106 107 108 109
Tmigd3→
I830077J02Rik←
Atp5f1←
Wdr77→
Gm42890→
Ovgp1→
Pifo←
Gm42722→
Gm42721←
Chil5←
Gm4540→
Gm9504←
Gm4248→
Chia1→
Chil3←
Gm43709←
Chil4←
Gm6522→
Gm43212→
Chil6←
Gm10673
Gm38244→
2010016I18Rik←
Dennd2d→
Cept1←
9030425P06Rik
Dram2→
Gm43070←
Gm43071→
5530402H23Rik
Gm4549
Gm38271→
Lrif1→
Gm38253→
Cd53←
Olfr266←
Gm35507←
Gm18162
Gm27008←
Kcna3→
AI504432→
Gm38712←
Kcna2→
A930002I21Rik→
Kcna10→
Cym←
A630076J17Rik→
Prok1←
Lamtor5→
Slc16a4→
Rbm15←
Gm5279→
Gm35700→
Gm40120→
Gm24383←
Kcnc4←
A330043J11Rik
Slc6a17←
Gm36097→
Ubl4b←
Alx3→
Strip1←
Gm10961→
Ahcyl1←
Gm40121→
Csf1←
Gm43233→
Gm36211←
Gm5075←
Eps8l3→
4930554G22Rik→
Gm10667
Gm43745→
4933431E20Rik←
Gstm5→
Gm9515←
Gm12489→
Gstm7←
Gstm6←
Gm12494←
Gstm3←
Gm12497→
Gstm2←
Gm43746←
Gstm1←
Gm12498←
Gm12502→
Gm12499←
Gstm4←
Gm36498←
Gm25592→
Ampd2←
Gm12500→
Gnat2→
Gnai3←
Gpr61←
Gm12524→
Gm40122←
Amigo1→
Cyb561d1←
Atxn7l2←
Sypl2←
Gm40123→
Gm12501←
1700010K24Rik←
Psma5→
Gm12523←
Sort1→
Gm19343
Gm43099→
Gm12525→
Mybphl→
Gm12522←
Psrc1→
Celsr2←
Sars←
Gm22942→
Gm43438←
5330417C22Rik←
Gm23336→
Gm37859←
1700013F07Rik→
Scarna2←
Gm43435→
Tmem167b←
Gm22860←
Taf13→
Wdr47→
Gm12517←
Clcc1→
Gpsm2←
Gm27244→
Aknad1→
Stxbp3←
Fndc7←
Gm43097→
Prpf38b←
Henmt1→
Gm9857←
Fam102b←
Gm43221→
Gm44384→
Gm36778→
4930408K08Rik←
Slc25a54→
Gm19391←
Slc25a24→
Gm13865←
Vav3→
C130083B21Rik
Last Week Mean 30% EtOH Choice SNP Effects
Chr3 LOD Peak Support Interval 1
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Discussion 
 
Chromosome 4 Locus 
To our knowledge the locus we identified for Whole Study Mean Total Ethanol 
Preference and Consumption, and Last Week Mean Total Ethanol Preference and 
Consumption on Chr4 has not previously been found to be associated with alcohol-related 
phenotypes, and is therefore a novel finding. Upon further investigation, three of the top 
candidate genes for the Chr4 locus were particularly interesting: Car8, Tox, and Impad1. 
Car8 was the only top candidate gene present in this interval for all four of its related 
phenotypes. Its expression has been found to be associated with cerebellar ataxia, tremor, and 
dendritic growth and development in Purkinje cells (173-175). These functions could be 
relevant to the neuroplastic changes that occur in response to long-term ethanol abuse. 
Similar to Car8, Tox is evidenced to act as a transcription factor, regulating neurite 
outgrowth and neural stem cell proliferation during corticogenesis (or the development of the 
cerebral cortex) (176). It has also shown association with response to antipsychotics in 
human GWASs (170). Finally, human GWASs also indicate that Impad1, a gene involved in 
the hydrolysis of PAP (phosphoadenosine phosphate) into AMP (adenosine monophosphate) 
(177), is associated with not only alcohol dependence, but also response to SSRIs in 
depression treatment and hepatocyte growth factor levels (170). Given that depression and 
alcohol dependence are highly comorbid, and the metabolism of psychotropic drugs (such as 
alcohol or SSRIs) in the liver is important to response levels (as with ADH and ALDH 
enzymes), this gene is particularly intriguing.  
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Chromosome 1 Locus 
 The support interval of the locus we identified on Chr1, for Last Week and Whole 
Study Mean Total Ethanol Preference, overlaps with previously identified loci associated 
with ethanol preference and hypnotic sensitivity to high doses of ethanol in F2 and 
recombinant inbred mice, and with ethanol consumption in the GSCAN GWAS (86, 178). 
Five genes that fell within our Last Week support interval SLC45A3, NUCKS1, RAB29, 
SLC41A1, and PM20D1 all contained variants that were considered to be in linkage 
disequilibrium (r2 > 0.3) with the significant SNP rs823114 (p = 2.31*10-9).  NUCKS1 also 
displayed significance in the gene-wise analysis of this study (Liu et al., 2019). However, our 
support interval was 48Mbp smaller (50Mbp vs. 2Mbp) than the (highly overlapping) 
previously identified loci. All five of the top SNPs for this locus are intron variants in the 
gene Csrp1 (cysteine and glycine-rich protein 1), which may be involved in the development 
of muscle tissue (179). However, unlike other genes in this region, Csrp1 does not appear to 
have been previously associated with psychiatric- or addiction-related traits. It is possible 
that intron variants in this gene could regulate the expression of genes up- or down-stream of 
it. Based on evidential support examined from the other studies mentioned above (Rhesus 
macaque chronic drinking anterior cingulate cortex and subgenual cortex gene expression 
data, acute-ethanol-treated BXD brain-region-specific gene expression data, DO liver eQTL, 
and human alcohol-related phenotype GWAS results), this locus contained several top 
candidate genes: Lmod1, Nav1, Pm20d1, Slc41a1 and Nucks1. Lmod1 and Nav1 were 
captured in both the Last Week and Whole Study QTL. Lmod1’s encoded protein, Leiomodin-
1, is an actin-binding protein that is involved in the nucleation of actin filaments (180), and 
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Nav1’s protein, neuron navigator 1, is also associated with microtubule-mediated neuronal 
migration (181).  Actin is often thought to be involved solely in muscle function, but it also 
serves as scaffolding for microtubules as they migrate to the to the end of the axon to 
facilitate cone outgrowth (182). Although the Whole Study QTL support interval does not 
encompass the final three top candidate genes for this locus, it is still tagging the same 
chromosomal region. Therefore, for thoroughness, all genes within the larger support interval 
should be considered, as done with the Chr4 locus. Pm20d1, Slc41a1 and Nucks1 all contain 
significant SNPs for Average Drinks per Week in the GSCAN GWAS (61). The association 
of three genes within one region in each of two studies is not a coincidence. This region is, in 
fact, conserved across the mouse and human genomes. This suggests that our analysis, which 
is investigating the mouse behavioral model for average drinks per week (after long-term 
alcohol exposure), replicated a locus identified in a human GWAS.  
Nucks1 is a particularly interesting gene in this region, as it has shown association 
with Alcohol Consumption and Parkinson’s Disease in human GWAS (61, 170), and its 
expression levels (in brain or blood) are significantly associated with Parkinson’s, 
Alzheimer’s Disease, Bipolar Disorder, and depression, all psychiatric and neurological 
disorders (140, 183-185). The exact function of Nucks1 is unknown. However, there is 
evidence of its involvement in homologous recombination and inflammatory immune 
reactions. It is expressed ubiquitously throughout the body, and possesses phosphorylation 
sites for cyclin-dependent kinases and casein kinase II, both of which play regulatory roles in 
the cell cycle (186).  
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Chromosome 3 Loci 
 QTL previously identified for ethanol-conditioned taste aversion and body 
temperature change in response to methamphetamine, overlap all three of the loci identified 
in the present study for Chr3 for Last Week Mean Total 30% Ethanol Choice (68, 71). The 
most proximal two loci were directly juxtaposed, with support intervals separated by only 
1.45Mbp, and were positioned over the same LOD score peak. Therefore, while looking for 
candidate genes, we considered these two loci to be part of a single QTL, and considered all 
genes within and between (i.e. within the 1.45Mbp gap) them. Even when considering both 
of these loci together, their combined support interval is 42.2Mbp smaller (7.8Mbp vs. 
50Mbp) than those identified in the aforementioned previous studies. None of the analyzed 
variants in the more distal of these two intervals followed the expected haplotype effects. 
However, it could potentially contain a gene affected by a variant in the most proximal 
interval. It could also possess other variants that may affect the same gene, but with a smaller 
effect size than the variant located in the more proximal locus. The top-scoring SNP for this 
region (rs49087152) is classified as a nonmediated decay transcript for the gene Aknad1 
(AKNA domain containing 1), about which very little is known, although one study suggests 
that it is regulated by TNF-α, which increases in expression during muscle degeneration 
(187). The SNPs with the next two highest scores (rs217960262 and rs244300971) are 
downstream variants of this gene. SNPs rs246339091 and rs213764891 are a non-coding 
transcript variant and intron variant of the gene Stxbp3 (syntaxin binding protein 3), 
respectively. Interestingly, Stxbp3 encodes a syntaxin protein. This type of protein binds with 
synaptotagmin, a type of protein that is encoded by one of the top candidate genes for this 
region, Syt6. This gene translates into the synaptotagmin 6 protein, which binds to calcium 
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and participates in anchoring vesicles to the presynaptic membrane in the process of 
exocytosis of neurotransmitters, and plays a role in neurite outgrowth. Given its highly 
relevant function, it is not surprising that is has displayed association with elicit drug use and 
Bipolar Disorder and Schizophrenia in humans (170).  
Three other top candidate genes stood out after further investigation: Gnai3, Tspan2, 
and Sort1. Gnai3 encodes the alpha subunit of G proteins, which are involved in intracellular 
signaling cascades, and it has been found to be associated with unipolar depression in human 
GWAS (170). Tspan2’s encoded protein, tetraspanin-2, is also involved in signal 
transduction, specifically for signals involved in cell development and motility 
(https://www.ncbi.nlm.nih.gov/gene/10100#reference-sequences). Not only does it display a 
significant association with the neurological disorders Schizophrenia and migraines in human 
GWAS (170), but its expression has also been shown to be associated with impulsivity and 
neuroinflammation in mice (188, 189). High impulsivity is a hallmark symptom of both 
inebriation and long-term alcoholism, and neuroinflammation is known to be associated with 
chronic alcoholism (8) (Kohno et al., 2019; Tyler et al., 2019). 
Sortilin, encoded by Sort1, is a cell-surface and Golgi apparatus protein. It has several 
functions including: being responsible for the endocytosis of neurotensin; sorting proteins 
(including neurotensin) for transport from the Golgi to lysosomes and endosomes; and 
moderating apoptosis of neurons via its involvement in BDNF and NGFB endocytosis (190) 
(191) (192). Human GWAS shows association between this gene and intelligence (170). 
Sort1-deficient mice exhibit increased anxiety-like behavior (193), however, increased levels 
has been shown to be associated with depression in humans (194). It also plays a role in 
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NGF-moderated neurodegeneration, autoimmune-related neuroinflammation, familial 
essential tremor, Alzheimer’s, and frontotemporal dementia (195-197) (198) (199). 
Finally, the most distal of the three bQTL on Chr3 for Last Week Mean 30% Ethanol 
Choice, was located above a LOD peak that appeared to be distinct from the one spanned by 
the more proximal two loci. Therefore, this locus was analyzed as a distinct QTL. Its support 
interval was only 1.4Mbp wide, compared to the 50Mbp intervals previously identified. 
Although this locus contained variants with SNP-based LOD scores > 4, none of the tested 
variants in this region followed the expected haplotype patterns in the progenitor strains. 
Therefore this interval is to be interpreted with more skepticism than the other, more 
proximal loci. Nonetheless, both of the top candidate genes for this QTL (Dpyd and Ptbp2) 
have exhibited associations with a wide array of neurocognitive and psychological traits in 
previous studies. Dpyd encodes the protein dihydropyrimidine dehydrogenase, which is 
involved in the catabolism of pyrimidines (uracil and thymine nucleotides) (131).  Despite its 
regulatory function, rare mutations in this gene have been found, and are related to 
schizophrenia and intellectual disability (200) (201). Furthermore, human GWAS have 
identified associations between normal variants in this gene and Schizophrenia, as well as 
several other relevant phenotypes, including: intelligence, nervousness, sleep duration, 
educational attainment, cognitive function, risk-taking behavior, social interaction, reaction 
time, and borderline personality disorder (2, 170). Ptbp2 is also associated with 
Schizophrenia, social interaction, and reaction time, as well as headaches, in human GWAS. 
This gene’s protein also has a pyrimidine-related function: binding to poly-pyrimidine 
strands of mRNA introns to regulate splicing, specifically in the brain (202, 203). This 
protein plays a role in neurogenesis and axonogenesis, and rare mutations in this gene are 
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associated with autism spectrum disorder and infantile neuroaxonal dystrophy (203, 204). 
Like Car8, Tox, Zbtb20, Spast, and Syt6, Ptbp2 be specifically involved in the neuroplastic 
changes in the brain that are so heavily involved in the development and maintenance of 
alcohol dependence (15). 
Because the loci identified in other studies had such large support intervals, it is 
unclear which of our loci is most likely tagging the same affective genes. However, the 
previously identified QTL were discovered in BXD samples. This means that a 
polymorphism between C57BL/6J and DBA/2J must have contributed to these effects. Of the 
top candidate genes for the two more proximal loci, Syt6 (which falls within the middle 
interval) and Dpyd (which falls in the most distal interval) are the only ones that contain 
polymorphisms between C57BL/6J and DBA/2J (205). However, variants that fall outside 
the predefined realms of a gene (within a certain number of Mbp) can and do affect the 
transcription of genes farther down- or up-stream of them. Additionally, none of the analyzed 
variants in Syt6 or Dpyd match the expected founder haplotype patterns for the middle or 
most distal interval, respectively. Therefore, although this provides further evidence that 
polymorphisms within these two genes are affecting 30% Ethanol Choice, we cannot 
definitively rule out the other top candidate genes in these regions.   
 
Chromosomes 16 and 17 Loci 
 The two loci that showed suggestive association with Last Week Mean Total Ethanol 
Preference are located on Chromosomes 16 and 17. Both of these loci overlap with QTL 
previously shown to be associated with methamphetamine-induced body temperature change 
sensitivity (just as the loci we identified on Chr3), and for locomotor responsiveness to 
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cocaine (67, 68). Individually, the Chr17 QTL overlaps with a QTL identified for locomotor 
responsiveness to nicotine, and the Chr16 QTL overlaps with an interval identified for 
ethanol preference (206, 207). All of the loci identified in previous research were 50Mbp in 
size, whereas our support intervals only spanned 2.3Mbp for the Chr17 locus, and 6.3Mbp 
for the Chr16 locus. Not only does Lsamp contain four of the five top candidate SNPs, but it 
also shows compelling evidence for association with alcohol-related phenotypes in the 
literature.  
Of the three top candidate genes on Chr16, Lsamp and Zbtb20 were especially 
intriguing. Zbtb20 encodes a transcription factor that regulates neurogenesis and 
astrocytogenesis, playing a role in cortical and pituitary development (208-211). It has a 
particularly well-documented role in the development of the hippocampus (212, 213). These 
findings are especially relevant, due to the involvement of the hippocampus in motivation, 
and the well-documented reversible (by alcohol abstinence) reduction in hippocampal 
volume in long-term alcoholics (214). Additionally, human GWAS, expression, and 
methylation studies have provided evidence for its association with: risk-taking behavior; 
seasonality and depression; depression; schizophrenia; seasonal affective disorder; and 
smoking behavior (170, 215-218).   
Even more compellingly, human GWASs have uncovered associations between 
Lsamp and age of onset of AD, as well as several other neurological- and psychiatric-related 
traits, including: comorbid Major Depressive Disorder and AD, unipolar depression and 
depressive symptoms, smoking status, mood stability, neuroticism, well-being, feelings of 
misery, educational attainment, cognition, and comorbid Tourette’s Syndrome and Obsessive 
Compulsive Disorder (170). The protein encoded by this gene (limbic-system-associated 
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membrane protein) is a neuron surface glycoprotein that contributes to the cell’s growth, and 
to axon guidance and synaptic plasticity in fetal brain and adult limbic system (which is 
involved in emotional processing and motivation); and is very highly conserved between 
rodents and humans (214, 219-223). This protein is a member of the immunoglobulin 
superfamily (IgSF), with high sequence similarity to fellow IgSF family member opioid-
binding cell adhesion molecule (221), which is striking because ethanol binds to many opioid 
receptors. Furthermore, mice deficient in this protein have shown several drug-related, 
behavioral, and neurological abnormalities, including: decreased sensitivity to amphetamines 
resulting in increased serotonin release; decreased aggressive behavior; decreased anxiety-
like behavior; and decrease in long-term potentiation in the hippocampus (224-226). Given 
its association with preference for alcohol over water, specifically after long-term alcohol 
exposure, these results suggest that Lsamp may mediate limbic-system neuron synaptic 
plasticity in response to long-term alcohol exposure, contributing to the development and 
maintenance of dependence.  
Although neither of the top-SNP-containing genes (Lclat1 and Gm25406) shows 
association with psychiatric and behavioral disorders in GWAS, one of the top candidate 
genes, Spast, has a well-documented relationship with neurological function and disease. 
Spastin, its encoded protein, targets and cleaves polyglutamated microtubules, and is thereby 
involved in neurite outgrowth and stability (227-229). Mutations and changes of activity in 
spastin are associated with paraplegia and Alzheimer’s disease, via neurite degenerative 
processes (230). 
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Initial Drinking Loci 
The support interval of the Chr12 locus for First Week Mean Total Ethanol 
Preference overlaps with loci previously found to be associated with ethanol consumption in 
female mice and cocaine-induced increase in locomotor activity, which both were 50Mbp 
wide, compared to our support interval of 1.9Mbp in length (231, 232). Arg2, Plekhh1, and 
Zfyve26 are top candidate genes for this region, and each contains one of the 5 top candidate 
SNPs. However, the most functionally intriguing of the top candidate genes encodes another 
microtubule-associated neuronal protein, Gphn. Gephyrin is a highly conserved protein 
responsible for agglomerating glycine and GABA at post-inhibitory-synaptic membranes, 
thereby increasing signal amplitude and frequency (233) (233). Because of its important 
neurological regulatory function, mutations in this gene have been found to be associated 
with autism, schizophrenia, and seizure disorders; and it exhibited associated with unipolar 
depression in human GWAS (170, 234-236). Interestingly, this protein’s function is inhibited 
by phosphorylation by GSK3β (glycogen synthase kinase 3 beta). Expression levels of this 
gene have been shown to be responsive to acute doses of ethanol in the PFC, and 
manipulations of its expression levels are associated with changes in voluntary ethanol 
consumption, such that increases in GSK3β expression in the PFC lead to higher 
consumption (27, 97). Gephyrin is also stabilized by cleavage by calpain-1 (whose gene 
family member, calpain-13, is a top candidate gene for Last Week Mean 30% Ethanol 
Choice, within our Chr3 locus). Finally, expression levels of a gene encoding GABRG2 
(which participates in the gephyrin-mediated post-synaptic clustering of GABA at GABAA 
receptors) showed significant expression level differences between postmortem hippocampi 
of alcohol- and cocaine-dependent individuals and non-addicted controls, and between 
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alcohol-preferring rats and alcohol-non-preferring rats (237). In light of this compelling 
evidence for gephyrin’s association with alcohol-related traits, we believe that the top-
scoring SNPs likely participate in regulating the expression of this Gphn, thereby affecting 
ethanol preference levels. 
Another locus was identified for First Week Mean Total Ethanol Consumption on 
Chr6, which overlaps with QTL identified in previous studies for several alcohol- and drug-
related phenotypes, including: locomotor responsiveness to cocaine, sensitivity to 
methamphetamine-induced change in body temperature, ethanol-induced hypothermia, and 
ethanol-conditioned taste aversion (67, 68, 71, 86). These intervals were all 50Mbp wide, 
whereas our support interval was 2.57Mbp wide. All of the top 5 SNPs for this region are 
located in gene Atp2b2, one of the top candidate genes for this region, and two (rs30214990 
and rs48409474) are classified as noncoding transcript variants. All three of the top candidate 
genes (Atp2b2, Slc6a1, and Slc6a11) in this region displayed involvement in relevant 
psychiatric and neurological disorders in the literature. Atp2b2 encodes a plasma membrane 
Ca2+ pump that appears to play a major role in the neurosignaling involved in hearing and 
cognition, due to the association of mutations with deafness and autism (238-241). Human 
GWASs have identified additional associations between cognitive decline, schizophrenia, 
and opioid dependence (117, 170), with mechanistic and pharmacogenetic studies providing 
further evidence for its association with schizophrenia (217).  
Even more convincingly, human GWASs have indicated that Slc6a11 is associated 
with initial alcohol sensitivity, and that the closely related gene Slc6a1 (also a top candidate 
gene for this QTL) is associated with longitudinal alcohol consumption, as well as conduct 
disorder and feelings of loneliness (170). Fittingly, these two genes both encode GABA 
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transporters, as indicated by their proteins’ alternate names: neurotransmitter transporter, 
GABA, members 1 and 11 (242).  Not surprisingly, given their function, other human studies 
have shown evidence of association of Slc6a11 with autism, and of Slc6a1 with 
schizophrenia, epilepsy, and alcoholism (243-247). Furthermore, a mouse study has shown 
that GABA transporter 1 antagonists increase ethanol sensitivity (248). Given this evidence, 
and the known direct effects of alcohol on GABA signaling and this interaction’s 
contribution to dependence (249), we believe it is likely that SNPs in one or both of these 
genes affected ethanol preference in our study. 
 
Adjacent Chromosome 11 Loci 
Both the Whole Study and Last Week Mean Total Ethanol Consumption QTLs 
identified on Chr11 overlaps with previously identified QTL for ethanol preference and 
withdrawal, as well as nicotine-induced changes in locomotor activity, in other mouse strains 
(114, 206, 250, 251). These intervals were all 50Mbp, whereas we identified support 
intervals of only 1.56Mbp. Of the top candidate genes for this locus, Arrb2 possessed the 
most convincing evidence for alcohol association in the literature. Its encoded protein, β-
Arrestin-2, participates in several G-protein-coupled-receptor-related (and some G-protein 
unrelated) pathways, moderating the responsiveness of these signaling cascades (252, 253). 
Although it has not shown association with any neurological of psychiatric traits in human 
GWAS studies, results from several mechanistic studies indicate that it is important to 
alcohol-targeted signaling pathways. Specifically, lower β-Arrestin-2 levels or receptor 
responsiveness result in a sensitized reward response to alcohol, lower consumption of and 
preference for alcohol, and lower Dorsal Root Ganglia opioid tolerance levels in mice (141, 
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254, 255).  Furthermore, like gephyrin, the literature suggests that β-Arrestin-2 interacts with 
the alcohol-consumption associated gene GSK3β, that both of the proteins’ expression levels 
increase in response to long-term alcohol exposure (likely leading to alcohol-induced kidney 
disease), in an interactive fashion (97, 127, 256, 257). 
Lastly, to our knowledge, the only top candidate gene for the Chr11 QTL for Last 
Week Mean Total Ethanol Consumption that has shown association with a neurological, 
behavioral, or psychiatric phenotype is Canx. This gene encodes the protein calnexin, which 
is a calcium-binding molecular chaperone that interacts with glycoproteins in the 
endoplasmic reticulum. Although it has not shown association with any neurological or 
psychiatric traits in GWAS, one study has suggested that mutations in this gene may be 
associated with familial autism (258). Three of the top five SNPs are classified as intron or 
upstream variants for Adamts2, which encodes a disintegrin-like and metallopeptidase 
(reprolysin type) with thrombospondin type 1 motif, 2. This protein acts as a protease in the 
extracellular matrix (259). Although this gene is not in our top candidate gene list, with 
respect to empirical support from our selected external datasets, other literature provides 
compelling evidence for the association of this gene with psychiatric and neurological 
phenotypes. GWASs have found significant associations between this gene and Attention 
Deficit Disorder, interferon-induced depression, and reaction time (170). Furthermore, its 
expression levels have been shown to significantly increase in response to alcohol in muscle 
tissue, and decrease in response to atypical antipsychotics in blood (260, 261). Given its 
involvement in extracellular matrix structuring, this gene could potentially mediate synaptic 
remodeling in response to ethanol, by reacting with (and thereby degrading) proteins in the 
extracellular matrix to change its structure and reroute neuronal processes. In fact, gene 
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family members ADAMTS4, 5, and 15 have all been shown play a significant role in 
neuroplastic changes in this way (262).  
 
Summary, Limitations, and Future Directions 
 In order to obtain substantial power this study used an all-male sample, so that 
qualitative genetic sex differences would not mask any effects. Therefore, some of the 
identified loci may not be generalizable to females. However, many of our findings were 
supported by human GWASs that included both sexes. It is also possible that there are 
female-specific QTL that could not have been detected in an all-male or mixed sex sample. It 
is therefore important for future studies to examine these phenotypes in female mice, in order 
to determine the generalizability of genetic results across sexes, specifically for DO mice.    
We anticipated some loci to be identified for the Whole Study mean phenotypes that 
also exhibited lesser (possibly sub-threshold) signals for the First and Last Week mean 
phenotypes. These QTL would reflect effects on overall drinking levels, regardless of 
exposure stage, that would be better captured by phenotypes averaged across all drinking 
days, reducing noise that could potentially be created by a single aberrant drinking day. We 
identified one locus for Whole Week Mean Total Ethanol Preference (on Chr1) that had a 
higher LOD score than an overlapping QTL identified for Last Week Mean Total Ethanol 
Preference, and had an overlapping sub-threshold peak for First Week Total Ethanol 
Consumption. This region contained five genes that showed significant association with 
“drinks per week” in the GSCAN GWAS sample (61). Upon further investigation, we found 
that these genes are also adjacent to one another on Chr1 in humans, indicating that this 
genomic region is conserved between mice and humans (263). A candidate gene for on other 
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QTL, the Chr6 locus for First Week Mean Total Ethanol Consumption, Slc6a1, has been 
found to be significantly associated with ethanol consumption in a human GWAS sample 
(170). Another gene in that interval, Slc6a11 (in the same gene family as Slc6a1) was 
identified with initial alcohol sensitivity in human GWAS, along with Tm4sf5, a candidate 
gene on the Chr11 locus that was uniquely identified for Whole Study Mean Total Ethanol 
Consumption (170). No candidate genes from QTL that were unique to Last Week drinking 
behaviors have been identified for either of these phenotypes in human GWAS. However, all 
three of the candidate genes from this study that have been identified in AD GWASs 
(Impad1, Lsamp, and Ubl4b) were associated with QTL for Last Week phenotypes.  
Finally, only one QTL was identified for 30% ethanol choice, and it was only 
identified for the last week time interval. Because no taste additives were present in the 
alcohol solutions, higher levels of preference for 30% ethanol indicate that, despite the more 
noxious taste, mice prefer the heightened level of psychotropic reward provided by 30% 
ethanol over 15% ethanol. These findings suggest that our hypothesis was correct, not only in 
that we would identify some common and some unique QTL between time intervals, but also 
in that the first week of drinking appears to model initial sensitivity and non-pathological 
drinking in humans, whereas the last week is modeling a phenotype that better models 
dependence. The two QTL that appeared to represent genetic effects that were relatively 
consistent across time appeared to be modeling genetically driven alcohol consumption and 
sensitivity in humans, like those identified for initial drinking behaviors. 
In sum, this study identified one novel locus for ethanol consumption and preference 
with greater precision, and several previously identified drug- and ethanol-associated loci, 
with far greater precision than prior studies. We were also able to gain insight into the 
211	
differing biological mechanisms that underlie initial drinking behaviors and those that occur 
after long-term ethanol exposure. Our results indicated that genetic pathways associated with 
voluntary ethanol consumption behaviors under an intermittent ethanol access paradigm 
qualitatively differ between initial exposure and post-long-term exposure time points, as was 
expected for many of the identified variants. They also suggest that initial voluntary ethanol 
consumption models ethanol sensitivity and consumption in humans, whereas long-term 
consumption under IEA models mechanisms relevant to dependence. Specifically, initial 
drinking appears to be associated with pathways associated with GABA-related signaling, 
based on the function of top candidate genes Slc6a1, Slc6a11, and Gphn; whereas long-term 
drinking genetic effects appeared to be mediated by pathways related to neurogenesis and 
neurite outgrowth, immune and neuroinflammatory responses, and presynaptic vesicle 
anchoring. The relevance of these pathways to alcoholism is well supported by studies 
displaying the neuroinflammation seen in the brains of chronic alcoholics, and neuroplastic 
changes that are involved in the development of dependence (9, 15, 264, 265). Future studies 
should take this into consideration when studying voluntary ethanol consumption in mouse 
models, as it appears that long-term consumption may be a better biological model 
dependence-like drinking and initial consumption may be a better model for reward-
associated learning and sensitivity to alcohol with respect to physical symptoms of 
intoxication. Such phenotypes should be examined in mice in which one of a candidate gene 
identified in this study is over- or under-expressed, to determine direct effects of each gene 
on drinking behaviors. One potential way to narrow down the candidate gene list further, 
based on our candidate SNP findings, would be to use Capture-C to determine which regions 
of the chromosome are physically interacting with the SNP-containing region (266). Another 
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option would be to mutate each of the candidate SNPs in an inbred mouse strain using 
CRISPR-Cas9 technology, and examine its effect on both behavior and on gene expression 
levels, in order to determine which genes each SNP regulates and which SNPs are the true 
causative SNPs. Overall, our study identified several candidate SNPs and genes that effect 
distinct periods of voluntary ethanol consumption in the Diversity Outbred mice. These 
genes and variants can be targeted in future functional studies in order to determine the exact 
biological mechanisms involved in these behaviors that can be targeted by 
pharmacotherapies for alcohol dependence.    
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Chapter 5 
Characterization of Genome-Wide Gene Expression in the Prefrontal 
Cortex 
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Introduction 
 As described previously, human genetic association studies for alcohol use disorders 
have had relatively limited success in accounting for the total heritability of these traits 
estimated by twin studies (~50%) (21-23). Recent studies with hundreds of thousands 
participants have come closer to this goal, identifying up to 90 variants associated for ethanol 
consumption, due to increased power provided by the large sample sizes (25, 26, 61). 
However, even after significant genetic associations have been identified, many of these 
results do not replicate across samples, there is no mechanistic explanation for the association 
beyond that which can be gathered from unrelated, previously performed, functional studies. 
Gene expression networks are capable of providing information regarding groups of co-
functioning or co-regulated genes whose overall biological function and mechanisms of 
regulation are related to the trait of interest. Our findings in Chapter 1 suggest that different 
genetic associations found in separate populations may be identifying similar mechanistic 
pathways. This suggests that gene networks not only provide information regarding 
functional networks through which these genes may affect the examined trait, but also 
provide testable groups of genes that may be more powerful for association analysis than any 
single constituent gene, due to combined effects. Furthermore, although some studies have 
identified differentially expressed genes in brain tissue between alcoholics and that from non-
alcoholics, gene expression data collected from post-mortem brain tissue samples can be 
unreliable and difficult to interpret. This is due to lack of experimental control and limited 
sample sizes. For these reasons, many researchers have turned to mouse models to examine 
gene expression networks in the brain relevant to physiological response to alcohol and 
alcohol-related behaviors (28 2012, 96).  
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 Several gene expression studies have successfully identified networks of co-
expressed genes that are differentially expressed between alcohol-exposed mice and controls 
in brain regions related to the dopaminergic reward pathway (specifically, the Ventral 
Tegmental Area, Nucleus Accumbens, and Prefrontal Cortex (PFC))  (27-30). Some of these 
studies identified a network that was overrepresented with human GWAS signals for alcohol 
dependence, one of which possessed a hub gene that has since been shown to be a promising 
target for pharmacotherapy to treat alcoholism (27, 29, 97). The study presented in Chapter 1 
of this thesis examined gene networks whose structures were perturbed by alcohol treatment 
in these three brain regions, in combination with human alcohol dependence GWAS 
summary statistics and protein-protein interaction data. To identify networks associated with 
alcohol consumption behaviors, this chapter examines gene expression networks in the 
prefrontal cortex of the voluntarily drinking Diversity Outbred mouse sample described in 
the previous chapter. The prefrontal cortex was chosen due to its involvement in the 
dopaminergic reward pathway, but also because of its role in behavioral inhibition and 
decision-making. The Intermittent Ethanol Access (IEA) paradigm to which these mice were 
exposed models the progressive increase in alcohol consumption seen in the early stages of 
dependence development, despite the noxious taste of ethanol and the unpleasantness of 
intoxication (36, 37, 267).  
  Specifically, we map networks of co-expressed genes in the PFC of 100 of the 
highest drinking and 100 of the lowest drinking IEA-exposed DO mice. We then test for 
overlap between bQTL identified for drinking behaviors in the previous chapter and 
expression QTL for each network’s first principal component (representing the overall 
variance in expression throughout the network). We also test for overrepresentation of 
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networks with functional groups and with genes significantly associated with ethanol 
consumption in the Genome-Wide Association Study (GWAS) Sequencing Consortium for 
Alcohol of Nicotine use sample (GSCAN). Finally, we examine individual genes whose 
expression levels significantly predict ethanol drinking behaviors, and genes whose 
expression levels differ between high drinking DO mice and controls (exposed to water 
only). Genes exhibiting significance in both analyses are considered to be ethanol-regulated. 
However, as described in Bogenpohl et al. (in progress), a study that analyzed gene 
expression in tissue from chronically voluntarily drinking Rhesus Macaques, we anticipate 
there to be genes that will not differ between drinkers and controls in DEseq, but will have a 
continuous relationship with drinking values. Although causation cannot be confirmed in this 
study, such genes are thought to be ethanol behavior-regulating, as opposed to alcohol-
regulated. This means their expression levels do not change in response to ethanol exposure, 
but expression differences between mice drives variation in alcohol consumption and 
preference levels (Bogenpohl et al., in progress). We may also see genes that have a 
significant continuous relationship with ethanol drinking behaviors but do not show 
significant differential expression between IEA-treated and control mice, which was also 
reported by Bogenpohl et al. (in progress). Such results will be interpreted as follows: there is 
likely a ceiling effect of alcohol on the gene’s expression levels that is reached at relatively 
low doses of ethanol, resulting in a true relationship that appears to be dose-independent. 
Whole networks were also tested for expression levels that correlated with ethanol 
consumption and for overrepresentation with genes that are differentially expressed between 
high drinkers and controls, in order to determine which networks are likely ethanol-
regulating vs. ethanol-regulated. Just as for the single gene analyses, we anticipated the 
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identification of several networks that were ethanol-regulated and some that were ethanol-
regulating (i.e. that moderated ethanol consumption behavior).  Overall, this study was the 
first to successfully identified such modules in a Diversity Outbred mouse sample. These 
networks were functionally overrepresented for pathways largely involved in neurocognitive 
development, synaptic signaling, protein modulation and regulation, and the Notch signaling 
pathway.  
 
Methods 
 
Experimental Design 
 This experiment utilized the same sample of 636 adult male Diversity Outbred mice 
reported in Chapter 4. As previously described, these mice were exposed to an intermittent 
ethanol access (IEA) paradigm, in which mice were subject to alternate periods of access to 
ethanol and water, and periods of access to water only (forced ethanol abstinence). The 
experiment followed a three-bottle choice paradigm, in which mice were given access to one 
bottle of 30% EtOH, one of 15% EtOH, and one of water on ethanol access days, and to three 
bottles of water on days of forced abstinence. Ethanol access was granted for 24hr periods, 
12hrs in the light and 12hrs in the dark, 3 days per week for 4 weeks. Controls (N=49) had 
access to water only, throughout the course of the experiment. Mice then underwent post- 
anxiety-like behavioral testing and continued to drink for one more week, in order to re-
establish ethanol-driven expression patterns in the absence of additional testing. Humane 
sacrifice, and immediately subsequent tissue and trunk blood collection, occurred 24hrs 
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following their last ethanol access period. Brain tissue was microdissected into 8 regions, one 
of them being the Prefrontal Cortex for gene expression analysis. 
Gene Expression Data Collection and Assay 
Mice were chosen for RNAseq by their average total ethanol consumption values 
during the last week of drinking, before anxiety-like testing began (IEA week 4), with 100 
mice being chosen from each extreme of the distribution. In addition to these 100 high 
drinkers and 100 low drinkers, tissue from 20 controls (exposed to water only) was also 
sequenced. RNA was extracted from Prefrontal Cortex tissue using Qiagen RNAeasy mRNA 
extraction kit. Samples were randomized, prior to extraction, to prevent correspondence 
between extraction variability and mouse cohort. RNA purity and concentration were 
examined using a Thermo Scientific NanoDrop. All samples had 206/280 values ≥ 1.9, 
indicating high RNA purity. RNA samples were shipped on dry ice to Novogene 
Bioinformatics Institute, Sacramento, California where poly-A selected library construction 
and sequencing were performed. Before sequencing, the quality of each sample was checked 
via the 2100 Agilent Bioanalyzer. All samples had RNA Integrity Numbers (RINs) ≥ 7, with 
93% of the samples having RINs ≥ 9. Only 2 samples yielded < 1µg of RNA, the lowest 
yield being 0.46µg. However, these samples had good RIN numbers (9.8 and 9.3). Therefore, 
these two samples were moved forward to sequencing. The Illumina HiSeqX was used to 
pair-end sequence 150bp fragments, with 20 million reads per sample. All samples had > 
90% alignment, with an average of 94.46% (Table 1). Overall alignment percentages are 
expected to be slightly lower than what would typically be seen (in the high 90s), due to the 
use of a single inbred mouse genome as the reference to align samples that possess up to 
45mill variants that differ from this reference (171). However, algorithms and statistical 
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packages for alignment to personalized genomes are still being perfected with respect to 
alignment percentages, and are only more accurate than standard alignment when examining 
novel variants or computing allele specific expression (171, 268). A minimum of 95.14% and 
88.73% of reads in each sample had Phred Quality scores of Q20 and Q30 or higher, 
respectively, indicating high read quality.  The minimum number of flow cells (241) was 
used, and were run on the same machine, to reduce technical variability. A minimum of 
95.14% and 88.73% of reads in each sample had Phred Quality scores of Q20 and Q30 or 
higher, respectively, indicating high read quality. Samples that did not reach a minimum of 
18.5 million raw reads (N=9) were re-sequenced up to 20 million reads.   
 
Alignment and Read Count Processing 
Post-sequencing quality control was performed using FastQC 0.11.7 
(https://www.bioinformatics.babraham.ac.uk/projects/fastqc/). Quality was assessed based on 
several metrics: base sequence quality, tile sequence quality, base sequence content, GC 
content, sequence length (should equal 150bp), sequence duplication levels, and adapter 
content. As typical of RNAseq analysis, base quality values at the far ends of each read were 
lower than the rest of the fragment (Figure 1). Therefore, Trimmomatic 0.38 (269) was used 
the trim the first 5bp from the 3’ end of each read, and trim the 5’ end based on quality 
(sliding window method). FastQC was performed again after trimming, and all samples 
passed QC. Although there appeared to be slight differences in per-sample average sequence 
quality between flow cell lanes, all lanes yielded high-quality reads (Figure 1).  
 The RNAseq processing pipeline is laid out in . Samples were aligned to a C57 
reference genome (GenCode, Assembly GRCm38.p6) with STAR 2.6.1a, using default 
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settings for advanced alignment options (270). All samples had > 90% alignment. The 
alignment rates were expected to be lower than those that would be typical for inbred strains, 
given the large number of SNPs in the DO genomes compared to the reference genome. Gene 
counts were determined by HTSeq 0.8.0, using the “union” method to handle multi-mapping 
reads, and using an alignment quality threshold of 10 (i.e. removed reads if alignment quality 
< 10) (271). After quantification, all ribosomal and mitochondrial genes were removed. 
These values were converted to Transcripts per Million (TPM) before genes with extremely 
low expression values were removed, due to the likelihood that these signals were 
attributable to noise. Genes were removed if  > 66% of the TPM values were ≤ 0.5 
(https://github.com/mdozmorov), leaving 17,709 genes for analysis. Failing genes were also 
removed from raw gene count data, before performing DEseq2. To satisfy the normality 
assumptions of correlative and regressive methods, we used the log2(1+TPM) as expression 
values for all analyses, except DEseq2 (which requires raw, untransformed count data) and 
WGCNA (which requires batch corrections, described below).  
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Total	number	of	RNAseq	read	counts,	total	number	of	counts	aligned,	and	alignment	percentages	for	each	sample.	 
Sample Total.Counts Unmapped % Aligned Sample Total.Counts Unmapped % Aligned Sample Total.Counts Unmapped % Aligned
DO100 60061542 2805612 95.32 DO290 68854424 3925048 94.51 DO520 66949192 7450484 88.06
DO107 59984080 3296966 93.91 DO291 71472948 3991576 93.37 DO521 62406630 3862764 93.22
DO108 54127782 2591640 95.21 DO294 60185186 3015752 96.09 DO522 57003326 3363450 94.20
DO109 54131948 7373076 90.90 DO295 77037432 3795106 94.59 DO523 58001646 3319378 95.56
DO11 80991436 3912004 94.51 DO297 70170606 3715916 94.20 DO526 74747588 3817808 94.04
DO110 71306000 3299538 93.99 DO298 64097424 3455950 94.69 DO530 64004398 3011390 95.30
DO114 54924774 3095858 94.77 DO30 65092922 3026106 94.59 DO534 66147368 3900570 94.06
DO116 59213674 2541140 96.34 DO300 55920042 3130716 94.23 DO537 65674894 4416276 91.20
DO118 69337118 5631120 90.15 DO306 54302532 3001040 94.65 DO545 50197412 2825816 95.85
DO120 57172250 3005066 94.39 DO307 56064850 2578042 95.20 DO550 68030698 3420632 94.30
DO122 53536656 2967544 94.88 DO309 53734954 2963886 94.55 DO552 60019622 2892246 95.14
DO123 57961234 2786326 95.49 DO311 54412274 2832794 96.14 DO554 59552996 2928150 95.14
DO125 61759062 3171606 94.82 DO312 73358706 3957524 92.94 DO558 60282852 3147422 95.12
DO126 61179730 2843724 94.79 DO320 56033856 2508618 95.09 DO56 64431636 4446434 93.56
DO128 54574032 3366570 93.69 DO321 51101002 2502874 95.78 DO560 69020852 4154952 93.25
DO130 53339298 3029026 95.27 DO328 59286006 3134116 95.21 DO563 61581426 3439106 94.10
DO132 64050344 3275500 94.28 DO329 65444390 3355354 94.32 DO564 58283936 3388518 94.01
DO133 57221488 3151306 94.66 DO333 59037682 2546494 96.46 DO569 56556464 3283632 93.93
DO134 59060932 3146202 94.85 DO334 71975510 3838442 93.45 DO57 54103040 3437792 94.20
DO135 61124944 3776386 94.34 DO337 58636806 4354444 92.45 DO571 59255864 2512492 96.07
DO141 66750010 3533978 94.62 DO339 57685196 3310020 95.42 DO572 63972442 3307326 94.21
DO143 65722422 5146336 91.03 DO34 72328256 3678740 93.76 DO575 57116544 2767572 96.19
DO144 57393674 3610910 93.67 DO349 58953030 5052100 91.56 DO577 72728350 4268242 92.93
DO146 57023630 3375814 94.43 DO350 59863926 3232960 94.78 DO579 60329660 3011226 94.78
DO149 60569412 3305740 95.58 DO352 61935954 3398832 94.52 DO580 57631976 3904222 94.31
DO154 74854534 4157218 92.51 DO354 62027456 3155858 94.27 DO581 68568906 3681168 94.63
DO156 55535408 2939792 95.16 DO357 55028106 2919582 94.55 DO588 63027572 3990602 92.49
DO159 60781302 2794082 95.40 DO363 53521594 3287566 94.47 DO589 53113592 2822590 95.11
DO165 65549792 3731320 94.40 DO370 59427882 2717600 95.15 DO59 57718814 2951894 95.71
DO171 66617802 4038710 93.23 DO374 56003660 3065636 94.59 DO590 68876472 4276852 93.53
DO174 59672922 2676650 95.64 DO38 56665730 2980490 94.59 DO592 66089236 3881934 93.40
DO175 61400400 3324374 95.40 DO382 55095516 2771136 95.25 DO596 58854248 3120448 94.44
DO177 72300172 3916886 93.38 DO383 58329854 3462276 93.38 DO597 56094710 3155744 94.29
DO179 59196528 2976534 95.39 DO384 52334428 2835584 94.50 DO599 55292604 3235742 95.10
DO187 64588844 3424166 94.48 DO390 51531008 2854266 94.96 DO60 66014984 3583952 94.50
DO189 62066372 3488748 93.98 DO395 56621774 2979194 95.02 DO600 65175416 3622230 94.70
DO190 57977934 2748566 95.52 DO401 59767234 3275800 94.34 DO601 68400126 3484454 93.90
DO194 61361530 3360528 94.17 DO404 57901000 4650882 92.18 DO604 57080504 3324392 94.91
DO196 57635288 3089116 95.19 DO405 59471608 3400754 94.33 DO606 65321346 3931814 94.15
DO197 64187860 3218052 94.91 DO406 60011210 3526338 94.92 DO609 67200726 3615088 94.58
DO200 63231204 4935442 91.75 DO410 69471166 3479948 94.44 DO61 66645850 4266034 92.86
DO204 59815016 2778566 96.49 DO412 62582952 3415702 94.49 DO616 59740004 3384656 93.69
DO205 79271054 4627594 92.71 DO415 61963898 3205404 94.33 DO619 53633082 2704274 96.49
DO207 63491078 3493982 94.07 DO416 56527980 3059160 95.36 DO621 77028670 4520022 91.42
DO208 58877904 5029220 93.20 DO42 65918402 4131914 93.38 DO625 52658372 2407212 95.91
DO209 74010456 4154802 93.27 DO420 62371430 3485238 94.41 DO629 58897234 3212504 94.90
DO210 61728946 3118768 95.39 DO435 67764034 3328222 94.65 DO64 62998294 3393738 95.59
DO211 67652216 3672048 94.33 DO439 62213940 3284706 94.72 DO68 76868902 3800362 93.87
DO212 64812564 3171132 95.33 DO440 54189998 3307210 94.39 DO7 62041636 4434286 92.03
DO215 67966682 3763628 94.62 DO441 58956512 4748108 91.94 DO71 55612608 2962358 95.13
DO221 69916578 4001994 93.38 DO443 58938274 3582732 93.45 DO74 60849464 2550626 95.79
DO222 60428146 3274972 95.31 DO448 54686876 2651720 95.63 DO75 60654222 3636290 93.72
DO232 69775884 5055824 90.99 DO45 60728150 3613058 94.14 DO76 57906114 3317224 93.49
DO233 56112512 3563204 94.05 DO450 61681994 3376430 94.80 DO77 50986462 2570020 96.36
DO238 59858906 3246276 93.86 DO451 64958862 2912274 96.23 DO78 70562482 3008610 94.81
DO239 52886702 2773932 95.17 DO453 77328534 4573738 92.14 DO8 57951766 4087380 94.14
DO24 57375224 2478728 95.17 DO454 58158262 2813364 95.80 DO80 69700998 3604044 94.12
DO241 51279044 2731298 95.83 DO457 67033182 3627668 94.59 DO81 61329568 3106710 93.97
DO244 65486004 3734788 93.38 DO464 65196384 3124062 94.34 DO82 51519238 2689808 95.76
DO246 56405998 3823172 93.90 DO47 55238862 3283724 94.06 DO84 63502192 2712790 94.93
DO247 62687214 3423190 94.41 DO480 55637752 2965520 94.57 DO86 53519968 2830042 94.86
DO249 61267248 3132916 93.76 DO481 54591708 4681558 92.43 DO92 55103050 2852168 96.06
DO255 50218496 2591260 95.66 DO485 61860702 3555776 94.20 DO94 72350666 2757940 95.35
DO256 59679234 3279772 93.77 DO488 61286972 3490376 94.41 DO96 59312542 3473256 94.23
DO262 52611434 4578528 92.51 DO490 62444002 3159186 94.89 DO98 60147052 2781666 93.03
DO264 61137734 3416214 94.49 DO493 61825072 3517398 94.26 DO105 39923306 1212683 96.82
DO270 62013018 2867062 95.18 DO494 61229264 2931280 96.19 DO164 38133769 1194554 96.63
DO278 59486302 2617486 95.53 DO496 76937110 3776022 93.65 DO434 35431831 1265280 96.69
DO279 58549750 3332402 93.77 DO498 59477566 3258660 94.08 DO44 38202609 1061161 97.26
DO280 53506708 2739266 95.12 DO509 55027588 2913696 95.19 DO458 38700376 1219663 96.64
DO285 56098488 3095140 95.01 DO513 60620452 4355208 92.82 DO474 36277231 1053105 97.18
DO289 61981960 3222024 94.14 DO519 64683066 3038750 95.04 DO514 37367937 1175353 97.97
DO29 54995770 2698648 96.08 DO52 61312456 2883306 95.69 DO532 57798447 2059952 96.44
DO587 61967046 3042650 95.09
Table 1: Alignment Percentages 
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Figure 1: Average sequence quality score count (a) and base quality score count (b) across the length of reads, for each 
flow cell lane. Colors and line type represent a single lane on a single flow cell, as shown in the legends. Red hued lines 
are for the first read, of paired end sequencing, and blue hued lines are for the second read. First reads are expected to 
have higher values (notice log scale in (a)), as depicted here. Overall, flow cell and lane did not have any striking effects 
on read quality.  
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Figure 2: RNAseq data processing pipeline for each analysis described in this chapter.  
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Statistical Methods 
 
 Principal component analysis was performed on log-transformed TPM values, in 
order to examine effects of Cohort (which directly correlates with DO mouse generation) and 
Flow Cell on expression values, because experimental groups and drinking groups were not 
distributed evenly across cohorts (Figure 3). There was clear clustering by Flow Cell, but the 
effects of Cohort on expression were less clear (Figure 4a-b). Because low drinkers and 
controls on the first flow cell cluster with the high drinkers on the same flow cell, as opposed 
to clustering with the low drinkers on the second flow cell, it is clear that these effects are 
largely due to technical differences across flow cells and not experimental differences 
(drinking amount) between groups (Figure 4c). For clarification, we examined the 
significance of effects of Cohort on the first three principal components (PCs) via logistic 
regression, while including Flow cell as a covariate, to remove technical variation. Cohort 
did significantly affect the second and third principal components. For our network analysis, 
which does not allow for the inclusion of covariates, we used the Limma R-package to 
remove the effects of Flow Cell and Cohort from log-transformed TPM values (272). For all 
other analyses, Flow Cell and Cohort were included as covariates while analyzing log-
transformed TPM values. For all analyses, for samples that required data from a second 
round of sequencing, Flow Cell was determined by the original Flow Cell on which that 
sample was run, because these samples clustered well with other samples from their original 
flow cells (Figure 3), as the majority of reads for these samples came from the original flow 
cells.   
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Figure 3: Histograms of mice per cohort, separated by experimental group (left) and drinking group within the 
ethanol-exposed experimental group (right).   
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Figure 4: Gene expression principal component plots for samples, colored by RNAseq flow cell (a), Experimental 
Cohort (b), and Drinking Level (c), before (left) and after (right) Limma correction for Flow Cell and Experimental 
Cohort. Lack of clustering in the right-hand plots indicates that Limma successfully corrected for covariate effects, 
and that no other covariates with strikingly visible results exist.     
 
 
 
 
 
 
 
 
 
 
 
 
 Differential Expression and Expression-Phenotype Associations 
Differential expression between the highest drinkers and controls was tested for each 
gene using DEseq2. The lowest drinkers were not included in this analysis, as many of them 
consumed negligible amounts of ethanol, which means their ethanol exposure levels were 
similar to that of controls. Because the goal of this particular analysis was to detect ethanol-
regulated genes (i.e. genes whose expression levels change in response to ethanol), as 
opposed to ethanol-regulating genes (i.e. genes whose expression levels moderate ethanol 
consumption levels), the inclusion of the lowest drinkers in either group would reduce our 
power. Furthermore, correction for flow cell differences would decrease power to detect true 
biological differences between low drinkers and high drinkers, because the majority of the 
low drinkers were placed on the same flow cell. The comparison of high drinkers v. controls 
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did not require this power-limiting correction, because they were sequenced on the same flow 
cell. The program utilizes a Wald test to examine expression differences between two groups. 
It adjusts p-values using the Benjamini-Hochberg formula, after removing values for genes 
that did not have sufficient variance for the implemented normalization algorithm (273). As 
mentioned above, this analysis was performed on raw gene counts, and Cohort was included 
as a covariate. An adjusted p-value < 0.1 was considered to represent significant expression 
differences between groups. To take advantage of the continuous nature of our alcohol 
consumption phenotype, we also tested for a relationship between expression values and Last 
Week Mean Total Ethanol Consumption. Unlike DEseq2, this analysis examined the linear 
relationship between continuous drinking values, as reflection of a behavioral trait as well as 
biological exposure. Therefore, high and low drinkers were included in this analysis, and 
flow cell was incorporated into the regression model as a covariate. We used Robust Linear 
Model regression from the MASS R-package to test for linear relationships between log-
transformed TPM values and the following phenotypes, using expression as the predictor and 
ethanol consumption as the dependent variable: Last Week, First Week, and Whole Study 
Mean Total Ethanol Consumption and Preference. This method was used because it is robust 
against non-normality of dependent variables, as is seen in our drinking data, due to our 
sampling of extreme values (100 highest drinkers and 100 lowest drinkers). As for other 
analyses, Cohort and Flow Cell were included as categorical covariates. Significance was 
defined as a False Discovery Rate (q) < 0.1, calculated within each drinking phenotype. 
Because high drinking group in the differential expression analysis was designated based on 
last week mean total ethanol consumption levels, differential expression results will only be 
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compared to results from the linear regression testing for expression association with last 
week mean total ethanol consumption, for consistency.  
Gene Expression Network Analysis  
 We used Weighted Gene Co-expression Network Analysis (38) to map scale-free 
networks, or “modules”, of genes with highly correlated expression values (38). This method 
works via hierarchical clustering, based on topological overlap, which takes into account 
adjacency (or transformed expression correlation) and network topology (or the 
connectedness of two genes, based on their shared connections).  Because this method does 
not use algorithms that allow for the inclusion of covariates, expression data was corrected 
for effects of RNAseq Flow Cell (NSamplesFC1=148, NSamplesFC2=42) and Cohort (groups in 
which mice underwent experimentation) before network construction, using R-package 
Limma’s batch effects correction function (272).  
WGCNA is a weighted network-mapping method meaning there is no hard 
association threshold for the presence of a connection between two genes to be granted. The 
resulting networks are scale-free, meaning the probability of being connected to a certain 
number of nodes follows a power distribution (100). Scale-free networks are characterized by 
the presence of highly connected “hubs”, rendering robustness of the network structure 
against the removal of single edges (or connections between genes) (100). These types of 
networks are commonly occurring in nature and are a good representation of biological 
frameworks, for which there are often molecular “hubs” that affect many other peripheral 
genes or proteins (100). In order to achieve optimal scale-free nature, while balancing the 
connectivity (a value that incorporates the number and strength of connections between one 
gene and all other genes), the adjacency values must raised to a user-specified power. 
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Typically, scale-free conformance increases and connectivity (for which moderate values 
provide the most informative results) decreases, both asymptotically, as this power value 
increases in pre-clustered (by K-means clustering) networks. However, because this 
relationship between soft threshold value and scale-free conformance was displayed by our 
data, we set the power to which the adjacency values would be raised to 6, as suggested in 
Horvath et al., (100) (Figure 5). We used the unsigned bi-weight correlation method (which 
is robust to outliers) for adjacency calculations, and determined module membership by a 
dendrogram (or relatedness tree) with a deep split cut parameter of 4, in order to maximize 
sensitivity, allowing modules to be no smaller than 30 genes. Modules were merged if their 
branches met at a dendrogram height < 0.05. These networks were analyzed in ethanol-
exposed mice only, as ethanol can affect correlations between gene expression values, and 
therefore network structure (30, 274).  
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Figure 5: Scale-free topology fit index, and mean, median, and maximum connectivity for rudimentary modules mapped via 
K-means clustering, for each of several potential adjacency power thresholds. The ideal power value maximizes scale-free 
fit while keeping connectivity at moderate, interpretable values (i.e. modules that are not too large or too small to interpret 
biologically). Typically, scale-free fit increases asymptotically with power, so that any power around the asymptote can be 
chosen based on the connectivity spline. However, in samples in which groups exist (like our high and low drinkers), 
aberrant distribution of scale-free fit values over power values are often seen.  In these cases, a standard power of 6 is 
recommended by the creators of the WGCNA package.  
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Spearman correlations were used to determine the relationship between each modules 
first principal component (“Eigen Gene”) and Last Week Mean Total Ethanol Consumption. 
A corresponding p-value < 0.05 was considered to be significant. Module Membership (or 
correlation with the module Eigen gene) and Intramodular Connectivity (a metric 
representing the number of connections a single gene has within its network) were calculated 
for each gene, using functions provided by the WGCNA package (38). Genes with Module 
Membership > 0.8 and Intramodular Connectivity > 0.9 were considered to be hub genes. 
Modules with significant drinking level correlations are thought to either drive drinking 
differences, or to be moderated by alcohol exposure. In either case, they represent important 
functional frameworks relevant to cortical pathways that mediate drinking behaviors. These 
modules were also tested for overrepresentation with genes that were significantly 
differentially expressed between high drinkers and controls, via Fisher’s exact test, with a 
qFDR < 0.1 representing significance. Finally, we tested all modules for overrepresentation 
with genes containing significant SNPs in the GSCAN GWAS on average alcoholic drinks 
per week (61). For this test, empirical p-values were calculated via permutation, as different 
gene sets (i.e. human genes vs. mouse genes) were used for each of the original analyses. For 
each module, random modules of the same size were permuted 10,000 times, and the number 
of genes containing significant (p < 5*10-8) was plotted to create the null distribution. 
Modules that contained a number of significant SNP-containing genes that fell above the 5th 
percentile of this distribution, representing a p-value < 0.05, were considered to be 
significantly overrepresented. Because these p-values were empirical, no multiple testing 
correction was performed. The GSCAN sample is a meta-analytical sample composed of 
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941,280 participants from several different samples including UK Biobank, dbGAP, ARIC, 
MESA, eMERGE, Stroke, BEAGESS, and Jackson Heart Study 
(https://genome.psych.umn.edu/index.php/GSCAN_dbGaP). All samples were imputed to 
the Haplotype Reference Consortium (275), using Minimac3 (276) or IMPUTE2 (126). 
Meta-analysis was performed using rarGWAMA 
(https://github.com/dajiangliu/rareGWAMA/), on summary statistics obtained from 
RVTESTS (277) for effect of variants on average number of alcoholic drinks consumed per 
week (61). Relatedness for family samples, cryptic relatedness for population samples, and 
population stratification were handled by including genomic principal components or kinship 
matrices as covariates during the original generation of summary statistics (61). Significance 
threshold for meta-analysis was 5*10-8 for variants with Minor Allele Frequency ≥ 1%, and 
5*10-9 for those with MAF < 1% and > 0.1%. Gene-wise p-values were calculated using 
PASCAL (278).  
Expression Quantitative Trait Locus Mapping 
 According to methods described in Chapter 4, we mapped expression quantitative 
trait loci (eQTL), or loci at which alleles affect expression values of a given gene, for top 
candidate genes for ethanol consumption and preference (for ethanol over water and 30% 
ethanol over 15% ethanol) from Chapter 4, using the R qtl2 package (165). To identify loci 
that affect the overall expression of such modules, we also performed eQTL analysis on each 
WGCNA network’s Eigen Genes, to identify loci where alleles result in module-wide 
expression differences. Flow Cell and Cohort were included as categorical covariates, and 
Kinship was included as a fixed effect, in a linear mixed model. Kinship was estimated based 
on haplotype probabilities (i.e. the probability that each region of DNA was inherited from 
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each of the 8 progenitor strains, identity by descent), using the Leave One Chromosome Out 
method (156, 165). Expression was quantified as log-transformed TPM, and genotypes were 
represented by haplotype probabilities (as they were in the kinship estimation).  
Because of the computational intensiveness of the permutation analysis required for 
determining significance thresholds for each individual analysis (i.e. each gene whose 
expression is being analyzed) and the similarity of thresholds between traits seen in Chapter 
4, all loci with LOD peaks > 6 were considered to be suggestive, and those with LOD peaks 
> 7.58 (the average threshold LOD peak corresponding to p < 0.05 in the bQTL-based 
permutations) were considered to be significant. The 95% Bayesian support intervals for 
suggestive and significant loci will be compared to those of behavioral QTL mapped for 
drinking behaviors in these mice in a previous study (Chapter 4) to test for overlap between 
95% Bayesian support intervals. Overlap between bQTL and eQTL provides evidence that 
the bQTL effects drinking behavior via a mechanistic pathway related to the gene that the 
overlapping eQTL regulates.  
Functional Overrepresentation 
Modules that were significantly correlated with Last Week Mean Total Ethanol 
Consumption, and were significantly overrepresented with GSCAN GWAS significant genes 
for average drinks per week, or with significantly differentially expressed genes between 
high drinking DO mice and controls, were tested for functional overrepresentation. All 
modules with Eigen Gene eQTL 95% Bayesian support intervals that overlapped with bQTL 
identified for drinking behaviors in these mice were tested for functional overrepresentation, 
as well. ToppGene’s ToppFun function was used to perform gene ontology-based functional 
overrepresentation testing (279). All overrepresentations with p < 0.01 were considered 
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significant, but those with qFDR < 0.1 were considered to be highly significant functions. For 
larger modules with > 20 highly significant overrepresentation groups per ontological 
category, the top 20 groups for each category are shown in results tables. All significant 
results are reported in supplementary tables. Categories were limited to those that included 
anywhere between 3 and 1,000 genes from a given module. The following categories were 
tested for overrepresentation: molecular function, biological process, cellular component, 
human phenotype, mouse phenotype, pathway, and disease.  
 
 
Results 
Differential Expression and Drinking Associations for Individual Genes 
 Total ethanol consumption and preference values for the 100 highest and 100 lowest 
drinkers can be seen in Figure 6. (See full distribution of consumption values for all mice in 
Chapter 4.) One high drinker was removed due to potential sample mix up before 
sequencing, however all other samples were retained after quality control. These groups 
varied across experimental cohorts, but were not unbiased, and expression values appeared to 
group with Cohort in principal component plots (Figure 3 & 4c). As described in the 
Methods section, we either corrected for Cohort or included it as a covariate in all of our 
analyses. Furthermore, due to a breach in protocol, we discovered that flow cell on which the 
samples were sequenced corresponded with drinking groups, such that the highest drinkers, 
controls, and 28 of the highest drinking low drinkers were on the first flow cell, and the 
remaining 72 lowest drinkers were on 
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Figure 6: Histograms of total ethanol consumption (left) and preference (right) values, across each tested time 
interval, indicated at the top of each plot. Distributions appear especially bimodal for the last week time interval, 
because of the sampling from extremes, based on last week mean total ethanol consumption values, for sequencing.  
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the second flow cell. This was also evident in the principal component plots of expression 
values (Figure 4c). Although correcting and controlling for flow cell would likely reduce our 
power, we decided to do so, in order to avoid the capture of false positive results due to 
technical variation. After using Limma to correct for Flow Cell and Cohort, these clusters 
disappeared in principal component plots, indicating adequate correction for the correct 
covariates (Figure 4c). However, it was not necessary to control for flow cell differences for 
DEseq comparisons between high drinkers and controls, as these two groups were run on the 
same flow cell.  
 All results for gene expression level covariation with ethanol drinking behaviors, and 
for differential expression between high drinkers and controls for all genes can be seen in 
Table S1. Of the 17,709 genes analyzed, 376 analyses failed to converge in regressions 
against Last Week Mean Total Ethanol Consumption. Therefore, when comparing DEseq 
results to Last Week Mean Total Ethanol Consumption correlation results, we only consider 
those that successfully yielded results in both analyses (Ngenes=17,333). For the differential 
expression analysis between high drinkers and controls, 1,171 genes were significant; 
whereas 6,968 genes significantly predicted Last Week Mean Total Ethanol Consumption 
across all 200 drinkers. Of these, 564 genes displayed significance in both analyses. After 
removing genes that had missing values in DEseq due to failure of that gene to meet the 
normalization algorithm assumptions (Nfailed=2,038), in order to compare differences in 
results between analyses, 6,371 of the significantly ethanol consumption-associated genes 
remained. This means that 607 genes were differentially expressed between high drinkers 
and controls, but did not significantly predict ethanol consumption, and the opposite was true 
for 5,807 genes. To determine functional trends, gene ontology overrepresentation analysis 
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was run on each of three gene sets, using ToppGene (279): genes that were both significantly 
differentially expressed and significantly predictive of ethanol consumption levels; genes that 
were only significantly differentially expressed; and genes that were only significantly 
predictive of ethanol consumption levels. The same parameters were used for this 
overrepresentation as those used for the ToppGene analysis of WGCNA modules. However, 
because this analysis is focused on finding general functional trends in groups of genes as 
opposed to attributing function and pathology to a specific network, only the categories of 
molecular function, cellular component, biological process, and pathway were searched.  All 
results with p < 0.01 were considered significant (Table S4), and the top 20 highly significant 
results (qFDR < 0.1) for each ontological category can be seen in Table 2a-c.  
 
Gene Network Analysis 
 WGNCA results yielded a total of 33 modules, and one “module” consisting of 7,709 
genes that were not assigned a module, meaning they were removed from modules during 
clustering, due to low module membership (correlation with the Eigen gene) (Figure 7). 
Module Membership, Intramodular Connectivity, and Hub Gene status for each gene are 
represented in Table S1. Results for each module’s association with ethanol drinking 
behaviors, and overrepresentation for differentially expressed genes between high drinkers 
and controls, are presented in Table S3. Seventeen modules had Eigen Genes significantly 
correlated with at least one of Total Ethanol Consumption or Preference for the first week of 
IEA, last week of IEA, or the whole study (Figure 9).  Not surprisingly, given that gene 
expression data was collected after the last week of drinking, none of the modules were 
significantly correlated with First Week Mean phenotypes. These 17 modules were carried 
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forward for testing for overrepresentation of differentially expressed genes between high 
drinkers and controls (from the DEseq2 analysis) and significantly drinking level-associated 
genes from GSCAN, and for overlap between Eigen Gene eQTL and bQTL for ethanol 
drinking phenotypes identified in the previous chapter. Seven of these modules (Light 
Yellow, Brown, Turquoise, Magenta, Yellow, Pink, and Black) were significantly 
overrepresented with differentially expressed genes, and two modules (Turquoise and Blue) 
were significantly overrepresented with genes harboring GSCAN GWAS significant SNPs 
(Table 3a,c).  
Finally, eight significant eQTL were identified for module Eigen Genes, each 
belonging to a unique module, and 50 suggestive QTL were identified (Figure 8, Table 4). 
Five of these eQTL overlapped with support intervals of behavioral QTL identified for Last 
Week Mean Total Ethanol Consumption, Last Week Mean Total Ethanol Preference, and 
First Week Mean Total Ethanol Consumption. The eQTL for six modules’ Eigen Genes 
overlapped with behavioral QTL identified in the Chapter 4. Modules Blue, Light Green, and 
Pale Turquoise overlap with the Chr1 bQTL for Last Week and Whole Study Mean Total 
Ethanol Preference; modules Brown and Light Green overlap with the Chr6 bQTL for First 
Week Mean Total Ethanol Consumption; and module Dark Turquoise overlaps with the 
Chr16 bQTL for Last Week Mean Total Ethanol Preference. However, the Bayesian support 
intervals for five of these eQTL (those on Chr1 and Chr6) are extremely large ( >130Mbp), 
so these results are to be interpreted with caution. In accordance with the criteria discussed in 
the Methods section of this chapter, six modules were chosen to be carried over for functional 
overrepresentation analysis: Brown, Turquoise, Light Green, Blue, Dark Turquoise, and Pale 
Turquoise. Complete tables of overrepresentation results with p < 0.01 can be seen in Table 
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Figure 7: Cluster dendrogram representing module relationships. Each leaf of the tree represents a single 
module, while branching represents correlation. Height represents distance (or the inverse of correlation). 
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S4. All highly significant results can be seen in Table 2. Every module was significantly 
overrepresented within each functional category. Although, not all modules had highly 
significant overrepresentations in every category, every module was highly significantly 
overrepresented in at least 2 categories (as is evident in Table 3), indicating that our analysis 
was successful at identifying groups of ethanol-associated and functionally related genes.  
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Module marker LOD.Score Chr Position.(Mbp) Downstream.
95%.Bayesian.SI
Upstream.95%.
Bayesian.SI
MElightcyan UNCHS005711 9.52 2 90.5673 90.5656 90.5673
MEviolet UNC12205668 8.85 6 138.3612 137.3680 139.2137
MEgreen UNC9440121 8.66 5 72.2247 67.5711 73.9091
MEorange c4.loc58.78 8.36 4 135.8440 135.7429 135.9371
MEgrey60 c6.loc63.83 8.33 6 139.1233 135.1719 139.2640
MEdarkred UNCHS005711 8.31 2 90.5673 10.8933 90.5673
MEdarkolivegreen UNC16043985 7.62 9 27.3563 26.3948 27.8608
MEpurple cX.loc34.87 7.62 X 84.9481 75.0489 87.3748
MEtan c5.loc71.61 7.53 5 146.6990 144.4243 146.8857
MElightyellow cX.loc33.44 7.38 X 75.8546 74.3731 87.3278
MEblue c5.loc71.6 7.37 5 146.6973 144.4352 146.8572
MEdarkolivegreen UNC25242206 7.31 15 27.1487 13.4260 28.4144
MEblue UNCHS005711 7.29 2 90.5673 3.1767 166.5001
MElightgreen UNCHS005711 7.28 2 90.5673 3.1767 179.7984
MEdarkgreen UNCHS005711 7.24 2 90.5673 3.1767 168.5210
MElightyellow UNCHS016304 7.21 5 147.2071 139.0748 147.2197
MEmidnightblue UNC9776212 7.14 5 100.4211 100.2420 102.8197
MEblack UNC29114578 7.12 18 41.6204 38.9586 42.4633
MEroyalblue UNC16011855 7.08 9 24.6765 23.3848 27.3563
MEred c5.loc71.61 6.94 5 146.6990 144.4016 146.8572
MEsaddlebrown UNCHS015190 6.87 5 101.7593 100.2420 102.9887
MEsteelblue UNC9816473 6.82 5 102.9887 99.5884 147.6169
MEskyblue UNCHS014691 6.81 5 71.9714 67.6002 139.1954
MEpurple JAX00486143 6.81 2 28.3310 26.2775 77.1019
MEwhite c6.loc61.18 6.76 6 135.9998 133.9692 137.7865
MEpaleturquoise UNC22338724 6.71 13 29.4673 27.8470 30.6940
MEcyan UNCHS005711 6.61 2 90.5673 3.1767 180.1845
MEblack c4.loc58.76 6.55 4 135.8216 135.7295 135.9371
MEdarkred UNC16043985 6.54 9 27.3563 23.3848 40.7505
MEdarkturquoise UNCHS037737 6.52 14 27.8875 25.5451 91.6242
MEgrey JAX00147136 6.50 6 135.2173 3.2002 139.4509
MEviolet UNCHS032383 6.47 11 114.6716 106.6006 115.1819
MEdarkorange UNC23726899 6.47 14 25.6757 25.5613 88.0969
MEgreenyellow JAX00345858 6.44 12 110.1658 97.5934 112.2763
MEgreenyellow UNCHS005711 6.43 2 90.5673 3.1767 172.8370
MElightgreen c6.loc60.53 6.43 6 135.0735 3.2002 139.4509
MEdarkred c5.loc71.61 6.43 5 146.6990 144.4016 146.8448
MEpurple c12.loc0.8 6.41 12 6.0204 3.9307 70.5633
MEdarkorange UNC25242206 6.40 15 27.1487 14.3397 30.1815
MEdarkgreen UNCHS012241 6.40 4 104.0428 101.1600 104.3381
MEdarkturquoise UNC26725019 6.39 16 44.2626 39.9709 48.5580
MEgreenyellow UNC10385175 6.39 5 146.7027 24.2063 147.8497
MEblack JAX00171884 6.39 9 60.7010 60.1659 61.3391
MElightcyan UNC9799387 6.28 5 102.0051 99.3871 147.0045
MEorange UNCHS019510 6.27 7 17.0169 3.1577 95.6569
MEpaleturquoise UNC386248 6.25 1 32.1956 10.1715 160.1762
MEsaddlebrown UNCHS005711 6.24 2 90.5673 3.4337 180.1137
MEred UNCHS005711 6.19 2 90.5673 3.1767 161.1323
MEdarkorange UNC16043985 6.19 9 27.3563 22.8308 41.1797
MEblue UNC14510156 6.16 8 36.3829 3.1232 102.7612
MEroyalblue UNC29056323 6.15 18 37.1504 35.7468 38.2154
MEmagenta UNC23794297 6.13 14 31.5658 30.7098 33.1612
MElightgreen JAX00246131 6.12 1 33.7401 30.4238 164.2401
MEbrown UNCHS016395 6.10 6 3.4501 3.2002 138.3612
MEblue JAX00246131 6.09 1 33.7401 24.5680 187.6188
MEdarkorange UNC385804 6.03 1 32.1123 31.3310 34.4871
MEblack UNCHS029800 6.01 11 10.4093 9.5554 16.1413
MEgreenyellow UNCHS011115 6.00 4 44.4351 20.1889 155.3592
Table 4: Module Eigen Gene eQTL 
Significant (LOD > 7.58), 
and suggestive (LOD > 6) 
module Eigen Gene eQTL 
with the name and 
chromosomal position in 
Mega base pairs (Mbp) of 
the top-scoring marker for 
each locus. 95% Bayesian 
support interval 
calculations were used to 
determine the upper and 
lower bounds (in Mbp) of 
each QTL. Module names 
are highlighted in grey to 
indicate that those eQTLs 
overlapped with behavioral 
QTLs for ethanol drinking 
behaviors.  
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Figure 8: LOD scores across all chromosomes 
yielded by module Eigen Gene eQTL analysis, 
for each WGCNA module. The first 5 LOD 
plots (shown on this page) are for modules that 
had an eQTL that overlapped with a behavioral 
QTL for an ethanol drinking behavior. (Plots 
for remaining modules are below) These 
specific eQTLs are denoted by red arrows. 
Blue and red dotted lines represent suggestive 
and significant LOD score thresholds, 
respectively. Scores that fall above those lines 
are either suggestive or significant, 
respectively.  
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Module Correlations with Ethanol Behaviors
-1
-0.5
0
0.5
1
Fir
st 
W
ee
k E
tO
H 
Co
ns
.
La
st 
W
ee
k E
tO
H 
Co
ns
.
W
ho
le 
St
ud
y E
tO
H 
Co
ns
.
Fir
st 
W
ee
k E
tO
H 
Pr
ef.
La
st 
W
ee
k E
tO
H 
Pr
ef.
W
ho
le 
St
ud
y E
tO
H 
Pr
ef.
0.17
(0.02*)
0.12
(0.1)
0.16
(0.02*)
0.2
(0.004*)
0.13
(0.06)
0.19
(0.007*)
-0.034
(0.6)
0.064
(0.4)
-0.029
(0.7)
-0.077
(0.3)
0.0013
(1)
-0.062
(0.4)
-0.058
(0.4)
-0.022
(0.8)
-0.096
(0.2)
-0.12
(0.09)
-0.042
(0.6)
-0.14
(0.05)
-0.0034
(1)
0.058
(0.4)
-0.035
(0.6)
-0.022
(0.8)
0.059
(0.4)
-0.057
(0.4)
-0.021
(0.8)
-0.052
(0.5)
-0.091
(0.2)
-0.019
(0.8)
-0.052
(0.5)
-0.11
(0.1)
-0.035
(0.6)
-0.045
(0.5)
-0.078
(0.3)
-0.056
(0.4)
-0.098
(0.2)
-0.11
(0.1)
-0.097
(0.2)
-0.055
(0.4)
-0.15
(0.04*)
-0.12
(0.08)
-0.095
(0.2)
-0.17
(0.01*)
-0.087
(0.2)
-0.066
(0.4)
-0.15
(0.03*)
-0.12
(0.09)
-0.091
(0.2)
-0.19
(0.008*)
-0.096
(0.2)
-0.069
(0.3)
-0.16
(0.02*)
-0.14
(0.06)
-0.11
(0.1)
-0.2
(0.006*)
-0.077
(0.3)
-0.061
(0.4)
-0.15
(0.04*)
-0.12
(0.1)
-0.11
(0.1)
-0.2
(0.004*)
0.035
(0.6)
0.093
(0.2)
0.048
(0.5)
0.015
(0.8)
0.07
(0.3)
0.021
(0.8)
-0.081
(0.3)
0.013
(0.9)
-0.11
(0.1)
-0.11
(0.1)
-0.016
(0.8)
-0.15
(0.03*)
-0.06
(0.4)
-0.013
(0.9)
-0.094
(0.2)
-0.082
(0.2)
-0.052
(0.5)
-0.14
(0.05)
-0.056
(0.4)
0.017
(0.8)
-0.064
(0.4)
-0.075
(0.3)
-0.013
(0.9)
-0.1
(0.2)
0.047
(0.5)
0.1
(0.2)
0.059
(0.4)
0.0087
(0.9)
-0.0024
(1)
-0.015
(0.8)
0.042
(0.6)
0.17
(0.01*)
0.075
(0.3)
0.024
(0.7)
0.15
(0.03*)
0.052
(0.5)
-0.017
(0.8)
0.13
(0.07)
-0.006
(0.9)
-0.026
(0.7)
0.11
(0.1)
-0.022
(0.8)
-0.045
(0.5)
0.05
(0.5)
-0.071
(0.3)
-0.051
(0.5)
0.014
(0.8)
-0.1
(0.1)
0.0072
(0.9)
0.1
(0.1)
0.0034
(1)
0.021
(0.8)
0.074
(0.3)
-0.016
(0.8)
0.052
(0.5)
-0.023
(0.7)
0.016
(0.8)
0.033
(0.6)
-0.076
(0.3)
-0.034
(0.6)
0.039
(0.6)
0.11
(0.1)
0.078
(0.3)
0.071
(0.3)
0.1
(0.1)
0.073
(0.3)
0.087
(0.2)
0.099
(0.2)
0.1
(0.1)
0.078
(0.3)
0.069
(0.3)
0.068
(0.3)
-0.038
(0.6)
0.045
(0.5)
-0.045
(0.5)
-0.042
(0.6)
0.014
(0.8)
-0.059
(0.4)
0.085
(0.2)
0.17
(0.01*)
0.11
(0.1)
0.05
(0.5)
0.16
(0.03*)
0.1
(0.2)
0.085
(0.2)
0.15
(0.04*)
0.098
(0.2)
0.048
(0.5)
0.13
(0.06)
0.076
(0.3)
0.1
(0.1)
0.17
(0.01*)
0.14
(0.05)
0.1
(0.2)
0.17
(0.02*)
0.14
(0.05)
0.098
(0.2)
0.19
(0.009*)
0.14
(0.05)
0.077
(0.3)
0.18
(0.01*)
0.13
(0.06)
0.047
(0.5)
0.12
(0.08)
0.058
(0.4)
0.068
(0.3)
0.12
(0.09)
0.055
(0.4)
0.016
(0.8)
0.1
(0.1)
0.016
(0.8)
0.044
(0.5)
0.096
(0.2)
0.02
(0.8)
0.021
(0.8)
0.051
(0.5)
0.018
(0.8)
-0.00071
(1)
0.051
(0.5)
0.027
(0.7)
0.16
(0.02*)
0.14
(0.05*)
0.19
(0.008*)
0.17
(0.02*)
0.16
(0.03*)
0.22
(0.002*)
0.13
(0.06)
0.16
(0.02*)
0.16
(0.02*)
0.12
(0.08)
0.15
(0.04*)
0.17
(0.01*)
0.055
(0.4)
0.11
(0.1)
0.077
(0.3)
0.074
(0.3)
0.11
(0.1)
0.092
(0.2)
-0.0094
(0.9)
0.073
(0.3)
-0.031
(0.7)
-0.033
(0.6)
0.033
(0.6)
-0.059
(0.4)
lightyellow
green
steelblue
grey60
purple
skyblue
brown
turquoise
magenta
yellow
greenyellow
blue
red
tan
darkgreen
lightcyan
lightgreen
cyan
darkred
darkgrey
darkolivegreen
royalblue
white
midnightblue
violet
darkturquoise
saddlebrown
darkorange
salmon
orange
pink
black
paleturquoise
grey
Figure 8: Module Eigen-Gene correlation values with each drinking behavior tested. Each row represents a module, indicated 
by color on the left-hand side of the plot. Green cell coloring indicates negative correlations, and red coloring indicates 
positive correlation, with darker colors representing stronger correlations. Values within cells represent the correlation 
coefficient above the p-value for that correlation. Asterisks are placed next to significant p-values (< 0.05).  
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 Discussion 
 
Differential Expression and Ethanol Consumption Association 
Of the 1,171 genes that were significantly differentially expressed between controls 
and high drinkers, 607 did not predict drinking levels amongst the high and low drinkers, 
whereas 5,807 of the 6,371 genes that predicted drinking levels were not significantly 
differentially expressed. We anticipated seeing genes fitting three of these descriptions. 
Genes fitting the latter description are likely ethanol-regulating (meaning their expression 
levels moderate drinking behaviors), as opposed to being ethanol-regulated (meaning ethanol 
exposure moderates expression levels). In contrast, genes that were significantly 
differentially expressed between high drinkers and controls but did not predict ethanol 
consumption may be highly sensitive to ethanol, creating a ceiling effect, rendering different 
expression levels between ethanol-naïve and ethanol-exposed mice, and similar expression 
levels across mice that consumed low and high amounts of ethanol. Therefore, these genes 
would still be classified as ethanol-regulated, but with extreme ethanol sensitivity or tight 
regulation by feedback loops, creating a ceiling effect. Top results from functional analysis 
revealed that these genes are highly overrepresented with functions related to: 
transmembrane cation (specifically potassium) transport; localization in all parts of neurons 
(axons, soma, and dendrites); calcium signaling; alpha adrenergic signaling; insulin 
secretion; cardiac conduction; and muscle contraction (Table 2a). Neuronal signaling, ion 
transporters, signaling cascades are just the types of pathways that one would be expect to be 
affected by alcohol exposure.  
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For the 607 genes with more ethanol dose-dependent expression levels, or those that 
were significantly differentially expressed and predictive of consumption levels, several of 
the top functional enrichment categories were particularly involved in neuronal function. 
These categories included: transmembrane transporter activity; neuron projection 
development; and localization in the myelin sheath. There were also several categories 
involving cellular metabolism, and energy production and release, including: mitochondrial 
activity; cellular respiration; citrate and tricarboxylic acid metabolism; oxidation; pyruvate 
dehydrogenase activity; glucose metabolism; and ATP synthesis. Interestingly, these genes 
are also involved in processes related to Parkinson’s, Alzheimer’s, and Huntington’s 
diseases, all of which involve neuron death and myelin degeneration (Table 2b). It could be 
that one component of alcohol’s toxicity to neurons is the perturbation of highly sensitive, 
energy-related pathways that could be related to neuronal and myelin integrity, or to neuron 
projection maintenance and development. These findings are supported by prior research that 
has shown significant death, demyelination, and synaptic remodeling of neurons, and 
ethanol-regulated gene expression changes, in the Prefrontal Cortex of long-term alcoholics 
(280) (30) (96). They also indicate that these pathways could even be disrupted by long-term 
relatively low levels of chronic alcohol consumption.  
Finally, the 5,807 genes that we believe to be ethanol-regulating, due to their 
significant association with ethanol consumption levels but lack of significant differences 
between high drinkers and controls, top functional enrichment displayed many protein-level 
regulatory pathways (Table 2c). Specifically, these functions are centered around protein-
level and activity control: RNA processing, ubiquitination, proline hydroxylation, GDP 
binding and GTPase activity, and proteolysis. We hypothesize that these associations may be 
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stem from robustness against ethanol-induced perturbation of protein levels and activity, 
which may be protective against increases in consumption and the development of 
dependence. The remaining top functional categories were largely related to: hydrolase 
activity; membrane trafficking and vesicle-mediated transport; and immune function. 
Membrane trafficking and vesicle-mediated transport are particularly interesting categories, 
as these functions are involved in intracellular signaling. Just as with the protein-processing 
pathways, there may be a certain robustness to these pathways against ethanol-induced 
change. This quality could render an individual less prone to tolerance, which is mediated by 
changes in transmembrane receptor density, and craving, which is mediated by synaptic 
plasticity in response to ethanol-induced changes to normal signaling (249) (8). Finally, 
immune function has been found to be compromised by long-term alcohol consumption, and 
neuroinflammation and immune-related changes have been found to be increased in 
alcoholics (265) (264) (28) (106).  
It is important to note that some of the differences in results between DEseq2 and the 
correlations between gene expression values and Last Week Mean total Ethanol Consumption 
and Preference may differ due to lack of power in DEseq2 compared to the phenotype 
regressions, as there were only 20 samples in the control group. This could have resulted in 
fewer significant genes in DEseq, making it appear as though many genes were ethanol-
regulating (i.e. significantly predicted consumption and preference values) but not ethanol-
regulated (i.e. did not differ between controls and high drinkers). However, the algorithms 
used DEseq2 were specifically designed to be robust against both small samples sizes and 
difference in sample sizes between groups (273). Therefore, we believe that the differences 
between these two analyses are biologically relevant.   
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Gene Expression Networks 
 Our analysis revealed 17 gene expression networks in the PFC whose Eigen Genes 
were significantly correlated with Last Week Mean Total Ethanol Consumption. This 
indicates that the overall expression levels of the genes in those modules are either ethanol-
regulated or ethanol-regulating. Seven of these modules were also overrepresented with 
genes that were differentially expressed between high drinkers and controls, indicating that 
these modules may be ethanol-regulated. One of these seven modules (Turquoise) and four 
additional modules were significantly overrepresented with genes displaying significant 
associations with “average drinks per week” in the GSCAN GWAS. These results suggest 
that Turquoise is an ethanol-regulated module that contains genes that also regulate alcohol 
consumption. We believe that the sensitivity of these genes to ethanol likely mediates the 
relationship between the associated SNPs and drinking levels in humans. Finally, five 
modules’ Eigen Gene eQTLs overlapped with bQTLs identified for ethanol drinking 
behaviors in these mice in the previous chapter, two of which (Blue and Light Green) were 
overrepresented for GSCAN GWAS significant genes, and one of which (Brown) was also 
significantly overrepresented with differentially expressed genes between high drinking and 
control DO mice. Because Blue and Light Green show evidence for mediating the effects of 
genetic variants on drinking, but are not significantly overrepresented with differentially 
expressed genes between highly drinking and non-drinking mice, these results suggest that 
affective variants moderate basal expression levels or functionality which then affect 
drinking behaviors. Similar to Turquoise, we theorize that the sensitivity of genes in the 
Brown module to ethanol may mediate the effects of the variants in the Chr1 bQTL interval 
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on long-term ethanol consumption. However, as expressed in the Methods, the eQTL 
intervals for four of these modules (Blue, Light Green, Pale Turquoise, and Dark Turquoise) 
were quite large (> 130Mbp), so results should be interpreted with caution.  
 The Turquoise module was highly significantly overrepresented for pathways largely 
related to the following functions: cognitive impairment and developmental delays; 
microcephaly and abnormal brain morphology; muscular hypertonia and atrophy; abnormal 
facial feature morphology; abnormal eye movement; ubiquitin and ligase activity; ATP- and 
GTP-binding; protein modification; organelle and chromosomal organization; and Golgi 
vesicle transport (Table 3a). This module’s hub genes were Appbp2 (amyloid beta precursor 
protein (cytoplasmic tail) binding protein 2), Pafah1b1 (platelet-activating factor 
acetylhydrolase, isoform 1b, subunit 1), Dnm1l (dynamin 1-like), and Mtpn (myotrophin). 
Expression levels of all of these genes are significantly associated with Last Week Mean 
Total Ethanol Consumption, but surprisingly (given this module’s overrepresentation with 
differentially expressed genes), only Pafah1b1 is differentially expressed between high 
drinking mice and controls (Table S1). One possible explanation for this is that basal levels 
of expression of the other three hub genes affect the ethanol-sensitivity of the remaining 
genes in the module, one of which is Pafah1b1. All four hub genes were present in highly 
significantly overrepresented functional groups for this module, and even shared some 
functional categories. Appbp2 and Dnm1l are both involved in phosphatase and hydrolase 
activity, and are known to be located in vesicles. Furthermore, prior literature has shown 
support for the association of Dnm1l and Beta-Amyloid (the precursor of which binds to 
Appbp2, hence this gene’s name) with neurodegenerative diseases (281, 282). Dnm1l and 
Mtpn are both associated with protein complex assembly, and Mtpn and Pafah1b1 are both 
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localized in axons. Relevant to both of these functional categories, Mtpn moderates the 
dimerization of the protein NFκB’s (nuclear factor kappa B) subunits. This protein is 
primarily known for activating the transcription of cytokines as a function of immune 
response, but it is also associated with drug-related reward, response to stress, and Beta-
Amyloid levels in the brain (283, 284). Additionally, both NFκB and Dnm1l are upregulated 
by cocaine exposure in microglia (285, 286). Finally, Dnm1l and Pafah1b1 share several 
functions, including: cellular response to stress; muscular hypotonia; organelle fission; cell 
part morphogenesis; microcephaly; brain atrophy (i.e. neurodegeneration); and seizures. It 
appears that the overarching theme of functionality for this network is neurodegeneration. In 
fact, a neuropathological relationship between Alzheimer’s and Alcohol Dependence has 
already been suggested by Venkataraman et al. (287). The proposed shared mechanisms are 
neuroinflammatory in nature and involve Beta-Amyloid and TLR4 (toll-like receptor 4), 
which is responsible for promoting the NFκB signaling pathway in microglia (287).  
 The Brown module was highly significantly overrepresented with functional 
categories that largely represented DNA damage repair, apoptosis (particularly in response to 
DNA damage), as well as cognitive impairment and developmental delays (Table 3b). Of the 
six hub genes for this module (Brd8, Ino80, Fam214a, Elac1, Osbpl2, and Zbtb25), two of 
them, Brd8 (bromodomain 8) and Ino80 (INO80 complex subunit), were observed in highly 
significant functional groups. Two of these functional groups contained both of these genes: 
“transferase complex” and “INO80-type complex” (Table S4). Ino80 is involved in 
chromatin remodeling, and consequently the moderation expression levels of associated 
genes, and Brd8 is involved in hormone-moderated transcription activation (288, 289). Ino80 
also appears in several functional groups related to DNA repair (Table S4). Neither gene’s 
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expression levels are significantly differentially expressed between high drinking and control 
mice. However, Ino8’s expression levels are significantly correlated with Last Week Mean 
Total Ethanol Consumption. A likely mechanism of association with ethanol consumption is 
that basal expression level differences in this gene directly moderate expression levels of the 
other genes in this module (via its role in chromatin remodeling), many of which are 
differentially expressed between high drinker and controls. The Ino80-moderated basal 
expression levels of these genes may affect the sensitivity of related mechanisms to ethanol 
exposure. For instance, if a mouse already expresses a gene at low levels, and ethanol 
decreases the expression of that gene, the corresponding mechanisms may be compromised 
more so than they would be for a mouse with basally higher expression levels. Functional 
overrepresentation results suggest that these corresponding mechanisms are involved in 
pathways related to DNA repair and, like Turquoise, cognitive ability. In fact, human 
GWASs have revealed associations between Ino80 and intelligence and cognitive ability 
(170). This is indicative that cognitive ability and drinking behaviors may therefore involve 
some of the same pathways. Furthermore, another study has suggested that dopaminergic 
neuronal plasticity in the midbrain mediates prefrontal cortex-driven cognitive control over 
task-related behaviors in  (8).  It is well known that dopaminergic pathways are involved in 
drinking behaviors (8), so it is possible that these shared pathways between cognition and 
drinking behaviors are both associated with dopaminergic signaling to the prefrontal cortex.     
Like Turquoise, the Blue module was highly significantly overrepresented with 
functions related to microcephaly, cognitive impairments and developmental delays, 
abnormal facial feature morphology, and muscular hypertonia, all features of syndromes 
characterized by developmental delays. Additionally, it was highly significantly 
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overrepresented pathways associated with: synaptic signaling; axon guidance; vesicular 
transport; cell-cell signaling (via several types of molecules, including hormones, ions, 
neurotransmitters, growth factors); mood disorders; actin-related processes; cellular and 
tissue development and organization; ligase activity; and oxidoreductase activity. This 
modules’ hub genes were: Nf1 (neurofibromin 1), Trip12 (thyroid hormone receptor 
interactor 12), Gapvd1 (GTPase activating protein and VPS9 domains 1), Ash1l (ASH1 like 
histone lysine methyltransferase), Cnot1 (CCR4-NOT transcription complex, subunit 1), and 
Aff4 (AF4/FMR2 family, member 4). Nf1, Trip12, and Cnot1 were all in groups representing: 
transcription factor activity, cellular response to DNA damage, and macromolecular 
catabolism. Nf1, Ash1l, and Aff4 were in functional groups related to localization on 
chromosomes; and Nf1, Trip12, and Aff4 were related to embryonic development. Nf1 and 
Gapvd1 are both involved in the promotion of hydrolysis of GTP by Ras (290, 291). 
Mutations in this gene are associated with neurofibromatosis, characterized by the formation 
of neuronal tumors (292). Cnot1 encodes a subunit of a transcription complex and is involved 
in the deadenylation of mRNA, transcriptional repression, and mRNA degradation (293). 
Somewhat similar in functionality, Ash1l is a histone methyltransferase, Aff4 encodes a 
subunit of a complex (super elongation complex) that catalyzes RNA polymerase II activity, 
and Trip12 is involved in the degradation of proteins via ubiquitination, all functions that 
regulate gene expression and protein levels (294-296). Unexpectedly, none of these genes’ 
expression levels were significantly correlated with ethanol consumption in our mouse 
sample, and were not differentially expressed between the high drinking mice and controls. 
Although the expression levels of genes in this module do not appear to be ethanol-regulated 
or ethanol-regulating, it is overrepresented with genes associated with alcohol consumption 
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in the GSCAN GWAS, and its Eigen Gene eQTL overlaps with a bQTL on Chr1 for Last 
Week and Whole Study Mean Total Ethanol Consumption in our DO mouse sample. 
Furthermore, several of Blue’s hub genes have shown significant associations with 
substance-related and psychiatric traits in human GWAS. In the GSCAN GWAS dataset, Nf1 
is significantly associated with average drinks per week, and Gapvd1 is associated with 
smoking initiation. Gapvd1 is also associated with smoking status in another GWAS sample 
(170). Finally, Cnot1 is significantly associated with Schizophrenia in several GWAS 
datasets (170). Paring this information with the functional overrepresentation results, it 
appears that this module contains genes that are part of the same functional pathways that 
moderate drinking behavior in a post-transcriptional or post-translational fashion that cannot 
be detected by RNA-level analyses. Given the overrepresentation of several functions 
involving regulation of proteins at the protein level (ligase activity, ubiquitination, mRNA 
modification (which could affect translation)), this module may regulate protein abundance 
or function in an ethanol-associated manner without affecting mRNA levels, which were 
measured in our expression analyses. Considering that many of the functionally 
overrepresented groups that did not contain hub genes were associated with neuronal 
signaling, synaptic processes, axon guidance, and development, these changes in protein 
activity likely affect short-term neuronal signaling changes and longer-term synaptic 
remodeling in the PFC, in response to alcohol. Sensitivity to these changes could be 
determined by genetic variants in the hub genes (affecting the network as a whole) or even in 
the ancillary genes (affecting one particular mechanism’s response to change in hub gene 
activity).   
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Light Green’s highly significant functional overrepresentation results revealed that its 
constituent genes are largely involved in ubiquitination and neurite growth. The hub genes 
for this module (Cacna1b (calcium channel, voltage-dependent, N type, alpha 1B subunit), 
Cdc42bpb (CDC42 binding protein kinase beta), Farp1 (FERM, RhoGEF (Arhgef) and 
pleckstrin domain protein 1 (chondrocyte-derived)), Tnrc6c (trinucleotide repeat containing 
6C), and Sugp2 (SURP and G patch domain containing 2)) are not contained in the 
significant functional overrepresentation groups. Not much is known about the function of 
Sugp2, however the remaining four hub genes take part in well-characterized mechanisms 
that are highly relevant to ethanol-mediated changes in gene expression and neuroplasticity. 
Cdc42bpb regulates actin reorganization in the cytoskeleton, a process that is thought to be 
involved in synaptic plasticity (297, 298). Tnrc6c is involved in miRNA-moderated gene 
silencing (299). As its name suggests, Cacna1b encodes a subunit of voltage-gated calcium 
channels, which play an important role in synaptic transmission (300). Finally, Farp1 is a 
guanine nucleotide exchange factor, and plays an important role in dendritic growth during 
motor neuron development (301). Accordingly, Farp1 and Cacna1b both appeared in highly 
significant functional overrepresentation groups related to localization at synapses, in 
dendrites, and in the somatodendritic compartment. Although these genes have highly 
relevant functions, their expression levels were not associated with ethanol drinking traits or 
significantly differentially expressed genes between high drinkers and controls. However, in 
addition to its hub genes’ relevant functionality, this module is significantly overrepresented 
with GSCAN GWAS-significant genes for alcohol consumption, and multiple human 
GWASs have revealed significant associations between several of its hub genes and 
substance use-relate and psychiatric traits. These associations include: Cacna1b with 
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decrease in Schizophrenia symptoms in response to paliperidone; Cdc42bpb with depression 
and smoking status; Tnrc6c with psychosis in Alzheimer’s patients; and Farp1 with 
migraines, brain structure, neuroticism, cognitive function, risk-taking behavior, response to 
d-amphetamines, and Alzheimer’s related phenotypes (170). Much like Blue, the levels and 
activity of proteins encoded by the genes in this module are likely ethanol-responsive at a 
post-transcriptional level. As stated above, hub gene Tnrc6c is involved in miRNA gene 
silencing. This process does not reduce mRNA levels, but it prevents mRNA molecules from 
being translated into proteins, thereby affecting protein levels. Furthermore, this module is 
overrepresented with genes related to ubiquitination, a post-translational level of control over 
protein abundance that would also not be detected by RNAseq. The modulation of proteins 
encoded by genes in this module likely affects synaptic transmission (due to their localization 
in myelin and involvement in voltage-gated Ca2+ signaling) and synaptic remodeling (due to 
their involvement in neuronal development and cytoskeletal remodeling).     
Dark Turquoise was highly significantly overrepresented with genes associated with 
phosphatase activity, cell-cell adhesion, and medullablastomas. This module had two hub 
genes: Baiap2 (brain-specific angiogenesis inhibitor 1-associated protein 2) and Samd4b 
(sterile alpha motif domain containing 4B). Neither of these genes was present in the highly 
significant functional groups for this module. Samd4b is a transcriptional regulator of 
multiple apoptotic proteins, including p53, which targets Baiap2 (302, 303). Baiap2 mediates 
neurite growth via the reorganization of cytoskeletal actin, and has shown association with 
memory, neuroticism, and depressive symptoms in human GWASs (170, 303, 304). Like the 
module’s Eigen Gene, these two genes’ expression levels were neither different between high 
drinkers and controls, nor correlated with ethanol consumption or preference. However, like 
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Blue and Light Green, the Eigen Gene’s eQTL overlapped with the Chr16 bQTL for Last 
Week Mean Total Ethanol Preference. Given its overrepresentation of phosphatase activity, 
Dark Turquoise is yet another example of a module potentially exhibiting ethanol-affected 
post-transcriptional regulation of proteins. Because genes that encode apoptotic proteins are 
not seen in this module, it is possible that Samd4b down-regulated these proteins (rendering 
them undetectable) in the PFC in response to ethanol, allowing Baiap2 to mediate rerouting 
of neuronal pathways in response to long-term ethanol exposure, relatively unhindered.  
Pale Turquoise is highly significantly overrepresented with genes in the following 
functional categories: location in abaxonal myelin sheath; NOTCH and Wnt signaling; 
abdominal wall herniation; and craniorachischisis (a severe neural tube defect). The hub gene 
of this module, Atxn2l (ataxin 2-like), is associated with intelligence and cognitive ability, as 
evidenced by several GWASs, but its function is not well understood (170). This gene is not 
significantly associated with ethanol consumption or preference, or significantly 
differentially expressed between high drinkers and controls in our sample. However, like 
Blue and Light Green, its Eigen Gene’s eQTL overlapped with the Chr1 bQTL for Last Week 
Mean and Whole Study Total Ethanol Consumption. It is also not present in the highly 
significantly overrepresentation functional groups for this module. However, this is due to 
the fact that the function of this gene is unknown. Regarding the functional 
overrepresentation groups for this module as a whole, NOTCH and Wnt signaling involve 
communicating signaling cascades that mediate neurogenesis (305). Given that several genes 
in this module are associated with NOTCH signaling, as evidenced by the functional 
overrepresentation results (Table 3f), we believe that this module, and the gene Atxn2l, are 
likely involved in the process of generating novel neuronal connections, which would help 
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explain Atxn2l’s association with intelligence and cognitive ability in GWASs.  This 
module’s overlap with the Chr16 bQTL for ethanol preference and its overrepresentation for 
Notch and Wnt signaling pathways, and the prior associations found between its hub gene 
and cognition and intelligence, we believe that this module is involved in the development of 
novel neuronal connections (i.e. neurite outgrowth and the formation of new synapses) in 
response to long-term ethanol use. This relationship is likely mediated by a gene’s or 
protein’s sensitivity to ethanol due to allelic differences; or, like many of the other modules 
discussed here, post-trascriptional or post-translational regulation processes (that cannot be 
detected by examining RNA levels) resulting in protein-level changes.  
Overall, this study was the first to our knowledge to characterize gene expression 
networks in the prefrontal cortex of Diversity Outbred mice, in the context of voluntary 
ethanol consumption under an intermittent access paradigm. Our gene expression analysis 
may have been limited by the alignment of RNAseq reads to a standard, inbred reference 
genome for a population of mice whose genomes contain several millions of variants that 
differ from this genome. This could have caused the measured expression levels of genome 
segments carrying many variants to be biased towards mice in which that segment was 
inherited from the C57BL/6J progenitor strain. This could have potentially led to the 
identification of false QTL for the expression of these genes, due to C57 haplotypes 
appearing to confer higher expression values (171). Future analyses in our laboratory will 
include the alignment of reads to a reference genome containing inserted SNPs unique to 
each mouse, based on each individual’s genotype. Genotypes can be determined via the data 
collected from genotyping arrays described in the last chapter, or from rudimentary 
alignments to the C57BL/6J genome, allowing large mismatches purely for the sake of 
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genotyping. These programs estimate the contributing founder haplotype for each fragment 
by using Hidden Markov Models to determine the probability that a given read came from 
each of several likely regions of the genome from each possible founder strain (268) (171). 
However, these programs are currently not yet suitable for easy application by the public. 
Nonetheless, we were able to identify several networks of genes whose overall expression 
levels were correlated with ethanol consumption. As expected, some of these networks were 
overrepresented with genes that were differentially expressed between high drinking mice 
and controls (indicating that their expression levels were regulated by ethanol), and others 
were not (indicating that their expression levels moderate drinking behavior). Interestingly, 
the Blue module, which we believe to moderate drinking behaviors, was overrepresented 
with neuronal signaling involving glutamate, calcium, hormones, and neuronal growth factor, 
in addition to pathways involved in neuroplasticity. This was the only discussed module with 
such overrepresentation, and was also the only discussed module that was believed to be 
ethanol-regulating. The remaining modules were either ethanol-regulated (Turquoise and 
Brown) or were associated with ethanol via variant associations as opposed to RNA levels 
(Light Green, Dark Turquoise, and Pale Turquoise), and were largely overrepresented with 
pathways involved in protein regulation, cell cycle regulation, and neuroplasticity.  
Our study was limited by the inability to collect longitudinal expression data with 
respect to ethanol exposure duration, rendering us unable to make definitive causal 
inferences regarding the relationship between ethanol consumption and gene expression. This 
was due to the need for collecting behavioral data related to long-term drinking on enough 
mice to have enough power to detect QTL for these behaviors, and could therefore not spare 
any animals to collect brain tissue during the early stages of ethanol exposure. Future studies 
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should examine the networks we identified on a longitudinal basis with respect to ethanol 
exposure, in order to determine whether the constituent genes are truly regulated by ethanol 
consumption, regulating ethanol consumption, or both. They can do so by manipulating the 
expression of the genes in these networks (particularly the hub genes) and measuring its 
effects on drinking behaviors compared to controls, and examining pre- and post-ethanol-
exposure expression levels of the genes in the prefrontal cortex, in subsamples of mice from 
each group, at different time points with respect to experimental duration. Subsequent studies 
can then explore the exact molecular mechanisms through which these genes are associated 
with ethanol.  
Additionally, this study largely focuses on the assumption that genetic associations 
are mediated by gene expression changes where eQTL overlap with bQTL or GWAS loci. 
However, it could be that the sensitivity of gene expression to the presence of ethanol is 
moderated by genotype. It could also be that the relationship between that specific bQTL and 
network is independent of their associations with drinking behaviors. Future studies should 
examine these relationships in a causal manner, in order to determine the nature of the 
associations. Such studies could examine the effects of candidate SNPs on basal gene 
expression and gene expression changes in response to ethanol exposure. They could also 
investigate the effects of candidate SNPs on drinking behaviors when their effects on 
candidate network expression are prevented or reversed (i.e. when the potential mediator is 
blocked).  
Given our results, we hypothesize that gene expression networks that are not affected 
by alcohol but whose basal expression levels affect drinking behaviors are affiliated with the 
early stages of dependence development (initial consumption to tolerance development), in 
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which neurotransmitter levels (such as glutamate) are perturbed. The sensitivity of these 
systems determines the extent to which receptors are subsequently up- or down-regulated in 
response to ethanol-induced over- or under-stimulation. Contrastingly, networks of genes 
whose expression or protein levels are regulated by, or sensitive to, ethanol may be 
responsible for the neuroplastic changes involved in the development of withdrawal and 
possibly craving. In sum, this study has identified several functionally relevant groups of 
genes that are associated with ethanol consumption, and are likely involved in the various 
stages of AD development. Upon further investigation, these networks will likely reveal 
specific targetable genes for pharmacotherapeutic treatment of alcohol dependence. 
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Category Name p,value
q,value1
FDR1B&H
Hit1Count1in1
Query1List
Hit1Count1
in1Genome
GO:1Biological1Process cation1transmembrane1transport 4.19E,13 2.15E,09 60 738
GO:1Biological1Process metal1ion1transport 2.63E,12 6.74E,09 64 855
GO:1Biological1Process inorganic1cation1transmembrane1transport 8.07E,12 1.38E,08 54 667
GO:1Biological1Process monovalent1inorganic1cation1transport 1.50E,11 1.92E,08 51 617
GO:1Biological1Process inorganic1ion1transmembrane1transport 3.13E,11 3.21E,08 57 754
GO:1Biological1Process potassium1ion1transport 3.03E,10 2.59E,07 27 222
GO:1Biological1Process regulation1of1ion1transport 2.39E,09 1.75E,06 49 669
GO:1Biological1Process synaptic1signaling 1.57E,08 9.21E,06 48 687
GO:1Biological1Process regulation1of1ion1transmembrane1transport 1.62E,08 9.21E,06 37 455
GO:1Biological1Process chemical1synaptic1transmission 2.85E,08 1.22E,05 47 678
GO:1Cellular1Component synapse 1.17E,14 6.70E,12 69 870
GO:1Cellular1Component synapse1part 5.03E,11 1.16E,08 54 708
GO:1Cellular1Component axon 6.07E,11 1.16E,08 47 567
GO:1Cellular1Component transmembrane1transporter1complex 3.50E,10 5.02E,08 33 327
GO:1Cellular1Component transporter1complex 5.60E,10 6.44E,08 33 333
GO:1Cellular1Component cation1channel1complex 1.24E,09 1.00E,07 23 176
GO:1Cellular1Component ion1channel1complex 1.35E,09 1.00E,07 30 291
GO:1Cellular1Component axon1part 1.40E,09 1.00E,07 31 309
GO:1Cellular1Component somatodendritic1compartment 1.01E,08 6.43E,07 56 867
GO:1Cellular1Component main1axon 1.91E,08 1.10E,06 14 74
GO:1Molecular1Function cation1channel1activity 8.48E,13 1.02E,09 36 306
GO:1Molecular1Function channel1activity 6.92E,12 2.61E,09 44 470
GO:1Molecular1Function passive1transmembrane1transporter1activity 7.44E,12 2.61E,09 44 471
GO:1Molecular1Function gated1channel1activity 8.67E,12 2.61E,09 36 331
GO:1Molecular1Function ion1channel1activity 1.34E,11 3.23E,09 41 424
GO:1Molecular1Function inorganic1cation1transmembrane1transporter1activity 1.91E,11 3.40E,09 47 542
GO:1Molecular1Function cation1transmembrane1transporter1activity 1.98E,11 3.40E,09 52 642
GO:1Molecular1Function substrate,specific1channel1activity 3.73E,11 5.61E,09 41 438
GO:1Molecular1Function metal1ion1transmembrane1transporter1activity 5.94E,11 7.93E,09 40 426
GO:1Molecular1Function ion1transmembrane1transporter1activity 1.50E,10 1.80E,08 61 873
Pathway Neuronal1System 1.12E,11 2.04E,08 37 351
Pathway Calcium1signaling1pathway 7.95E,08 7.27E,05 21 182
Pathway Muscle1contraction 5.54E,07 3.38E,04 21 204
Pathway Cardiac1conduction 8.26E,07 3.78E,04 17 142
Pathway Alpha1adrenergic1receptor1signaling1pathway 1.41E,06 5.15E,04 7 21
Pathway Voltage1gated1Potassium1channels 4.05E,06 1.24E,03 9 44
Pathway Insulin1secretion 6.27E,06 1.50E,03 12 85
Pathway Potassium1Channels 6.57E,06 1.50E,03 13 100
Pathway Transmission1across1Chemical1Synapses 2.18E,05 4.43E,03 19 218
Pathway Ion1homeostasis 3.18E,05 5.82E,03 9 56
Table 2a: Top Functional Overrepresentation Groups for Genes with Significant Differential Expression 
Only 
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Category Name p.value
q.value1FDR1
B.H
Hit.Count1in1
Query1List
Hit1Count1In1
Genome
GO:1Biological1Process citrate1metabolic1process 1.53EG08 8.08EG05 10 33
GO:1Biological1Process cellular1respiration 3.37EG08 8.89EG05 21 178
GO:1Biological1Process tricarboxylic1acid1cycle 6.47EG08 9.09EG05 9 29
GO:1Biological1Process tricarboxylic1acid1metabolic1process 6.89EG08 9.09EG05 10 38
GO:1Biological1Process neuron1projection1development 1.70EG07 0.0001792 56 953
GO:1Biological1Process generation1of1precursor1metabolites1and1energy 2.88EG07 0.0002529 31 393
GO:1Biological1Process developmental1growth1involved1in1morphogenesis 4.13EG07 0.000311 23 242
GO:1Biological1Process energy1derivation1by1oxidation1of1organic1compounds 6.34EG07 0.0004179 25 286
GO:1Biological1Process extracellular1matrix1organization 1.03EG06 0.000574 28 354
GO:1Biological1Process extracellular1structure1organization 1.09EG06 0.000574 28 355
GO:1Cellular1Component myelin1sheath 2.55EG18 1.43EG15 35 202
GO:1Cellular1Component inner1mitochondrial1membrane1protein1complex 1.15EG08 3.21EG06 17 112
GO:1Cellular1Component mitochondrial1protein1complex 1.60EG07 2.98EG05 18 149
GO:1Cellular1Component mitochondrial1membrane1part 2.98EG07 4.16EG05 20 189
GO:1Cellular1Component mitochondrial1part 5.76EG07 6.43EG05 55 987
GO:1Cellular1Component mitochondrial1inner1membrane 5.12EG06 0.0004757 33 507
GO:1Cellular1Component extracellular1matrix 6.66EG06 0.0005308 30 444
GO:1Cellular1Component oxidoreductase1complex 1.46EG05 0.001016 12 97
GO:1Cellular1Component mitochondrial1envelope 1.70EG05 0.001055 41 736
GO:1Cellular1Component mitochondrial1membrane 2.26EG05 0.001259 39 694
GO:1Molecular1Function active1transmembrane1transporter1activity 1.27EG08 1.36EG05 32 363
GO:1Molecular1Function active1ion1transmembrane1transporter1activity 2.33EG08 1.36EG05 21 175
GO:1Molecular1Function anion1transmembrane1transporter1activity 1.18EG06 0.0004599 25 297
GO:1Molecular1Function ion1transmembrane1transporter1activity 3.43EG06 0.0009481 49 873
GO:1Molecular1Function glycosaminoglycan1binding 4.07EG06 0.0009481 20 219
GO:1Molecular1Function collagen1binding 5.04EG06 0.0009785 11 72
GO:1Molecular1Function amino1acid1transmembrane1transporter1activity 1.43EG05 0.00201 11 80
GO:1Molecular1Function pyruvate1dehydrogenase1(NAD+)1activity 2.03EG05 0.00201 4 7
GO:1Molecular1Function pyruvate1dehydrogenase1activity 2.03EG05 0.00201 4 7
GO:1Molecular1Function pyruvate1dehydrogenase1[NAD(P)+]1activity 2.03EG05 0.00201 4 7
Pathway The1citric1acid1(TCA)1cycle1and1respiratory1electron1transport 1.44EG09 2.70EG06 23 171
Pathway Parkinson's1disease 7.75EG09 7.27EG06 20 142
Pathway Mitochondrial1Electron1Transport1Chain 1.99EG08 1.24EG05 8 18
Pathway Alzheimer's1disease 3.87EG08 1.82EG05 21 171
Pathway Citrate1cycle1(TCA1cycle) 1.42EG07 5.31EG05 9 30
Pathway Hypoacetylaspartia 4.81EG07 0.0001507 7 18
Pathway superpathway1of1conversion1of1glucose1to1acetyl1CoA1and1entry1into1the1TCA1cycle 7.94EG07 0.000213 9 36
Pathway Respiratory1electron1transport,1ATP1synthesis1by1chemiosmotic1coupling,1and1heat1
production1by1uncoupling1proteins.
1.05EG06 0.0002453 16 126
Pathway Huntington's1disease 1.31EG06 0.0002725 20 193
Pathway pyruvate1metabolic 1.94EG06 0.000364 8 30
Table 2b: Top Functional Overrepresentation Groups for Genes with Significant Differential Expression 
and Covariance with Ethanol Consumption 
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Table 2c: Top Functional Overrepresentation Groups for Ethanol-Correlated Only Genes 
Top highly significant (q < 0.1) functional overrepresentation groups from TopFunn ontological analysis, for genes that were 
significant in DEseq2 high drinker v. control analysis only (a), significant in both DEseq2 analysis and in regression testing for 
covariance with ethanol consumption (b), and significant only in regression testing (c). Category and Name columns represent 
the functional categories selected in TopFunn and the name of the exact function or related biological entity for which the 
module was overrepresented, respectively.  Hit Count in Query List indicates the number of genes in the module that were 
identified in the group of total genes, the size of which is indicated by Hit Count in Genome.  
Category Name p,value
q,value1
FDR1B&H
Hit1Count1in1
Query1List
Hit1Count1
in1Genome
GO:1Biological1Process cellular1macromolecule1catabolic1process 4.64E,30 4.22E,26 419 977
GO:1Biological1Process proteolysis1involved1in1cellular1protein1catabolic1process 3.50E,25 1.59E,21 297 662
GO:1Biological1Process cellular1protein1catabolic1process 9.01E,25 2.73E,21 307 694
GO:1Biological1Process proteasomal1protein1catabolic1process 1.81E,24 4.11E,21 209 422
GO:1Biological1Process modification,dependent1macromolecule1catabolic1process 3.58E,23 6.51E,20 272 606
GO:1Biological1Process modification,dependent1protein1catabolic1process 9.95E,23 1.51E,19 268 598
GO:1Biological1Process proteasome,mediated1ubiquitin,dependent1protein1catabolic1process 1.39E,22 1.81E,19 194 393
GO:1Biological1Process ubiquitin,dependent1protein1catabolic1process 2.76E,22 3.14E,19 264 590
GO:1Biological1Process ribonucleoprotein1complex1biogenesis 1.39E,21 1.41E,18 219 468
GO:1Biological1Process RNA1processing 1.08E,20 9.86E,18 368 913
GO:1Cellular1Component ribonucleoprotein1complex 3.25E,31 3.82E,28 338 745
GO:1Cellular1Component nucleolus 5.14E,24 3.02E,21 367 891
GO:1Cellular1Component mitochondrial1part 2.97E,21 1.16E,18 389 987
GO:1Cellular1Component transferase1complex 1.93E,20 5.67E,18 300 722
GO:1Cellular1Component mitochondrial1envelope 6.60E,17 1.55E,14 293 736
GO:1Cellular1Component proteasome1complex 1.64E,15 3.21E,13 54 78
GO:1Cellular1Component mitochondrial1membrane 8.55E,15 1.44E,12 272 694
GO:1Cellular1Component ribosome 1.27E,14 1.86E,12 116 235
GO:1Cellular1Component ubiquitin1ligase1complex 4.14E,14 5.41E,12 129 274
GO:1Cellular1Component Golgi1membrane 5.65E,14 6.64E,12 276 716
GO:1Molecular1Function ubiquitin1protein1ligase1activity 4.77E,14 1.21E,10 107 212
GO:1Molecular1Function ubiquitin,like1protein1ligase1activity 1.20E,13 1.52E,10 108 217
GO:1Molecular1Function ubiquitin,protein1transferase1activity 1.84E,11 1.55E,08 171 414
GO:1Molecular1Function GDP1binding 3.21E,11 1.79E,08 40 59
GO:1Molecular1Function ubiquitin,like1protein1transferase1activity 3.54E,11 1.79E,08 179 441
GO:1Molecular1Function GTPase1activity 9.14E,11 3.85E,08 108 236
GO:1Molecular1Function hydrolase1activity,1acting1on1acid1anhydrides,1in1phosphorus,containing1anhydrides 1.28E,10 4.37E,08 300 829
GO:1Molecular1Function hydrolase1activity,1acting1on1acid1anhydrides 1.49E,10 4.37E,08 300 830
GO:1Molecular1Function nucleoside,triphosphatase1activity 1.55E,10 4.37E,08 286 785
GO:1Molecular1Function pyrophosphatase1activity 2.51E,10 6.36E,08 298 827
Pathway Infectious1disease 9.43E,20 2.97E,16 184 393
Pathway Membrane1Trafficking 1.66E,18 2.61E,15 256 614
Pathway Vesicle,mediated1transport 1.36E,16 1.43E,13 265 660
Pathway Antigen1processing:1Ubiquitination1&1Proteasome1degradation 2.00E,16 1.58E,13 148 314
Pathway Cell1Cycle 2.88E,15 1.81E,12 249 624
Pathway Oxygen,dependent1proline1hydroxylation1of1Hypoxia,inducible1Factor1Alpha 4.85E,15 2.40E,12 49 69
Pathway HIV1Infection 5.34E,15 2.40E,12 118 240
Pathway Processing1of1Capped1Intron,Containing1Pre,mRNA 1.38E,14 5.44E,12 120 248
Pathway mRNA1Splicing1,1Major1Pathway 3.23E,14 1.04E,11 97 188
Pathway mRNA1Splicing 3.29E,14 1.04E,11 100 196
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Category Name p-value q-value FDR B&H
Hit Count in 
Query List
Hit Count 
in Genome
GO: Molecular Function ubiquitin-like protein transferase activity 1.11E-12 2.36E-09 131 441
GO: Molecular Function ubiquitin-protein transferase activity 2.41E-12 2.55E-09 124 414
GO: Molecular Function GDP binding 1.74E-10 1.23E-07 31 59
GO: Molecular Function ubiquitin-like protein ligase activity 5.03E-09 2.66E-06 70 217
GO: Molecular Function ubiquitin protein ligase activity 2.64E-08 1.12E-05 67 212
GO: Molecular Function ubiquitin-like protein ligase binding 9.59E-07 3.20E-04 77 277
GO: Molecular Function ubiquitin protein ligase binding 1.06E-06 3.20E-04 76 273
GO: Molecular Function hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides 4.76E-06 1.21E-03 184 829
GO: Molecular Function hydrolase activity, acting on acid anhydrides 5.14E-06 1.21E-03 184 830
GO: Molecular Function pyrophosphatase activity 6.14E-06 1.30E-03 183 827
GO: Molecular Function ubiquitin-like protein binding 6.99E-06 1.35E-03 41 127
GO: Molecular Function ubiquitin-like protein conjugating enzyme activity 1.08E-05 1.91E-03 16 32
GO: Molecular Function ligase activity 1.58E-05 2.57E-03 101 415
GO: Molecular Function ubiquitin conjugating enzyme activity 3.37E-05 5.09E-03 15 31
GO: Molecular Function nucleoside-triphosphatase activity 4.56E-05 6.43E-03 170 785
GO: Molecular Function ligase activity, forming carbon-nitrogen bonds 5.83E-05 7.11E-03 74 293
GO: Molecular Function ribonucleoprotein complex binding 5.88E-05 7.11E-03 37 120
GO: Molecular Function RNA-dependent ATPase activity 6.62E-05 7.11E-03 24 66
GO: Molecular Function ATP-dependent RNA helicase activity 6.62E-05 7.11E-03 24 66
GO: Molecular Function GTPase activity 6.72E-05 7.11E-03 62 236
GO: Biological Process protein modification by small protein conjugation 8.75E-20 7.12E-16 254 903
GO: Biological Process protein ubiquitination 4.57E-16 1.86E-12 216 781
GO: Biological Process RNA processing 3.95E-14 1.07E-10 237 913
GO: Biological Process modification-dependent macromolecule catabolic process 3.78E-13 7.50E-10 169 606
GO: Biological Process modification-dependent protein catabolic process 4.61E-13 7.50E-10 167 598
GO: Biological Process ubiquitin-dependent protein catabolic process 5.61E-13 7.61E-10 165 590
GO: Biological Process proteolysis involved in cellular protein catabolic process 7.46E-13 8.67E-10 180 662
GO: Biological Process protein polyubiquitination 8.68E-13 8.82E-10 88 254
GO: Biological Process cellular protein-containing complex assembly 1.33E-12 1.20E-09 247 991
GO: Biological Process cellular protein catabolic process 2.41E-12 1.96E-09 185 694
GO: Biological Process mRNA processing 4.53E-12 3.35E-09 138 479
GO: Biological Process proteasomal protein catabolic process 1.33E-10 8.98E-08 121 422
GO: Biological Process protein catabolic process 1.46E-10 9.14E-08 209 844
GO: Biological Process RNA splicing 2.09E-10 1.15E-07 116 402
GO: Biological Process proteasome-mediated ubiquitin-dependent protein catabolic process 2.11E-10 1.15E-07 114 393
GO: Biological Process RNA splicing, via transesterification reactions 2.36E-10 1.20E-07 95 309
GO: Biological Process mitotic cell cycle process 5.23E-10 2.50E-07 224 931
GO: Biological Process mRNA splicing, via spliceosome 1.34E-09 5.75E-07 92 305
GO: Biological Process RNA splicing, via transesterification reactions with bulged adenosine as nucleophile 1.34E-09 5.75E-07 92 305
GO: Biological Process ribonucleoprotein complex biogenesis 8.13E-09 3.31E-06 125 468
GO: Cellular Component transferase complex 2.51E-20 2.61E-17 213 722
GO: Cellular Component nucleolus 1.57E-15 8.17E-13 234 891
GO: Cellular Component nucleoplasm part 3.17E-11 1.10E-08 186 732
GO: Cellular Component ubiquitin ligase complex 1.93E-10 5.02E-08 86 274
GO: Cellular Component Golgi membrane 1.73E-09 3.60E-07 176 716
GO: Cellular Component mitochondrial matrix 4.71E-09 8.18E-07 115 425
GO: Cellular Component mitochondrial part 7.40E-09 1.02E-06 226 987
GO: Cellular Component ribonucleoprotein complex 7.81E-09 1.02E-06 179 745
GO: Cellular Component Golgi apparatus part 1.67E-08 1.93E-06 213 928
GO: Cellular Component nuclear body 2.06E-08 2.15E-06 100 364
GO: Cellular Component vacuolar membrane 1.18E-07 1.11E-05 144 593
GO: Cellular Component endoplasmic reticulum membrane 3.13E-07 2.72E-05 219 994
GO: Cellular Component cullin-RING ubiquitin ligase complex 3.67E-07 2.94E-05 50 154
GO: Cellular Component microbody 4.33E-07 3.01E-05 47 142
GO: Cellular Component peroxisome 4.33E-07 3.01E-05 47 142
GO: Cellular Component transport vesicle 6.34E-07 4.13E-05 97 374
GO: Cellular Component serine/threonine protein kinase complex 1.23E-06 7.54E-05 31 81
GO: Cellular Component transferase complex, transferring phosphorus-containing groups 2.08E-06 1.21E-04 68 244
GO: Cellular Component endosomal part 2.33E-06 1.28E-04 107 434
GO: Cellular Component vacuolar part 3.43E-06 1.79E-04 158 700
Table 3a: Top Turquoise Functional Overrepresentation Groups 
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Human Phenotype Generalized hypotonia 1.09E-09 5.59E-06 188 808
Human Phenotype Microcephaly 5.35E-09 9.15E-06 191 839
Human Phenotype Decreased head circumference 5.35E-09 9.15E-06 191 839
Human Phenotype Delayed speech and language development 1.07E-07 1.37E-04 104 407
Human Phenotype Nystagmus 2.27E-07 2.00E-04 179 811
Human Phenotype Abnormality of the cerebral white matter 2.36E-07 2.00E-04 133 563
Human Phenotype Abnormal involuntary eye movements 2.73E-07 2.00E-04 181 824
Human Phenotype Neurological speech impairment 8.20E-07 5.16E-04 177 814
Human Phenotype Aplasia/Hypoplasia of the corpus callosum 1.15E-06 5.16E-04 112 467
Human Phenotype Strabismus 1.20E-06 5.16E-04 157 708
Human Phenotype Spasticity 1.21E-06 5.16E-04 185 863
Human Phenotype Hypertonia 1.21E-06 5.16E-04 185 863
Human Phenotype Abnormal corpus callosum morphology 1.50E-06 5.93E-04 115 485
Human Phenotype Abnormality of the cerebral subcortex 2.39E-06 8.75E-04 143 639
Human Phenotype Abnormal conjugate eye movement 1.09E-05 3.72E-03 157 733
Human Phenotype Feeding difficulties 1.33E-05 4.26E-03 137 625
Human Phenotype Intellectual disability, severe 2.69E-05 7.89E-03 66 258
Human Phenotype Abnormal location of ears 2.77E-05 7.89E-03 121 546
Human Phenotype Open mouth 3.51E-05 9.48E-03 31 95
Human Phenotype Motor delay 4.00E-05 1.03E-02 89 379
Mouse Phenotype embryonic lethality prior to organogenesis 1.81E-13 1.24E-09 219 792
Mouse Phenotype embryonic lethality prior to tooth bud stage 1.64E-12 5.62E-09 236 887
Mouse Phenotype embryonic lethality between implantation and placentation 1.31E-07 2.99E-04 122 447
Mouse Phenotype abnormal myocardial fiber physiology 1.43E-05 2.45E-02 53 172
Mouse Phenotype embryonic growth retardation 2.69E-05 3.68E-02 152 639
Mouse Phenotype prenatal growth retardation 5.07E-05 5.79E-02 170 736
Mouse Phenotype abnormal learning/memory/conditioning 7.41E-05 6.86E-02 156 671
Mouse Phenotype abnormal cognition 8.02E-05 6.86E-02 156 672
Mouse Phenotype abnormal cell cycle 1.31E-04 9.99E-02 85 332
Pathway Membrane Trafficking 2.27E-10 6.61E-07 157 614
Pathway Antigen processing: Ubiquitination & Proteasome degradation 5.31E-10 7.75E-07 93 314
Pathway Ubiquitin mediated proteolysis 3.34E-09 3.25E-06 50 137
Pathway Class I MHC mediated antigen processing & presentation 7.20E-09 5.25E-06 103 376
Pathway Cell Cycle 9.01E-09 5.26E-06 153 624
Pathway Vesicle-mediated transport 1.66E-08 8.07E-06 159 660
Pathway Processing of Capped Intron-Containing Pre-mRNA 2.21E-08 9.21E-06 74 248
Pathway mRNA Splicing 1.75E-07 6.40E-05 60 196
Pathway S Phase 2.07E-07 6.70E-05 45 132
Pathway Cell Cycle, Mitotic 2.77E-07 8.08E-05 126 517
Pathway mRNA Splicing - Major Pathway 5.04E-07 1.34E-04 57 188
Pathway Processing and activation of SUMO 5.64E-07 1.36E-04 9 10
Pathway Mitotic G1-G1/S phases 6.05E-07 1.36E-04 47 145
Pathway Mitotic Anaphase 7.35E-07 1.53E-04 55 181
Pathway Mitotic Metaphase and Anaphase 8.93E-07 1.74E-04 55 182
Pathway Separation of Sister Chromatids 1.17E-06 2.14E-04 52 170
Pathway Retrograde transport at the Trans-Golgi-Network 1.58E-06 2.71E-04 22 49
Pathway GABA A receptor activation 1.87E-06 3.03E-04 10 13
Pathway Organelle biogenesis and maintenance 2.86E-06 4.39E-04 87 341
Pathway RNA transport 3.37E-06 4.92E-04 51 171
Disease Muscle hypotonia 9.55E-09 3.86E-05 134 575
Disease Global developmental delay 9.79E-09 3.86E-05 167 757
Disease Epilepsy 2.85E-08 7.48E-05 201 962
Disease Mental Retardation 6.25E-08 1.23E-04 186 885
Disease Poor school performance 6.22E-07 6.99E-04 140 649
Disease Low intelligence 6.22E-07 6.99E-04 140 649
Disease Dull intelligence 6.22E-07 6.99E-04 140 649
Disease Mental deficiency 7.46E-07 7.34E-04 140 651
Disease Hyperreflexia 1.18E-06 1.04E-03 57 209
Disease Cognitive delay 2.62E-06 1.77E-03 131 614
Disease Mental and motor retardation 2.62E-06 1.77E-03 131 614
Disease Mental Retardation, X-Linked 2.69E-06 1.77E-03 35 109
Disease Leigh Disease 9.63E-06 5.83E-03 30 92
Disease Dysarthria 1.76E-05 9.92E-03 51 196
Disease Acidosis, Lactic 1.95E-05 1.03E-02 40 142
Disease Action Tremor 2.71E-05 1.28E-02 14 30
Disease Muscle Spasticity 2.76E-05 1.28E-02 61 251
Disease Drooling 3.47E-05 1.52E-02 13 27
Disease Widely spaced teeth 4.27E-05 1.77E-02 14 31
Disease Small head 4.64E-05 1.83E-02 83 375
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Category Name p,value
q,value1
FDR1B&H
Hit1Count1in1
Query1List
Hit1Count1
in1Genome
GO:1Biological1Process response1to1UV 8.09E,06 3.15E,02 14 140
GO:1Biological1Process activation1of1cysteine,type1endopeptidase1activity1involved1in1apoptotic1
process1by1cytochrome1c
2.22E,05 4.32E,02 4 8
GO:1Biological1Process UV,damage1excision1repair 6.40E,05 6.58E,02 4 10
GO:1Biological1Process DNA1repair 6.76E,05 6.58E,02 28 516
GO:1Biological1Process DNA1recombination 9.86E,05 7.68E,02 18 267
GO:1Cellular1Component transferase1complex 5.93E,05 2.74E,02 35 722
GO:1Cellular1Component INO80,type1complex 1.11E,04 2.74E,02 5 21
GO:1Cellular1Component Ino801complex 2.63E,04 4.31E,02 4 14
GO:1Cellular1Component DNA1helicase1complex 3.52E,04 4.33E,02 4 15
GO:1Cellular1Component ubiquitin1ligase1complex 9.33E,04 9.18E,02 16 274
Human1Phenotype Increased1sensitivity1to1ionizing1radiation 1.29E,06 3.31E,03 8 32
Human1Phenotype Abnormality1of1DNA1repair 2.14E,06 3.31E,03 8 34
Human1Phenotype Abnormality1of1the1cell1cycle 7.90E,06 8.16E,03 8 40
Human1Phenotype Multiple1cutaneous1malignancies 3.15E,05 1.95E,02 4 8
Human1Phenotype Flat1nasal1alae 3.15E,05 1.95E,02 4 8
Human1Phenotype Abnormality1of1chromosome1stability 5.11E,05 2.36E,02 8 51
Human1Phenotype Severe1photosensitivity 6.07E,05 2.36E,02 5 17
Human1Phenotype Poikiloderma 6.09E,05 2.36E,02 6 27
Human1Phenotype Microcephaly 8.76E,05 2.71E,02 40 839
Human1Phenotype Decreased1head1circumference 8.76E,05 2.71E,02 40 839
Human1Phenotype Skeletal1muscle1atrophy 1.36E,04 3.82E,02 27 483
Human1Phenotype Intellectual1disability,1progressive 1.48E,04 3.82E,02 13 149
Human1Phenotype Conjunctival1telangiectasia 2.90E,04 6.42E,02 5 23
Human1Phenotype Ankyloblepharon 2.90E,04 6.42E,02 4 13
Human1Phenotype Abnormal1vasculature1of1the1conjunctiva1morphology 4.39E,04 8.67E,02 5 25
Human1Phenotype Complement1deficiency 4.48E,04 8.67E,02 8 69
Pathway Global1Genome1Nucleotide1Excision1Repair1(GG,NER) 4.35E,07 4.91E,04 12 85
Pathway Cytochrome1c,mediated1apoptotic1response 1.27E,06 4.91E,04 4 5
Pathway Activation1of1caspases1through1apoptosome,mediated1cleavage 1.27E,06 4.91E,04 4 5
Pathway Nucleotide1Excision1Repair 1.44E,06 4.91E,04 13 112
Pathway DNA1Repair 3.52E,06 9.62E,04 22 319
Pathway Apoptotic1factor,mediated1response 8.55E,06 1.95E,03 4 7
Pathway Nucleotide1excision1repair 8.22E,05 1.52E,02 7 47
Pathway SMAC1binds1to1IAPs 1.11E,04 1.52E,02 3 5
Pathway SMAC,mediated1apoptotic1response 1.11E,04 1.52E,02 3 5
Pathway SMAC,mediated1dissociation1of1IAP:caspase1complexes 1.11E,04 1.52E,02 3 5
Pathway DNA1Damage1Recognition1in1GG,NER 2.23E,04 2.77E,02 6 39
Pathway Resolution1of1D,loop1Structures1through1Synthesis,Dependent1Strand1
Annealing1(SDSA)
3.09E,04 3.52E,02 5 27
Pathway Formation1of1Incision1Complex1in1GG,NER 3.86E,04 4.06E,02 6 43
Pathway intrinsic1apoptotic 4.37E,04 4.27E,02 5 29
Pathway Apoptosis1is1mediated1by1caspases,1cysteine1proteases1arranged1in1a1
proteolytic1cascade.
7.63E,04 6.96E,02 4 19
Pathway Resolution1of1D,loop1Structures1through1Holliday1Junction1Intermediates 1.07E,03 9.14E,02 5 35
Pathway Role1of1Mitochondria1in1Apoptotic1Signaling 1.14E,03 9.15E,02 4 21
Pathway Resolution1of1D,Loop1Structures 1.22E,03 9.27E,02 5 36
Pathway Apoptotic1Signaling1in1Response1to1DNA1Damage 1.37E,03 9.83E,02 4 22
Disease Progressive1mental1retardation 8.30E,06 2.65E,02 7 37
Disease Cockayne1Syndrome 9.47E,05 9.19E,02 8 71
Disease Cystic1Kidney1Diseases 1.05E,04 9.19E,02 5 24
Disease Conjunctival1telangiectasis 1.44E,04 9.19E,02 4 14
Disease Nephronophthisis,1familial1juvenile 1.44E,04 9.19E,02 4 14
Table 3a: Top Brown Functional Overrepresentation Groups 
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Category Name p,value q,value1
FDR1B&H
Hit1Count1in1
Query1List
Hit1Count1
in1Genome
GO:1Molecular1Function GTPase1binding 1.36E,13 2.26E,10 67 327
GO:1Molecular1Function cytoskeletal1protein1binding 6.69E,13 4.85E,10 130 886
GO:1Molecular1Function small1GTPase1binding 8.76E,13 4.85E,10 62 301
GO:1Molecular1Function Ras1GTPase1binding 4.38E,12 1.82E,09 58 281
GO:1Molecular1Function GTPase1regulator1activity 3.45E,10 1.15E,07 58 312
GO:1Molecular1Function GTPase1activator1activity 1.51E,09 4.18E,07 53 283
GO:1Molecular1Function chromatin1binding 2.95E,09 7.00E,07 79 513
GO:1Molecular1Function nucleoside,triphosphatase1regulator1activity 5.88E,09 1.22E,06 59 344
GO:1Molecular1Function steroid1hormone1receptor1binding 9.38E,09 1.73E,06 25 89
GO:1Molecular1Function protein1domain1specific1binding 1.33E,08 2.20E,06 100 729
GO:1Molecular1Function Rab1GTPase1binding 1.45E,07 2.18E,05 29 129
GO:1Molecular1Function enzyme1activator1activity 1.71E,07 2.37E,05 74 515
GO:1Molecular1Function estrogen1receptor1binding 2.37E,07 3.02E,05 16 47
GO:1Molecular1Function calmodulin1binding 4.65E,07 5.51E,05 36 190
GO:1Molecular1Function hormone1receptor1binding 5.30E,07 5.87E,05 35 183
GO:1Molecular1Function ion1channel1binding 1.24E,06 1.22E,04 27 127
GO:1Molecular1Function protein1kinase1binding 1.25E,06 1.22E,04 82 620
GO:1Molecular1Function kinase1binding 1.37E,06 1.26E,04 89 691
GO:1Molecular1Function nuclear1hormone1receptor1binding 2.00E,06 1.75E,04 31 161
GO:1Molecular1Function beta,catenin1binding 3.26E,06 2.70E,04 21 89
GO:1Biological1Process cell1projection1morphogenesis 3.66E,14 1.19E,10 136 904
GO:1Biological1Process neuron1projection1development 4.57E,14 1.19E,10 141 953
GO:1Biological1Process endomembrane1system1organization 5.21E,14 1.19E,10 99 578
GO:1Biological1Process cell1part1morphogenesis 9.99E,14 1.71E,10 137 925
GO:1Biological1Process histone1modification 1.94E,13 2.66E,10 82 447
GO:1Biological1Process covalent1chromatin1modification 4.48E,13 5.11E,10 83 462
GO:1Biological1Process neuron1projection1morphogenesis 1.93E,12 1.89E,09 101 630
GO:1Biological1Process regulation1of1GTPase1activity 6.65E,12 5.32E,09 106 688
GO:1Biological1Process cell1morphogenesis1involved1in1neuron1differentiation 6.99E,12 5.32E,09 95 590
GO:1Biological1Process Golgi1vesicle1transport 9.91E,12 6.79E,09 65 340
GO:1Biological1Process positive1regulation1of1GTPase1activity 2.97E,11 1.85E,08 98 632
GO:1Biological1Process regulation1of1cell1projection1organization 5.49E,11 3.14E,08 100 657
GO:1Biological1Process vacuolar1transport 1.38E,10 7.28E,08 56 288
GO:1Biological1Process regulation1of1cellular1component1biogenesis 1.61E,10 7.89E,08 117 829
GO:1Biological1Process regulation1of1cell1morphogenesis 4.95E,10 2.26E,07 92 609
GO:1Biological1Process positive1regulation1of1cell1projection1organization 7.85E,10 3.24E,07 64 367
GO:1Biological1Process brain1development 8.03E,10 3.24E,07 107 755
GO:1Biological1Process chromatin1organization 1.21E,09 4.50E,07 108 770
GO:1Biological1Process axonogenesis 1.25E,09 4.50E,07 76 475
GO:1Biological1Process head1development 1.53E,09 5.25E,07 111 802
GO:1Cellular1Component postsynaptic1specialization 3.33E,20 1.41E,17 64 232
GO:1Cellular1Component postsynaptic1density 3.33E,20 1.41E,17 64 232
GO:1Cellular1Component synapse 7.50E,20 2.12E,17 145 870
GO:1Cellular1Component postsynapse 3.33E,18 5.79E,16 91 449
GO:1Cellular1Component excitatory1synapse 3.42E,18 5.79E,16 64 252
GO:1Cellular1Component synapse1part 1.48E,17 2.09E,15 121 708
GO:1Cellular1Component dendrite 4.93E,14 5.97E,12 99 590
GO:1Cellular1Component somatodendritic1compartment 1.79E,13 1.90E,11 128 867
GO:1Cellular1Component dendritic1spine 7.23E,12 6.82E,10 39 151
GO:1Cellular1Component neuron1spine 1.12E,11 9.53E,10 39 153
GO:1Cellular1Component axon 5.67E,09 4.37E,07 83 567
GO:1Cellular1Component transferase1complex 1.29E,08 8.50E,07 98 722
GO:1Cellular1Component nucleoplasm1part 1.30E,08 8.50E,07 99 732
GO:1Cellular1Component perinuclear1region1of1cytoplasm 1.48E,08 8.98E,07 98 724
GO:1Cellular1Component cell1leading1edge 1.20E,07 6.76E,06 60 389
GO:1Cellular1Component site1of1polarized1growth 1.99E,07 1.05E,05 36 187
GO:1Cellular1Component microtubule1organizing1center 2.41E,07 1.20E,05 86 646
GO:1Cellular1Component axon1part 3.08E,07 1.45E,05 50 309
GO:1Cellular1Component endosome 4.02E,07 1.79E,05 103 826
GO:1Cellular1Component neuronal1cell1body 4.61E,07 1.96E,05 82 616
Table 3c: Top Blue Functional Overrepresentation Groups  
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Human&Phenotype Brain&atrophy 3.23E509 8.10E506 83 488
Human&Phenotype Brain&very&small 3.57E509 8.10E506 83 489
Human&Phenotype Cerebral&hypoplasia 1.11E508 1.49E505 87 534
Human&Phenotype Microcephaly 1.64E508 1.49E505 121 839
Human&Phenotype Decreased&head&circumference 1.64E508 1.49E505 121 839
Human&Phenotype Cerebral&atrophy 2.11E508 1.59E505 77 457
Human&Phenotype Atrophy/Degeneration&affecting&the&cerebrum 4.91E508 3.18E505 78 474
Human&Phenotype Abnormal&corpus&callosum&morphology 6.28E508 3.56E505 79 485
Human&Phenotype Abnormality&of&the&cerebral&subcortex 1.15E507 5.78E505 96 639
Human&Phenotype Aplasia/Hypoplasia&of&the&corpus&callosum 2.66E507 1.10E504 75 467
Human&Phenotype Abnormality&of&globe&location 2.75E507 1.10E504 109 768
Human&Phenotype Hyperactivity 2.92E507 1.10E504 49 258
Human&Phenotype Delayed&speech&and&language&development 1.11E506 3.87E504 66 407
Human&Phenotype Abnormality&of&the&cerebral&white&matter 1.20E506 3.90E504 84 563
Human&Phenotype Abnormality&of&globe&location&or&size 1.36E506 3.94E504 124 933
Human&Phenotype Abnormality&of&the&chin 1.46E506 3.94E504 44 233
Human&Phenotype Brachycephaly 1.48E506 3.94E504 40 203
Human&Phenotype Spasticity 1.95E506 4.65E504 116 863
Human&Phenotype Hypertonia 1.95E506 4.65E504 116 863
Human&Phenotype Hyperreflexia 2.24E506 5.08E504 87 598
Mouse&Phenotype abnormal&CNS&synaptic&transmission 5.02E510 2.99E506 121 734
Mouse&Phenotype abnormal&synaptic&transmission 1.99E508 5.91E505 143 965
Mouse&Phenotype abnormal&prenatal&body&size 3.18E507 4.79E504 137 956
Mouse&Phenotype reduced&long&term&potentiation 3.68E507 4.79E504 36 156
Mouse&Phenotype abnormal&emotion/affect&behavior 4.58E507 4.79E504 99 638
Mouse&Phenotype abnormal&cerebral&hemisphere&morphology 4.82E507 4.79E504 100 647
Mouse&Phenotype abnormal&telencephalon&morphology 5.70E507 4.86E504 126 870
Mouse&Phenotype abnormal&long&term&potentiation 9.00E507 6.71E504 47 238
Mouse&Phenotype preweaning&lethality,&incomplete&penetrance 1.10E506 7.30E504 99 650
Mouse&Phenotype abnormal&spatial&learning 1.43E506 8.51E504 48 249
Mouse&Phenotype abnormal&motor&coordination/balance 1.67E506 9.03E504 124 870
Mouse&Phenotype abnormal&reflex 1.86E506 9.23E504 127 898
Mouse&Phenotype abnormal&cognition 2.83E506 1.21E503 100 672
Mouse&Phenotype abnormal&neurite&morphology 2.91E506 1.21E503 75 465
Mouse&Phenotype abnormal&hippocampus&morphology 3.06E506 1.21E503 63 370
Mouse&Phenotype abnormal&brain&development 3.27E506 1.21E503 118 829
Mouse&Phenotype abnormal&prepulse&inhibition 3.52E506 1.21E503 46 242
Mouse&Phenotype small&cerebellum 3.67E506 1.21E503 35 164
Mouse&Phenotype abnormal&learning/memory/conditioning 4.66E506 1.43E503 99 671
Mouse&Phenotype abnormal&cerebellum&morphology 5.10E506 1.43E503 75 472
Pathway Membrane&Trafficking 9.55E511 2.22E507 92 614
Pathway Vesicle5mediated&transport 4.35E509 5.04E506 92 660
Pathway Phosphatidylinositol&signaling&system 7.45E509 5.76E506 26 97
Pathway Neuronal&System 2.47E508 1.43E505 57 351
Pathway Reelin&signaling&pathway 5.18E508 2.40E505 13 29
Pathway Chromatin&modifying&enzymes 1.39E507 4.60E505 47 279
Pathway Chromatin&organization 1.39E507 4.60E505 47 279
Pathway Transmission&across&Chemical&Synapses 3.33E507 9.64E505 39 218
Pathway Axon&guidance 8.44E507 2.17E504 74 554
Pathway Thyroid&hormone&signaling&pathway 1.36E506 3.16E504 25 116
Pathway Transport&to&the&Golgi&and&subsequent&modification 1.82E506 3.84E504 31 165
Pathway RORA&activates&gene&expression 2.78E506 5.38E504 11 28
Pathway Signalling&by&NGF 6.20E506 1.11E503 64 483
Pathway Control&of&Gene&Expression&by&Vitamin&D&Receptor 7.73E506 1.28E503 7 12
Pathway Asparagine&N5linked&glycosylation 9.19E506 1.32E503 43 285
Pathway Alpha&adrenergic&receptor&signaling&pathway 9.83E506 1.32E503 9 21
Pathway Rho&GTPase&cycle 9.88E506 1.32E503 27 145
Pathway CXCR45mediated&signaling&events 1.02E505 1.32E503 18 76
Pathway Endocytosis 1.17E505 1.36E503 40 260
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Table 3d: Top Light Green Functional Overrepresentation Groups 
Category Name p,value
q,value1
FDR1B&H
Hit1Count1in1
Query1List
Hit1Count1
in1Genome
GO:1Molecular1Function ubiquitin,protein1transferase1activity 2.22E,04 8.80E,02 9 414
GO:1Molecular1Function ubiquitin,like1protein1transferase1activity 3.53E,04 8.80E,02 9 441
GO:1Biological1Process regulation1of1cellular1response1to1heat 3.89E,05 6.70E,02 5 76
GO:1Cellular1Component somatodendritic1compartment 2.91E,04 4.19E,02 13 867
GO:1Cellular1Component dendrite 6.02E,04 4.19E,02 10 590
GO:1Cellular1Component growth1cone1membrane 6.47E,04 4.19E,02 2 8
GO:1Cellular1Component intraciliary1transport1particle1A 6.47E,04 4.19E,02 2 8
GO:1Cellular1Component neuronal1cell1body 8.38E,04 4.34E,02 10 616
GO:1Cellular1Component ciliary1tip 1.38E,03 5.78E,02 3 45
GO:1Cellular1Component cell1body 1.98E,03 5.78E,02 10 691
GO:1Cellular1Component growth1cone 1.98E,03 5.78E,02 5 182
GO:1Cellular1Component axon1terminus 2.18E,03 5.78E,02 5 186
GO:1Cellular1Component site1of1polarized1growth 2.23E,03 5.78E,02 5 187
GO:1Cellular1Component neuron1projection1terminus 2.92E,03 6.87E,02 5 199
GO:1Cellular1Component synapse 3.37E,03 7.00E,02 11 870
GO:1Cellular1Component histone1deacetylase1complex 3.61E,03 7.00E,02 3 63
GO:1Cellular1Component pericentric1heterochromatin 3.82E,03 7.00E,02 2 19
GO:1Cellular1Component axon1part 4.05E,03 7.00E,02 6 309
GO:1Cellular1Component COPI,coated1vesicle 5.57E,03 9.02E,02 2 23
GO:1Cellular1Component axon 6.50E,03 9.90E,02 8 567
Mouse1Phenotype abnormal1lung1position1or1orientation 3.68E,05 6.72E,02 5 58
Pathway Intra*Golgi0and0retrograde0Golgi*to*ER0traffic 1.18E*05 1.36E*03 31 180
Disease Mental0Retardation 2.54E*18 1.58E*14 137 885
Disease Autistic0Disorder 3.47E*16 1.09E*12 106 644
Disease Poor0school0performance 1.87E*13 2.33E*10 100 649
Disease Low0intelligence 1.87E*13 2.33E*10 100 649
Disease Dull0intelligence 1.87E*13 2.33E*10 100 649
Disease Mental0deficiency 2.27E*13 2.36E*10 100 651
Disease Dysarthria 7.64E*12 6.81E*09 44 196
Disease Seizures 1.66E*11 1.29E*08 128 982
Disease Muscle0hypotonia 2.05E*11 1.42E*08 87 575
Disease Global0developmental0delay 1.67E*10 1.04E*07 103 757
Disease Small0head 5.01E*10 2.84E*07 62 375
Disease Delayed0speech0and0language0development 2.04E*09 9.11E*07 29 116
Disease Speech0impairment 2.04E*09 9.11E*07 29 116
Disease Language0Delay 2.04E*09 9.11E*07 29 116
Disease Cognitive0delay 3.14E*09 1.23E*06 85 614
Disease Mental0and0motor0retardation 3.14E*09 1.23E*06 85 614
Disease Cerebellar0Ataxia 4.79E*09 1.76E*06 68 453
Disease Speech0Delay 5.60E*09 1.94E*06 30 128
Disease Degenerative0brain0disorder 7.31E*09 2.40E*06 27 108
Disease Epilepsy 8.67E*09 2.71E*06 117 962
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Top highly significant (q < 0.1) functional overrepresentation groups from TopFunn ontological analysis, for modules Turquoise 
(a), Brown (b), Blue (c), Light Green (d), Dark Turquoise (e), and Pale Turquoise (f). Category and Name columns represent the 
functional categories selected in TopFunn and the name of the exact function or related biological entity for which the module 
was overrepresented, respectively.  Hit Count in Query List indicates the number of genes in the module that were identified in 
the group of total genes, the size of which is indicated by Hit Count in Genome.  
Category Name p,value
q,value1
FDR1B&H
Hit1Count1in1
Query1List
Hit1Count1
in1Genome
GO:1Molecular1Function phosphatase1inhibitor1activity 4.47E,04 8.15E,02 3 41
GO:1Molecular1Function phosphatase1binding 5.99E,04 8.15E,02 5 187
GO:1Molecular1Function cell,cell1adhesion1mediator1activity 8.43E,04 8.15E,02 2 12
Disease Medulloblastoma 2.25E,05 2.27E,02 9 558
Table 3e: Top Dark Turquoise Functional Overrepresentation Groups 
Table 3f: Top Pale Turquoise Functional Overrepresentation Groups 
Category Name p,value q,value1
FDR1B&H
Hit1Count1in1
Query1List
Hit1Count1
in1Genome
GO:1Cellular1Component myelin1sheath1abaxonal1region 2.30E,04 3.32E,02 2 9
Mouse1Phenotype herniated1abdominal1wall 2.18E,05 2.00E,02 3 20
Pathway Notch1signaling1pathway 2.03E,04 3.87E,02 3 48
Pathway Constitutive1Signaling1by1NOTCH11HD1Domain1Mutants 5.78E,04 3.87E,02 2 15
Pathway the1planar1cell1polarity1Wnt1signaling 5.78E,04 3.87E,02 2 15
Pathway Signaling1by1NOTCH11HD1Domain1Mutants1in1Cancer 5.78E,04 3.87E,02 2 15
Pathway NOTCH21Activation1and1Transmission1of1Signal1to1the1Nucleus 1.15E,03 6.14E,02 2 21
Disease Craniorachischisis 1.81E,04 9.29E,02 2 9
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Chapter 6 
 
Final Discussion: Overview and Implications 
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Overview of Findings and Implications 
 
Despite the estimated 50% heritability of alcohol use disorder (21, 22), genetic 
association studies have yet to account for a large proportion of this variability (23). Well-
powered studies with extremely large sample sizes (hundreds of thousands to over a million) 
have identified hundreds of loci associated with alcohol consumption, but one recent study has 
indicated that problematic drinking may be more closely genetically correlated with other 
psychiatric disorders than it is with alcohol consumption (25). Furthermore, although these 
studies are able to identify single genes with individually small effect sizes, they do not provide 
information regarding larger biological frameworks related to the trait. Gene expression studies 
are capable of providing this insight into functional networks through which these loci are likely 
affecting drinking behaviors. Mouse models are important resources for examining gene 
expression patterns, because they provide experimental control not available in human studies. 
The benefit of human participants is that they present fully complex behaviors generalizable to 
non-experimental settings, and possess genomes with millions of testable variants with small 
linkage disequilibrium blocks, allowing for more precise mapping of affective loci than that 
which can be done in mouse models. 
The studies presented in this thesis capitalize on the best of both worlds by examining 
gene expression networks in mouse brains, in the context of acute ethanol treatment and 
voluntary ethanol consumption, and human genetic association data. We successfully identified 
functionally interrelated groups of genes associated with ethanol exposure and ethanol 
consumption in genetically complex mice. Many of these networks were significantly 
overrepresented with genes associated with alcohol consumption or dependence in human 
GWAS samples. Furthermore, we identified genetic loci associated with ethanol consumption 
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behaviors in the Diversity Outbred stock of mice, with unprecedented genomic precision, and 
replicated a finding from a large GWAS on average drinking levels. Finally, some of the 
identified loci overlapped with loci containing variants associated with expression levels of 
ethanol-associated networks. These networks and loci were largely associated with ubiquitin 
activity, neurite outgrowth, and axonal guidance, indicating that neuroplastic mechanisms are 
involved in drinking behaviors well before the development of withdrawal or craving symptoms 
arise. Experiments and implications are discussed in greater detail below. 
 
 
Chapter 2 
 
In Chapter 2, we examined ethanol-responsive modules (or small, parsed out networks) in 
dopaminergic reward pathway-related brain regions (Prefrontal Cortex, Nucleus Accumbens, and 
Ventral Tegmental Area) of acute ethanol-treated mice, in combination with Alcohol 
Dependence GWAS data. Previous findings have suggested that gene expression networks in the 
mouse brain are capable of providing insight into human AD, given significant 
overrepresentation of human GWAS signals in mouse-derived ethanol-regulated networks (97). 
Therefore, we hypothesized that the integration of mouse gene expression data (with the benefits 
of experimental control offered by model organisms) and human GWAS data would allow us to 
identify novel genes associated with AD, in the context of mechanistic frameworks. For the 
VTA, specifically, module scores (dependent on ethanol sensitivity of expression correlations 
and GWAS significance of the constituent genes) significantly predicted average p-values in the 
independent GWAS sample. Gene ontology overrepresentation analysis revealed network 
functions related to ubiquitination, Syndecan and Wnt signaling, actin-related activity, and 
transcription regulation (274). These 
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results implicated: 1) that the co-analysis of mouse gene expression and human GWAS data is an 
effective method for identifying novel gene networks associated with alcohol-related traits; 2) 
that different signals between GWAS datasets are identifying similar functional pathways; 3) that 
the correlation between initial ethanol sensitivity (or neural reactivity) and the risk for 
developing dependence may be mediated by pathways primarily in the VTA, especially via 
ubiquitin-related mechanisms, but also by actin-mediated synaptic remodeling in the PFC, and 
syndecan signaling and transcription regulation in the NAc. 
This analysis examined gene expression in BXD recombinant inbred mice (a genetic 
panel of mice which allows for technical replication across multiple mice with identical 
genotypes) that had been treated with ethanol, as opposed to voluntarily exposing themselves. 
This choice was made to capitalize on the experimental advantages of using mouse models: 1) 
experimental control over the environment and ethanol exposure in amount and timing; 2) 
technical replication; and 3) precise timing between last ethanol exposure and time of death; 4) 
specifically the collection of data that is expected to vary over these variables (time, 
environments, and timing of death) with experimental control over them. We also capitalized on 
the advantages of human genetic data by testing for effects of a genetic variable that is not 
expected to vary across these covariates (i.e. genotypes) to test their effects on behavioral 
measures, which are more complex than what can be exhibited by mice, with greater genomic 
precision and on a larger number of genetic variants than most mouse models allow (due to small 
numbers of founder strains and large linkage disequilibrium blocks). After performing an 
analysis that took full advantage of the benefits of using data from model organisms and humans, 
we wanted to examine related phenotypes in a mouse model that possessed features of both. We 
therefore elected to study voluntary ethanol consumption in Diversity Outbred stock, a 
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genetically (and therefore behaviorally) complex population of mice that allows for precise 
genetic mapping of behavioral traits across 45 million genetic variants. 
 
 
Chapter 3 
 
In Chapter 3, we determined the genetic mappability of voluntary ethanol consumption 
under intermittent and chronic access models, by examining the heritability of drinking 
behaviors in the 8 progenitor strains of the DO mouse stock. Ethanol drinking behaviors had not 
yet been examined in several of these strains, so this experiment had the added contribution of 
being the first to characterize voluntary ethanol consumption and preference in these strains. 
Because voluntary ethanol consumption and preference over water have been shown to differ 
significantly between lab-derived inbred mouse strains (implicating a genetic component of these 
behaviors), we anticipated that these strains (three of which are wild-derived) would yield high 
heritability coefficients for these phenotypes, indicating that they were genetically driven and 
therefore likely mappable (79). These behaviors were, in fact, highly significantly heritable 
across these strains, with several combinations of significant pair-wise differences between 
strains, indicating that each strain was contributing alleles relevant to drinking behavior. Results 
suggested that these differences may be driven by pharmacokinetics, but this finding was not 
able to undergo rigorous statistical testing due to small sample sizes. 
Because heritability coefficients were slightly higher under intermittent access than under 
chronic access, an intermittent access paradigm was selected to be use for genetically mapping 
ethanol consumption and preference in DO mice. 
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Chapter 4 
In Chapter 4, we discussed our genetic analysis of ethanol consumption and preference 
under an intermittent ethanol access paradigm in a sample of over 600 Diversity Outbred mice. 
Given that these mice have been used in recently published studies to map behavioral loci with 
greater precision than prior studies utilizing other mouse strains, we hypothesized that we would 
have the same success with respect to drinking behaviors (35). As expected, we identified 
several behavioral Quantitative Trait Loci for total ethanol consumption, total ethanol 
preference, and preference for 30% ethanol over 15% ethanol (i.e. “30% ethanol choice”), with 
unprecedented precision. Several candidate genes appeared in the literature as being associated 
with other neurological, psychiatric, and behavioral traits. These results supported findings from 
Sanchez-Roige et al. (25), which showed that problematic drinking is genetically correlated 
with other psychiatric disorders. 
This experiment had the added benefit of access to longitudinal drinking data, allowing 
us to identify QTL that were unique to initial and long-term drinking. Because intermittent 
ethanol access has been shown to increase voluntary drinking over time, which is believed to be 
attributable to relapse-like drinking following forced abstinence, we believed that some of our 
identified QTL would differ between time points across ethanol exposure, reflecting the unique 
mechanisms involved in long-term vs. initial drinking behaviors (37). However, we also 
anticipated some genetic effects to be stable across time. To test this hypothesis, we mapped 
QTL for initial consumption by averaging drinking values over the first week of ethanol 
exposure, and long-term consumption by averaging values over the last week of exposure. To 
reduce within-mouse variation, and therefore increase power, we averaged values across the 
whole study to examine consistent effects, expecting to see lesser peaks for these specific QTL 
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for first and last week averages and higher peaks, more significant peaks for the whole study 
average. 
As expected, we identified several QTL unique to either long-term or initial phenotypes. 
 
However, we only identified one QTL that was seen consistently across time points (although 
not significant for the first week timeframe), and one QTL uniquely significant for the whole 
study time point (Chr11 locus for total ethanol consumption). One QTL identified for whole- 
study phenotypes were also identified for the corresponding last-week phenotypes, but had a 
greater LOD score for the last-week time interval, indicating that the signal was truly related to 
long-term drinking but was being picked up by the whole study average. Candidate genes for the 
two loci that were significant for first week mean total ethanol consumption and preference 
showed associations with GABA signaling. The loci identified for last-week and whole-study 
phenotypes had many previous associations with behavioral, neurological, and psychiatric 
phenotypes (including alcohol-related traits), but very few with cognitive ability. Additionally, 
several loci were unique to the last week of consumption and the only locus for 30% ethanol 
choice was identified for this time interval. The top candidate genes for these QTL were largely 
involved in neurogenesis, growth and development, synaptic plasticity, axon guidance, and 
neuroinflammation. These findings indicate that long-term drinking under intermittent access is, 
in fact, driven by unique mechanisms, likely involving neuroinflammatory responses and 
rerouting of neuronal pathways in response to long-term ethanol exposure. We believe these 
mechanisms are likely those involved in the beginning stages of dependence. 
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Chapter 5 
In Chapter 5, we examined ethanol-associated gene expression patterns and networks in 
the PFCs of the same sample of DO mice studied in Chapter 4. First, we examined individual 
genes for differential expression between the 100 highest drinking mice and controls, then 
examined the correlation of these genes with ethanol consumption within the 100 highest and 
100 lowest drinkers. As expected, some genes to be significant in both analyses, but others to 
only be significantly associated with ethanol consumption in drinking mice. Investigators from a 
previous study that identified genes exhibiting similar behaviors (Bogenpohl et al., in 
preparation) proposed that the former genes were likely ethanol-regulated (meaning their 
expression levels change in response to ethanol exposure) and the latter genes were ethanol- 
regulating (meaning that their basal expression levels drive drinking behaviors). As expected, we 
did uncover genes fitting each of these descriptions, and genes that were significantly 
differentially expressed between high drinkers and controls but were not correlated with ethanol 
consumption amongst ethanol-exposed mice. These results indicate that there are many genes 
whose expression levels are sensitive to ethanol in a relatively dose-independent fashion, in that 
the ceiling of effects on expression is reached at very low doses of ethanol. These could be genes 
that are either very tightly regulated by feedback loops, such that only a small amount of 
variation is tolerated before efficient compensatory mechanisms are triggered. Although 
biologically less likely, they could also potentially be genes that are on the opposite end of the 
spectrum, and are very loosely regulated, such that any amount of perturbation yields similar, 
relatively unrestricted effects. Functional overrepresentation analysis revealed that genes that we 
believe to be ethanol-regulating were largely involved in protein- and RNA-regulatory 
mechanisms and immune response. This result suggests that basal differences in protein level 
and activity regulatory mechanisms, as well as immune-related pathways, mediate differences in 
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drinking behaviors. The ethanol-regulated genes, however, were overrepresented with functions 
related to transmembrane transport, neuron projection, and cell-maintenance (specifically, 
cellular respiration and metabolism, and energy use and production). Interestingly, these genes 
were also associated with Parkinson’s, Alzheimer’s, and Huntington’s Diseases, all of which are 
neurodegenerative in nature. This is consistent with prior studies that have associated long-term 
alcoholism with neuronal death (306). These results suggest that, in addition to 
neurotransmission, ethanol affects mechanisms involved in maintaining neurons’ metabolic 
processes and their ability to transmit signals to other neurons, likely activating synaptic 
plasticity and neuronal death. 
To gain more refined insight into the mechanistic networks in which these genes were 
functioning, we mapped co-expression networks, and determined their relationship with ethanol 
consumption and their overrepresentation with genes that presented differential expression 
between high drinkers and controls. We identified multiple networks whose expression levels 
appeared to be either ethanol-regulating or ethanol-regulated, with respect to expression 
correlations with drinking behaviors and overrepresentation with genes differentially expressed 
between high drinkers and controls. We also discovered several networks whose eQTL 
overlapped with bQTL for ethanol consumption and preference, and networks that were 
significantly overrepresented with genes associated with drinking levels in the GSCAN GWAS 
sample, implicating that these genetic associations with drinking behaviors are mediated by 
functions in which these networks are involved. Functional overrepresentation analysis revealed 
that many of these networks were associated with either ubiquitin-activity, or neurite growth 
and remodeling. From these findings, we concluded that gene expression studies in voluntarily 
ethanol drinking mice are capable of providing insight to neuronal mechanisms related to 
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drinking behaviors in humans, and that neuroplasticity may play a role in earlier stages of 
dependence than previously thought. We elaborate further on this point below. 
 
 
Overarching Themes and Future Directions 
 
 
Consumption vs. Dependence 
 
Twin samples have revealed significant genetic correlations between alcohol 
consumption and dependence (meaning they are driven by many of the same genes) (82). 
However, a recent GWAS study tested the ability of polygenic risk scores (or genetic risk scores 
based on the number of trait-related minor alleles an individual’s genome possesses, weighted by 
their effect size) derived from alcohol consumption values in a non-dependent population to 
predict problematic alcohol use in another sample (25). 
Results indicated that problematic alcohol use is more highly genetically correlated with other 
psychiatric conditions than it is with alcohol consumption. Because it is difficult to obtain deep 
phenotypic data from extremely large numbers of participants (largely due to limited resources 
and increased time commitment required from participants), many of the more recent well- 
powered, alcohol-related GWASs have examined drinking behaviors with the intention of 
identifying dependence-relevant genes. The results from Sanchez-Roige et al. (25) called into 
question the interpretability of results from such studies with respect to alcoholism. 
Intermittent Ethanol Access voluntary consumption models have been shown to model 
relapse-like increases in ethanol consumption over time in certain mouse strains, and has been 
used to gain insight into genetic and biological mechanisms relevant to alcohol dependence 
(31, 36, 37, 79, 97). For 
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these paradigms, mice have intermittent access to alcohol with continuous access to water, so 
that all ethanol consumption is voluntary. Our study characterized ethanol consumption and 
preference for ethanol over water, under an IEA paradigm, in the eight Diversity Outbred strains, 
and in alignment with findings from studies performed on other strains, revealed high heritability 
of these traits (Chap. 3) (37) (36) (79). We then sought to identify specific genetic loci and 
mechanistic networks contributing to these phenotypes by mapping behavioral quantitative trait 
loci and ethanol-correlated gene expression networks in a large sample of DO mice. These 
analyses yielded results that overlapped with human studies on AD and other psychiatric 
disorders, as well as those on alcohol drinking, indicating that this model is capable of 
identifying genetic loci networks relevant to both alcohol consumption and dependence. 
Specifically, genes that fell within our QTL support intervals uniquely for long-term 
ethanol consumption and preference had significant associations with AD in GWASs, but not 
with consumption or alcohol sensitivity (170). However, QTL identified for the first week and 
whole study possessed genes that were associated with initial alcohol sensitivity and alcohol 
consumption in human GWASs. We interpreted these results to mean that initial drinking values 
were successfully modeling drinking behaviors related to pre-dependence drinking behaviors. 
These behaviors are thought to be moderated by initial sensitivity and positively reinforcing 
motivators that drive individuals to drink before developing dependence, such as reward and 
anxiolysis (249). Furthermore, several of the top candidate genes (Atp2b2, Slc6a1, Slc6a11, and 
Gphn) in initial drinking behavior QTL were directly involved in GABA (gamma-aminbutyric 
acid) signaling, which is moderated by alcohol and plays a multifaceted role in the development 
of dependence (45) 
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(50) (13). These results also suggest that drinking behaviors later in the study, after enduring 
several alternating periods of exposure and abstinence, successfully modeled drinking behaviors 
in humans that are specifically associated with dependence. Although no animal model perfectly 
reflects human behavior, this study suggests that voluntary ethanol consumption paradigms in 
mice are capable of revealing biological mechanisms relevant to dependence. 
In addition to the insights our studies have provided regarding animal models, our data 
can be interpreted in the context of shedding light on the relevance of human alcohol 
consumption genetic findings to alcohol dependence. Our study identified genes unique to early 
and long-term drinking, but also identified one locus that appeared to represents ethanol 
consumption relatively stably across time (on Chr1 for total ethanol preference). This locus 
replicated results from the recent GSCAN GWAS study on alcohol consumption (61). The most 
empirically supported gene in this region was Nucks1, which has relatively unknown 
functionality, but has been found to be associated with neurodegenerative diseases and 
inflammation (184) (185) (186) (183). Given that this QTL was most highly significant for the 
whole study time interval than it was for either the first (not significant, but a trending peak) or 
last week timeframes, we believe that this gene may be specifically involved in neuronal 
mechanisms that drive non- dependent (or not yet dependent) individuals to consume alcohol. 
Given that this locus appeared in both humans and singly-house mice, these mechanisms are 
likely related to psychotropic reward, as opposed to qualities that might be unique to social 
drinking, such as personality traits or social anxiety (8). 
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Future studies should examine the effects of mutations in the gene Nucks1 on subjective 
reward, and neurological pathways involved in reward, such as those involved in the 
mesolimbocortical. This could be done by directly mutating the gene, or changing its expression 
levels and examining its effects on drinking behavior in a model organism. These studies should 
specifically focus on drinking behaviors after consumption levels have become stable over time, 
as our results indicate that this gene may be associated with initial drinking levels, but its effects 
are more evident on a longer term scale. Such studies should also examine specifically more 
negative-reinforcement-driven behaviors in these mice, such as craving- or withdrawal-driven 
self-administration. These results could determine whether Nucks1 is related to the negative 
reinforcing properties of alcohol seen in the later stages of dependence development, or if it is 
unique to positive-reinforcement-driven substance use, as our findings suggest. Finally, the 
relationship between this gene and neuroinflammation and neuronal death should be explored. 
It is known that alcoholism is associated with decreased white matter and increased 
inflammation in the brain (264, 265). Because this gene appears to be associated with positive 
reward-driven drinking, these studies may reveal interactions between alcohol- induced 
overstimulation of dopaminergic neurons and neurotoxicity. 
 
 
Ubiquitin and Alcohol 
 
Both the human-mouse integrative gene expression network study on acute ethanol- 
treated BXDs (Chap. 2), and the study on gene expression in the brain of voluntarily drinking 
Diversity Outbred mice (Chap. 5), several networks were associated with regulation of protein 
levels, at transcriptional, translational, and post-translational levels. In particular, ubiquitin 
activity was overrepresented in: the discussed BXD Ventral Tegmental Area network (Bisque); 
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the ethanol-regulating genes in the DO PFC; and DO PFC modules Turquoise and Light Green. 
Showing significant overrepresentation with differentially expressed genes between DO high 
drinkers and controls, Turquoise was considered to be an ethanol-regulated module, whereas 
Blue and Light Green were not. Pairing this information with the knowledge that similar 
functional overrepresentation appeared in our acute-ethanol-treated sample, these results 
collectively suggest that these protein-level regulatory activities begin responding to alcohol 
upon initial exposure and continue to do so through long-term exposure. Furthermore, these 
ubiquitin-related modules were identified in two distinct brain regions involved in the 
dopaminergic reward pathway (VTA and PFC). 
Multiple other studies have identified significant associations between ethanol-related 
behaviors and ubiquitin genes (307 & Ebihara, 2013, 308 2014). One study in particular, 
conducted by Melendez et al. (309 & Becker) identified genes with altered expression levels in 
the PFC (as well as other brain regions) related to involuntary chronic intermittent ethanol 
exposure (via ethanol vapor), and performed functional overrepresentation analysis on 
significant genes. Taking a more targeted approach, one study has specifically examined the 
response of ethanol-related phenotypes to the down regulation of a specific ubiquitin gene. Mice 
exhibited a decreased ethanol preference and decreased recovery time from the sedating effects 
of ethanol, in response to systematic down regulation of ubiquitin-specific peptidase 46, which is 
involved in deubiquitination (although the exact proteins with which it interacts are unknown) 
(307). Additionally, this particular protein has been found to be ubiquitously expressed in the 
frontal lobe of mice (310). These results suggest that the ubiquitin proteins with which this 
enzyme interacts are partly responsible for increased ethanol sensitivity of these mice, 
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possibly specifically in the frontal lobe. Although ubiquitin proteins are involved in many 
different processes, due to their interactions with a vast array of proteins, this example provides 
further evidence that ubiquitin-related mechanisms do moderate ethanol-related behaviors, and 
even specifically ethanol preference. 
Other study have shown both increases and decreases in expression levels of ubiquitin 
genes in brain white matter and cortical neurons in alcoholics compared to controls (308) 
(308) (311) (312). 
Furthermore, ubiquitin activity has been shown to be sensitive to changes in neuronal signaling, 
resulting in the ubiquitination of synaptic and cytoskeletal proteins, implicating its involvement 
in neuroplasticity (313). Ubiquitin has also been implicated in the process of developing long-
term potentiation, which also suggests involvement in synaptic plasticity (314). As discussed in 
more detail below, several of our analyses identified genes related to actin activity, extracellular 
matrix integrity, and other processes that suggest a role of synaptic remodeling, not just in the 
later stages of dependence, but in the beginning stages, as well. We believe that these changes 
are likely ubiquitin-mediated. Future studies should examine the effects of down- and up-
regulation of ubiquitin-related genes identified in our modules (ex. 
Trip12) in a similar fashion, examining differences in voluntary ethanol consumption and 
preference between these mice and wild type controls, but also determining the effects of ethanol 
on these exact systems after ethanol treatment or exposure. They should also study the effects of 
these genes on other genes specifically in our ubiquitin-overrepresented modules, particularly 
those related to the neurite outgrowth and routing involved in neuroplastic processes. Although 
ubiquitin genes are not likely to be feasible pharmacotherapeutic targets for alcoholism, due to 
their roles in cell maintenance and stability, identifying proteins targeted by these genes could be 
281 
 
illuminating with respect to the exact pathways involved in alcohol-mediated neuroplasticity, and 
therefore the development of addiction. 
 
 
Neuroplasticity in Early Dependence 
 
Some potential dependence-relevant targets of ubiquitin could be proteins involved 
specifically in neurite outgrowth and axon guidance. Our studies identified several behavioral 
QTL, and ethanol-associated networks in the PFC in both BXD and DO mice that were 
associated with cell structural and scaffolding proteins. Specifically, the bQTL that were specific 
to long-term (i.e. last week) drinking behaviors in the DO mice contained genes that were largely 
involved in neurite growth, actin activity, and extracellular matrix integrity. A gene that 
contained all of the top-scoring SNPs on the Chr11 QTL for last week mean total ethanol 
consumption in the DO mice (Adamts2) acts as a protease that moderates neuroplastic changes 
by acting on proteins in the extracellular matrix. The module Alice Blue in the PFC of acute- 
ethanol exposed BXD mice, which contained a significant number of AD-associated genes 
spanning across two independent GWAS datasets, was significantly overrepresented with 
functions related to actin. Modules Blue, Dark Turquoise, Pale Turquoise, and Light Green in the 
DO mouse PFC were also overrepresented with functions related to actin-mediated neurogenesis, 
neurite growth, and axonal re-routing. The Blue module was identified as being “ethanol 
regulating”, indicating that basal expression levels or sensitivity of these proteins drives drinking 
behaviors. Furthermore, both this module and Light Green were overrepresented with genes 
associated with alcohol consumption in the GSCAN GWAS. Finally, three of these four 
modules’ Eigen Gene eQTLs overlapped with the Nucks1-containing bQTL for last week total 
ethanol consumption on Chr1 discussed above; and the remaining module’s (Pale Turquoise) 
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Eigen Gene eQTL overlapped with the Chr16 bQTL for last week mean preference, which 
contained top candidate genes with functions related to neurogenesis, axon guidance, and 
synaptic plasticity. Together, these results implicate that genes related to neurite outgrowth and 
axon guidance moderate drinking behaviors. We believe that the sensitivity of these genes to 
ethanol varies across alleles, which moderates the extent to which neuroplastic changes occur in 
response to ethanol, and thereby affect the risk for developing alcoholism. 
Addiction is thought to be a lifelong disease, because of irreversible changes that occur in 
the brain in response to chronic drug exposure resulting in over- and under-stimulation of 
primarily, but certainly not only, glutamatergic, GABAergic, dopaminergic, and serotonergic 
pathways in the brain. However, these changes are thought to occur during the late-stages of 
dependence development, when signs of withdrawal and craving begin to be presented (9, 249). 
All of these modules and QTL have been identified in acutely ethanol-exposed mice or mice 
exhibiting increased levels of ethanol consumption over time, modeling the very early stages of 
dependence development. 
Furthermore, at least one of the relevant modules (DO PFC Blue) is thought to be ethanol- 
regulating based on our results, and other modules were overrepresented with GWAS signals for 
dependence or alcohol consumption, indicating that basal genetic differences drive drinking 
behaviors. Neuroplastic changes related to alcohol dependence are thought to occur in response 
to the weakening and strengthening of synaptic signals that are caused by gene expression 
changes moderated by long-term exposure to alcohol (9, 249). However, our results indicate that 
mechanisms related to synaptic remodeling and axon guidance are relevant much earlier on in 
the process of dependence development. 
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Future studies should examine the effects of acute and short-term alcohol exposure on 
proteins involved in changes in cytoskeletal proteins (particularly actin) and extra-cellular 
scaffolding proteins in and around neurons. These pathways could be associated with the 
rewarding properties of alcohol that lead to abuse, as our results indicate that they may not be 
involved not only in the transition from abusive to addictive use, but also in early drinking 
behaviors and abuse tendencies. We hypothesize that these studies will find that the innate 
sensitivity of cytoskeletal and scaffolding proteins affects an individual’s propensity for drinking 
alcohol abusively, and therefore for developing dependence. 
 
 
Final Conclusions 
 
This collection of studies examined the genetics of alcohol consumption and dependence 
by analyzing gene expression networks and genetic associations in genetically complex mouse 
strains, in the context of ethanol treatment and voluntary ethanol consumption. By integrating 
this data with human alcohol dependence and drinking genetic association data, we were able to 
identify several mechanistic pathways relevant to these two phenotypes. Specifically, our results 
suggested involvement of functions related to ubiquitination and actin-mediated neurite growth 
and axon guidance in drinking behaviors that occur before and during the early stages of the 
development of dependence. They also implicated that alcohol consumption models in mice are 
capable of modeling both non-pathological early drinking behaviors, as well as abusive drinking 
that leads to the development of addiction. Finally, our study on voluntary ethanol drinking in a 
genetically diverse mouse stock replicated results from a human genome wide association study 
on alcohol consumption, by identifying a locus on Chr1 relevant to long-term consumption, 
implicating the involvement in the gene Nucks1 in drinking behaviors. Overall, these studies 
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indicated that negative protein regulation and synaptic plasticity moderate drinking behaviors 
exhibited during the early, reward-driven stages of the development of alcohol dependence.
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